<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="css/feed.xsl"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:media="http://search.yahoo.com/mrss/" xmlns:og="http://ogp.me/ns#">
<channel>
<atom:link rel="self" href="http://192.168.1.4/fivefilters/makefulltextfeed.php?url=hnrss.org%2Fnewest%3Fpoints%3D200&amp;max=10&amp;links=preserve&amp;exc=" />
<atom:link rel="alternate" title="Source URL" href="http://hnrss.org/newest?points=200" />
<atom:link rel="related" title="Subscribe to feed" href="http://www.subtome.com/#/subscribe?feeds=http%3A%2F%2F192.168.1.4%2Ffivefilters%2Fmakefulltextfeed.php%3Furl%3Dhnrss.org%252Fnewest%253Fpoints%253D200%26max%3D10%26links%3Dpreserve%26exc%3D&amp;back=http%3A%2F%2F192.168.1.4%2Ffivefilters%2Fmakefulltextfeed.php%3Furl%3Dhnrss.org%252Fnewest%253Fpoints%253D200%26max%3D10%26links%3Dpreserve%26exc%3D" />
<title>Hacker News: Newest</title>
<link>https://news.ycombinator.com/newest</link>
<description>Hacker News RSS</description>
<item>
<title>Tired of Stack Overflow</title>
<link>https://arp242.net/stackoverflow.html</link>
<guid isPermaLink="true" >https://arp242.net/stackoverflow.html</guid>
<description>&lt;p&gt;I‚Äôve been active on Stack Overflow in some form or the other since 2011, and I‚Äôve grown increasingly tired of it.&lt;/p&gt;
&lt;p&gt;There are many reasons for this ‚Äì not all of them are Stack Overflow‚Äôs fault ‚Äì but what prompted this post was a &lt;a href=&quot;https://stackoverflow.com/q/55807322/660921&quot;&gt;basic but valid question&lt;/a&gt; getting downvoted to -4 (it‚Äôs now -3, since I added an upvote):&lt;/p&gt;
&lt;blockquote readability=&quot;6&quot;&gt;
&lt;p&gt;Is there a way to list all standard Go packages? I have a list of packages and I want to figure out if this is a standard package.&lt;/p&gt;
&lt;/blockquote&gt;
&lt;p&gt;Seems like a pretty valid question to me, so why is it downvoted to -4? Stack Overflow is intended to &lt;a href=&quot;https://twitter.com/codinghorror/status/991082088689381376&quot;&gt;build a collection of useful question to the programming community at large&lt;/a&gt;, and this question is exactly the sort of thing that will be useful to others as well. There are even multiple valid answers, none of which show up in the first two pages of Google results, and the answers are not completely obvious from the documentation either (&lt;code&gt;go list std&lt;/code&gt; is not documented in &lt;code&gt;go help list&lt;/code&gt;, and &lt;code&gt;golang.org/x/tools/go/packages&lt;/code&gt; is fairly new, and the kind of thing you just have to know about).&lt;/p&gt;
&lt;p&gt;Fun fact: this question now sits on the first page of Google results for ‚Äúgo list standard packages‚Äù, and is the only link which contains the actual answer.&lt;/p&gt;
&lt;p&gt;Fun fact 2: the very similar question ‚Äú&lt;a href=&quot;https://stackoverflow.com/q/28166249/660921&quot;&gt;how to list all packages&lt;/a&gt;‚Äù from 2015 has a +24 score with no downvotes.&lt;/p&gt;
&lt;p&gt;Stack Overflow has downvotes to add a degree of quality control to the site, so people looking to answer questions questions can more easily filter out unclear or off-topic questions. Great! But how does that apply here?&lt;/p&gt;
&lt;p&gt;I have no idea why this is downvoted at all, much less to -4. I‚Äôm also wondering what went through the head of the person who saw the question at a score of -3 and just &lt;em&gt;had&lt;/em&gt; to add their own downvote, because ‚Äúfuck this question just a bit more‚Äù. Downvotes are useful for quality control, but there is no real difference between -3 and -4.&lt;/p&gt;
&lt;p&gt;Not only is this question useful, it‚Äôs also exactly the sort of question that Stack Overflow is useful for: ‚Äú&lt;em&gt;How do I do X?‚Äù&lt;/em&gt;. Often, &lt;em&gt;X&lt;/em&gt; is quite a simple thing, like &lt;em&gt;‚Äúappend to a list‚Äù&lt;/em&gt;, or &lt;em&gt;‚Äúmerge two dictionaries‚Äù&lt;/em&gt;. I find that the longer I program with all sorts of different languages, the more I struggle remembering all that sort of stuff.&lt;/p&gt;
&lt;p&gt;For example, I recently wanted to know how to merge dictionaries in VimScript. Turns out that &lt;a href=&quot;https://duckduckgo.com/?q=How+can+I+merge+two+dictionaries+in+Vim%3F&quot;&gt;search results&lt;/a&gt; were not that helpful (lots of Python answers, and &lt;a href=&quot;http://vim.1045645.n5.nabble.com/vim7-merging-of-dictionaries-td1195738.html&quot;&gt;one outdated Vim answer&lt;/a&gt;. So &lt;a href=&quot;https://vi.stackexchange.com/q/20842/51&quot;&gt;I asked a question&lt;/a&gt; and answered it myself. Now it‚Äôs on top of the above search result, being useful to everyone who has the same question in the future.&lt;/p&gt;
&lt;hr/&gt;&lt;p&gt;This is a mild example, &lt;a href=&quot;https://stackoverflow.com/q/35518226/660921&quot;&gt;this question&lt;/a&gt;&lt;sup id=&quot;fnref:del&quot;/&gt; got downvoted to -46 (+29/-75). Sure, it‚Äôs a very basic question, and certainly asked by a beginner. Arguably it‚Äôs not a good fit for Stack Overflow, but it did get closed as a duplicate of a question with a score of +34 (+38/-4), and it wasn‚Äôt an effortless or ‚Äúlazy‚Äù question either. There is no ‚Äúquality control‚Äù in downvoting a question to double-digits. The simple truth is that you‚Äôre just being a gigantic twat if you keep piling on votes like that. If you think that‚Äôs harsh then take a deep breath and consider the perspective of the person who asked the question. I don‚Äôt think I ever have been more disappointed in the Stack Overflow community than with that question.&lt;/p&gt;
&lt;p&gt;If you‚Äôre wondering why that question in particular got those amounts of downvotes: it was the topic &lt;a href=&quot;https://meta.stackoverflow.com/q/318482/660921&quot;&gt;of a Meta question&lt;/a&gt;. People came in on Meta, and just &lt;em&gt;had&lt;/em&gt; to vote. This is not uncommon, and even has a name: &lt;a href=&quot;https://meta.stackoverflow.com/q/269349/660921&quot;&gt;‚Äúthe Meta effect‚Äù&lt;/a&gt;. Can people truly not comprehend how downvoting a post to -20 (or more) is perceived by the author of that post? Considering many incidents like this and the overwhelmingly negative feedback to almost any suggestion that would make the site less abrasive (e.g. &lt;a href=&quot;https://meta.stackoverflow.com/a/356263/660921&quot;&gt;this&lt;/a&gt;, &lt;a href=&quot;https://meta.stackoverflow.com/a/340177/660921&quot;&gt;this&lt;/a&gt;), it would seem that quite a lot of people genuinely don‚Äôt understand.&lt;/p&gt;
&lt;p&gt;There are others aspects of the Stack Overflow system that can be harsh and abrasive, most notably the closing of questions. There‚Äôs a good reason questions are closed ‚Äì just like downvotes exist for good reasons ‚Äì but there seems to be a complete lack of understanding how that can be perceived.&lt;/p&gt;
&lt;p&gt;To be fair, a big part of the problem is that the UI and feedback sucks. I‚Äôve always felt that fairly simple changes such as rephrasing &lt;em&gt;‚Äúyour question was put on hold‚Äù&lt;/em&gt; to something like &lt;em&gt;‚Äúwaiting for more information before we can provide an answer‚Äù&lt;/em&gt; would make a &lt;em&gt;huge&lt;/em&gt; difference.&lt;/p&gt;
&lt;hr/&gt;&lt;p&gt;Every time these kind of topics get brought up on Meta people get &lt;em&gt;very&lt;/em&gt; defensive and shout ‚Äúquality!‚Äù As if you need to be a dick to maintain ‚Äúquality‚Äù. It‚Äôs a false dichotomy: you can have quality &lt;em&gt;and&lt;/em&gt; be nice, but there is a complete unwillingness to even discus it.&lt;/p&gt;
&lt;p&gt;In general I find Meta an unfriendly place. It‚Äôs no surprise that Stack Overflow (the company) pretty much ignores Meta; the community can be borderline abusive. I still remember how Meta reacted to the Documentation effort of a few years ago. In particular I felt bad for Jon Ericson because he tried very hard to be constructive and to make it work. I too was critical of a lot of aspects of Documentation, but far too much wasn‚Äôt constructive, was just repeating the same stuff &lt;em&gt;ad nauseam&lt;/em&gt;, or was phrased very hostile.&lt;/p&gt;
&lt;p&gt;I don‚Äôt want to attack everyone on Meta here, because there are clearly also many great people, but the overall atmosphere is not pleasant. It‚Äôs tiresome, so for the most part I just stopped trying to make things better, which only resulted in even more selection bias in the Meta community.&lt;/p&gt;
&lt;p&gt;Meta, in general, has an overinflated sense of self-importance and entitlement. Many genuinely seem to think they represent the community, while in fact they just represent a small part because the rest got tired of them and left. As with many of these communities: it‚Äôs not who is right who wins the argument, it‚Äôs the one who is most active and most persistent. Some people call this ‚Äúmeritocracy‚Äù ü§∑&lt;/p&gt;
&lt;p&gt;Also see: &lt;a href=&quot;https://arp242.net/censorship.html&quot;&gt;The other kind of censorship&lt;/a&gt;.&lt;/p&gt;
&lt;hr/&gt;&lt;p&gt;Here‚Äôs another thing I‚Äôm completely fed up with: the ‚Äúknow-it-better‚Äù. People who just &lt;em&gt;love&lt;/em&gt; to show they actually know stuff better. Here‚Äôs a recent example on a Go question (entire comment):&lt;/p&gt;
&lt;blockquote readability=&quot;8&quot;&gt;
&lt;p&gt;There is no ‚Äúpass by reference‚Äù, so I‚Äôm not sure where you got that. You‚Äôre simply passing the value, which is a copy and not going to change the original.&lt;/p&gt;
&lt;/blockquote&gt;
&lt;p&gt;Technically correct, but everyone understands that ‚Äúpass a pointer‚Äù was intended. Yes, a new programmer got their terminology a bit incorrect (it is confusing!) and a note correcting that is fine, but this isn‚Äôt that. This is parading that they‚Äôre stupid and wrong, while beating your chest about how much smarter you are. Congratulations. Wipe off the spunk from your egowank already.&lt;/p&gt;
&lt;p&gt;I think this is also one reason for the ridiculous downvotes from the previous sections: &lt;em&gt;‚Äúlook how stupid that guy is, and look how clever I am pointing that out with my downvote!‚Äù&lt;/em&gt;&lt;/p&gt;
&lt;p&gt;This is exactly the sort of condescending attitude people are so tired of. I am, anyway, and it‚Äôs not even directed at me.&lt;/p&gt;
&lt;p&gt;Sometimes it can be hard to fully realize the impact of a certain type of behaviour if you‚Äôve never experienced that kind of behaviour yourself. Many people are only on one side (asking or answering), and they never really experience the ‚Äúother side‚Äù.&lt;/p&gt;
&lt;p&gt;I used to smoke a long time ago, and back in the day you were allowed to smoke in most places: the workplace, restaurants, public transport. I smoked in those places. I was raised in an environment where everyone smoked (inside the house!) so I had always been used to the smell of tobacco smoke. I never saw a problem with it.&lt;/p&gt;
&lt;p&gt;Until I quit, that is, and experienced a mostly smoke-free environment for the first time in my life. And hot damn was I ashamed of my previous behaviour once I actually started noticing the horrible smell of tobacco!&lt;/p&gt;
&lt;hr/&gt;&lt;p&gt;No one can deny that Stack Overflow is very successful: search any programming question and there‚Äôs a good chance you‚Äôll get an answer on the first page of Google results. How different it was before Stack Overflow!&lt;/p&gt;
&lt;p&gt;Some argue that all of this abrasiveness contributed to this success by maintaining ‚Äúquality‚Äù. I don‚Äôt buy it. Many other Stack Exchange sites are &lt;em&gt;not&lt;/em&gt; abrasive like this and have similar &lt;em&gt;or better&lt;/em&gt; quality. I‚Äôd argue that Stack Overflow is a success &lt;em&gt;in spite&lt;/em&gt; of all of the above, rather than &lt;em&gt;because&lt;/em&gt; of it.&lt;/p&gt;
&lt;p&gt;A lot of people complain that the site has many more low quality questions than it used to have. I tend to agree. This, apparently, justifies acting like a dick:&lt;/p&gt;
&lt;blockquote readability=&quot;6&quot;&gt;
&lt;p&gt;SE forces us to constantly interact with a stream of garbage; that will inevitably create hostility.&lt;/p&gt;
&lt;/blockquote&gt;
&lt;p&gt;Because ‚Äúnot saying anything‚Äù is not an option at all üôÑü§∑&lt;/p&gt;
&lt;p&gt;I have an alternate theory:&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;People are hostile.&lt;/li&gt;
&lt;li&gt;Reasonable people tend to stop coming.&lt;/li&gt;
&lt;li&gt;Who is left? Just the assholes, the clueless, and the people desperate to ask questions because they need it to do their job.&lt;/li&gt;
&lt;/ol&gt;&lt;p&gt;In other words, it‚Äôs a bed of their own making.&lt;/p&gt;
&lt;p&gt;The question now is: does Stack Overflow want to be a site that people tolerate, or one that people &lt;em&gt;like&lt;/em&gt;?&lt;/p&gt;
&lt;h2 id=&quot;way-forward&quot;&gt;Way forward &lt;/h2&gt;
&lt;p&gt;It‚Äôs my observation that it‚Äôs only a fairly small percentage of people who consistently engage in this kind of behaviour. In some tags that I follow (or used to follow) I can even point to the 1 or 2 people who are responsible for &amp;gt;80% of the shit.&lt;/p&gt;
&lt;p&gt;But managing this is really hard. Most of us make a harsher-than-intended comments every once in a while, and that‚Äôs okay. It‚Äôs the consistency and long-term patterns that are an issue. Most of the time these people never cross any hard lines (e.g. telling people that they‚Äôre dumb), so it‚Äôs hard to take action unless you‚Äôre really on top of things.&lt;/p&gt;
&lt;p&gt;These problems are not endemic to the Stack Exchange platform. A lot of these problems are &lt;em&gt;not&lt;/em&gt; present on some other Stack Exchange sites. The Vi &amp;amp; Vim Stack Exchange is &lt;em&gt;much&lt;/em&gt; better in my opinion (I am a moderator there, so I may be biased). We actually had one user being a condescending prick for a while, so we kicked him off. The site has been much better ever since.&lt;/p&gt;
&lt;hr/&gt;&lt;p&gt;At least several people in Stack Overflow (the company) realize not all is well. For example the &lt;a href=&quot;https://stackoverflow.blog/2018/04/26/stack-overflow-isnt-very-welcoming-its-time-for-that-to-change/&quot;&gt;Stack Overflow isn‚Äôt very welcoming&lt;/a&gt; post from over a year ago actually echoes a lot of my own sentiments, such as &lt;em&gt;‚Äúlet‚Äôs reject the false dichotomy between quality and kindness‚Äù&lt;/em&gt;. Great! Seems we arrived at the same conclusions.&lt;/p&gt;
&lt;p&gt;Yet ‚Ä¶ nothing has changed.&lt;/p&gt;
&lt;p&gt;The new &lt;a href=&quot;https://stackoverflow.com/conduct&quot;&gt;Code of Conduct&lt;/a&gt; hasn‚Äôt changed much. Personally, I still think the old &lt;a href=&quot;https://web.archive.org/web/20180101151003/https://stackoverflow.com/help/be-nice&quot;&gt;be nice&lt;/a&gt; policy was better phrased anyway, and you can write all the rules you like; it‚Äôs about enforcement. The entire thing was a distraction, IMHO.&lt;/p&gt;
&lt;p&gt;And these kind of sentiments aren‚Äôt new either: &lt;a href=&quot;https://meta.stackoverflow.com/questions/251758/why-is-stack-overflow-so-negative-of-late&quot;&gt;in 2014 people had similar sentiments&lt;/a&gt;, and I‚Äôm sure you can find even older ones if you search enough.&lt;/p&gt;
&lt;p&gt;I know many community Managers as kind and empathic people who genuinely care about this sort of stuff (even though they may not agree with all the particular I‚Äôve written down here), and I &lt;em&gt;do&lt;/em&gt; appreciate they‚Äôre in a tough spot. There are no ‚Äúquick fixes‚Äù here. But on the other hand, it seems that things are kind of in a stalemate, where everyone accepts that the status quo sucks but no one dares to take the (drastic) action that‚Äôs needed.&lt;/p&gt;
&lt;p&gt;And the drastic actions that &lt;em&gt;do&lt;/em&gt; get taken are meaningless and insignificant, like the whole &lt;a href=&quot;https://meta.stackexchange.com/a/316976/166789&quot;&gt;Hot Network Questions drama&lt;/a&gt;. If you think that an innocent and valid question about male/female relationships is the reason people don‚Äôt like Stack Overflow then you‚Äôve never been to Stack Overflow. A lot of effort, goodwill, stress, and time was lost on that which could have been much better spent elsewhere.&lt;/p&gt;
&lt;div class=&quot;postscript&quot;&gt;&lt;strong&gt;Related articles&lt;/strong&gt;
&lt;/div&gt;
&lt;div class=&quot;postscript&quot;&gt;&lt;strong&gt;Footnotes&lt;/strong&gt;
&lt;ol readability=&quot;-1.3333333333333&quot;&gt;&lt;li id=&quot;fn:del&quot; readability=&quot;0&quot;&gt;
&lt;p&gt;Now deleted, but people with more than 10‚Äâ000 reputation can still see it; &lt;a href=&quot;https://arp242.net/images/inf-ss.png&quot;&gt;screenshot&lt;/a&gt;.¬†&lt;/p&gt;
&lt;/li&gt;
&lt;/ol&gt;&lt;/div&gt;
&lt;footer class=&quot;postscript&quot; readability=&quot;17.021739130435&quot;&gt;&lt;strong&gt;Feedback&lt;/strong&gt;
&lt;p&gt;Mail me at &lt;a href=&quot;mailto:martin@arp242.net&quot;&gt;martin@arp242.net&lt;/a&gt; or &lt;a href=&quot;https://github.com/arp242/arp242.net/issues/new&quot;&gt;create a GitHub issue&lt;/a&gt; for feedback, questions, etc.&lt;/p&gt;
&lt;/footer&gt;


</description>
<pubDate>Mon, 02 Sep 2019 14:38:12 +0000</pubDate>
<dc:creator>mrzool</dc:creator>
<dc:language>en</dc:language>
<dc:format>text/html</dc:format>
<dc:identifier>https://arp242.net/stackoverflow.html</dc:identifier>
</item>
<item>
<title>Effects of short-term fasting on cancer treatment</title>
<link>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/</link>
<guid isPermaLink="true" >https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/</guid>
<description>&lt;div data-jigconfig=&quot;smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden'&quot; readability=&quot;210.53488488426&quot;&gt;
&lt;div class=&quot;fm-sec half_rhythm no_top_margin&quot;&gt;
&lt;div class=&quot;fm-citation half_rhythm no_top_margin clearfix&quot;&gt;
&lt;div class=&quot;inline_block eight_col va_top&quot; readability=&quot;4.4848484848485&quot;&gt;
&lt;div readability=&quot;5.2323232323232&quot;&gt;
&lt;p&gt;&lt;span class=&quot;cit&quot;&gt;&lt;span id=&quot;pmcmata&quot;&gt;J Exp Clin Cancer Res&lt;/span&gt;. 2019; 38: 209.&lt;/span&gt;&lt;/p&gt;

&lt;/div&gt;
&lt;/div&gt;
&lt;div class=&quot;inline_block four_col va_top show-overflow align_right&quot;&gt;
&lt;div class=&quot;fm-citation-ids&quot;&gt;
&lt;p&gt;&lt;span class=&quot;fm-citation-ids-label&quot;&gt;PMCID:&lt;/span&gt; &lt;span&gt;PMC6530042&lt;/span&gt;&lt;/p&gt;

&lt;/div&gt;
&lt;/div&gt;
&lt;/div&gt;

&lt;div class=&quot;half_rhythm&quot;&gt;
&lt;div class=&quot;contrib-group fm-author&quot;&gt;,&lt;sup&gt;1&lt;/sup&gt;,&lt;sup&gt;2&lt;/sup&gt;,&lt;sup&gt;1&lt;/sup&gt; and &lt;sup&gt;&lt;img src=&quot;https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/corrauth.gif&quot; alt=&quot;corresponding author&quot; /&gt;&lt;/sup&gt;&lt;sup&gt;1&lt;/sup&gt;&lt;/div&gt;

&lt;/div&gt;


&lt;/div&gt;


&lt;div id=&quot;Abs1&quot; lang=&quot;en&quot; class=&quot;tsec sec&quot; xml:lang=&quot;en&quot; readability=&quot;18&quot; xml:lang=&quot;en&quot;&gt;
&lt;h2 class=&quot;head no_bottom_margin&quot; id=&quot;Abs1title&quot;&gt;Abstract&lt;/h2&gt;
&lt;div readability=&quot;15&quot;&gt;
&lt;p id=&quot;Par1&quot; class=&quot;p p-first-last&quot;&gt;Growing preclinical evidence shows that short-term fasting (STF) protects from toxicity while enhancing the efficacy of a variety of chemotherapeutic agents in the treatment of various tumour types. STF reinforces stress resistance of healthy cells, while tumor cells become even more sensitive to toxins, perhaps through shortage of nutrients to satisfy their needs in the context of high proliferation rates and/or loss of flexibility to respond to extreme circumstances. In humans, STF may be a feasible approach to enhance the efficacy and tolerability of chemotherapy. Clinical research evaluating the potential of STF is in its infancy. This review focuses on the molecular background, current knowledge and clinical trials evaluating the effects of STF in cancer treatment. Preliminary data show that STF is safe, but challenging in cancer patients receiving chemotherapy. Ongoing clinical trials need to unravel if STF can also diminish toxicity and increase efficacy of chemotherapeutic regimes in daily practice.&lt;/p&gt;
&lt;/div&gt;
&lt;p&gt;&lt;strong class=&quot;kwd-title&quot;&gt;Keywords:&lt;/strong&gt; &lt;span class=&quot;kwd-text&quot;&gt;Short-term fasting, Fasting-mimicking diet, Chemotherapy, Differential stress resistance, Differential stress sensitization, Toxicity&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;div id=&quot;Sec1&quot; class=&quot;tsec sec&quot; readability=&quot;63.308613138686&quot;&gt;
&lt;h2 class=&quot;head no_bottom_margin&quot; id=&quot;Sec1title&quot;&gt;Background&lt;/h2&gt;
&lt;p id=&quot;Par24&quot; class=&quot;p p-first&quot;&gt;Chronic caloric restriction reduces and delays cancer incidence, and inhibits tumor progression and metastasis in rodents [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR1&quot; rid=&quot;CR1&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104712&quot; name=&quot;__tag_775104712&quot;&gt;1&lt;/a&gt;‚Äì&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR5&quot; rid=&quot;CR5&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104674&quot; name=&quot;__tag_775104674&quot;&gt;5&lt;/a&gt;]. Accordingly, cancer incidence and mortality are strongly reduced in chronic calorie restricted non-human primates [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR6&quot; rid=&quot;CR6&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104740&quot; name=&quot;__tag_775104740&quot;&gt;6&lt;/a&gt;]. Studies of long-term calorie restricted human subjects have shown a reduction of metabolic and hormonal factors associated with cancer risk [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR7&quot; rid=&quot;CR7&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104675&quot; name=&quot;__tag_775104675&quot;&gt;7&lt;/a&gt;‚Äì&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR9&quot; rid=&quot;CR9&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104682&quot; name=&quot;__tag_775104682&quot;&gt;9&lt;/a&gt;]. However, chronic caloric restriction is not a feasible clinical intervention. Evident difficulties, such as the long period required to be effective, and unacceptable weight loss [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR10&quot; rid=&quot;CR10&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104701&quot; name=&quot;__tag_775104701&quot;&gt;10&lt;/a&gt;, &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR11&quot; rid=&quot;CR11&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104735&quot; name=&quot;__tag_775104735&quot;&gt;11&lt;/a&gt;], hamper clinical application in cancer patients.&lt;/p&gt;
&lt;p id=&quot;Par25&quot;&gt;Preclinical studies suggest that short-term fasting (STF) protects rodents from toxic effects of chemotherapy, while simultaneously enhances the efficacy of a variety of chemotherapeutic agents in numerous distinct malignancies, e.g. breast cancer, melanoma, neuroblastoma, pancreatic cancer, and colorectal cancer [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR12&quot; rid=&quot;CR12&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104659&quot; name=&quot;__tag_775104659&quot;&gt;12&lt;/a&gt;]. In distinct strains of mice bearing xenograft malignancies, tumor growth clearly slows down in response to chemotherapy combined with a 24‚Äì60‚Äâh fast as compared to treatment with chemotherapy alone [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR13&quot; rid=&quot;CR13&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104751&quot; name=&quot;__tag_775104751&quot;&gt;13&lt;/a&gt;‚Äì&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR17&quot; rid=&quot;CR17&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104815&quot; name=&quot;__tag_775104815&quot;&gt;17&lt;/a&gt;]. STF simultaneously protects mice from chemotoxicity as well, because it reinforces stress resistance of healthy cells [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR17&quot; rid=&quot;CR17&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104731&quot; name=&quot;__tag_775104731&quot;&gt;17&lt;/a&gt;‚Äì&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR24&quot; rid=&quot;CR24&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104691&quot; name=&quot;__tag_775104691&quot;&gt;24&lt;/a&gt;]. The distinct response of healthy versus tumor cells to STF is called differential stress resistance (DSR). During nutrient deprivation, healthy cells re-invest energy in maintenance and repair that contribute to resistance to chemotherapy, while tumor cells are unable to slow down growth due to mutations in tumor suppressor genes and mitogenic pathways [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR19&quot; rid=&quot;CR19&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104717&quot; name=&quot;__tag_775104717&quot;&gt;19&lt;/a&gt;, &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR25&quot; rid=&quot;CR25&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104785&quot; name=&quot;__tag_775104785&quot;&gt;25&lt;/a&gt;]. Moreover, low serum levels of glucose during STF impose extra stress on tumor cells, as their energy needs under these circumstances are primarily met by means of glycolysis [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR14&quot; rid=&quot;CR14&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104812&quot; name=&quot;__tag_775104812&quot;&gt;14&lt;/a&gt;]. As a consequence of these differential responses of healthy versus cancer cells to STF, chemotherapy causes more DNA damage and apoptosis in tumor cells, while leaving healthy cells unharmed when it is combined with STF. Thus, STF protects healthy cells against the toxic properties of chemotherapy and renders tumor cells more sensitive, a phenomenon called differential stress sensitization (DSS).&lt;/p&gt;
&lt;p id=&quot;Par26&quot;&gt;In contrast to most cancer therapies, STF has only mild side effects, such as headaches, dizziness, nausea, weakness and short-term weight loss in humans [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR26&quot; rid=&quot;CR26&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104707&quot; name=&quot;__tag_775104707&quot;&gt;26&lt;/a&gt;]. Therefore, STF is a promising strategy to enhance the efficacy and tolerability of chemotherapy in cancer patients, especially as STF is an affordable and accessible approach and is potentially effective in a wide variety of tumors [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR12&quot; rid=&quot;CR12&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104781&quot; name=&quot;__tag_775104781&quot;&gt;12&lt;/a&gt;]. However, patients with severe weight loss, sarcopenia, cachexia or malnutrition are probably not good candidates for a STF intervention [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR27&quot; rid=&quot;CR27&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104754&quot; name=&quot;__tag_775104754&quot;&gt;27&lt;/a&gt;, &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR28&quot; rid=&quot;CR28&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104686&quot; name=&quot;__tag_775104686&quot;&gt;28&lt;/a&gt;]. Recent guidelines recommend to increase protein and fat consumption in patients with cachexia [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR29&quot; rid=&quot;CR29&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104753&quot; name=&quot;__tag_775104753&quot;&gt;29&lt;/a&gt;, &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR30&quot; rid=&quot;CR30&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104661&quot; name=&quot;__tag_775104661&quot;&gt;30&lt;/a&gt;]. Thus, STF may be particularly useful for relatively fit patients treated with (neo)adjuvant chemotherapy.&lt;/p&gt;
&lt;p id=&quot;Par27&quot; class=&quot;p p-last&quot;&gt;This narrative review will cover the current knowledge of the molecular mechanisms explaining ‚Äúdifferential stress resistance‚Äù of healthy- and cancer cells in response to STF. Moreover, it summarizes the available clinical data reflecting the impact of STF on the effects of chemotherapy in cancer patients. Finally, ongoing clinical studies of the effects of STF in cancer treatment will be critically reviewed.&lt;/p&gt;
&lt;/div&gt;
&lt;div id=&quot;Sec2&quot; class=&quot;tsec sec&quot; readability=&quot;87.268951773615&quot;&gt;
&lt;h2 class=&quot;head no_bottom_margin&quot; id=&quot;Sec2title&quot;&gt;Differential stress resistance and sensitization in response to STF&lt;/h2&gt;
&lt;p id=&quot;Par28&quot; class=&quot;p p-first&quot;&gt;In healthy cells, nutrient deprivation shuts down pathways promoting growth to re-invest energy in maintenance and repair pathways (Fig. ) [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR25&quot; rid=&quot;CR25&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104819&quot; name=&quot;__tag_775104819&quot;&gt;25&lt;/a&gt;, &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR31&quot; rid=&quot;CR31&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104765&quot; name=&quot;__tag_775104765&quot;&gt;31&lt;/a&gt;, &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR32&quot; rid=&quot;CR32&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104823&quot; name=&quot;__tag_775104823&quot;&gt;32&lt;/a&gt;]. This results in increased cellular protection, contributing to enhanced resistance to distinct stressors including chemotherapy and radiotherapy [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR19&quot; rid=&quot;CR19&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104801&quot; name=&quot;__tag_775104801&quot;&gt;19&lt;/a&gt;, &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR33&quot; rid=&quot;CR33&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104718&quot; name=&quot;__tag_775104718&quot;&gt;33&lt;/a&gt;]&lt;strong&gt;.&lt;/strong&gt; In contrast, tumor cells are unable to activate this protective response, due to: 1) uncontrolled activation of growth pathways and self-sufficiency in growth signals caused by oncogenic mutations or autocrine production of growth factors, and 2) loss of anti-proliferative signals due to mutations in tumor suppressor genes [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR34&quot; rid=&quot;CR34&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104660&quot; name=&quot;__tag_775104660&quot;&gt;34&lt;/a&gt;]. Thus, acquiring the ability to increase growth, tumor cells lose the ability to adapt to extreme environments, including nutrient deprivation. Additionally, the persistent increased growth rate of tumor cells requires abundant nutrients [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR35&quot; rid=&quot;CR35&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104790&quot; name=&quot;__tag_775104790&quot;&gt;35&lt;/a&gt;]. Therefore, STF increases DSS of tumor cells to several chemotherapeutic agents, radiotherapy and tyrosine kinase inhibitors (TKIs) (Table ) [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR12&quot; rid=&quot;CR12&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104734&quot; name=&quot;__tag_775104734&quot;&gt;12&lt;/a&gt;‚Äì&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR16&quot; rid=&quot;CR16&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104820&quot; name=&quot;__tag_775104820&quot;&gt;16&lt;/a&gt;, &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR18&quot; rid=&quot;CR18&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104724&quot; name=&quot;__tag_775104724&quot;&gt;18&lt;/a&gt;‚Äì&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR20&quot; rid=&quot;CR20&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104818&quot; name=&quot;__tag_775104818&quot;&gt;20&lt;/a&gt;, &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR36&quot; rid=&quot;CR36&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104807&quot; name=&quot;__tag_775104807&quot;&gt;36&lt;/a&gt;‚Äì&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR40&quot; rid=&quot;CR40&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104713&quot; name=&quot;__tag_775104713&quot;&gt;40&lt;/a&gt;]. Although the exact mechanism of DSR and DSS by STF is unknown, several growth factors and nutrient sensing pathways have been proposed to be key regulators, of which insulin-like growth factor-1 (IGF-1) is the most examined [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR41&quot; rid=&quot;CR41&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104791&quot; name=&quot;__tag_775104791&quot;&gt;41&lt;/a&gt;‚Äì&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR43&quot; rid=&quot;CR43&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104684&quot; name=&quot;__tag_775104684&quot;&gt;43&lt;/a&gt;]. Nutrient sensing pathways are activated or inhibited in response to a low amount of available nutrients and are highly conserved among distinct organisms to overcome periods of famine [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR44&quot; rid=&quot;CR44&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104793&quot; name=&quot;__tag_775104793&quot;&gt;44&lt;/a&gt;]. During nutrient scarcity, these pathways guide cells to invest energy in repair and maintenance rather than reproduction and growth [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR45&quot; rid=&quot;CR45&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104670&quot; name=&quot;__tag_775104670&quot;&gt;45&lt;/a&gt;‚Äì&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR47&quot; rid=&quot;CR47&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104797&quot; name=&quot;__tag_775104797&quot;&gt;47&lt;/a&gt;], presumably to enhance survival of periods of famine. Analogously, infection-induced anorexia is a common sign of sickness and may be an important strategy for host defence [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR48&quot; rid=&quot;CR48&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104813&quot; name=&quot;__tag_775104813&quot;&gt;48&lt;/a&gt;, &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR49&quot; rid=&quot;CR49&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104748&quot; name=&quot;__tag_775104748&quot;&gt;49&lt;/a&gt;].&lt;/p&gt;
&lt;div class=&quot;fig iconblock whole_rhythm clearfix&quot; id=&quot;Fig1&quot; co-legend-rid=&quot;lgnd_Fig1&quot;&gt;
&lt;div data-largeobj=&quot;&quot; data-largeobj-link-rid=&quot;largeobj_idm140231639428368&quot; class=&quot;figure&quot;&gt;&lt;img class=&quot;fig-image&quot; alt=&quot;An external file that holds a picture, illustration, etc. Object name is 13046_2019_1189_Fig1_HTML.jpg&quot; title=&quot;An external file that holds a picture, illustration, etc. Object name is 13046_2019_1189_Fig1_HTML.jpg&quot; src=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/bin/13046_2019_1189_Fig1_HTML.jpg&quot; /&gt;&lt;/div&gt;

&lt;div class=&quot;icnblk_cntnt&quot; id=&quot;lgnd_Fig1&quot; readability=&quot;7.5&quot;&gt;

&lt;div class=&quot;caption&quot; readability=&quot;10&quot;&gt;
&lt;p id=&quot;__p1&quot;&gt;Schematic overview of differential effects of short-term fasting on healthy and cancer cells.&lt;/p&gt;
&lt;p id=&quot;__p2&quot;&gt;Abbreviations: STF; short term fasting, IGF-1: insulin growth factor-1.&lt;/p&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;div class=&quot;table-wrap table anchored whole_rhythm&quot; id=&quot;Tab1&quot; readability=&quot;6.8883435582822&quot;&gt;
&lt;h3&gt;Table 1&lt;/h3&gt;
&lt;div class=&quot;caption&quot; readability=&quot;9&quot;&gt;
&lt;p id=&quot;__p3&quot;&gt;Overview of in vivo studies of the effect of STF on the toxicity and/or efficacy of chemotherapy, radiotherapy and tyrosine kinase inhibitors&lt;/p&gt;
&lt;/div&gt;
&lt;div data-largeobj=&quot;&quot; data-largeobj-link-rid=&quot;largeobj_idm140231630109712&quot; class=&quot;xtable&quot;&gt;
&lt;table frame=&quot;hsides&quot; rules=&quot;groups&quot; class=&quot;rendered small default_table&quot;&gt;&lt;thead&gt;&lt;tr&gt;&lt;th rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Author&lt;/th&gt;
&lt;th rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Strain&lt;/th&gt;
&lt;th rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Treatment&lt;/th&gt;
&lt;th rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Outcomes of STF&lt;/th&gt;
&lt;/tr&gt;&lt;/thead&gt;&lt;tbody readability=&quot;63.831433013734&quot;&gt;&lt;tr readability=&quot;9.8989898989899&quot;&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Raffaghello et al. 2008 [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR19&quot; rid=&quot;CR19&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104829&quot; name=&quot;__tag_775104829&quot;&gt;19&lt;/a&gt;]&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;A/J, CD-1, nude mice and A/J mice bearing subcutaneous NXS2 neuroblastoma&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;High dose etoposide ¬± 48‚Äì60‚Äâh STF&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Decreased mortality (toxicity) after high dose etoposide&lt;/td&gt;
&lt;/tr&gt;&lt;tr readability=&quot;2.9368421052632&quot;&gt;&lt;td rowspan=&quot;8&quot; colspan=&quot;1&quot;&gt;Lee et al. 2012 [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR12&quot; rid=&quot;CR12&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104840&quot; name=&quot;__tag_775104840&quot;&gt;12&lt;/a&gt;]&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;BALB/c, C57BL/6 and nude mice bearing subcutaneous:&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;¬±48‚Äì60‚Äâh STF and:&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;tr readability=&quot;7&quot;&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;4‚ÄâT1 breast cancer&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Cyclophosphamide&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot; readability=&quot;9&quot;&gt;
&lt;p id=&quot;__p4&quot;&gt;Increased efficacy of CT,&lt;/p&gt;
&lt;p id=&quot;__p5&quot;&gt;STF alone was as effective as CT alone,¬†Increased survival&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;&lt;tr readability=&quot;4&quot;&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;B16 melanoma&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Doxorubicin&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Increased efficacy of CT,¬†Increased survival,¬†Decreased metastasis&lt;/td&gt;
&lt;/tr&gt;&lt;tr readability=&quot;3&quot;&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;GL26 glioma&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Doxorubicin&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot; readability=&quot;5&quot;&gt;
&lt;p id=&quot;__p6&quot;&gt;Increased efficacy of CT&lt;/p&gt;
&lt;p id=&quot;__p7&quot;&gt;STF alone was as effective as CT alone&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;&lt;tr&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;ACN human neuroblastoma&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Doxorubicin&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Increased efficacy of CT&lt;/td&gt;
&lt;/tr&gt;&lt;tr&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;MDAMB-231 breast cancer&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Doxorubicin&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Increased efficacy of CT&lt;/td&gt;
&lt;/tr&gt;&lt;tr&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;OVCAR3 ovarian cancer&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Doxorubicin&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Increased efficacy of CT&lt;/td&gt;
&lt;/tr&gt;&lt;tr readability=&quot;3&quot;&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;NXS2 neuroblastoma&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Only STF&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;STF alone was effective,¬†Increased survival&lt;/td&gt;
&lt;/tr&gt;&lt;tr readability=&quot;9.4082125603865&quot;&gt;&lt;td rowspan=&quot;2&quot; colspan=&quot;1&quot;&gt;Safdie et al. 2012 [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR13&quot; rid=&quot;CR13&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104835&quot; name=&quot;__tag_775104835&quot;&gt;13&lt;/a&gt;]&lt;/td&gt;
&lt;td rowspan=&quot;2&quot; colspan=&quot;1&quot;&gt;C57BL/6‚ÄâN mice bearing subcutaneous or intracranial GL26 glioma&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Temozolomide ¬± 48‚Äâh STF&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot; readability=&quot;8&quot;&gt;
&lt;p id=&quot;__p8&quot;&gt;Increased efficacy of CT, STF alone was as effective as CT alone&lt;/p&gt;
&lt;p id=&quot;__p9&quot;&gt;(subcutaneous model only)&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;&lt;tr readability=&quot;4&quot;&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;p id=&quot;__p10&quot;&gt;Radiotherapy ¬±&lt;/p&gt;
&lt;p id=&quot;__p11&quot;&gt;48‚Äâh STF&lt;/p&gt;
&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Increased efficacy of radiotherapy&lt;/td&gt;
&lt;/tr&gt;&lt;tr readability=&quot;4.9519230769231&quot;&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Shi et al. 2012 [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR37&quot; rid=&quot;CR37&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104772&quot; name=&quot;__tag_775104772&quot;&gt;37&lt;/a&gt;]&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;CD-1 Nude mice bearing subcutaneous ZL55 mesothelioma and A549 lung carcinoma&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Cisplatin ¬±48‚Äâh STF&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Increased efficacy of CT, STF alone was more effective as CT alone (mesothelioma only)&lt;/td&gt;
&lt;/tr&gt;&lt;tr readability=&quot;3.9322033898305&quot;&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Kawaguchi et al. 2012 [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR62&quot; rid=&quot;CR62&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104681&quot; name=&quot;__tag_775104681&quot;&gt;62&lt;/a&gt;]&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;GFP-LC3 mice&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Doxorubicin ¬±48‚Äâh STF&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Decreased cardiotoxicity after high dose doxorubicin.&lt;/td&gt;
&lt;/tr&gt;&lt;tr readability=&quot;5.910447761194&quot;&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Brandhorst et al. 2013 [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR18&quot; rid=&quot;CR18&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104794&quot; name=&quot;__tag_775104794&quot;&gt;18&lt;/a&gt;]&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;AIN93G mice&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;High dose doxorubicin ¬±60‚Äâh STF&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Decreased mortality (toxicity) after high dose doxorubicin.&lt;/td&gt;
&lt;/tr&gt;&lt;tr readability=&quot;5.9302325581395&quot;&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Saleh et al. 2013 [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR38&quot; rid=&quot;CR38&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104802&quot; name=&quot;__tag_775104802&quot;&gt;38&lt;/a&gt;]&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;BALB/c mice bearing subcutaneous 67NR or NIH3 triple negative breast cancer&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;p id=&quot;__p12&quot;&gt;Radiotherapy ¬±&lt;/p&gt;
&lt;p id=&quot;__p13&quot;&gt;24‚Äâh STF (alternate)&lt;/p&gt;
&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Increased efficacy of radiotherapy&lt;/td&gt;
&lt;/tr&gt;&lt;tr readability=&quot;3.9407407407407&quot;&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Cheng et al. 2014 [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR22&quot; rid=&quot;CR22&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104798&quot; name=&quot;__tag_775104798&quot;&gt;22&lt;/a&gt;]&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;C57BL/6‚ÄâJ mice&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;p id=&quot;__p14&quot;&gt;Cyclophosphamide ¬±&lt;/p&gt;
&lt;p id=&quot;__p15&quot;&gt;48‚Äâh STF&lt;/p&gt;
&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Decreased mortality (toxicity) after high dose cyclophosphamide.&lt;/td&gt;
&lt;/tr&gt;&lt;tr readability=&quot;3.9365079365079&quot;&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Bianchi et al. 2015 [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR14&quot; rid=&quot;CR14&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104769&quot; name=&quot;__tag_775104769&quot;&gt;14&lt;/a&gt;]&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;BALB/c mice bearing subcutaneous CT26 colon cancer&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Oxaliplatin ¬± 48‚Äâh STF&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Increased efficacy of CT&lt;/td&gt;
&lt;/tr&gt;&lt;tr readability=&quot;5.9340659340659&quot;&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Shim et al. 2015 [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR15&quot; rid=&quot;CR15&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104838&quot; name=&quot;__tag_775104838&quot;&gt;15&lt;/a&gt;]&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;C57BL/6‚ÄâJ mice bearing subcutaneous B16 melanoma&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Doxorubicin or Cyclophosphamide ¬± 48‚Äâh STF&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Increased efficacy of CT STF alone was as effective as CT alone&lt;/td&gt;
&lt;/tr&gt;&lt;tr readability=&quot;5.9136690647482&quot;&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;D‚ÄôAronzo et al. 2015 [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR36&quot; rid=&quot;CR36&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104679&quot; name=&quot;__tag_775104679&quot;&gt;36&lt;/a&gt;]&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Nu/Nu mice bearing subcutaneous BxPC-3-luc pancreatic cancer&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Gemcitabine ¬± 24‚Äâh STF&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Increased efficacy of CT&lt;/td&gt;
&lt;/tr&gt;&lt;tr readability=&quot;4.9415204678363&quot;&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Huisman et al. 2015 [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR20&quot; rid=&quot;CR20&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104845&quot; name=&quot;__tag_775104845&quot;&gt;20&lt;/a&gt;]&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;FabplCre;Apc15lox/C mice bearing spontaneous intestinal malignancies&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Irinotecan ¬± 48‚Äâh STF&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot; readability=&quot;5&quot;&gt;
&lt;p id=&quot;__p16&quot;&gt;Decreased toxicity to CT&lt;/p&gt;
&lt;p id=&quot;__p17&quot;&gt;No effect on efficacy of CT&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;&lt;tr readability=&quot;12.397959183673&quot;&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Tinkum et al. 2015 [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR21&quot; rid=&quot;CR21&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104843&quot; name=&quot;__tag_775104843&quot;&gt;21&lt;/a&gt;]&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot; readability=&quot;10&quot;&gt;
&lt;p id=&quot;__p18&quot;&gt;B6(Cg)-Tyrc-2‚ÄâJ/J,&lt;/p&gt;
&lt;p id=&quot;__p19&quot;&gt;Bmi1CreERT/+;Rosa26R/+ HopXCreERT/+;Rosa26R/+&lt;/p&gt;
&lt;p id=&quot;__p20&quot;&gt;Lgr5EGFP-IRES-CreERT2/+;Rosa26R/+,&lt;/p&gt;
&lt;p id=&quot;__p21&quot;&gt;Lgr5EGFP-IRES-CreERT2/+ mice&lt;/p&gt;
&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;High dose etoposide ¬± 24‚Äâh STF&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Decreased mortality (toxicity) after high dose etoposide&lt;/td&gt;
&lt;/tr&gt;&lt;tr readability=&quot;5.9347826086957&quot;&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Caffa et al. 2015 [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR39&quot; rid=&quot;CR39&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104666&quot; name=&quot;__tag_775104666&quot;&gt;39&lt;/a&gt;]&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;BALB/c mice¬†bearing subcutaneous H3122 lung cancer or HCT116 colorectal cancer&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Crizotinib/regorafinib ¬± 48‚Äâh STF&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Increased efficacy of crizotinib/regorafinib&lt;/td&gt;
&lt;/tr&gt;&lt;tr readability=&quot;4.9342105263158&quot;&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Huisman et al. 2015 [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR23&quot; rid=&quot;CR23&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104732&quot; name=&quot;__tag_775104732&quot;&gt;23&lt;/a&gt;]&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;BALB/c mice bearing subcutaneous C26 colon cancer&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Irinotecan ¬± 72‚Äâh STF&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot; readability=&quot;5&quot;&gt;
&lt;p id=&quot;__p22&quot;&gt;Decreased toxicity to CT&lt;/p&gt;
&lt;p id=&quot;__p23&quot;&gt;No effect on efficacy of CT&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;&lt;tr readability=&quot;7.9234449760766&quot;&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Di Biase et al. 2016 [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR16&quot; rid=&quot;CR16&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104778&quot; name=&quot;__tag_775104778&quot;&gt;16&lt;/a&gt;]&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;BALB/c, BALB/c-nude and C57BL/6 mice bearing subcutaneous MCF7 and 4T1 breast cancer, B16 melanoma&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Doxorubicin and cyclophosphamide ¬±48‚Äâh STF or 96‚Äâh FMD&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Increased efficacy of CT&lt;/td&gt;
&lt;/tr&gt;&lt;tr readability=&quot;5.9124087591241&quot;&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Pietrocola et al. 2016 [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR40&quot; rid=&quot;CR40&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104789&quot; name=&quot;__tag_775104789&quot;&gt;40&lt;/a&gt;]&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Wild-type C57BL/6 and athymic (nu/nu) mice&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Mitoxantrone or oxaliplatin ¬± 48‚Äâh STF&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Increased efficacy of CT&lt;/td&gt;
&lt;/tr&gt;&lt;tr readability=&quot;5.9016393442623&quot;&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Di Biase et al. 2017 [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR17&quot; rid=&quot;CR17&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104698&quot; name=&quot;__tag_775104698&quot;&gt;17&lt;/a&gt;]&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;C57BL/6 mice&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Doxorubicin ¬±24‚Äì72‚Äâh STF&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Decreased cardiotoxicity after high dose doxorubicin.&lt;/td&gt;
&lt;/tr&gt;&lt;tr readability=&quot;1.9545454545455&quot;&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Jongbloed et al. 2019 [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR24&quot; rid=&quot;CR24&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104738&quot; name=&quot;__tag_775104738&quot;&gt;24&lt;/a&gt;]&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;BALB/c mice&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Irinotecan ¬± 72‚Äâh STF&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Decreased toxicity to CT&lt;/td&gt;
&lt;/tr&gt;&lt;tr&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Authors, site&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Subjects&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Treatment&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Outcome of STF&lt;/td&gt;
&lt;/tr&gt;&lt;tr readability=&quot;5.9189189189189&quot;&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Withers et al. 2014, UC Davis, USA [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR63&quot; rid=&quot;CR63&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104677&quot; name=&quot;__tag_775104677&quot;&gt;63&lt;/a&gt;]&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;20 dogs with lymphoma&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Doxorubicin ¬±24‚Äâh STF&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;p id=&quot;__p24&quot;&gt;Safe and feasible&lt;/p&gt;
&lt;p id=&quot;__p25&quot;&gt;Reduction in vomiting&lt;/p&gt;
&lt;p id=&quot;__p26&quot;&gt;No reduction in IGF-1&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;


&lt;/div&gt;
&lt;div id=&quot;Sec3&quot; class=&quot;sec&quot; readability=&quot;33.300571428571&quot;&gt;
&lt;h3 id=&quot;Sec3title&quot;&gt;IGF-1 and insulin as key regulators of DSR&lt;/h3&gt;
&lt;p id=&quot;Par29&quot; class=&quot;p p-first&quot;&gt;IGF-1 and insulin stimulate proliferation and growth and inhibit apoptosis in response to calorie and protein availability through signalling via the IGF-1 receptor (IGF-1R) and insulin receptor isoform A (IR-A), respectively [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR50&quot; rid=&quot;CR50&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104702&quot; name=&quot;__tag_775104702&quot;&gt;50&lt;/a&gt;‚Äì&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR53&quot; rid=&quot;CR53&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104766&quot; name=&quot;__tag_775104766&quot;&gt;53&lt;/a&gt;]. Serum IGF-1 levels decrease during STF [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR54&quot; rid=&quot;CR54&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104834&quot; name=&quot;__tag_775104834&quot;&gt;54&lt;/a&gt;‚Äì&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR56&quot; rid=&quot;CR56&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104665&quot; name=&quot;__tag_775104665&quot;&gt;56&lt;/a&gt;], because low insulin levels cause growth hormone (GH) resistance of the liver, which inhibits hepatic IGF-1 production [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR54&quot; rid=&quot;CR54&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104839&quot; name=&quot;__tag_775104839&quot;&gt;54&lt;/a&gt;, &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR57&quot; rid=&quot;CR57&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104676&quot; name=&quot;__tag_775104676&quot;&gt;57&lt;/a&gt;, &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR58&quot; rid=&quot;CR58&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104846&quot; name=&quot;__tag_775104846&quot;&gt;58&lt;/a&gt;]. Both insulin and IGF-1 activate the Ras/mitogen-activated protein kinase (MAPK) and phosphatidylinositol-3-kinase (PI3K)/Akt pathways. In healthy cells, inhibition of proliferation and/or investment in maintenance may contribute to increased stress resistance. For example, mice with a liver &lt;em&gt;Igf1&lt;/em&gt; gene deletion (LID), which have decreased IGF-1 levels similar to those during STF [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR59&quot; rid=&quot;CR59&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104695&quot; name=&quot;__tag_775104695&quot;&gt;59&lt;/a&gt;‚Äì&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR61&quot; rid=&quot;CR61&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104809&quot; name=&quot;__tag_775104809&quot;&gt;61&lt;/a&gt;], exhibit increased resistance to high doses of various chemotherapeutic agents [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR42&quot; rid=&quot;CR42&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104841&quot; name=&quot;__tag_775104841&quot;&gt;42&lt;/a&gt;] and this benefit was nullified through IGF-1 administration [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR12&quot; rid=&quot;CR12&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104747&quot; name=&quot;__tag_775104747&quot;&gt;12&lt;/a&gt;, &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR42&quot; rid=&quot;CR42&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104746&quot; name=&quot;__tag_775104746&quot;&gt;42&lt;/a&gt;]. Thus, the IGF-1R pathway seems to be a key mediator of stress resistance in response to STF in healthy cells.&lt;/p&gt;
&lt;p id=&quot;Par30&quot; class=&quot;p p-last&quot;&gt;During STF, the Ras/MAPK and PI3K/Akt pathways are down-regulated in cancer cells, whereby proliferation is inhibited [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR64&quot; rid=&quot;CR64&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104709&quot; name=&quot;__tag_775104709&quot;&gt;64&lt;/a&gt;]. Notably, resistance to the growth limiting effects of STF has been observed in cancer cells carrying mutations that cause a constitutive activation of the PI3K pathway, since these cells proliferate even in the absence of insulin or IGF-1 [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR65&quot; rid=&quot;CR65&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104722&quot; name=&quot;__tag_775104722&quot;&gt;65&lt;/a&gt;]. Therefore, the IGF-1R pathway is a key mediator of cancer cell growth and cancer resistance to commonly used therapeutics [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR42&quot; rid=&quot;CR42&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104728&quot; name=&quot;__tag_775104728&quot;&gt;42&lt;/a&gt;, &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR66&quot; rid=&quot;CR66&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104663&quot; name=&quot;__tag_775104663&quot;&gt;66&lt;/a&gt;, &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR67&quot; rid=&quot;CR67&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104830&quot; name=&quot;__tag_775104830&quot;&gt;67&lt;/a&gt;]. Thus, the reduction in circulating levels of IGF-1 and insulin during STF may contribute to the anticancer activity as well [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR68&quot; rid=&quot;CR68&quot; class=&quot; bibr popnode&quot;&gt;68&lt;/a&gt;].&lt;/p&gt;
&lt;/div&gt;
&lt;div id=&quot;Sec4&quot; class=&quot;sec&quot; readability=&quot;24.444885011895&quot;&gt;
&lt;h3 id=&quot;Sec4title&quot;&gt;AMPK and autophagy&lt;/h3&gt;
&lt;p id=&quot;Par31&quot; class=&quot;p p-first&quot;&gt;AMP-activated protein kinase (AMPK) may play a major part in DSR due to STF [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR69&quot; rid=&quot;CR69&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104847&quot; name=&quot;__tag_775104847&quot;&gt;69&lt;/a&gt;]. AMPK monitors cellular energy levels and becomes activated when ADP:ATP or AMP:ATP ratios in the cell increase [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR70&quot; rid=&quot;CR70&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104673&quot; name=&quot;__tag_775104673&quot;&gt;70&lt;/a&gt;]. AMPK inhibits energy consuming processes, such as cell proliferation and protein synthesis, and activates energy generating processes, such as glycolysis and fatty acid oxidation. It inhibits cell growth and stimulates autophagy [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR71&quot; rid=&quot;CR71&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104704&quot; name=&quot;__tag_775104704&quot;&gt;71&lt;/a&gt;]. Autophagy (Greek for ‚Äúself-eating‚Äù) is a highly conserved catabolic process among eukaryotes to survive periods of nutrient deprivation. This adaptive response of the cell involves damaged protein and organelle degradation to generate amino acids as an alternative energy source [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR72&quot; rid=&quot;CR72&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104715&quot; name=&quot;__tag_775104715&quot;&gt;72&lt;/a&gt;, &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR73&quot; rid=&quot;CR73&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104799&quot; name=&quot;__tag_775104799&quot;&gt;73&lt;/a&gt;]. Activation of AMPK and autophagy seems to play a major part in de protective effects of STF in healthy cells [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR17&quot; rid=&quot;CR17&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104836&quot; name=&quot;__tag_775104836&quot;&gt;17&lt;/a&gt;].&lt;/p&gt;
&lt;p id=&quot;Par32&quot; class=&quot;p p-last&quot;&gt;However, the effects of AMPK activation in distinct tumor cells may vary, as some tumors harbour constitutively active AMPK [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR74&quot; rid=&quot;CR74&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104678&quot; name=&quot;__tag_775104678&quot;&gt;74&lt;/a&gt;, &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR75&quot; rid=&quot;CR75&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104844&quot; name=&quot;__tag_775104844&quot;&gt;75&lt;/a&gt;] and others exhibit low AMPK activity [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR76&quot; rid=&quot;CR76&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104808&quot; name=&quot;__tag_775104808&quot;&gt;76&lt;/a&gt;‚Äì&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR78&quot; rid=&quot;CR78&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104737&quot; name=&quot;__tag_775104737&quot;&gt;78&lt;/a&gt;]. Tumors with diminished AMPK activity or autophagy may be highly sensitive to STF, as AMPK activation enhances immune surveillance [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR40&quot; rid=&quot;CR40&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104782&quot; name=&quot;__tag_775104782&quot;&gt;40&lt;/a&gt;], whereas tumors with highly active AMPK or autophagy may be resistant [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR77&quot; rid=&quot;CR77&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104816&quot; name=&quot;__tag_775104816&quot;&gt;77&lt;/a&gt;, &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR79&quot; rid=&quot;CR79&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104848&quot; name=&quot;__tag_775104848&quot;&gt;79&lt;/a&gt;‚Äì&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR82&quot; rid=&quot;CR82&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104664&quot; name=&quot;__tag_775104664&quot;&gt;82&lt;/a&gt;].&lt;/p&gt;
&lt;/div&gt;
&lt;div id=&quot;Sec5&quot; class=&quot;sec&quot; readability=&quot;26.641791044776&quot;&gt;
&lt;h3 id=&quot;Sec5title&quot;&gt;Glucose metabolism and the ‚ÄúWarburg effect‚Äù&lt;/h3&gt;
&lt;p id=&quot;Par33&quot; class=&quot;p p-first&quot;&gt;During STF, healthy cells, have the metabolic flexibility to cope with nutrient deprivation, since glucose can be replaced by ketone bodies and fatty acids as primary energy source.&lt;/p&gt;
&lt;p id=&quot;Par34&quot; class=&quot;p p-last&quot;&gt;In contrast, tumor cells depend on glucose to maintain the high rate of cellular proliferation [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR83&quot; rid=&quot;CR83&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104741&quot; name=&quot;__tag_775104741&quot;&gt;83&lt;/a&gt;, &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR84&quot; rid=&quot;CR84&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104669&quot; name=&quot;__tag_775104669&quot;&gt;84&lt;/a&gt;]. Akt stimulates the so called ‚ÄúWarburg effect‚Äù, characterized by an increased rate of glycolysis rather than oxidative phosphorylation even in the presence of oxygen [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR83&quot; rid=&quot;CR83&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104700&quot; name=&quot;__tag_775104700&quot;&gt;83&lt;/a&gt;‚Äì&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR85&quot; rid=&quot;CR85&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104806&quot; name=&quot;__tag_775104806&quot;&gt;85&lt;/a&gt;]. STF down-regulates anaerobic glycolysis while up-regulating oxidative phosphorylation in tumor cells, and this ‚Äúanti-Warburg effect‚Äù results in oxidative stress and apoptosis [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR14&quot; rid=&quot;CR14&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104780&quot; name=&quot;__tag_775104780&quot;&gt;14&lt;/a&gt;]. Also, a counterintuitive increase in protein translation during STF increases unmet energy needs, leading to cell death [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR12&quot; rid=&quot;CR12&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104814&quot; name=&quot;__tag_775104814&quot;&gt;12&lt;/a&gt;]. Moreover, the 20‚Äì40% reduction in circulating glucose during STF may be enough to kill anoxic tumor cells [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR85&quot; rid=&quot;CR85&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104743&quot; name=&quot;__tag_775104743&quot;&gt;85&lt;/a&gt;]. Thus, a decrease in nutrient availability during STF makes cancer cells more vulnerable to any challenge, including chemotherapy. However, overconsumption after a STF period might accelerate tumor growth, due to high glucose conditions and increased glycolysis [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR86&quot; rid=&quot;CR86&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104685&quot; name=&quot;__tag_775104685&quot;&gt;86&lt;/a&gt;].&lt;/p&gt;
&lt;/div&gt;
&lt;div id=&quot;Sec6&quot; class=&quot;sec&quot; readability=&quot;27.634782608696&quot;&gt;
&lt;h3 id=&quot;Sec6title&quot;&gt;Reactive oxygen species and DNA damage&lt;/h3&gt;
&lt;p id=&quot;Par35&quot; class=&quot;p p-first&quot;&gt;Chemotherapeutic agents inflict oxidative stress and DNA damage upon healthy cells, which are underlying mechanisms of toxicity [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR44&quot; rid=&quot;CR44&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104671&quot; name=&quot;__tag_775104671&quot;&gt;44&lt;/a&gt;, &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR87&quot; rid=&quot;CR87&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104837&quot; name=&quot;__tag_775104837&quot;&gt;87&lt;/a&gt;]. STF dampens oxidative stress in healthy cells by down-regulating metabolic rate and increasing scavenging of reactive oxygen species (ROS), which may contribute to DSR [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR33&quot; rid=&quot;CR33&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104708&quot; name=&quot;__tag_775104708&quot;&gt;33&lt;/a&gt;, &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR44&quot; rid=&quot;CR44&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104822&quot; name=&quot;__tag_775104822&quot;&gt;44&lt;/a&gt;]. As serum glucose levels decrease during STF, fatty acids serve as the main energy source. Beta-oxidation of fatty acids produces ketone bodies, which can be used as an alternative/additional fuel. Ketone bodies can also activate pathways involved in protection against ROS [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR88&quot; rid=&quot;CR88&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104687&quot; name=&quot;__tag_775104687&quot;&gt;88&lt;/a&gt;]. Moreover, STF presumably activates DNA repair processes in healthy cells [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR22&quot; rid=&quot;CR22&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104775&quot; name=&quot;__tag_775104775&quot;&gt;22&lt;/a&gt;]. For example, in mice fasted for 24‚Äâh before high dose infusion of etoposide, less DNA damage was seen in small intestinal stem cells 3‚Äâh after the infusion compared to mice who ate ad libitum. As 1.5‚Äâh post-treatment DNA damage was similar, DNA repair was likely more efficient in healthy cells due to STF [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR21&quot; rid=&quot;CR21&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104826&quot; name=&quot;__tag_775104826&quot;&gt;21&lt;/a&gt;].&lt;/p&gt;
&lt;p id=&quot;Par36&quot; class=&quot;p p-last&quot;&gt;In contrast, tumor cells exhibit increased ROS production if chemotherapy is combined with STF in vitro [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR12&quot; rid=&quot;CR12&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104739&quot; name=&quot;__tag_775104739&quot;&gt;12&lt;/a&gt;]. In breast cancer cells cultured in low glucose medium or serum of fasting mice, a 20-fold increase in DNA damage was seen in response to chemotherapy, as compared to cells cultured in regular medium or in serum of ad libitum fed mice [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR12&quot; rid=&quot;CR12&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104824&quot; name=&quot;__tag_775104824&quot;&gt;12&lt;/a&gt;].&lt;/p&gt;
&lt;/div&gt;
&lt;div id=&quot;Sec7&quot; class=&quot;sec sec-last&quot; readability=&quot;24.504337050805&quot;&gt;
&lt;h3 id=&quot;Sec7title&quot;&gt;Immune competence&lt;/h3&gt;
&lt;p id=&quot;Par37&quot; class=&quot;p p-first&quot;&gt;Chemotherapy causes bone marrow toxicity and depletion of circulating immune cells, especially myeloid cell depletion [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR89&quot; rid=&quot;CR89&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104852&quot; name=&quot;__tag_775104852&quot;&gt;89&lt;/a&gt;, &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR90&quot; rid=&quot;CR90&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104752&quot; name=&quot;__tag_775104752&quot;&gt;90&lt;/a&gt;]. Fasting protects hematopoietic stem cells and circulating immune cells from the detrimental effects of chemotherapy in mice [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR22&quot; rid=&quot;CR22&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104795&quot; name=&quot;__tag_775104795&quot;&gt;22&lt;/a&gt;, &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR91&quot; rid=&quot;CR91&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104657&quot; name=&quot;__tag_775104657&quot;&gt;91&lt;/a&gt;]. Additionally, more efficient immunity as a result of STF presumably causes a lower rate of infections and febrile neutropenia as well [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR92&quot; rid=&quot;CR92&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104776&quot; name=&quot;__tag_775104776&quot;&gt;92&lt;/a&gt;].&lt;/p&gt;
&lt;p id=&quot;Par38&quot; class=&quot;p p-last&quot;&gt;On the other hand, fasting improves the therapeutic effect of chemotherapy on the tumor possibly through cellular immunity in mice, as this effect is nullified in nu/nu mice, which lack T cells [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR40&quot; rid=&quot;CR40&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104764&quot; name=&quot;__tag_775104764&quot;&gt;40&lt;/a&gt;, &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR93&quot; rid=&quot;CR93&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104821&quot; name=&quot;__tag_775104821&quot;&gt;93&lt;/a&gt;]. Thus, STF may promote immunity and presentation of tumor-associated antigens (TAA), which promote efficient antitumor immunity contributing to increased efficacy of chemotherapy [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR94&quot; rid=&quot;CR94&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104800&quot; name=&quot;__tag_775104800&quot;&gt;94&lt;/a&gt;].&lt;/p&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;div id=&quot;Sec8&quot; class=&quot;tsec sec&quot; readability=&quot;22.680872150644&quot;&gt;
&lt;h2 class=&quot;head no_bottom_margin&quot; id=&quot;Sec8title&quot;&gt;From animal models to the clinic&lt;/h2&gt;
&lt;p id=&quot;Par39&quot; class=&quot;p p-first-last&quot;&gt;Preclinical data documenting the benefits of STF is abundant and promising. However, words of caution are appropriate regarding its application in patients with cancer. For instance, preclinical studies show severe, albeit transient, weight loss in animal models (20‚Äì40% of total bodyweight after 24‚Äì48‚Äâh of fasting [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR12&quot; rid=&quot;CR12&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104832&quot; name=&quot;__tag_775104832&quot;&gt;12&lt;/a&gt;, &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR19&quot; rid=&quot;CR19&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104694&quot; name=&quot;__tag_775104694&quot;&gt;19&lt;/a&gt;, &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR23&quot; rid=&quot;CR23&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104750&quot; name=&quot;__tag_775104750&quot;&gt;23&lt;/a&gt;, &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR39&quot; rid=&quot;CR39&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104706&quot; name=&quot;__tag_775104706&quot;&gt;39&lt;/a&gt;, &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR95&quot; rid=&quot;CR95&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104716&quot; name=&quot;__tag_775104716&quot;&gt;95&lt;/a&gt;]. In contrast, the impact of a few days of fasting on bodyweight of humans appears far more modest (~ 1‚Äâkg per day, largely water loss) [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR26&quot; rid=&quot;CR26&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104680&quot; name=&quot;__tag_775104680&quot;&gt;26&lt;/a&gt;], which is probably explained by metabolic differences between humans and mice [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR95&quot; rid=&quot;CR95&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104842&quot; name=&quot;__tag_775104842&quot;&gt;95&lt;/a&gt;]. This is reassuring in the context of safety. However, it may also mean that humans need to fast for a (much) longer period of time than mice to obtain the same benefits (see discussion below). Therefore, carefully controlled clinical trials monitoring tumor growth as well as adverse effects of distinct dietary regimes are required before fasting mimicking diets (FMDs) can be applied in clinical practice.&lt;/p&gt;
&lt;/div&gt;
&lt;div id=&quot;Sec9&quot; class=&quot;tsec sec&quot; readability=&quot;23.493506493506&quot;&gt;
&lt;h2 class=&quot;head no_bottom_margin&quot; id=&quot;Sec9title&quot;&gt;Metabolic risk factors for cancer&lt;/h2&gt;
&lt;p id=&quot;Par40&quot; class=&quot;p p-first-last&quot;&gt;Obesity is associated with an increased risk of developing several cancers, such as breast cancer, colon cancer, ovarian cancer, endometrial cancer and thyroid cancer [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR96&quot; rid=&quot;CR96&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104786&quot; name=&quot;__tag_775104786&quot;&gt;96&lt;/a&gt;, &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR97&quot; rid=&quot;CR97&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104833&quot; name=&quot;__tag_775104833&quot;&gt;97&lt;/a&gt;] and IGF-1 levels are positively associated with the risk of developing breast and prostate cancer [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR98&quot; rid=&quot;CR98&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104763&quot; name=&quot;__tag_775104763&quot;&gt;98&lt;/a&gt;, &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR99&quot; rid=&quot;CR99&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104672&quot; name=&quot;__tag_775104672&quot;&gt;99&lt;/a&gt;]. Moreover, obesity and high levels of insulin and IGF-1, as well as having diabetes mellitus are associated with worse survival in cancer [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR100&quot; rid=&quot;CR100&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104688&quot; name=&quot;__tag_775104688&quot;&gt;100&lt;/a&gt;‚Äì&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR103&quot; rid=&quot;CR103&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104825&quot; name=&quot;__tag_775104825&quot;&gt;103&lt;/a&gt;]. Obese subjects are often hyperglycemic and hyperinsulinemic, as a result of insulin resistance. Although circulating levels of total (free + bound) IGF-1 are normal or even low in obese subjects, levels of free (bioactive) IGF-1 are higher than in lean subjects [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR104&quot; rid=&quot;CR104&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104693&quot; name=&quot;__tag_775104693&quot;&gt;104&lt;/a&gt;]. Both insulin and free IGF-1 can bind the IGF-1R and IR-A [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR105&quot; rid=&quot;CR105&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104745&quot; name=&quot;__tag_775104745&quot;&gt;105&lt;/a&gt;] and activate the Ras/MAPK and PI3K/AKT pathway, through which cell proliferation is stimulated and apoptosis is inhibited, respectively [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR106&quot; rid=&quot;CR106&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104736&quot; name=&quot;__tag_775104736&quot;&gt;106&lt;/a&gt;]. Moreover, preclinically, obesity is associated with macrophage accumulation in adipose tissue resulting in an immune suppressive microenvironment [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR107&quot; rid=&quot;CR107&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104705&quot; name=&quot;__tag_775104705&quot;&gt;107&lt;/a&gt;]. These metabolic mechanisms may explain the increased risk of cancer as well as the worse prognosis of several cancers in obese subjects.&lt;/p&gt;
&lt;/div&gt;
&lt;div id=&quot;Sec10&quot; class=&quot;tsec sec&quot; readability=&quot;57.234796573876&quot;&gt;
&lt;h2 class=&quot;head no_bottom_margin&quot; id=&quot;Sec10title&quot;&gt;Clinical studies of fasting&lt;/h2&gt;
&lt;p id=&quot;Par41&quot; class=&quot;p p-first&quot;&gt;Voluntary fasting has been performed for many centuries and purposes, such as religious, ethical and cosmetic [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR26&quot; rid=&quot;CR26&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104771&quot; name=&quot;__tag_775104771&quot;&gt;26&lt;/a&gt;, &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR108&quot; rid=&quot;CR108&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104727&quot; name=&quot;__tag_775104727&quot;&gt;108&lt;/a&gt;]. Hippocrates was probably one of the first advocates of fasting for medical purposes (he recommended to fast during sickness). Since then, several doctors advised their patients to listen to their ‚Äòfasting instinct‚Äô (the natural loss of appetite during disease). Scientific research on the biomedical effects of fasting was performed from the late nineteenth century on, when several non-obese humans fasted for 20‚Äì40‚Äâdays [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR26&quot; rid=&quot;CR26&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104774&quot; name=&quot;__tag_775104774&quot;&gt;26&lt;/a&gt;]. The first clinical study of medical fasting for the treatment of obesity was performed in 1915 [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR109&quot; rid=&quot;CR109&quot; class=&quot; bibr popnode&quot;&gt;109&lt;/a&gt;]. The authors reported that short periods of four to six days of fasting is a safe and effective method for reducing bodyweight in obese humans. Since that time several studies were performed in obese subjects, with the longest fasting period lasting 382‚Äâdays (!) [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR110&quot; rid=&quot;CR110&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104697&quot; name=&quot;__tag_775104697&quot;&gt;110&lt;/a&gt;, &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR111&quot; rid=&quot;CR111&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104683&quot; name=&quot;__tag_775104683&quot;&gt;111&lt;/a&gt;]. Fasting therapy was observed to be generally safe and well tolerated. Only mild side effects were reported, including headaches, dizziness, nausea, dyspepsia and fatigue [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR109&quot; rid=&quot;CR109&quot; class=&quot; bibr popnode&quot;&gt;109&lt;/a&gt;‚Äì&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR114&quot; rid=&quot;CR114&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104817&quot; name=&quot;__tag_775104817&quot;&gt;114&lt;/a&gt;]. However, in rare cases fasting for periods longer than 2‚Äâweeks was fatal in obese subjects with comorbidities as cardiac disease or diabetes mellitus [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR26&quot; rid=&quot;CR26&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104770&quot; name=&quot;__tag_775104770&quot;&gt;26&lt;/a&gt;, &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR115&quot; rid=&quot;CR115&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104668&quot; name=&quot;__tag_775104668&quot;&gt;115&lt;/a&gt;‚Äì&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR117&quot; rid=&quot;CR117&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104831&quot; name=&quot;__tag_775104831&quot;&gt;117&lt;/a&gt;], and in one rare case a 53-day fast caused Wernicke encephalopathy in a patient with a lymphoma [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR118&quot; rid=&quot;CR118&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104792&quot; name=&quot;__tag_775104792&quot;&gt;118&lt;/a&gt;]. Additionally, fasting is not suitable for patients with rare metabolic illnesses such as glycogen storage disease or disorders of gluconeogenesis [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR119&quot; rid=&quot;CR119&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104784&quot; name=&quot;__tag_775104784&quot;&gt;119&lt;/a&gt;]. Benefits of fasting are improved cardiovascular risk factors, such as a decrease in blood pressure, improvement of lipid profile and insulin sensitivity, and weight loss in obese and non-obese subjects [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR114&quot; rid=&quot;CR114&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104723&quot; name=&quot;__tag_775104723&quot;&gt;114&lt;/a&gt;, &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR120&quot; rid=&quot;CR120&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104757&quot; name=&quot;__tag_775104757&quot;&gt;120&lt;/a&gt;]. The weight loss during STF is approximately 0.9‚Äâkg per day and decreases during prolonged fasting to 0.3‚Äâkg per day by the third week [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR26&quot; rid=&quot;CR26&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104699&quot; name=&quot;__tag_775104699&quot;&gt;26&lt;/a&gt;, &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR121&quot; rid=&quot;CR121&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104721&quot; name=&quot;__tag_775104721&quot;&gt;121&lt;/a&gt;]. Various studies examined the potential of fasting in the treatment of mood disorders, rheumatic diseases, asthma, chronic pain syndromes, hypertension, and metabolic syndrome [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR122&quot; rid=&quot;CR122&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104851&quot; name=&quot;__tag_775104851&quot;&gt;122&lt;/a&gt;, &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR123&quot; rid=&quot;CR123&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104733&quot; name=&quot;__tag_775104733&quot;&gt;123&lt;/a&gt;]. For example, a large cohort study of more than 2000 subjects with chronic illness and pain syndromes, who used a very low-calorie diet of 350‚Äâkcal per day for 7‚Äâdays, showed an increase in quality of life without any serious side effect [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR122&quot; rid=&quot;CR122&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104762&quot; name=&quot;__tag_775104762&quot;&gt;122&lt;/a&gt;]. In healthy subjects, STF by 3‚Äâcycles of a fasting mimicking diet (FMD) reduces common risk factors for cardiovascular diseases, diabetes and ageing, such as lowering blood pressure, body weight, glucose, triglycerides and cholesterol [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR124&quot; rid=&quot;CR124&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104811&quot; name=&quot;__tag_775104811&quot;&gt;124&lt;/a&gt;]. Additionally, STF may improve clinical outcome in patients undergoing a partial liver resection and may prevent acute kidney injury after cardiac surgery [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR125&quot; rid=&quot;CR125&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104828&quot; name=&quot;__tag_775104828&quot;&gt;125&lt;/a&gt;, &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR126&quot; rid=&quot;CR126&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104720&quot; name=&quot;__tag_775104720&quot;&gt;126&lt;/a&gt;].&lt;/p&gt;
&lt;div id=&quot;Sec11&quot; class=&quot;sec sec-last&quot; readability=&quot;27.467511885895&quot;&gt;
&lt;h3 id=&quot;Sec11title&quot;&gt;Metabolic changes during STF in humans&lt;/h3&gt;
&lt;p id=&quot;Par42&quot; class=&quot;p p-first-last&quot;&gt;STF has profound metabolic effects in humans [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR127&quot; rid=&quot;CR127&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104714&quot; name=&quot;__tag_775104714&quot;&gt;127&lt;/a&gt;]. Serum glucose levels drop after a few hours and are maintained at a lower level by endogenous glucose production, stimulated by glucagon. Glycogen storage capacity is limited so that stores are virtually depleted after 24‚Äâh. From then on, gluconeogenesis provides the brain with glucose as its major fuel source. Fatty acids are the primary fuel for the rest of the body. Beta-oxidation of fatty acids produces ketone bodies, which can serve as auxiliary energy source for the brain and the rest of the body. Insulin levels decrease rapidly and IGF-1 decreases dramatically after 36‚Äì72‚Äâh [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR41&quot; rid=&quot;CR41&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104768&quot; name=&quot;__tag_775104768&quot;&gt;41&lt;/a&gt;]. Since the liver is resistant to GH during prolonged fasting, IGF-1 production is profoundly reduced [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR128&quot; rid=&quot;CR128&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104729&quot; name=&quot;__tag_775104729&quot;&gt;128&lt;/a&gt;]. Diminished negative feedback control through reduction of circulating insulin and IGF-1 causes plasma GH levels to increase [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR129&quot; rid=&quot;CR129&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104788&quot; name=&quot;__tag_775104788&quot;&gt;129&lt;/a&gt;, &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR130&quot; rid=&quot;CR130&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104783&quot; name=&quot;__tag_775104783&quot;&gt;130&lt;/a&gt;]. IGF binding proteins, which regulate the bio-availability of IGF-1, change during fasting as well [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR41&quot; rid=&quot;CR41&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104755&quot; name=&quot;__tag_775104755&quot;&gt;41&lt;/a&gt;, &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR131&quot; rid=&quot;CR131&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104787&quot; name=&quot;__tag_775104787&quot;&gt;131&lt;/a&gt;, &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR132&quot; rid=&quot;CR132&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104756&quot; name=&quot;__tag_775104756&quot;&gt;132&lt;/a&gt;]. IGF-BP3 levels decrease, while IGF-BP1 levels increase 5‚Äì10-fold [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR133&quot; rid=&quot;CR133&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104725&quot; name=&quot;__tag_775104725&quot;&gt;133&lt;/a&gt;]. The decrease of IGF-I, downregulates the Ras/MAPK and PI3K/Akt pathways, through which cell proliferation is stimulated and apoptosis inhibited [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR12&quot; rid=&quot;CR12&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104779&quot; name=&quot;__tag_775104779&quot;&gt;12&lt;/a&gt;, &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR19&quot; rid=&quot;CR19&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104803&quot; name=&quot;__tag_775104803&quot;&gt;19&lt;/a&gt;]. Moreover, fasting down-regulates the hypothalamus-pituitary-thyroid axis activity. It particularly lowers triiodothyronine (T3), while thyroid stimulating hormone (TSH) and free thyroxine (fT4) are slightly decreased or not affected [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR134&quot; rid=&quot;CR134&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104810&quot; name=&quot;__tag_775104810&quot;&gt;134&lt;/a&gt;]. Clinical research shows that fasting periods longer than 48‚Äâh are required to facilitate a robust decrease in IGF-1 levels [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR41&quot; rid=&quot;CR41&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104805&quot; name=&quot;__tag_775104805&quot;&gt;41&lt;/a&gt;]. Therefore, it is likely that the positive effects of STF will be enhanced if the period of fasting is prolonged. A low sugar, low protein FMD may be an alternative to ease the burden of fasting, as it mimics the effects of STF on metabolism [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR91&quot; rid=&quot;CR91&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104719&quot; name=&quot;__tag_775104719&quot;&gt;91&lt;/a&gt;].&lt;/p&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;div id=&quot;Sec12&quot; class=&quot;tsec sec&quot; readability=&quot;98.997847757136&quot;&gt;
&lt;h2 class=&quot;head no_bottom_margin&quot; id=&quot;Sec12title&quot;&gt;Clinical studies of STF during chemotherapy&lt;/h2&gt;
&lt;p id=&quot;Par43&quot; class=&quot;p p-first&quot;&gt;To date, a few small clinical studies in humans exploring the effects of STF combined with chemotherapy have been published (Table ) [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR22&quot; rid=&quot;CR22&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104703&quot; name=&quot;__tag_775104703&quot;&gt;22&lt;/a&gt;, &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR131&quot; rid=&quot;CR131&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104804&quot; name=&quot;__tag_775104804&quot;&gt;131&lt;/a&gt;, &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR135&quot; rid=&quot;CR135&quot; class=&quot; bibr popnode&quot;&gt;135&lt;/a&gt;‚Äì&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR138&quot; rid=&quot;CR138&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104690&quot; name=&quot;__tag_775104690&quot;&gt;138&lt;/a&gt;]. The design and results of these studies in humans are summarized below.&lt;/p&gt;
&lt;div class=&quot;table-wrap table anchored whole_rhythm&quot; id=&quot;Tab2&quot; readability=&quot;5.6093868281605&quot;&gt;
&lt;h3&gt;Table 2&lt;/h3&gt;
&lt;div class=&quot;caption&quot; readability=&quot;7&quot;&gt;
&lt;p id=&quot;__p28&quot;&gt;Overview of clinical studies on the effect of STF on the toxicity of chemotherapy&lt;/p&gt;
&lt;/div&gt;
&lt;div data-largeobj=&quot;&quot; data-largeobj-link-rid=&quot;largeobj_idm140231679120512&quot; class=&quot;xtable&quot;&gt;
&lt;table frame=&quot;hsides&quot; rules=&quot;groups&quot; class=&quot;rendered small default_table&quot;&gt;&lt;thead&gt;&lt;tr&gt;&lt;th rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Authors, site&lt;/th&gt;
&lt;th rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Human Subjects&lt;/th&gt;
&lt;th rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Treatment&lt;/th&gt;
&lt;th rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Outcome&lt;/th&gt;
&lt;/tr&gt;&lt;/thead&gt;&lt;tbody readability=&quot;27.472366148532&quot;&gt;&lt;tr readability=&quot;11.827751196172&quot;&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Safdie et al. 2009, USC, USA [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR136&quot; rid=&quot;CR136&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104696&quot; name=&quot;__tag_775104696&quot;&gt;136&lt;/a&gt;]&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;10 human subjects with distinct malignancies&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Distinct, + STF varying from 48 to 140‚Äâh prior and 5‚Äì56‚Äâh after CT&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot; readability=&quot;5&quot;&gt;
&lt;p id=&quot;__p29&quot;&gt;Safe and feasible.&lt;/p&gt;
&lt;p id=&quot;__p30&quot;&gt;Reduction in CT-induced side effects.&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;&lt;tr readability=&quot;11.138461538462&quot;&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Badar et al. 2014, KFMC, Saudi Arabia, &lt;a id=&quot;__tag_775104865&quot; class=&quot;tag_hotlink&quot; href=&quot;https://clinicaltrials.gov/ct2/show/NCT00757094&quot; ref=&quot;reftype=extlink-clinical-trial&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CBody&amp;amp;TO=External%7CResource%7CClinical%20Trials%7CClinicalTrials.gov&quot; name=&quot;__tag_775104865&quot;&gt;NCT00757094&lt;/a&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR135&quot; rid=&quot;CR135&quot; class=&quot; bibr popnode&quot;&gt;135&lt;/a&gt;]&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;11 human subjects with distinct malignancies&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;IF during Ramadan when receiving CT&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot; readability=&quot;5&quot;&gt;
&lt;p id=&quot;__p31&quot;&gt;Safe and feasible.&lt;/p&gt;
&lt;p id=&quot;__p32&quot;&gt;Reduction in CT-induced side effects&lt;sup&gt;a&lt;/sup&gt;.&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;&lt;tr readability=&quot;15.933333333333&quot;&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Dorff et al. 2016, USC, USA, &lt;a id=&quot;__tag_775104861&quot; class=&quot;tag_hotlink&quot; href=&quot;https://clinicaltrials.gov/ct2/show/NCT00936364&quot; ref=&quot;reftype=extlink-clinical-trial&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CBody&amp;amp;TO=External%7CResource%7CClinical%20Trials%7CClinicalTrials.gov&quot; name=&quot;__tag_775104861&quot;&gt;NCT00936364&lt;/a&gt;, [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR22&quot; rid=&quot;CR22&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104760&quot; name=&quot;__tag_775104760&quot;&gt;22&lt;/a&gt;, &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR137&quot; rid=&quot;CR137&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104773&quot; name=&quot;__tag_775104773&quot;&gt;137&lt;/a&gt;]&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;20 human subjects with distinct malignancies&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Platinum based CT‚Äâ+‚Äâ24‚Äâh, 48‚Äâh or 72‚Äâh STF&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot; readability=&quot;7&quot;&gt;
&lt;p id=&quot;__p33&quot;&gt;Safe and feasible .&lt;/p&gt;
&lt;p id=&quot;__p34&quot;&gt;Reduces DNA damage in leukocytes (dose response).&lt;/p&gt;
&lt;p id=&quot;__p35&quot;&gt;Reduction of IGF-1 (dose response).&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;&lt;tr readability=&quot;10.457746478873&quot;&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;de Groot et al. 2015, LUMC, The Netherlands &lt;a id=&quot;__tag_775104872&quot; class=&quot;tag_hotlink&quot; href=&quot;https://clinicaltrials.gov/ct2/show/NCT01304251&quot; ref=&quot;reftype=extlink-clinical-trial&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CBody&amp;amp;TO=External%7CResource%7CClinical%20Trials%7CClinicalTrials.gov&quot; name=&quot;__tag_775104872&quot;&gt;NCT01304251&lt;/a&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR131&quot; rid=&quot;CR131&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104767&quot; name=&quot;__tag_775104767&quot;&gt;131&lt;/a&gt;]&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;13 women with stage II and III HER2 negative breast cancer&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;TAC CT‚Äâ¬±‚Äâ48‚Äâh STF&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot; readability=&quot;7&quot;&gt;
&lt;p id=&quot;__p36&quot;&gt;Safe and feasible.&lt;/p&gt;
&lt;p id=&quot;__p37&quot;&gt;Reduction in IGF-1&lt;/p&gt;
&lt;p id=&quot;__p38&quot;&gt;Beneficial effect on erythrocytes and thrombocytes&lt;/p&gt;
&lt;p id=&quot;__p39&quot;&gt;Possible reduction in DNA damage in healthy cells&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;&lt;tr readability=&quot;12.604265402844&quot;&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Bauersfeld et al. 2018, Charite University, Germany, &lt;a id=&quot;__tag_775104880&quot; class=&quot;tag_hotlink&quot; href=&quot;https://clinicaltrials.gov/ct2/show/NCT01954836&quot; ref=&quot;reftype=extlink-clinical-trial&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CBody&amp;amp;TO=External%7CResource%7CClinical%20Trials%7CClinicalTrials.gov&quot; name=&quot;__tag_775104880&quot;&gt;NCT01954836&lt;/a&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR138&quot; rid=&quot;CR138&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104853&quot; name=&quot;__tag_775104853&quot;&gt;138&lt;/a&gt;]&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;34 women with breast and ovarian cancer&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;CT‚Äâ¬±‚Äâ60‚Äâh STF (cross-over)&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot; readability=&quot;6&quot;&gt;
&lt;p id=&quot;__p40&quot;&gt;Safe and feasible&lt;/p&gt;
&lt;p id=&quot;__p41&quot;&gt;Beneficial effect on QOL, fatigue and well-being&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;


&lt;/div&gt;
&lt;p id=&quot;Par44&quot;&gt;In a case series from the University of Southern California (USC), 10 patients with distinct malignancies fasted in combination with docetaxel, carboplatin, paclitaxel and/or gemcitabine [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR136&quot; rid=&quot;CR136&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104849&quot; name=&quot;__tag_775104849&quot;&gt;136&lt;/a&gt;, &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR139&quot; rid=&quot;CR139&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104749&quot; name=&quot;__tag_775104749&quot;&gt;139&lt;/a&gt;]. Seven female and three male patients, with a median age of 61‚Äâyears, diagnosed with breast (&lt;em&gt;N‚Äâ=‚Äâ4&lt;/em&gt;), prostate (&lt;em&gt;N‚Äâ=‚Äâ2&lt;/em&gt;), esophagus, non-small cell lung cancer, uterus and ovary cancer were described. Patients fasted for 48‚Äì140‚Äâh prior to, and 5‚Äì56 after commencing chemotherapy. Six of the ten patients fasted alternately during the chemotherapy cycles (the other four fasted every cycle) and side effects were compared between cycles combined with STF and chemotherapy alone. Side effects were scored according to the Common Terminology Criteria for Adverse Events (CTCAE) 4.0. Besides hunger and dizziness, fasting had no significant side effects. The authors reported a decrease in chemotherapy-induced side effects, including fatigue, weakness, vomiting and diarrhea, when chemotherapy was combined with STF compared to chemotherapy alone. In five patients the tumor volume (evaluated with PET or PET-CT) or tumor markers (PSA or CA-125) were evaluated. STF did not diminish chemotherapy-induced reduction of tumor volume and tumor markers, suggesting that STF did not interfere with the efficacy of chemotherapy.&lt;/p&gt;
&lt;p id=&quot;Par45&quot;&gt;In the King Fahad Medical City a clinical trial (&lt;a id=&quot;__tag_775104858&quot; class=&quot;tag_hotlink&quot; href=&quot;https://clinicaltrials.gov/ct2/show/NCT00757094&quot; ref=&quot;reftype=extlink-clinical-trial&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CBody&amp;amp;TO=External%7CResource%7CClinical%20Trials%7CClinicalTrials.gov&quot; name=&quot;__tag_775104858&quot;&gt;NCT00757094&lt;/a&gt;) was conducted to evaluate the safety and feasibility of combining chemotherapy and intermittent fasting (including liquids) during the Ramadan [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR135&quot; rid=&quot;CR135&quot; class=&quot; bibr popnode&quot;&gt;135&lt;/a&gt;]. Eleven patients, with distinct types of malignancies, received one gift of chemotherapy. Side effects and blood counts were compared with values measured in response to a similar dose of chemotherapy, given 2‚Äâweeks after the end of Ramadan. The authors concluded that combining fasting and chemotherapy during the month of Ramadan was well tolerated and safe. Side effects of chemotherapy tended to be less. However, because the study group was small, no statistics were performed. Moreover, due to the short fasting period (approximately 12‚Äâh), major benefits may not be expected, as IGF-1 levels will evidently not be reduced [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR140&quot; rid=&quot;CR140&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104692&quot; name=&quot;__tag_775104692&quot;&gt;140&lt;/a&gt;].&lt;/p&gt;
&lt;p id=&quot;Par46&quot;&gt;We performed a randomized pilot study (&lt;a id=&quot;__tag_775104870&quot; class=&quot;tag_hotlink&quot; href=&quot;https://clinicaltrials.gov/ct2/show/NCT01304251&quot; ref=&quot;reftype=extlink-clinical-trial&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CBody&amp;amp;TO=External%7CResource%7CClinical%20Trials%7CClinicalTrials.gov&quot; name=&quot;__tag_775104870&quot;&gt;NCT01304251&lt;/a&gt;) to evaluate the effects of short-term fasting on tolerance to (neo) adjuvant chemotherapy in HER2-negative breast cancer patients in the Leiden University Medical Center (LUMC) [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR131&quot; rid=&quot;CR131&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104726&quot; name=&quot;__tag_775104726&quot;&gt;131&lt;/a&gt;]. Eligible patients had stage II/III breast cancer and received (neo)-adjuvant TAC (docetaxel/doxorubicin/cyclophosphamide) chemotherapy. Patients were randomized to fast 24‚Äâh before and 24‚Äâh after chemotherapy, or to eat according to the guidelines for healthy nutrition. Metabolic parameters (glucose, insulin and IGF-1) at baseline and immediately before chemotherapy infusion ‚Äìwhen patients in the STF group had fasted for 24‚Äâh- were compared. Toxicity in the two groups was compared as well. Additionally, chemotherapy-induced DNA damage was quantified in peripheral blood mononuclear cells (PBMCs) by the level of Œ≥-H2AX, as determined by flowcytometry. Thirteen patients were included, of whom seven were randomized to the STF arm. STF was well tolerated in our study. Plasma glucose levels increased and insulin levels remained constant in response to STF. We inferred that this phenomenon was the result of the concomitant use of dexamethasone, which was administered as an anti-emetic, for reduction of fluid retention and dampening of hypersensitivity reactions in response to docetaxel. Circulating IGF-1 levels were only modestly reduced in the study, which could be due to the use of dexamethasone as well [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR141&quot; rid=&quot;CR141&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104777&quot; name=&quot;__tag_775104777&quot;&gt;141&lt;/a&gt;, &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR142&quot; rid=&quot;CR142&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104742&quot; name=&quot;__tag_775104742&quot;&gt;142&lt;/a&gt;] or to the relatively short duration (24‚Äâh) of fasting prior to chemotherapy. Non-hematological toxicity did not differ between the groups. However, mean erythrocyte- and thrombocyte counts 7‚Äâdays post-chemotherapy were significantly higher in the STF group compared to the non-STF group. Levels of Œ≥-H2AX were significantly increased 30‚Äâmin post-chemotherapy in CD45‚Äâ+‚ÄâCD3- cells in non-STF, but not in STF patients [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR131&quot; rid=&quot;CR131&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104711&quot; name=&quot;__tag_775104711&quot;&gt;131&lt;/a&gt;]. This study provides evidence that STF attenuates bone marrow toxicity in these patients and reduces chemotherapy-induced DNA damage in PBMCs and/or accelerates its recovery.&lt;/p&gt;
&lt;p id=&quot;Par47&quot;&gt;Moreover, Dorff et al. reported results from a dose-escalating phase I study (&lt;a id=&quot;__tag_775104864&quot; class=&quot;tag_hotlink&quot; href=&quot;https://clinicaltrials.gov/ct2/show/NCT00936364&quot; ref=&quot;reftype=extlink-clinical-trial&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CBody&amp;amp;TO=External%7CResource%7CClinical%20Trials%7CClinicalTrials.gov&quot; name=&quot;__tag_775104864&quot;&gt;NCT00936364&lt;/a&gt;), wherein 20 human subjects with distinct malignancies were treated with platinum-based chemotherapy combined with 24, 48 or 72‚Äâh STF to identify the optimal fasting duration [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR22&quot; rid=&quot;CR22&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104850&quot; name=&quot;__tag_775104850&quot;&gt;22&lt;/a&gt;, &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR137&quot; rid=&quot;CR137&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104758&quot; name=&quot;__tag_775104758&quot;&gt;137&lt;/a&gt;]. Eligible patients had distinct cancer types for which platinum-based combination chemotherapy was given with curative or palliative intent. Metabolic parameters (glucose, insulin, IGF-1 and IGF-BP1) at baseline and immediately before chemotherapy were compared. Moreover, toxicities and chemotherapy-induced DNA damage in PBMCs (determined by the COMET assay) between the three groups were compared. Twenty patients were included, 6 in the 24‚Äâh group and 7 in the 48 and 72‚Äâh group. The fasting was feasible and fasting-related toxicities were limited to grade 1 according CTCAE 4.0. The authors reported that 72‚Äâh of STF was associated with normal lymphocyte counts and maintenance of a normal lineage balance in white blood counts (lymphoid/myeloid ratio) after 2‚Äâcycles of chemotherapy, while 24‚Äâh STF was not [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR22&quot; rid=&quot;CR22&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104662&quot; name=&quot;__tag_775104662&quot;&gt;22&lt;/a&gt;]. IGF-1 levels decreased by 30, 33 and 8% in the 24, 48 and 72‚Äâh fasting cohorts, respectively, after the first fasting period. Additionally, the COMET assay showed reduced DNA damage 24‚Äâh after chemotherapy in leukocytes from subjects who fasted for more than 48‚Äâh compared with subjects fasted for 24‚Äâh &lt;em&gt;(P‚Äâ=‚Äâ0.08).&lt;/em&gt;&lt;/p&gt;
&lt;p id=&quot;Par48&quot;&gt;Finally, Bauerfeld et al. published a randomized cross-over trial (&lt;a id=&quot;__tag_775104873&quot; class=&quot;tag_hotlink&quot; href=&quot;https://clinicaltrials.gov/ct2/show/NCT01954836&quot; ref=&quot;reftype=extlink-clinical-trial&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CBody&amp;amp;TO=External%7CResource%7CClinical%20Trials%7CClinicalTrials.gov&quot; name=&quot;__tag_775104873&quot;&gt;NCT01954836&lt;/a&gt;) evaluating the effect of STF on quality of life in breast cancer and ovarian cancer patients treated with chemotherapy [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR138&quot; rid=&quot;CR138&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104730&quot; name=&quot;__tag_775104730&quot;&gt;138&lt;/a&gt;]. Patients were randomized to fast, using an FMD, 36‚Äâh before and 24‚Äâh after chemotherapy or to eat a normocaloric Mediterranean diet for the first three cycles of chemotherapy. After three cycles the patient crossed over to the other group of nutrition (Mediterranean diet or fasting). The design of the study allows intra-individual comparisons regarding side effects of treatment, but precludes conclusions as efficacy of chemotherapy. In total, 50 patients were included in the study, but only 34 were analyzed because of early study discontinuation. The fasting was safe and feasible and five patients (14.7%) continued fasting after three cycles and did not cross over to the normocaloric diet. The authors concluded that STF led to a better tolerance to chemotherapy with less compromised quality of life (QOL) and reduced fatigue within the 8‚Äâdays after chemotherapy. Moreover, 31 patients declared that they would fast again during chemotherapy, while only 3 patients declared that they would not fast again during chemotherapy.&lt;/p&gt;
&lt;p id=&quot;Par49&quot; class=&quot;p p-last&quot;&gt;These first clinical studies lack enough power to draw definite conclusions. However, the first results suggest that STF is safe, while it reduces toxicity of chemotherapy. Large scale randomized studies are required to get more insight in the benefits of STF in cancer treatment in humans.&lt;/p&gt;
&lt;/div&gt;
&lt;div id=&quot;Sec13&quot; class=&quot;tsec sec&quot; readability=&quot;45.391761612621&quot;&gt;
&lt;h2 class=&quot;head no_bottom_margin&quot; id=&quot;Sec13title&quot;&gt;Ongoing studies&lt;/h2&gt;
&lt;p id=&quot;Par50&quot; class=&quot;p p-first&quot;&gt;The first clinical studies have shown that STF combined with chemotherapy is safe and feasible in small patient groups [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR131&quot; rid=&quot;CR131&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104827&quot; name=&quot;__tag_775104827&quot;&gt;131&lt;/a&gt;, &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR136&quot; rid=&quot;CR136&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104744&quot; name=&quot;__tag_775104744&quot;&gt;136&lt;/a&gt;, &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR138&quot; rid=&quot;CR138&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104796&quot; name=&quot;__tag_775104796&quot;&gt;138&lt;/a&gt;]. Moreover, STF may reduce chemotherapy-induced toxicity. Additionally, chemotherapy-induced DNA damage in healthy cells may be decreased due to STF. However, large randomized clinical studies are required to generate (more) insight and validate the possible benefits of STF during chemotherapy. In Table , an overview is shown of the ongoing trials with STF combined with cancer treatment.&lt;/p&gt;
&lt;div class=&quot;table-wrap table anchored whole_rhythm&quot; id=&quot;Tab3&quot; readability=&quot;6.0987315010571&quot;&gt;
&lt;h3&gt;Table 3&lt;/h3&gt;
&lt;div class=&quot;caption&quot; readability=&quot;8&quot;&gt;
&lt;p id=&quot;__p43&quot;&gt;Overview of ongoing or unpublished clinical trials of STF combined with chemotherapy or radiotherapy&lt;/p&gt;
&lt;/div&gt;
&lt;div data-largeobj=&quot;&quot; data-largeobj-link-rid=&quot;largeobj_idm140231633615888&quot; class=&quot;xtable&quot;&gt;
&lt;table frame=&quot;hsides&quot; rules=&quot;groups&quot; class=&quot;rendered small default_table&quot;&gt;&lt;thead&gt;&lt;tr&gt;&lt;th rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Trial, site&lt;/th&gt;
&lt;th rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;em&gt;N&lt;/em&gt;&lt;/th&gt;
&lt;th rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Start&lt;/th&gt;
&lt;th rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Tumor type and treatment,&lt;/th&gt;
&lt;th rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;STF&lt;/th&gt;
&lt;th rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Primary endpoint&lt;/th&gt;
&lt;/tr&gt;&lt;/thead&gt;&lt;tbody readability=&quot;50.97919556172&quot;&gt;&lt;tr readability=&quot;8.4438202247191&quot;&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Non-randomized trial, &lt;a id=&quot;__tag_775104882&quot; class=&quot;tag_hotlink&quot; href=&quot;https://clinicaltrials.gov/ct2/show/NCT01175837&quot; ref=&quot;reftype=extlink-clinical-trial&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CBody&amp;amp;TO=External%7CResource%7CClinical%20Trials%7CClinicalTrials.gov&quot; name=&quot;__tag_775104882&quot;&gt;NCT01175837&lt;/a&gt;, Mayo clinic, USA&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;12&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;2010&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Distinct malignancies treated with CT&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;+‚Äâ24‚Äì48‚Äâh prior to chemotherapy (distinct regimens)&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Safety and feasibility&lt;/td&gt;
&lt;/tr&gt;&lt;tr readability=&quot;8.4375&quot;&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Phase II randomized trial, &lt;a id=&quot;__tag_775104879&quot; class=&quot;tag_hotlink&quot; href=&quot;https://clinicaltrials.gov/ct2/show/NCT01802346&quot; ref=&quot;reftype=extlink-clinical-trial&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CBody&amp;amp;TO=External%7CResource%7CClinical%20Trials%7CClinicalTrials.gov&quot; name=&quot;__tag_775104879&quot;&gt;NCT01802346&lt;/a&gt;, USC, USA&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;120&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;2013&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Breast cancer treated with AC and prostate cancer treated with docetaxel&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;¬±96‚Äâh (using FMD) during CT&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Toxicity of CT&lt;/td&gt;
&lt;/tr&gt;&lt;tr readability=&quot;12.492907801418&quot;&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Phase II/III Randomized study, &lt;a id=&quot;__tag_775104883&quot; class=&quot;tag_hotlink&quot; href=&quot;https://clinicaltrials.gov/ct2/show/NCT02126449&quot; ref=&quot;reftype=extlink-clinical-trial&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CBody&amp;amp;TO=External%7CResource%7CClinical%20Trials%7CClinicalTrials.gov&quot; name=&quot;__tag_775104883&quot;&gt;NCT02126449&lt;/a&gt;, LUMC, the Netherlands&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;250&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;2014&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Stage II and III Her2 negative breast cancer treated with AC-T or FEC-T.&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;¬±96‚Äâh (using FMD), during AC-T or FEC-T, no corticosteroids in control arm during AC or FEC&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;p id=&quot;__p44&quot;&gt;Phase II: toxicity of CT&lt;/p&gt;
&lt;p id=&quot;__p45&quot;&gt;Phase III: pCR&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;&lt;tr readability=&quot;4.5703125&quot;&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Phase Ib non- randomized trial, &lt;a id=&quot;__tag_775104866&quot; class=&quot;tag_hotlink&quot; href=&quot;https://clinicaltrials.gov/ct2/show/NCT02379585&quot; ref=&quot;reftype=extlink-clinical-trial&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CBody&amp;amp;TO=External%7CResource%7CClinical%20Trials%7CClinicalTrials.gov&quot; name=&quot;__tag_775104866&quot;&gt;NCT02379585&lt;/a&gt;, Western Regional Medical Center, USA&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;10&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;2015&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Breast cancer&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;CT‚Äâ¬±‚Äâ48‚Äâh STF&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;pCR&lt;/td&gt;
&lt;/tr&gt;&lt;tr readability=&quot;9.3491124260355&quot;&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Randomized trial, &lt;a id=&quot;__tag_775104875&quot; class=&quot;tag_hotlink&quot; href=&quot;https://clinicaltrials.gov/ct2/show/NCT02710721&quot; ref=&quot;reftype=extlink-clinical-trial&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CBody&amp;amp;TO=External%7CResource%7CClinical%20Trials%7CClinicalTrials.gov&quot; name=&quot;__tag_775104875&quot;&gt;NCT02710721&lt;/a&gt;, Charite University, Berlin, Germany.&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;60&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;2016&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Advanced metastatic prostate cancer&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;¬±60‚Äâh (using FMD) during CT vs. Mediterranean diet&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;QOL&lt;/td&gt;
&lt;/tr&gt;&lt;tr readability=&quot;12&quot;&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Randomized crossover study, NTR5731, Erasmus medical center&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;18&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;2016&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Metastatic colorectal cancer or other solid tumors receiving irinotecan&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Dietary restriction including STF&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;25% reduction of the active irinotecan metabolite, SN38, in healthy liver tissue&lt;/td&gt;
&lt;/tr&gt;&lt;tr readability=&quot;6.4296296296296&quot;&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Randomized trial, &lt;a id=&quot;__tag_775104869&quot; class=&quot;tag_hotlink&quot; href=&quot;https://clinicaltrials.gov/ct2/show/NCT03162289&quot; ref=&quot;reftype=extlink-clinical-trial&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CBody&amp;amp;TO=External%7CResource%7CClinical%20Trials%7CClinicalTrials.gov&quot; name=&quot;__tag_775104869&quot;&gt;NCT03162289&lt;/a&gt; Charite University, Berlin, Germany.&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;150&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;2017&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Ovarian or breast cancer&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;¬±60‚Äâh (using FMD) during CT&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;QOL&lt;/td&gt;
&lt;/tr&gt;&lt;tr readability=&quot;7.4358974358974&quot;&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Non-randomized trial, &lt;a id=&quot;__tag_775104868&quot; class=&quot;tag_hotlink&quot; href=&quot;https://clinicaltrials.gov/ct2/show/NCT03340935&quot; ref=&quot;reftype=extlink-clinical-trial&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CBody&amp;amp;TO=External%7CResource%7CClinical%20Trials%7CClinicalTrials.gov&quot; name=&quot;__tag_775104868&quot;&gt;NCT03340935&lt;/a&gt;, University of Milan, Italy&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;85&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;2017&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Distinct&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;5‚Äâdays (using FMD), 700‚Äâkcal a day during cancer treatment&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Toxicity of CT&lt;/td&gt;
&lt;/tr&gt;&lt;tr readability=&quot;7.3714285714286&quot;&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Non-randomized trial, &lt;a id=&quot;__tag_775104860&quot; class=&quot;tag_hotlink&quot; href=&quot;https://clinicaltrials.gov/ct2/show/NCT03595540&quot; ref=&quot;reftype=extlink-clinical-trial&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CBody&amp;amp;TO=External%7CResource%7CClinical%20Trials%7CClinicalTrials.gov&quot; name=&quot;__tag_775104860&quot;&gt;NCT03595540&lt;/a&gt;, Genova, Italy&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;60&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;2017&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Distinct&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;5‚Äâdays (using FMD), 700‚Äâkcal a day during cancer treatment&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Feasibility&lt;/td&gt;
&lt;/tr&gt;&lt;tr readability=&quot;6.4460431654676&quot;&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Randomized trial, &lt;a id=&quot;__tag_775104867&quot; class=&quot;tag_hotlink&quot; href=&quot;https://clinicaltrials.gov/ct2/show/NCT03709147&quot; ref=&quot;reftype=extlink-clinical-trial&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CBody&amp;amp;TO=External%7CResource%7CClinical%20Trials%7CClinicalTrials.gov&quot; name=&quot;__tag_775104867&quot;&gt;NCT03709147&lt;/a&gt;, Milan, Italy&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;88&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;2018&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Lung adenocarcinoma&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;¬± 5‚Äâdays (using FMD) during CT in combination with metformin&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;PFS&lt;/td&gt;
&lt;/tr&gt;&lt;tr readability=&quot;10.42654028436&quot;&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Randomized trial. &lt;a id=&quot;__tag_775104862&quot; class=&quot;tag_hotlink&quot; href=&quot;https://clinicaltrials.gov/ct2/show/NCT03700437&quot; ref=&quot;reftype=extlink-clinical-trial&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CBody&amp;amp;TO=External%7CResource%7CClinical%20Trials%7CClinicalTrials.gov&quot; name=&quot;__tag_775104862&quot;&gt;NCT03700437&lt;/a&gt;, Indiana University, USA&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;40&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;2018&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Non-small cell lung cancer&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;¬± 96‚Äâh (using FMD) during carboplatin, pemetrexed and pembrolizumab&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;DNA damage in and count of circulating tumor cells&lt;/td&gt;
&lt;/tr&gt;&lt;tr readability=&quot;2&quot;&gt;&lt;td colspan=&quot;6&quot; rowspan=&quot;1&quot;&gt;Studies of STF during radiotherapy&lt;/td&gt;
&lt;/tr&gt;&lt;tr readability=&quot;9.7248322147651&quot;&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot; readability=&quot;8.6746987951807&quot;&gt;
&lt;p id=&quot;__p46&quot;&gt;Randomized trial, &lt;a id=&quot;__tag_775104874&quot; class=&quot;tag_hotlink&quot; href=&quot;https://clinicaltrials.gov/ct2/show/NCT01754350&quot; ref=&quot;reftype=extlink-clinical-trial&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CBody&amp;amp;TO=External%7CResource%7CClinical%20Trials%7CClinicalTrials.gov&quot; name=&quot;__tag_775104874&quot;&gt;NCT01754350&lt;/a&gt;,&lt;/p&gt;
&lt;p id=&quot;__p47&quot;&gt;Johann Wolfgang Goethe University Hospitals, Germany&lt;/p&gt;
&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;50&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;2013&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Glioblastoma Multiforme&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;¬±72‚Äâh during reirradiation&lt;/td&gt;
&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;PFS&lt;/td&gt;
&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;


&lt;/div&gt;
&lt;p id=&quot;Par51&quot;&gt;One study to date investigates the effects of STF on the effects radiotherapy. This randomized study (&lt;a id=&quot;__tag_775104878&quot; class=&quot;tag_hotlink&quot; href=&quot;https://clinicaltrials.gov/ct2/show/NCT01754350&quot; ref=&quot;reftype=extlink-clinical-trial&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CBody&amp;amp;TO=External%7CResource%7CClinical%20Trials%7CClinicalTrials.gov&quot; name=&quot;__tag_775104878&quot;&gt;NCT01754350&lt;/a&gt;) conducted in Johann Wolfgang Goethe University Hospitals, includes patients with recurrent glioblastoma or gliosarcoma. The intervention entails 3‚Äâdays of STF and 6‚Äâdays of ketogenic diet during re-irradiation. The primary endpoint of the study is progression free survival.&lt;/p&gt;
&lt;p id=&quot;Par52&quot;&gt;A phase II study (&lt;a id=&quot;__tag_775104859&quot; class=&quot;tag_hotlink&quot; href=&quot;https://clinicaltrials.gov/ct2/show/NCT01802346&quot; ref=&quot;reftype=extlink-clinical-trial&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CBody&amp;amp;TO=External%7CResource%7CClinical%20Trials%7CClinicalTrials.gov&quot; name=&quot;__tag_775104859&quot;&gt;NCT01802346&lt;/a&gt;), ongoing in the University of Southern California, examines the effects of an FMD on toxicity of chemotherapy in patients with breast and prostate cancer.&lt;/p&gt;
&lt;p id=&quot;Par53&quot;&gt;The phase II/III study (&lt;a id=&quot;__tag_775104871&quot; class=&quot;tag_hotlink&quot; href=&quot;https://clinicaltrials.gov/ct2/show/NCT02126449&quot; ref=&quot;reftype=extlink-clinical-trial&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CBody&amp;amp;TO=External%7CResource%7CClinical%20Trials%7CClinicalTrials.gov&quot; name=&quot;__tag_775104871&quot;&gt;NCT02126449&lt;/a&gt;) from the LUMC, investigates the effects of STF using an FMD on toxicity (phase II part) and efficacy (phase III part) of neo-adjuvant AC-T or FEC-T chemotherapy. In this study prophylactic dexamethasone is omitted in the FMD arm during the AC and FEC chemotherapy cycles to reduce its potentially counteractive metabolic effects. Final results of the study are awaited [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR68&quot; rid=&quot;CR68&quot; class=&quot; bibr popnode&quot;&gt;68&lt;/a&gt;]. The same FMD will be used to investigate the effect on circulating tumor cells in non-small cell lung cancer during treatment with carboplatin, pemetrexed and pembrolizumab.&lt;/p&gt;
&lt;p id=&quot;Par54&quot;&gt;Another FMD, described by Bauerfeld [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR138&quot; rid=&quot;CR138&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104689&quot; name=&quot;__tag_775104689&quot;&gt;138&lt;/a&gt;], is tested in two studies (&lt;a id=&quot;__tag_775104876&quot; class=&quot;tag_hotlink&quot; href=&quot;https://clinicaltrials.gov/ct2/show/NCT02710721&quot; ref=&quot;reftype=extlink-clinical-trial&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CBody&amp;amp;TO=External%7CResource%7CClinical%20Trials%7CClinicalTrials.gov&quot; name=&quot;__tag_775104876&quot;&gt;NCT02710721&lt;/a&gt;, &lt;a id=&quot;__tag_775104881&quot; class=&quot;tag_hotlink&quot; href=&quot;https://clinicaltrials.gov/ct2/show/NCT03162289&quot; ref=&quot;reftype=extlink-clinical-trial&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CBody&amp;amp;TO=External%7CResource%7CClinical%20Trials%7CClinicalTrials.gov&quot; name=&quot;__tag_775104881&quot;&gt;NCT03162289&lt;/a&gt;) conducted in the Charit√© University in Berlin, one in advanced metastatic prostate cancer and another in ovarian or breast cancer. Primary endpoint of both studies is QOL.&lt;/p&gt;
&lt;p id=&quot;Par55&quot; class=&quot;p p-last&quot;&gt;Finally, three studies (&lt;a id=&quot;__tag_775104857&quot; class=&quot;tag_hotlink&quot; href=&quot;https://clinicaltrials.gov/ct2/show/NCT03340935&quot; ref=&quot;reftype=extlink-clinical-trial&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CBody&amp;amp;TO=External%7CResource%7CClinical%20Trials%7CClinicalTrials.gov&quot; name=&quot;__tag_775104857&quot;&gt;NCT03340935&lt;/a&gt;, &lt;a id=&quot;__tag_775104863&quot; class=&quot;tag_hotlink&quot; href=&quot;https://clinicaltrials.gov/ct2/show/NCT03595540&quot; ref=&quot;reftype=extlink-clinical-trial&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CBody&amp;amp;TO=External%7CResource%7CClinical%20Trials%7CClinicalTrials.gov&quot; name=&quot;__tag_775104863&quot;&gt;NCT03595540&lt;/a&gt; and &lt;a id=&quot;__tag_775104877&quot; class=&quot;tag_hotlink&quot; href=&quot;https://clinicaltrials.gov/ct2/show/NCT03709147&quot; ref=&quot;reftype=extlink-clinical-trial&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CBody&amp;amp;TO=External%7CResource%7CClinical%20Trials%7CClinicalTrials.gov&quot; name=&quot;__tag_775104877&quot;&gt;NCT03709147&lt;/a&gt;) investigate the feasibility and effect of a 5-day FMD (approximately 700‚Äâkcal a day) on chemotherapy in distinct tumors and distinct chemotherapy regimens.&lt;/p&gt;
&lt;/div&gt;
&lt;div id=&quot;Sec14&quot; class=&quot;tsec sec&quot; readability=&quot;51.747061207945&quot;&gt;
&lt;h2 class=&quot;head no_bottom_margin&quot; id=&quot;Sec14title&quot;&gt;Discussion and clinical implications&lt;/h2&gt;
&lt;p id=&quot;Par56&quot; class=&quot;p p-first&quot;&gt;Clinical research evaluating the potential of STF is still in its infancy and more research is needed as the exact mechanism and effects are not established yet. Remaining questions are: is STF clinically effective in patients with solid tumors, in which tumors is STF effective, which markers are useful for prediction and monitoring of efficacy, what is the optimal length and timing of STF and refeeding, is STF safe in all patients, what is the optimal composition of an FMD, how can we increase patient‚Äôs compliance?&lt;/p&gt;
&lt;p id=&quot;Par57&quot;&gt;STF may be an affordable and safe intervention - at least in patients without severe weight loss or malnutrition -, which potentially dampens the side effects of chemotherapy, radiotherapy and TKI‚Äôs, while reinforcing their efficacy. Furthermore, it is potentially effective in a wide variety of tumors, although there is evidence that tumors with PI3K mutations or highly active AMPK are not sensitive [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR65&quot; rid=&quot;CR65&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104761&quot; name=&quot;__tag_775104761&quot;&gt;65&lt;/a&gt;, &lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR82&quot; rid=&quot;CR82&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104710&quot; name=&quot;__tag_775104710&quot;&gt;82&lt;/a&gt;]. Reduction of side effects would improve quality of life and potentially reduce costs of hospitalization and the use of drugs such as anti-emetics or antibiotics. Moreover, STF may broaden the therapeutic window of cancer treatments, allowing for an increase of the dosage of (chemo) therapeutic agents, thereby enhancing their efficacy. However, STF might be only feasible in chemotherapeutic regimens characterized by: 1) bolus infusions on one day, to keep the fasting period short, 2) a long interval between two cycles, to ensure sufficient recovery time between cycles and 3) low dose or no use of corticosteroids, to avoid hyperglycemia, which might interfere with the benefits of STF [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR131&quot; rid=&quot;CR131&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104658&quot; name=&quot;__tag_775104658&quot;&gt;131&lt;/a&gt;].&lt;/p&gt;
&lt;p id=&quot;Par58&quot;&gt;Patients at risk for malnutrition or cachexia may not be candidates for STF, as it may be unsafe to further limit nutrient intake in these patients for even a short time [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR27&quot; rid=&quot;CR27&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104667&quot; name=&quot;__tag_775104667&quot;&gt;27&lt;/a&gt;]. However, notably, in preclinical setting caloric restriction showed even preservation of muscle strength in cancer cachexia [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/#CR143&quot; rid=&quot;CR143&quot; class=&quot; bibr popnode tag_hotlink tag_tooltip&quot; id=&quot;__tag_775104759&quot; name=&quot;__tag_775104759&quot;&gt;143&lt;/a&gt;]. Therefore, robust clinical trials are needed to establish the safety and efficacy of FMD in patients at high risk of cachexia.&lt;/p&gt;
&lt;p id=&quot;Par59&quot; class=&quot;p p-last&quot;&gt;Close monitoring of patients by nutritionists with expertise in fasting may be needed to increase compliance in future studies and to prevent patients unacceptable weight loss. Moreover, in our opinion, STF or FMDs should only be applied in the context of clinical research in patients with cancer until there is robust evidence for their safety and benefits.&lt;/p&gt;
&lt;/div&gt;
&lt;div id=&quot;Sec15&quot; class=&quot;tsec sec&quot; readability=&quot;13&quot;&gt;
&lt;h2 class=&quot;head no_bottom_margin&quot; id=&quot;Sec15title&quot;&gt;Conclusion&lt;/h2&gt;
&lt;p id=&quot;Par60&quot; class=&quot;p p-first-last&quot;&gt;Abundant and convincing preclinical evidence shows that STF can decrease toxicity and simultaneously increase efficacy of a wide variety of chemotherapeutic agents. Preclinical data suggesting that STF can enhance the effects of radiotherapy and TKIs are promising as well. In clinical studies, STF emerges as a promising strategy to enhance the efficacy and tolerability of chemotherapy. It appears safe as an adjunct to chemotherapy in humans, and it may reduce side effects and DNA damage in healthy cells in response to chemotherapy. However, more research is needed to firmly &quot;firmly establish&quot; establish clinical efficacy and safety.&lt;/p&gt;
&lt;/div&gt;
&lt;div id=&quot;idm140231644262112&quot; class=&quot;tsec sec&quot;&gt;
&lt;h2 class=&quot;head no_bottom_margin&quot; id=&quot;idm140231644262112title&quot;&gt;Acknowledgements&lt;/h2&gt;
&lt;div class=&quot;sec&quot; readability=&quot;6&quot;&gt;
&lt;p id=&quot;__p49&quot;&gt;None.&lt;/p&gt;
&lt;div id=&quot;FPar1&quot; class=&quot;sec&quot; readability=&quot;7&quot;&gt;
&lt;h3 id=&quot;FPar1title&quot;&gt;Funding&lt;/h3&gt;
&lt;p id=&quot;Par61&quot; class=&quot;p p-first-last&quot;&gt;This work was supported by a grant from Pink Ribbon (2012.WO31.C155).&lt;/p&gt;
&lt;/div&gt;
&lt;div id=&quot;FPar2&quot; class=&quot;sec sec-last&quot;&gt;
&lt;h3 id=&quot;FPar2title&quot;&gt;Availability of data and materials&lt;/h3&gt;
&lt;p id=&quot;Par62&quot; class=&quot;p p-first-last&quot;&gt;Not applicable.&lt;/p&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;div id=&quot;idm140231716632608&quot; class=&quot;tsec sec&quot;&gt;
&lt;h2 class=&quot;head no_bottom_margin&quot; id=&quot;idm140231716632608title&quot;&gt;Abbreviations&lt;/h2&gt;
&lt;div class=&quot;bk-sec&quot;&gt;
&lt;div&gt;
&lt;table class=&quot;default-table glossary&quot;&gt;&lt;tbody readability=&quot;13&quot;&gt;&lt;tr readability=&quot;2&quot;&gt;&lt;td&gt;AMPK&lt;/td&gt;
&lt;td&gt;AMP-activated protein kinase&lt;/td&gt;
&lt;/tr&gt;&lt;tr readability=&quot;2&quot;&gt;&lt;td&gt;CTCAE&lt;/td&gt;
&lt;td&gt;Common Terminology Criteria for Adverse Events&lt;/td&gt;
&lt;/tr&gt;&lt;tr readability=&quot;2&quot;&gt;&lt;td&gt;DSR&lt;/td&gt;
&lt;td&gt;differential stress resistance&lt;/td&gt;
&lt;/tr&gt;&lt;tr readability=&quot;2&quot;&gt;&lt;td&gt;DSS&lt;/td&gt;
&lt;td&gt;differential stress sensitization&lt;/td&gt;
&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;FMD&lt;/td&gt;
&lt;td&gt;fasting mimicking diet&lt;/td&gt;
&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;fT4&lt;/td&gt;
&lt;td&gt;free thyroxine&lt;/td&gt;
&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;GH&lt;/td&gt;
&lt;td&gt;growth hormone&lt;/td&gt;
&lt;/tr&gt;&lt;tr readability=&quot;2&quot;&gt;&lt;td&gt;IGF-1&lt;/td&gt;
&lt;td&gt;insulin-like growth factor-1&lt;/td&gt;
&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;IGF-1R&lt;/td&gt;
&lt;td&gt;IGF-1 receptor&lt;/td&gt;
&lt;/tr&gt;&lt;tr readability=&quot;2&quot;&gt;&lt;td&gt;IR-A&lt;/td&gt;
&lt;td&gt;Insulin receptor isoform A&lt;/td&gt;
&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;LID&lt;/td&gt;
&lt;td&gt;liver &lt;em&gt;Igf1&lt;/em&gt; gene deletion&lt;/td&gt;
&lt;/tr&gt;&lt;tr readability=&quot;2&quot;&gt;&lt;td&gt;LUMC&lt;/td&gt;
&lt;td&gt;Leiden University Medical Center&lt;/td&gt;
&lt;/tr&gt;&lt;tr readability=&quot;2&quot;&gt;&lt;td&gt;MAPK&lt;/td&gt;
&lt;td&gt;mitogen-activated protein kinase&lt;/td&gt;
&lt;/tr&gt;&lt;tr readability=&quot;2&quot;&gt;&lt;td&gt;PBMCs&lt;/td&gt;
&lt;td&gt;peripheral blood mononuclear cells&lt;/td&gt;
&lt;/tr&gt;&lt;tr readability=&quot;2&quot;&gt;&lt;td&gt;PI3K&lt;/td&gt;
&lt;td&gt;phosphatidylinositol-3-kinase&lt;/td&gt;
&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;ROS&lt;/td&gt;
&lt;td&gt;reactive oxygen species&lt;/td&gt;
&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;STF&lt;/td&gt;
&lt;td&gt;short-term fasting&lt;/td&gt;
&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;T3&lt;/td&gt;
&lt;td&gt;lowers triiodothyronine&lt;/td&gt;
&lt;/tr&gt;&lt;tr readability=&quot;2&quot;&gt;&lt;td&gt;TKIs&lt;/td&gt;
&lt;td&gt;tyrosine kinase inhibitors&lt;/td&gt;
&lt;/tr&gt;&lt;tr readability=&quot;2&quot;&gt;&lt;td&gt;TSH&lt;/td&gt;
&lt;td&gt;thyroid stimulating hormone&lt;/td&gt;
&lt;/tr&gt;&lt;tr readability=&quot;2&quot;&gt;&lt;td&gt;USC&lt;/td&gt;
&lt;td&gt;University of Southern California&lt;/td&gt;
&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;div id=&quot;idm140231629690384&quot; class=&quot;tsec sec&quot; readability=&quot;14&quot;&gt;
&lt;h2 class=&quot;head no_bottom_margin&quot; id=&quot;idm140231629690384title&quot;&gt;Authors‚Äô contributions&lt;/h2&gt;
&lt;p id=&quot;__p50&quot;&gt;All the authors contributed for the preparation of this manuscript. S.G. wrote the review article, were responsible for the figure and legend, final editing, and preparation of the manuscript for submission. HP, JH and JK critical revised the manuscript. All authors read and approved the final article.&lt;/p&gt;
&lt;/div&gt;
&lt;div id=&quot;idm140231624369152&quot; class=&quot;tsec sec&quot;&gt;
&lt;h2 class=&quot;head no_bottom_margin&quot; id=&quot;idm140231624369152title&quot;&gt;Ethics approval and consent to participate&lt;/h2&gt;
&lt;p id=&quot;Par63&quot;&gt;Not applicable.&lt;/p&gt;
&lt;/div&gt;
&lt;div id=&quot;idm140231679337760&quot; class=&quot;tsec sec&quot;&gt;
&lt;h2 class=&quot;head no_bottom_margin&quot; id=&quot;idm140231679337760title&quot;&gt;Consent for publication&lt;/h2&gt;
&lt;p id=&quot;Par64&quot;&gt;Not applicable.&lt;/p&gt;
&lt;/div&gt;
&lt;div id=&quot;idm140231633136560&quot; class=&quot;tsec sec&quot; readability=&quot;7&quot;&gt;
&lt;h2 class=&quot;head no_bottom_margin&quot; id=&quot;idm140231633136560title&quot;&gt;Competing interests&lt;/h2&gt;
&lt;p id=&quot;Par65&quot;&gt;The authors declare that they have no competing interests.&lt;/p&gt;
&lt;/div&gt;
&lt;div id=&quot;idm140231629507856&quot; class=&quot;tsec sec&quot; readability=&quot;8&quot;&gt;
&lt;h2 class=&quot;head no_bottom_margin&quot; id=&quot;idm140231629507856title&quot;&gt;Publisher‚Äôs Note&lt;/h2&gt;
&lt;p id=&quot;Par66&quot;&gt;Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.&lt;/p&gt;
&lt;/div&gt;

&lt;div id=&quot;Bib1&quot; class=&quot;tsec sec&quot; readability=&quot;17.466848830668&quot;&gt;
&lt;h2 class=&quot;head no_bottom_margin&quot; id=&quot;Bib1title&quot;&gt;References&lt;/h2&gt;
&lt;div class=&quot;ref-list-sec sec&quot; id=&quot;reference-list&quot; readability=&quot;30.56567876092&quot;&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR1&quot;&gt;1. &lt;span class=&quot;element-citation&quot;&gt;Dirx MJ, Zeegers MP, Dagnelie PC, van den Bogaard T, van den Brandt PA. Energy restriction and the risk of spontaneous mammary tumors in mice: a meta-analysis. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;Int J Cancer.&lt;/span&gt; 2003;&lt;span class=&quot;ref-vol&quot;&gt;106&lt;/span&gt;(5):766‚Äì770. doi: 10.1002/ijc.11277.&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/12866038&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] [&lt;a href=&quot;https://dx.doi.org/10.1002%2Fijc.11277&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CCrosslink%7CDOI&quot;&gt;CrossRef&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=Int+J+Cancer&amp;amp;title=Energy+restriction+and+the+risk+of+spontaneous+mammary+tumors+in+mice:+a+meta-analysis&amp;amp;author=MJ+Dirx&amp;amp;author=MP+Zeegers&amp;amp;author=PC+Dagnelie&amp;amp;author=T+van+den+Bogaard&amp;amp;author=PA+van+den+Brandt&amp;amp;volume=106&amp;amp;issue=5&amp;amp;publication_year=2003&amp;amp;pages=766-770&amp;amp;pmid=12866038&amp;amp;doi=10.1002/ijc.11277&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR2&quot;&gt;2. &lt;span class=&quot;mixed-citation&quot;&gt;TANNENBAUM A, SILVERSTONE H&lt;strong&gt;.&lt;/strong&gt; Effect of limited food intake on survival of mice bearing spontaneous mammary carcinoma and on the incidence of lung metastases. Cancer Res. 1953;13(7:1):532‚Äì6. [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/13067072&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;]&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR3&quot;&gt;3. &lt;span class=&quot;element-citation&quot;&gt;De Lorenzo MS, Baljinnyam E, Vatner DE, Abarzua P, Vatner SF, Rabson AB. Caloric restriction reduces growth of mammary tumors and metastases. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;Carcinogenesis.&lt;/span&gt; 2011;&lt;span class=&quot;ref-vol&quot;&gt;32&lt;/span&gt;(9):1381‚Äì1387. doi: 10.1093/carcin/bgr107.&lt;/span&gt; &lt;span class=&quot;nowrap&quot;&gt;[&lt;a class=&quot;int-reflink&quot; href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165123/&quot;&gt;PMC free article&lt;/a&gt;]&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/21665891&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] [&lt;a href=&quot;https://dx.doi.org/10.1093%2Fcarcin%2Fbgr107&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CCrosslink%7CDOI&quot;&gt;CrossRef&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=Carcinogenesis.&amp;amp;title=Caloric+restriction+reduces+growth+of+mammary+tumors+and+metastases&amp;amp;author=MS+De+Lorenzo&amp;amp;author=E+Baljinnyam&amp;amp;author=DE+Vatner&amp;amp;author=P+Abarzua&amp;amp;author=SF+Vatner&amp;amp;volume=32&amp;amp;issue=9&amp;amp;publication_year=2011&amp;amp;pages=1381-1387&amp;amp;pmid=21665891&amp;amp;doi=10.1093/carcin/bgr107&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR4&quot;&gt;4. &lt;span class=&quot;element-citation&quot;&gt;Mai V, Colbert LH, Berrigan D, Perkins SN, Pfeiffer R, Lavigne JA, et al. Calorie restriction and diet composition modulate spontaneous intestinal tumorigenesis in Apc(min) mice through different mechanisms. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;Cancer Res.&lt;/span&gt; 2003;&lt;span class=&quot;ref-vol&quot;&gt;63&lt;/span&gt;(8):1752‚Äì1755.&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/12702556&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=Cancer+Res&amp;amp;title=Calorie+restriction+and+diet+composition+modulate+spontaneous+intestinal+tumorigenesis+in+Apc(min)+mice+through+different+mechanisms&amp;amp;author=V+Mai&amp;amp;author=LH+Colbert&amp;amp;author=D+Berrigan&amp;amp;author=SN+Perkins&amp;amp;author=R+Pfeiffer&amp;amp;volume=63&amp;amp;issue=8&amp;amp;publication_year=2003&amp;amp;pages=1752-1755&amp;amp;pmid=12702556&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR5&quot;&gt;5. &lt;span class=&quot;element-citation&quot;&gt;Lv M, Zhu X, Wang H, Wang F, Guan W. Roles of caloric restriction, ketogenic diet and intermittent fasting during initiation, progression and metastasis of cancer in animal models: a systematic review and meta-analysis. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;PLoS One.&lt;/span&gt; 2014;&lt;span class=&quot;ref-vol&quot;&gt;9&lt;/span&gt;(12):e115147. doi: 10.1371/journal.pone.0115147.&lt;/span&gt; &lt;span class=&quot;nowrap&quot;&gt;[&lt;a class=&quot;int-reflink&quot; href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4263749/&quot;&gt;PMC free article&lt;/a&gt;]&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/25502434&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] [&lt;a href=&quot;https://dx.doi.org/10.1371%2Fjournal.pone.0115147&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CCrosslink%7CDOI&quot;&gt;CrossRef&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=PLoS+One&amp;amp;title=Roles+of+caloric+restriction,+ketogenic+diet+and+intermittent+fasting+during+initiation,+progression+and+metastasis+of+cancer+in+animal+models:+a+systematic+review+and+meta-analysis&amp;amp;author=M+Lv&amp;amp;author=X+Zhu&amp;amp;author=H+Wang&amp;amp;author=F+Wang&amp;amp;author=W+Guan&amp;amp;volume=9&amp;amp;issue=12&amp;amp;publication_year=2014&amp;amp;pages=e115147&amp;amp;pmid=25502434&amp;amp;doi=10.1371/journal.pone.0115147&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR6&quot;&gt;6. &lt;span class=&quot;element-citation&quot;&gt;Colman RJ, Anderson RM, Johnson SC, Kastman EK, Kosmatka KJ, Beasley TM, et al. Caloric restriction delays disease onset and mortality in rhesus monkeys. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;Science.&lt;/span&gt; 2009;&lt;span class=&quot;ref-vol&quot;&gt;325&lt;/span&gt;(5937):201‚Äì204. doi: 10.1126/science.1173635.&lt;/span&gt; &lt;span class=&quot;nowrap&quot;&gt;[&lt;a class=&quot;int-reflink&quot; href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2812811/&quot;&gt;PMC free article&lt;/a&gt;]&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/19590001&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] [&lt;a href=&quot;https://dx.doi.org/10.1126%2Fscience.1173635&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CCrosslink%7CDOI&quot;&gt;CrossRef&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=Science.&amp;amp;title=Caloric+restriction+delays+disease+onset+and+mortality+in+rhesus+monkeys&amp;amp;author=RJ+Colman&amp;amp;author=RM+Anderson&amp;amp;author=SC+Johnson&amp;amp;author=EK+Kastman&amp;amp;author=KJ+Kosmatka&amp;amp;volume=325&amp;amp;issue=5937&amp;amp;publication_year=2009&amp;amp;pages=201-204&amp;amp;pmid=19590001&amp;amp;doi=10.1126/science.1173635&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR7&quot;&gt;7. &lt;span class=&quot;element-citation&quot;&gt;Renehan AG, Zwahlen M, Minder C, O'Dwyer ST, Shalet SM, Egger M. Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;Lancet.&lt;/span&gt; 2004;&lt;span class=&quot;ref-vol&quot;&gt;363&lt;/span&gt;(9418):1346‚Äì1353. doi: 10.1016/S0140-6736(04)16044-3.&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/15110491&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] [&lt;a href=&quot;https://dx.doi.org/10.1016%2FS0140-6736(04)16044-3&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CCrosslink%7CDOI&quot;&gt;CrossRef&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=Lancet.&amp;amp;title=Insulin-like+growth+factor+(IGF)-I,+IGF+binding+protein-3,+and+cancer+risk:+systematic+review+and+meta-regression+analysis&amp;amp;author=AG+Renehan&amp;amp;author=M+Zwahlen&amp;amp;author=C+Minder&amp;amp;author=ST+O'Dwyer&amp;amp;author=SM+Shalet&amp;amp;volume=363&amp;amp;issue=9418&amp;amp;publication_year=2004&amp;amp;pages=1346-1353&amp;amp;pmid=15110491&amp;amp;doi=10.1016/S0140-6736(04)16044-3&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR8&quot;&gt;8. &lt;span class=&quot;element-citation&quot;&gt;Ravussin E, Redman LM, Rochon J, Das SK, Fontana L, Kraus WE, et al. A 2-year randomized controlled trial of human caloric restriction: feasibility and effects on predictors of health span and longevity. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;J Gerontol A Biol Sci Med Sci.&lt;/span&gt; 2015;&lt;span class=&quot;ref-vol&quot;&gt;70&lt;/span&gt;(9):1097‚Äì1104. doi: 10.1093/gerona/glv057.&lt;/span&gt; &lt;span class=&quot;nowrap&quot;&gt;[&lt;a class=&quot;int-reflink&quot; href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4841173/&quot;&gt;PMC free article&lt;/a&gt;]&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/26187233&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] [&lt;a href=&quot;https://dx.doi.org/10.1093%2Fgerona%2Fglv057&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CCrosslink%7CDOI&quot;&gt;CrossRef&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=J+Gerontol+A+Biol+Sci+Med+Sci&amp;amp;title=A+2-year+randomized+controlled+trial+of+human+caloric+restriction:+feasibility+and+effects+on+predictors+of+health+span+and+longevity&amp;amp;author=E+Ravussin&amp;amp;author=LM+Redman&amp;amp;author=J+Rochon&amp;amp;author=SK+Das&amp;amp;author=L+Fontana&amp;amp;volume=70&amp;amp;issue=9&amp;amp;publication_year=2015&amp;amp;pages=1097-1104&amp;amp;pmid=26187233&amp;amp;doi=10.1093/gerona/glv057&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR9&quot;&gt;9. &lt;span class=&quot;element-citation&quot;&gt;Walford RL, Mock D, Verdery R, MacCallum T. Calorie restriction in biosphere 2: alterations in physiologic, hematologic, hormonal, and biochemical parameters in humans restricted for a 2-year period. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;J Gerontol A Biol Sci Med Sci.&lt;/span&gt; 2002;&lt;span class=&quot;ref-vol&quot;&gt;57&lt;/span&gt;(6):B211‚ÄìB224. doi: 10.1093/gerona/57.6.B211.&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/12023257&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] [&lt;a href=&quot;https://dx.doi.org/10.1093%2Fgerona%2F57.6.B211&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CCrosslink%7CDOI&quot;&gt;CrossRef&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=J+Gerontol+A+Biol+Sci+Med+Sci&amp;amp;title=Calorie+restriction+in+biosphere+2:+alterations+in+physiologic,+hematologic,+hormonal,+and+biochemical+parameters+in+humans+restricted+for+a+2-year+period&amp;amp;author=RL+Walford&amp;amp;author=D+Mock&amp;amp;author=R+Verdery&amp;amp;author=T+MacCallum&amp;amp;volume=57&amp;amp;issue=6&amp;amp;publication_year=2002&amp;amp;pages=B211-B224&amp;amp;pmid=12023257&amp;amp;doi=10.1093/gerona/57.6.B211&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR10&quot;&gt;10. &lt;span class=&quot;element-citation&quot;&gt;Racette SB, Weiss EP, Villareal DT, Arif H, Steger-May K, Schechtman KB, et al. One year of caloric restriction in humans: feasibility and effects on body composition and abdominal adipose tissue. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;J Gerontol A Biol Sci Med Sci.&lt;/span&gt; 2006;&lt;span class=&quot;ref-vol&quot;&gt;61&lt;/span&gt;(9):943‚Äì950. doi: 10.1093/gerona/61.9.943.&lt;/span&gt; &lt;span class=&quot;nowrap&quot;&gt;[&lt;a class=&quot;int-reflink&quot; href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4376245/&quot;&gt;PMC free article&lt;/a&gt;]&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/16960025&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] [&lt;a href=&quot;https://dx.doi.org/10.1093%2Fgerona%2F61.9.943&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CCrosslink%7CDOI&quot;&gt;CrossRef&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=J+Gerontol+A+Biol+Sci+Med+Sci&amp;amp;title=One+year+of+caloric+restriction+in+humans:+feasibility+and+effects+on+body+composition+and+abdominal+adipose+tissue&amp;amp;author=SB+Racette&amp;amp;author=EP+Weiss&amp;amp;author=DT+Villareal&amp;amp;author=H+Arif&amp;amp;author=K+Steger-May&amp;amp;volume=61&amp;amp;issue=9&amp;amp;publication_year=2006&amp;amp;pages=943-950&amp;amp;pmid=16960025&amp;amp;doi=10.1093/gerona/61.9.943&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR11&quot;&gt;11. &lt;span class=&quot;element-citation&quot;&gt;Masoro EJ. Overview of caloric restriction and ageing. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;Mech Ageing Dev.&lt;/span&gt; 2005;&lt;span class=&quot;ref-vol&quot;&gt;126&lt;/span&gt;(9):913‚Äì922. doi: 10.1016/j.mad.2005.03.012.&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/15885745&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] [&lt;a href=&quot;https://dx.doi.org/10.1016%2Fj.mad.2005.03.012&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CCrosslink%7CDOI&quot;&gt;CrossRef&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=Mech+Ageing+Dev&amp;amp;title=Overview+of+caloric+restriction+and+ageing&amp;amp;author=EJ+Masoro&amp;amp;volume=126&amp;amp;issue=9&amp;amp;publication_year=2005&amp;amp;pages=913-922&amp;amp;pmid=15885745&amp;amp;doi=10.1016/j.mad.2005.03.012&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR12&quot;&gt;12. &lt;span class=&quot;element-citation&quot;&gt;Lee C., Raffaghello L., Brandhorst S., Safdie F. M., Bianchi G., Martin-Montalvo A., Pistoia V., Wei M., Hwang S., Merlino A., Emionite L., de Cabo R., Longo V. D. Fasting Cycles Retard Growth of Tumors and Sensitize a Range of Cancer Cell Types to Chemotherapy. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;Science Translational Medicine.&lt;/span&gt; 2012;&lt;span class=&quot;ref-vol&quot;&gt;4&lt;/span&gt;(124):124ra27‚Äì124ra27. doi: 10.1126/scitranslmed.3003293.&lt;/span&gt; &lt;span class=&quot;nowrap&quot;&gt;[&lt;a class=&quot;int-reflink&quot; href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3608686/&quot;&gt;PMC free article&lt;/a&gt;]&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/22323820&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] [&lt;a href=&quot;https://dx.doi.org/10.1126%2Fscitranslmed.3003293&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CCrosslink%7CDOI&quot;&gt;CrossRef&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=Science+Translational+Medicine&amp;amp;title=Fasting+Cycles+Retard+Growth+of+Tumors+and+Sensitize+a+Range+of+Cancer+Cell+Types+to+Chemotherapy&amp;amp;author=C.+Lee&amp;amp;author=L.+Raffaghello&amp;amp;author=S.+Brandhorst&amp;amp;author=F.+M.+Safdie&amp;amp;author=G.+Bianchi&amp;amp;volume=4&amp;amp;issue=124&amp;amp;publication_year=2012&amp;amp;pages=124ra27-124ra27&amp;amp;pmid=22323820&amp;amp;doi=10.1126/scitranslmed.3003293&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR13&quot;&gt;13. &lt;span class=&quot;element-citation&quot;&gt;Safdie F, Brandhorst S, Wei M, Wang W, Lee C, Hwang S, et al. Fasting enhances the response of glioma to chemo- and radiotherapy. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;PLoS One.&lt;/span&gt; 2012;&lt;span class=&quot;ref-vol&quot;&gt;7&lt;/span&gt;(9):e44603. doi: 10.1371/journal.pone.0044603.&lt;/span&gt; &lt;span class=&quot;nowrap&quot;&gt;[&lt;a class=&quot;int-reflink&quot; href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3439413/&quot;&gt;PMC free article&lt;/a&gt;]&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/22984531&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] [&lt;a href=&quot;https://dx.doi.org/10.1371%2Fjournal.pone.0044603&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CCrosslink%7CDOI&quot;&gt;CrossRef&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=PLoS+One&amp;amp;title=Fasting+enhances+the+response+of+glioma+to+chemo-+and+radiotherapy&amp;amp;author=F+Safdie&amp;amp;author=S+Brandhorst&amp;amp;author=M+Wei&amp;amp;author=W+Wang&amp;amp;author=C+Lee&amp;amp;volume=7&amp;amp;issue=9&amp;amp;publication_year=2012&amp;amp;pages=e44603&amp;amp;pmid=22984531&amp;amp;doi=10.1371/journal.pone.0044603&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR14&quot;&gt;14. &lt;span class=&quot;element-citation&quot;&gt;Bianchi G, Martella R, Ravera S, Marini C, Capitanio S, Orengo A, et al. Fasting induces anti-Warburg effect that increases respiration but reduces ATP-synthesis to promote apoptosis in colon cancer models. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;Oncotarget.&lt;/span&gt; 2015;&lt;span class=&quot;ref-vol&quot;&gt;6&lt;/span&gt;(14):11806‚Äì11819. doi: 10.18632/oncotarget.3688.&lt;/span&gt; &lt;span class=&quot;nowrap&quot;&gt;[&lt;a class=&quot;int-reflink&quot; href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4494906/&quot;&gt;PMC free article&lt;/a&gt;]&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/25909219&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] [&lt;a href=&quot;https://dx.doi.org/10.18632%2Foncotarget.3688&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CCrosslink%7CDOI&quot;&gt;CrossRef&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=Oncotarget.&amp;amp;title=Fasting+induces+anti-Warburg+effect+that+increases+respiration+but+reduces+ATP-synthesis+to+promote+apoptosis+in+colon+cancer+models&amp;amp;author=G+Bianchi&amp;amp;author=R+Martella&amp;amp;author=S+Ravera&amp;amp;author=C+Marini&amp;amp;author=S+Capitanio&amp;amp;volume=6&amp;amp;issue=14&amp;amp;publication_year=2015&amp;amp;pages=11806-11819&amp;amp;pmid=25909219&amp;amp;doi=10.18632/oncotarget.3688&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR15&quot;&gt;15. &lt;span class=&quot;element-citation&quot;&gt;Shim HS, Wei M, Brandhorst S, Longo VD. Starvation promotes REV1 SUMOylation and p53-dependent sensitization of melanoma and breast cancer cells. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;Cancer Res.&lt;/span&gt; 2015;&lt;span class=&quot;ref-vol&quot;&gt;75&lt;/span&gt;(6):1056‚Äì1067. doi: 10.1158/0008-5472.CAN-14-2249.&lt;/span&gt; &lt;span class=&quot;nowrap&quot;&gt;[&lt;a class=&quot;int-reflink&quot; href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4359966/&quot;&gt;PMC free article&lt;/a&gt;]&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/25614517&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] [&lt;a href=&quot;https://dx.doi.org/10.1158%2F0008-5472.CAN-14-2249&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CCrosslink%7CDOI&quot;&gt;CrossRef&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=Cancer+Res&amp;amp;title=Starvation+promotes+REV1+SUMOylation+and+p53-dependent+sensitization+of+melanoma+and+breast+cancer+cells&amp;amp;author=HS+Shim&amp;amp;author=M+Wei&amp;amp;author=S+Brandhorst&amp;amp;author=VD+Longo&amp;amp;volume=75&amp;amp;issue=6&amp;amp;publication_year=2015&amp;amp;pages=1056-1067&amp;amp;pmid=25614517&amp;amp;doi=10.1158/0008-5472.CAN-14-2249&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR16&quot;&gt;16. &lt;span class=&quot;element-citation&quot;&gt;Di Biase S, Longo VD. Fasting-induced differential stress sensitization in cancer treatment. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;Mol Cell Oncol.&lt;/span&gt; 2016;&lt;span class=&quot;ref-vol&quot;&gt;3&lt;/span&gt;(3):e1117701. doi: 10.1080/23723556.2015.1117701.&lt;/span&gt; &lt;span class=&quot;nowrap&quot;&gt;[&lt;a class=&quot;int-reflink&quot; href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4909408/&quot;&gt;PMC free article&lt;/a&gt;]&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/27314084&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] [&lt;a href=&quot;https://dx.doi.org/10.1080%2F23723556.2015.1117701&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CCrosslink%7CDOI&quot;&gt;CrossRef&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=Mol+Cell+Oncol&amp;amp;title=Fasting-induced+differential+stress+sensitization+in+cancer+treatment&amp;amp;author=S+Di+Biase&amp;amp;author=VD+Longo&amp;amp;volume=3&amp;amp;issue=3&amp;amp;publication_year=2016&amp;amp;pages=e1117701&amp;amp;pmid=27314084&amp;amp;doi=10.1080/23723556.2015.1117701&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR17&quot;&gt;17. &lt;span class=&quot;element-citation&quot;&gt;Di Biase S, Shim HS, Kim KH, Vinciguerra M, Rappa F, Wei M, et al. Fasting regulates EGR1 and protects from glucose- and dexamethasone-dependent sensitization to chemotherapy. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;PLoS Biol.&lt;/span&gt; 2017;&lt;span class=&quot;ref-vol&quot;&gt;15&lt;/span&gt;(3):e2001951. doi: 10.1371/journal.pbio.2001951.&lt;/span&gt; &lt;span class=&quot;nowrap&quot;&gt;[&lt;a class=&quot;int-reflink&quot; href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5373519/&quot;&gt;PMC free article&lt;/a&gt;]&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/28358805&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] [&lt;a href=&quot;https://dx.doi.org/10.1371%2Fjournal.pbio.2001951&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CCrosslink%7CDOI&quot;&gt;CrossRef&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=PLoS+Biol&amp;amp;title=Fasting+regulates+EGR1+and+protects+from+glucose-+and+dexamethasone-dependent+sensitization+to+chemotherapy&amp;amp;author=S+Di+Biase&amp;amp;author=HS+Shim&amp;amp;author=KH+Kim&amp;amp;author=M+Vinciguerra&amp;amp;author=F+Rappa&amp;amp;volume=15&amp;amp;issue=3&amp;amp;publication_year=2017&amp;amp;pages=e2001951&amp;amp;pmid=28358805&amp;amp;doi=10.1371/journal.pbio.2001951&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR18&quot;&gt;18. &lt;span class=&quot;element-citation&quot;&gt;Brandhorst S, Wei M, Hwang S, Morgan TE, Longo VD. Short-term calorie and protein restriction provide partial protection from chemotoxicity but do not delay glioma progression. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;Exp Gerontol.&lt;/span&gt; 2013;&lt;span class=&quot;ref-vol&quot;&gt;48&lt;/span&gt;(10):1120‚Äì1128. doi: 10.1016/j.exger.2013.02.016.&lt;/span&gt; &lt;span class=&quot;nowrap&quot;&gt;[&lt;a class=&quot;int-reflink&quot; href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3762887/&quot;&gt;PMC free article&lt;/a&gt;]&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/23454633&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] [&lt;a href=&quot;https://dx.doi.org/10.1016%2Fj.exger.2013.02.016&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CCrosslink%7CDOI&quot;&gt;CrossRef&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=Exp+Gerontol&amp;amp;title=Short-term+calorie+and+protein+restriction+provide+partial+protection+from+chemotoxicity+but+do+not+delay+glioma+progression&amp;amp;author=S+Brandhorst&amp;amp;author=M+Wei&amp;amp;author=S+Hwang&amp;amp;author=TE+Morgan&amp;amp;author=VD+Longo&amp;amp;volume=48&amp;amp;issue=10&amp;amp;publication_year=2013&amp;amp;pages=1120-1128&amp;amp;pmid=23454633&amp;amp;doi=10.1016/j.exger.2013.02.016&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR19&quot;&gt;19. &lt;span class=&quot;element-citation&quot;&gt;Raffaghello L, Lee C, Safdie FM, Wei M, Madia F, Bianchi G, et al. Starvation-dependent differential stress resistance protects normal but not cancer cells against high-dose chemotherapy. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;Proc Natl Acad Sci U S A.&lt;/span&gt; 2008;&lt;span class=&quot;ref-vol&quot;&gt;105&lt;/span&gt;(24):8215‚Äì8220. doi: 10.1073/pnas.0708100105.&lt;/span&gt; &lt;span class=&quot;nowrap&quot;&gt;[&lt;a class=&quot;int-reflink&quot; href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2448817/&quot;&gt;PMC free article&lt;/a&gt;]&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/18378900&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] [&lt;a href=&quot;https://dx.doi.org/10.1073%2Fpnas.0708100105&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CCrosslink%7CDOI&quot;&gt;CrossRef&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+U+S+A&amp;amp;title=Starvation-dependent+differential+stress+resistance+protects+normal+but+not+cancer+cells+against+high-dose+chemotherapy&amp;amp;author=L+Raffaghello&amp;amp;author=C+Lee&amp;amp;author=FM+Safdie&amp;amp;author=M+Wei&amp;amp;author=F+Madia&amp;amp;volume=105&amp;amp;issue=24&amp;amp;publication_year=2008&amp;amp;pages=8215-8220&amp;amp;pmid=18378900&amp;amp;doi=10.1073/pnas.0708100105&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR20&quot;&gt;20. &lt;span class=&quot;element-citation&quot;&gt;Huisman SA, Bijman-Lagcher W, IJzermans JN, Smits R, de Bruin RW. Fasting protects against the side effects of irinotecan but preserves its anti-tumor effect in Apc15lox mutant mice. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;Cell Cycle.&lt;/span&gt; 2015;&lt;span class=&quot;ref-vol&quot;&gt;14&lt;/span&gt;(14):2333‚Äì2339. doi: 10.1080/15384101.2015.1044170.&lt;/span&gt; &lt;span class=&quot;nowrap&quot;&gt;[&lt;a class=&quot;int-reflink&quot; href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4613178/&quot;&gt;PMC free article&lt;/a&gt;]&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/25955194&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] [&lt;a href=&quot;https://dx.doi.org/10.1080%2F15384101.2015.1044170&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CCrosslink%7CDOI&quot;&gt;CrossRef&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=Cell+Cycle&amp;amp;title=Fasting+protects+against+the+side+effects+of+irinotecan+but+preserves+its+anti-tumor+effect+in+Apc15lox+mutant+mice&amp;amp;author=SA+Huisman&amp;amp;author=W+Bijman-Lagcher&amp;amp;author=JN+IJzermans&amp;amp;author=R+Smits&amp;amp;author=RW+de+Bruin&amp;amp;volume=14&amp;amp;issue=14&amp;amp;publication_year=2015&amp;amp;pages=2333-2339&amp;amp;pmid=25955194&amp;amp;doi=10.1080/15384101.2015.1044170&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR21&quot;&gt;21. &lt;span class=&quot;element-citation&quot;&gt;Tinkum KL, Stemler KM, White LS, Loza AJ, Jeter-Jones S, Michalski BM, et al. Fasting protects mice from lethal DNA damage by promoting small intestinal epithelial stem cell survival. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;Proc Natl Acad Sci U S A.&lt;/span&gt; 2015;&lt;span class=&quot;ref-vol&quot;&gt;112&lt;/span&gt;(51):E7148‚ÄìE7E54.&lt;/span&gt; &lt;span class=&quot;nowrap&quot;&gt;[&lt;a class=&quot;int-reflink&quot; href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4697381/&quot;&gt;PMC free article&lt;/a&gt;]&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/26644583&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+U+S+A&amp;amp;title=Fasting+protects+mice+from+lethal+DNA+damage+by+promoting+small+intestinal+epithelial+stem+cell+survival&amp;amp;author=KL+Tinkum&amp;amp;author=KM+Stemler&amp;amp;author=LS+White&amp;amp;author=AJ+Loza&amp;amp;author=S+Jeter-Jones&amp;amp;volume=112&amp;amp;issue=51&amp;amp;publication_year=2015&amp;amp;pages=E7148-E7E54&amp;amp;pmid=26644583&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR22&quot;&gt;22. &lt;span class=&quot;element-citation&quot;&gt;Cheng CW, Adams GB, Perin L, Wei M, Zhou X, Lam BS, et al. Prolonged fasting reduces IGF-1/PKA to promote hematopoietic-stem-cell-based regeneration and reverse immunosuppression. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;Cell Stem Cell.&lt;/span&gt; 2014;&lt;span class=&quot;ref-vol&quot;&gt;14&lt;/span&gt;(6):810‚Äì823. doi: 10.1016/j.stem.2014.04.014.&lt;/span&gt; &lt;span class=&quot;nowrap&quot;&gt;[&lt;a class=&quot;int-reflink&quot; href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4102383/&quot;&gt;PMC free article&lt;/a&gt;]&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/24905167&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] [&lt;a href=&quot;https://dx.doi.org/10.1016%2Fj.stem.2014.04.014&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CCrosslink%7CDOI&quot;&gt;CrossRef&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=Cell+Stem+Cell&amp;amp;title=Prolonged+fasting+reduces+IGF-1/PKA+to+promote+hematopoietic-stem-cell-based+regeneration+and+reverse+immunosuppression&amp;amp;author=CW+Cheng&amp;amp;author=GB+Adams&amp;amp;author=L+Perin&amp;amp;author=M+Wei&amp;amp;author=X+Zhou&amp;amp;volume=14&amp;amp;issue=6&amp;amp;publication_year=2014&amp;amp;pages=810-823&amp;amp;pmid=24905167&amp;amp;doi=10.1016/j.stem.2014.04.014&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR23&quot;&gt;23. &lt;span class=&quot;mixed-citation&quot;&gt;Huisman SA, de BP, Ghobadi Moghaddam-Helmantel IM, IJzermans JN, Wiemer EA, Mathijssen RH, et al. Fasting protects against the side-effects of irinotecan treatment but does not abrogate anti-tumor activity in mice. Br. J Pharmacol. 2015. &lt;span class=&quot;nowrap&quot;&gt;[&lt;a class=&quot;int-reflink&quot; href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4761088/&quot;&gt;PMC free article&lt;/a&gt;]&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/26332723&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;]&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR24&quot;&gt;24. &lt;span class=&quot;mixed-citation&quot;&gt;Franny Jongbloed SAH, Harry van Steeg, Jeroen L.A. Pennings, Jan N.M. IJzermans, Martijn E.T. Doll√© and Ron W.F. de Bruin&lt;strong&gt;.&lt;/strong&gt; The transcriptomic response to irinotecan in colon carcinoma bearing mice preconditioned by fasting. Oncotarget. 2019. &lt;span class=&quot;nowrap&quot;&gt;[&lt;a class=&quot;int-reflink&quot; href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481335/&quot;&gt;PMC free article&lt;/a&gt;]&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/31040913&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;]&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR25&quot;&gt;25. &lt;span class=&quot;element-citation&quot;&gt;Schumacher B, Garinis GA, Hoeijmakers JH. Age to survive: DNA damage and aging. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;Trends Genet.&lt;/span&gt; 2008;&lt;span class=&quot;ref-vol&quot;&gt;24&lt;/span&gt;(2):77‚Äì85. doi: 10.1016/j.tig.2007.11.004.&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/18192065&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] [&lt;a href=&quot;https://dx.doi.org/10.1016%2Fj.tig.2007.11.004&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CCrosslink%7CDOI&quot;&gt;CrossRef&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=Trends+Genet&amp;amp;title=Age+to+survive:+DNA+damage+and+aging&amp;amp;author=B+Schumacher&amp;amp;author=GA+Garinis&amp;amp;author=JH+Hoeijmakers&amp;amp;volume=24&amp;amp;issue=2&amp;amp;publication_year=2008&amp;amp;pages=77-85&amp;amp;pmid=18192065&amp;amp;doi=10.1016/j.tig.2007.11.004&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR26&quot;&gt;26. &lt;span class=&quot;element-citation&quot;&gt;Kerndt PR, Naughton JL, Driscoll CE, Loxterkamp DA. Fasting: the history, pathophysiology and complications. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;West J Med.&lt;/span&gt; 1982;&lt;span class=&quot;ref-vol&quot;&gt;137&lt;/span&gt;(5):379‚Äì399.&lt;/span&gt; &lt;span class=&quot;nowrap&quot;&gt;[&lt;a class=&quot;int-reflink&quot; href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1274154/&quot;&gt;PMC free article&lt;/a&gt;]&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/6758355&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=West+J+Med&amp;amp;title=Fasting:+the+history,+pathophysiology+and+complications&amp;amp;author=PR+Kerndt&amp;amp;author=JL+Naughton&amp;amp;author=CE+Driscoll&amp;amp;author=DA+Loxterkamp&amp;amp;volume=137&amp;amp;issue=5&amp;amp;publication_year=1982&amp;amp;pages=379-399&amp;amp;pmid=6758355&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR27&quot;&gt;27. &lt;span class=&quot;element-citation&quot;&gt;Caccialanza R, De Lorenzo F, Gianotti L, Zagonel V, Gavazzi C, Farina G, et al. Nutritional support for cancer patients: still a neglected right? &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;Support Care Cancer.&lt;/span&gt; 2017;&lt;span class=&quot;ref-vol&quot;&gt;25&lt;/span&gt;(10):3001‚Äì3004. doi: 10.1007/s00520-017-3826-1.&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/28710645&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] [&lt;a href=&quot;https://dx.doi.org/10.1007%2Fs00520-017-3826-1&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CCrosslink%7CDOI&quot;&gt;CrossRef&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=Support+Care+Cancer&amp;amp;title=Nutritional+support+for+cancer+patients:+still+a+neglected+right?&amp;amp;author=R+Caccialanza&amp;amp;author=F+De+Lorenzo&amp;amp;author=L+Gianotti&amp;amp;author=V+Zagonel&amp;amp;author=C+Gavazzi&amp;amp;volume=25&amp;amp;issue=10&amp;amp;publication_year=2017&amp;amp;pages=3001-3004&amp;amp;pmid=28710645&amp;amp;doi=10.1007/s00520-017-3826-1&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR28&quot;&gt;28. &lt;span class=&quot;mixed-citation&quot;&gt;Caccialanza R, Aprile G, Cereda E, Pedrazzoli P. Fasting in oncology: a word of caution. Nat Rev Cancer. 2019. [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/30651606&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;]&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR29&quot;&gt;29. &lt;span class=&quot;element-citation&quot;&gt;Arends J, Bachmann P, Baracos V, Barthelemy N, Bertz H, Bozzetti F, et al. ESPEN guidelines on nutrition in cancer patients. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;Clin Nutr.&lt;/span&gt; 2017;&lt;span class=&quot;ref-vol&quot;&gt;36&lt;/span&gt;(1):11‚Äì48. doi: 10.1016/j.clnu.2016.07.015.&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/27637832&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] [&lt;a href=&quot;https://dx.doi.org/10.1016%2Fj.clnu.2016.07.015&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CCrosslink%7CDOI&quot;&gt;CrossRef&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=Clin+Nutr&amp;amp;title=ESPEN+guidelines+on+nutrition+in+cancer+patients&amp;amp;author=J+Arends&amp;amp;author=P+Bachmann&amp;amp;author=V+Baracos&amp;amp;author=N+Barthelemy&amp;amp;author=H+Bertz&amp;amp;volume=36&amp;amp;issue=1&amp;amp;publication_year=2017&amp;amp;pages=11-48&amp;amp;pmid=27637832&amp;amp;doi=10.1016/j.clnu.2016.07.015&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR30&quot;&gt;30. &lt;span class=&quot;element-citation&quot;&gt;Arends J, Baracos V, Bertz H, Bozzetti F, Calder PC, Deutz NEP, et al. ESPEN expert group recommendations for action against cancer-related malnutrition. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;Clin Nutr.&lt;/span&gt; 2017;&lt;span class=&quot;ref-vol&quot;&gt;36&lt;/span&gt;(5):1187‚Äì1196. doi: 10.1016/j.clnu.2017.06.017.&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/28689670&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] [&lt;a href=&quot;https://dx.doi.org/10.1016%2Fj.clnu.2017.06.017&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CCrosslink%7CDOI&quot;&gt;CrossRef&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=Clin+Nutr&amp;amp;title=ESPEN+expert+group+recommendations+for+action+against+cancer-related+malnutrition&amp;amp;author=J+Arends&amp;amp;author=V+Baracos&amp;amp;author=H+Bertz&amp;amp;author=F+Bozzetti&amp;amp;author=PC+Calder&amp;amp;volume=36&amp;amp;issue=5&amp;amp;publication_year=2017&amp;amp;pages=1187-1196&amp;amp;pmid=28689670&amp;amp;doi=10.1016/j.clnu.2017.06.017&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR31&quot;&gt;31. &lt;span class=&quot;element-citation&quot;&gt;Bishop NA, Guarente L. Genetic links between diet and lifespan: shared mechanisms from yeast to humans. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;Nat Rev Genet.&lt;/span&gt; 2007;&lt;span class=&quot;ref-vol&quot;&gt;8&lt;/span&gt;(11):835‚Äì844. doi: 10.1038/nrg2188.&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/17909538&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] [&lt;a href=&quot;https://dx.doi.org/10.1038%2Fnrg2188&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CCrosslink%7CDOI&quot;&gt;CrossRef&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=Nat+Rev+Genet&amp;amp;title=Genetic+links+between+diet+and+lifespan:+shared+mechanisms+from+yeast+to+humans&amp;amp;author=NA+Bishop&amp;amp;author=L+Guarente&amp;amp;volume=8&amp;amp;issue=11&amp;amp;publication_year=2007&amp;amp;pages=835-844&amp;amp;pmid=17909538&amp;amp;doi=10.1038/nrg2188&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;


&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR34&quot;&gt;34. &lt;span class=&quot;element-citation&quot;&gt;Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;Cell.&lt;/span&gt; 2011;&lt;span class=&quot;ref-vol&quot;&gt;144&lt;/span&gt;(5):646‚Äì674. doi: 10.1016/j.cell.2011.02.013.&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/21376230&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] [&lt;a href=&quot;https://dx.doi.org/10.1016%2Fj.cell.2011.02.013&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CCrosslink%7CDOI&quot;&gt;CrossRef&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=Cell.&amp;amp;title=Hallmarks+of+cancer:+the+next+generation&amp;amp;author=D+Hanahan&amp;amp;author=RA+Weinberg&amp;amp;volume=144&amp;amp;issue=5&amp;amp;publication_year=2011&amp;amp;pages=646-674&amp;amp;pmid=21376230&amp;amp;doi=10.1016/j.cell.2011.02.013&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR35&quot;&gt;35. &lt;span class=&quot;element-citation&quot;&gt;Ward PS, Thompson CB. Metabolic reprogramming: a cancer hallmark even Warburg did not anticipate. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;Cancer Cell.&lt;/span&gt; 2012;&lt;span class=&quot;ref-vol&quot;&gt;21&lt;/span&gt;(3):297‚Äì308. doi: 10.1016/j.ccr.2012.02.014.&lt;/span&gt; &lt;span class=&quot;nowrap&quot;&gt;[&lt;a class=&quot;int-reflink&quot; href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3311998/&quot;&gt;PMC free article&lt;/a&gt;]&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/22439925&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] [&lt;a href=&quot;https://dx.doi.org/10.1016%2Fj.ccr.2012.02.014&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CCrosslink%7CDOI&quot;&gt;CrossRef&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=Cancer+Cell&amp;amp;title=Metabolic+reprogramming:+a+cancer+hallmark+even+Warburg+did+not+anticipate&amp;amp;author=PS+Ward&amp;amp;author=CB+Thompson&amp;amp;volume=21&amp;amp;issue=3&amp;amp;publication_year=2012&amp;amp;pages=297-308&amp;amp;pmid=22439925&amp;amp;doi=10.1016/j.ccr.2012.02.014&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR36&quot;&gt;36. &lt;span class=&quot;mixed-citation&quot;&gt;D'Aronzo M, Vinciguerra M, Mazza T, Panebianco C, Saracino C, Pereira SP, et al. Fasting cycles potentiate the efficacy of gemcitabine treatment in in vitro and in vivo pancreatic cancer models. Oncotarget. 2015. &lt;span class=&quot;nowrap&quot;&gt;[&lt;a class=&quot;int-reflink&quot; href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4621909/&quot;&gt;PMC free article&lt;/a&gt;]&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/26176887&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;]&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR37&quot;&gt;37. &lt;span class=&quot;element-citation&quot;&gt;Shi Y, Felley-Bosco E, Marti TM, Orlowski K, Pruschy M, Stahel RA. Starvation-induced activation of ATM/Chk2/p53 signaling sensitizes cancer cells to cisplatin. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;BMC Cancer.&lt;/span&gt; 2012;&lt;span class=&quot;ref-vol&quot;&gt;12&lt;/span&gt;:571. doi: 10.1186/1471-2407-12-571.&lt;/span&gt; &lt;span class=&quot;nowrap&quot;&gt;[&lt;a class=&quot;int-reflink&quot; href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3527202/&quot;&gt;PMC free article&lt;/a&gt;]&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/23211021&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] [&lt;a href=&quot;https://dx.doi.org/10.1186%2F1471-2407-12-571&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CCrosslink%7CDOI&quot;&gt;CrossRef&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=BMC+Cancer&amp;amp;title=Starvation-induced+activation+of+ATM/Chk2/p53+signaling+sensitizes+cancer+cells+to+cisplatin&amp;amp;author=Y+Shi&amp;amp;author=E+Felley-Bosco&amp;amp;author=TM+Marti&amp;amp;author=K+Orlowski&amp;amp;author=M+Pruschy&amp;amp;volume=12&amp;amp;publication_year=2012&amp;amp;pages=571&amp;amp;pmid=23211021&amp;amp;doi=10.1186/1471-2407-12-571&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR38&quot;&gt;38. &lt;span class=&quot;element-citation&quot;&gt;Saleh AD, Simone BA, Palazzo J, Savage JE, Sano Y, Dan T, et al. Caloric restriction augments radiation efficacy in breast cancer. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;Cell Cycle.&lt;/span&gt; 2013;&lt;span class=&quot;ref-vol&quot;&gt;12&lt;/span&gt;(12):1955‚Äì1963. doi: 10.4161/cc.25016.&lt;/span&gt; &lt;span class=&quot;nowrap&quot;&gt;[&lt;a class=&quot;int-reflink&quot; href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3735710/&quot;&gt;PMC free article&lt;/a&gt;]&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/23708519&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] [&lt;a href=&quot;https://dx.doi.org/10.4161%2Fcc.25016&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CCrosslink%7CDOI&quot;&gt;CrossRef&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=Cell+Cycle&amp;amp;title=Caloric+restriction+augments+radiation+efficacy+in+breast+cancer&amp;amp;author=AD+Saleh&amp;amp;author=BA+Simone&amp;amp;author=J+Palazzo&amp;amp;author=JE+Savage&amp;amp;author=Y+Sano&amp;amp;volume=12&amp;amp;issue=12&amp;amp;publication_year=2013&amp;amp;pages=1955-1963&amp;amp;pmid=23708519&amp;amp;doi=10.4161/cc.25016&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR40&quot;&gt;40. &lt;span class=&quot;element-citation&quot;&gt;Pietrocola F, Pol J, Vacchelli E, Rao S, Enot DP, Baracco EE, et al. Caloric restriction mimetics enhance anticancer Immunosurveillance. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;Cancer Cell.&lt;/span&gt; 2016;&lt;span class=&quot;ref-vol&quot;&gt;30&lt;/span&gt;(1):147‚Äì160. doi: 10.1016/j.ccell.2016.05.016.&lt;/span&gt; &lt;span class=&quot;nowrap&quot;&gt;[&lt;a class=&quot;int-reflink&quot; href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5715805/&quot;&gt;PMC free article&lt;/a&gt;]&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/27411589&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] [&lt;a href=&quot;https://dx.doi.org/10.1016%2Fj.ccell.2016.05.016&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CCrosslink%7CDOI&quot;&gt;CrossRef&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=Cancer+Cell&amp;amp;title=Caloric+restriction+mimetics+enhance+anticancer+Immunosurveillance&amp;amp;author=F+Pietrocola&amp;amp;author=J+Pol&amp;amp;author=E+Vacchelli&amp;amp;author=S+Rao&amp;amp;author=DP+Enot&amp;amp;volume=30&amp;amp;issue=1&amp;amp;publication_year=2016&amp;amp;pages=147-160&amp;amp;pmid=27411589&amp;amp;doi=10.1016/j.ccell.2016.05.016&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR41&quot;&gt;41. &lt;span class=&quot;element-citation&quot;&gt;Thissen JP, Ketelslegers JM, Underwood LE. Nutritional regulation of the insulin-like growth factors. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;Endocr Rev.&lt;/span&gt; 1994;&lt;span class=&quot;ref-vol&quot;&gt;15&lt;/span&gt;(1):80‚Äì101.&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/8156941&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=Endocr+Rev&amp;amp;title=Nutritional+regulation+of+the+insulin-like+growth+factors&amp;amp;author=JP+Thissen&amp;amp;author=JM+Ketelslegers&amp;amp;author=LE+Underwood&amp;amp;volume=15&amp;amp;issue=1&amp;amp;publication_year=1994&amp;amp;pages=80-101&amp;amp;pmid=8156941&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR42&quot;&gt;42. &lt;span class=&quot;element-citation&quot;&gt;Lee C, Safdie FM, Raffaghello L, Wei M, Madia F, Parrella E, et al. Reduced levels of IGF-I mediate differential protection of normal and cancer cells in response to fasting and improve chemotherapeutic index. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;Cancer Res.&lt;/span&gt; 2010;&lt;span class=&quot;ref-vol&quot;&gt;70&lt;/span&gt;(4):1564‚Äì1572. doi: 10.1158/0008-5472.CAN-09-3228.&lt;/span&gt; &lt;span class=&quot;nowrap&quot;&gt;[&lt;a class=&quot;int-reflink&quot; href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2836202/&quot;&gt;PMC free article&lt;/a&gt;]&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/20145127&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] [&lt;a href=&quot;https://dx.doi.org/10.1158%2F0008-5472.CAN-09-3228&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CCrosslink%7CDOI&quot;&gt;CrossRef&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=Cancer+Res&amp;amp;title=Reduced+levels+of+IGF-I+mediate+differential+protection+of+normal+and+cancer+cells+in+response+to+fasting+and+improve+chemotherapeutic+index&amp;amp;author=C+Lee&amp;amp;author=FM+Safdie&amp;amp;author=L+Raffaghello&amp;amp;author=M+Wei&amp;amp;author=F+Madia&amp;amp;volume=70&amp;amp;issue=4&amp;amp;publication_year=2010&amp;amp;pages=1564-1572&amp;amp;pmid=20145127&amp;amp;doi=10.1158/0008-5472.CAN-09-3228&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR43&quot;&gt;43. &lt;span class=&quot;element-citation&quot;&gt;Hursting SD, Lavigne JA, Berrigan D, Donehower LA, Davis BJ, Phang JM, et al. Diet-gene interactions in p53-deficient mice: insulin-like growth factor-1 as a mechanistic target. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;J Nutr.&lt;/span&gt; 2004;&lt;span class=&quot;ref-vol&quot;&gt;134&lt;/span&gt;(9):2482S‚Äì2486S. doi: 10.1093/jn/134.9.2482S.&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/15333746&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] [&lt;a href=&quot;https://dx.doi.org/10.1093%2Fjn%2F134.9.2482S&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CCrosslink%7CDOI&quot;&gt;CrossRef&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=J+Nutr&amp;amp;title=Diet-gene+interactions+in+p53-deficient+mice:+insulin-like+growth+factor-1+as+a+mechanistic+target&amp;amp;author=SD+Hursting&amp;amp;author=JA+Lavigne&amp;amp;author=D+Berrigan&amp;amp;author=LA+Donehower&amp;amp;author=BJ+Davis&amp;amp;volume=134&amp;amp;issue=9&amp;amp;publication_year=2004&amp;amp;pages=2482S-2486S&amp;amp;pmid=15333746&amp;amp;doi=10.1093/jn/134.9.2482S&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR44&quot;&gt;44. &lt;span class=&quot;element-citation&quot;&gt;Lee C, Longo VD. Fasting vs dietary restriction in cellular protection and cancer treatment: from model organisms to patients. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;Oncogene.&lt;/span&gt; 2011;&lt;span class=&quot;ref-vol&quot;&gt;30&lt;/span&gt;(30):3305‚Äì3316. doi: 10.1038/onc.2011.91.&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/21516129&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] [&lt;a href=&quot;https://dx.doi.org/10.1038%2Fonc.2011.91&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CCrosslink%7CDOI&quot;&gt;CrossRef&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=Oncogene.&amp;amp;title=Fasting+vs+dietary+restriction+in+cellular+protection+and+cancer+treatment:+from+model+organisms+to+patients&amp;amp;author=C+Lee&amp;amp;author=VD+Longo&amp;amp;volume=30&amp;amp;issue=30&amp;amp;publication_year=2011&amp;amp;pages=3305-3316&amp;amp;pmid=21516129&amp;amp;doi=10.1038/onc.2011.91&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR45&quot;&gt;45. &lt;span class=&quot;element-citation&quot;&gt;Kirkwood TB, Shanley DP. Food restriction, evolution and ageing. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;Mech Ageing Dev.&lt;/span&gt; 2005;&lt;span class=&quot;ref-vol&quot;&gt;126&lt;/span&gt;(9):1011‚Äì1016. doi: 10.1016/j.mad.2005.03.021.&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/15893805&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] [&lt;a href=&quot;https://dx.doi.org/10.1016%2Fj.mad.2005.03.021&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CCrosslink%7CDOI&quot;&gt;CrossRef&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=Mech+Ageing+Dev&amp;amp;title=Food+restriction,+evolution+and+ageing&amp;amp;author=TB+Kirkwood&amp;amp;author=DP+Shanley&amp;amp;volume=126&amp;amp;issue=9&amp;amp;publication_year=2005&amp;amp;pages=1011-1016&amp;amp;pmid=15893805&amp;amp;doi=10.1016/j.mad.2005.03.021&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR47&quot;&gt;47. &lt;span class=&quot;element-citation&quot;&gt;Heilbronn LK, Ravussin E. Calorie restriction and aging: review of the literature and implications for studies in humans. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;Am J Clin Nutr.&lt;/span&gt; 2003;&lt;span class=&quot;ref-vol&quot;&gt;78&lt;/span&gt;(3):361‚Äì369. doi: 10.1093/ajcn/78.3.361.&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/12936916&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] [&lt;a href=&quot;https://dx.doi.org/10.1093%2Fajcn%2F78.3.361&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CCrosslink%7CDOI&quot;&gt;CrossRef&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=Am+J+Clin+Nutr&amp;amp;title=Calorie+restriction+and+aging:+review+of+the+literature+and+implications+for+studies+in+humans&amp;amp;author=LK+Heilbronn&amp;amp;author=E+Ravussin&amp;amp;volume=78&amp;amp;issue=3&amp;amp;publication_year=2003&amp;amp;pages=361-369&amp;amp;pmid=12936916&amp;amp;doi=10.1093/ajcn/78.3.361&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR48&quot;&gt;48. &lt;span class=&quot;element-citation&quot;&gt;Murray MJ, Murray AB. Anorexia of infection as a mechanism of host defense. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;Am J Clin Nutr.&lt;/span&gt; 1979;&lt;span class=&quot;ref-vol&quot;&gt;32&lt;/span&gt;(3):593‚Äì596. doi: 10.1093/ajcn/32.3.593.&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/283688&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] [&lt;a href=&quot;https://dx.doi.org/10.1093%2Fajcn%2F32.3.593&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CCrosslink%7CDOI&quot;&gt;CrossRef&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=Am+J+Clin+Nutr&amp;amp;title=Anorexia+of+infection+as+a+mechanism+of+host+defense&amp;amp;author=MJ+Murray&amp;amp;author=AB+Murray&amp;amp;volume=32&amp;amp;issue=3&amp;amp;publication_year=1979&amp;amp;pages=593-596&amp;amp;pmid=283688&amp;amp;doi=10.1093/ajcn/32.3.593&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR49&quot;&gt;49. &lt;span class=&quot;element-citation&quot;&gt;Exton MS. Infection-induced anorexia: active host defence strategy. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;Appetite.&lt;/span&gt; 1997;&lt;span class=&quot;ref-vol&quot;&gt;29&lt;/span&gt;(3):369‚Äì383. doi: 10.1006/appe.1997.0116.&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/9468766&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] [&lt;a href=&quot;https://dx.doi.org/10.1006%2Fappe.1997.0116&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CCrosslink%7CDOI&quot;&gt;CrossRef&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=Appetite.&amp;amp;title=Infection-induced+anorexia:+active+host+defence+strategy&amp;amp;author=MS+Exton&amp;amp;volume=29&amp;amp;issue=3&amp;amp;publication_year=1997&amp;amp;pages=369-383&amp;amp;pmid=9468766&amp;amp;doi=10.1006/appe.1997.0116&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR50&quot;&gt;50. &lt;span class=&quot;element-citation&quot;&gt;Giovannucci E, Pollak M, Liu Y, Platz EA, Majeed N, Rimm EB, et al. Nutritional predictors of insulin-like growth factor I and their relationships to cancer in men. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;Cancer Epidemiol Biomark Prev.&lt;/span&gt; 2003;&lt;span class=&quot;ref-vol&quot;&gt;12&lt;/span&gt;(2):84‚Äì89.&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/12582016&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=Cancer+Epidemiol+Biomark+Prev&amp;amp;title=Nutritional+predictors+of+insulin-like+growth+factor+I+and+their+relationships+to+cancer+in+men&amp;amp;author=E+Giovannucci&amp;amp;author=M+Pollak&amp;amp;author=Y+Liu&amp;amp;author=EA+Platz&amp;amp;author=N+Majeed&amp;amp;volume=12&amp;amp;issue=2&amp;amp;publication_year=2003&amp;amp;pages=84-89&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR51&quot;&gt;51. &lt;span class=&quot;element-citation&quot;&gt;Prisco M, Romano G, Peruzzi F, Valentinis B, Baserga R. Insulin and IGF-I receptors signaling in protection from apoptosis. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;Horm Metab Res.&lt;/span&gt; 1999;&lt;span class=&quot;ref-vol&quot;&gt;31&lt;/span&gt;(2‚Äì3):80‚Äì89. doi: 10.1055/s-2007-978703.&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/10226786&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] [&lt;a href=&quot;https://dx.doi.org/10.1055%2Fs-2007-978703&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CCrosslink%7CDOI&quot;&gt;CrossRef&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=Horm+Metab+Res&amp;amp;title=Insulin+and+IGF-I+receptors+signaling+in+protection+from+apoptosis&amp;amp;author=M+Prisco&amp;amp;author=G+Romano&amp;amp;author=F+Peruzzi&amp;amp;author=B+Valentinis&amp;amp;author=R+Baserga&amp;amp;volume=31&amp;amp;issue=2%E2%80%933&amp;amp;publication_year=1999&amp;amp;pages=80-89&amp;amp;pmid=10226786&amp;amp;doi=10.1055/s-2007-978703&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR52&quot;&gt;52. &lt;span class=&quot;element-citation&quot;&gt;Fontana L, Weiss EP, Villareal DT, Klein S, Holloszy JO. Long-term effects of calorie or protein restriction on serum IGF-1 and IGFBP-3 concentration in humans. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;Aging Cell.&lt;/span&gt; 2008;&lt;span class=&quot;ref-vol&quot;&gt;7&lt;/span&gt;(5):681‚Äì687. doi: 10.1111/j.1474-9726.2008.00417.x.&lt;/span&gt; &lt;span class=&quot;nowrap&quot;&gt;[&lt;a class=&quot;int-reflink&quot; href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2673798/&quot;&gt;PMC free article&lt;/a&gt;]&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/18843793&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] [&lt;a href=&quot;https://dx.doi.org/10.1111%2Fj.1474-9726.2008.00417.x&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CCrosslink%7CDOI&quot;&gt;CrossRef&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=Aging+Cell&amp;amp;title=Long-term+effects+of+calorie+or+protein+restriction+on+serum+IGF-1+and+IGFBP-3+concentration+in+humans&amp;amp;author=L+Fontana&amp;amp;author=EP+Weiss&amp;amp;author=DT+Villareal&amp;amp;author=S+Klein&amp;amp;author=JO+Holloszy&amp;amp;volume=7&amp;amp;issue=5&amp;amp;publication_year=2008&amp;amp;pages=681-687&amp;amp;pmid=18843793&amp;amp;doi=10.1111/j.1474-9726.2008.00417.x&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR53&quot;&gt;53. &lt;span class=&quot;element-citation&quot;&gt;Belfiore A, Malaguarnera R, Vella V, Lawrence MC, Sciacca L, Frasca F, et al. Insulin receptor isoforms in physiology and disease: an updated view. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;Endocr Rev.&lt;/span&gt; 2017;&lt;span class=&quot;ref-vol&quot;&gt;38&lt;/span&gt;(5):379‚Äì431. doi: 10.1210/er.2017-00073.&lt;/span&gt; &lt;span class=&quot;nowrap&quot;&gt;[&lt;a class=&quot;int-reflink&quot; href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5629070/&quot;&gt;PMC free article&lt;/a&gt;]&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/28973479&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] [&lt;a href=&quot;https://dx.doi.org/10.1210%2Fer.2017-00073&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CCrosslink%7CDOI&quot;&gt;CrossRef&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=Endocr+Rev&amp;amp;title=Insulin+receptor+isoforms+in+physiology+and+disease:+an+updated+view&amp;amp;author=A+Belfiore&amp;amp;author=R+Malaguarnera&amp;amp;author=V+Vella&amp;amp;author=MC+Lawrence&amp;amp;author=L+Sciacca&amp;amp;volume=38&amp;amp;issue=5&amp;amp;publication_year=2017&amp;amp;pages=379-431&amp;amp;pmid=28973479&amp;amp;doi=10.1210/er.2017-00073&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR54&quot;&gt;54. &lt;span class=&quot;element-citation&quot;&gt;Ketelslegers JM, Maiter D, Maes M, Underwood LE, Thissen JP. Nutritional regulation of insulin-like growth factor-I. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;Metabolism.&lt;/span&gt; 1995;&lt;span class=&quot;ref-vol&quot;&gt;44&lt;/span&gt;(10 Suppl 4):50‚Äì57. doi: 10.1016/0026-0495(95)90221-X.&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/7476312&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] [&lt;a href=&quot;https://dx.doi.org/10.1016%2F0026-0495(95)90221-X&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CCrosslink%7CDOI&quot;&gt;CrossRef&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=Metabolism.&amp;amp;title=Nutritional+regulation+of+insulin-like+growth+factor-I&amp;amp;author=JM+Ketelslegers&amp;amp;author=D+Maiter&amp;amp;author=M+Maes&amp;amp;author=LE+Underwood&amp;amp;author=JP+Thissen&amp;amp;volume=44&amp;amp;issue=10+Suppl+4&amp;amp;publication_year=1995&amp;amp;pages=50-57&amp;amp;pmid=7476312&amp;amp;doi=10.1016/0026-0495(95)90221-X&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR55&quot;&gt;55. &lt;span class=&quot;element-citation&quot;&gt;Henning PC, Scofield DE, Rarick KR, Pierce JR, Staab JS, Lieberman HR, et al. Effects of acute caloric restriction compared to caloric balance on the temporal response of the IGF-I system. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;Metabolism.&lt;/span&gt; 2013;&lt;span class=&quot;ref-vol&quot;&gt;62&lt;/span&gt;(2):179‚Äì187. doi: 10.1016/j.metabol.2012.07.004.&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/22906764&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] [&lt;a href=&quot;https://dx.doi.org/10.1016%2Fj.metabol.2012.07.004&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CCrosslink%7CDOI&quot;&gt;CrossRef&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=Metabolism.&amp;amp;title=Effects+of+acute+caloric+restriction+compared+to+caloric+balance+on+the+temporal+response+of+the+IGF-I+system&amp;amp;author=PC+Henning&amp;amp;author=DE+Scofield&amp;amp;author=KR+Rarick&amp;amp;author=JR+Pierce&amp;amp;author=JS+Staab&amp;amp;volume=62&amp;amp;issue=2&amp;amp;publication_year=2013&amp;amp;pages=179-187&amp;amp;pmid=22906764&amp;amp;doi=10.1016/j.metabol.2012.07.004&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR56&quot;&gt;56. &lt;span class=&quot;element-citation&quot;&gt;Snel M, Wijngaarden MA, Bizino MB, van der Grond J, Teeuwisse WM, van Buchem MA, et al. Food cues do not modulate the neuroendocrine response to a prolonged fast in healthy men. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;Neuroendocrinology.&lt;/span&gt; 2012;&lt;span class=&quot;ref-vol&quot;&gt;96&lt;/span&gt;(4):285‚Äì293. doi: 10.1159/000336500.&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/22508366&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] [&lt;a href=&quot;https://dx.doi.org/10.1159%2F000336500&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CCrosslink%7CDOI&quot;&gt;CrossRef&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=Neuroendocrinology.&amp;amp;title=Food+cues+do+not+modulate+the+neuroendocrine+response+to+a+prolonged+fast+in+healthy+men&amp;amp;author=M+Snel&amp;amp;author=MA+Wijngaarden&amp;amp;author=MB+Bizino&amp;amp;author=J+van+der+Grond&amp;amp;author=WM+Teeuwisse&amp;amp;volume=96&amp;amp;issue=4&amp;amp;publication_year=2012&amp;amp;pages=285-293&amp;amp;pmid=22508366&amp;amp;doi=10.1159/000336500&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR57&quot;&gt;57. &lt;span class=&quot;element-citation&quot;&gt;Beauloye V, Willems B. de C, V, frank SJ, Edery M, Thissen JP&lt;strong&gt;.&lt;/strong&gt; Impairment of liver GH receptor signaling by fasting. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;Endocrinology.&lt;/span&gt; 2002;&lt;span class=&quot;ref-vol&quot;&gt;143&lt;/span&gt;(3):792‚Äì800. doi: 10.1210/endo.143.3.8692.&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/11861499&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] [&lt;a href=&quot;https://dx.doi.org/10.1210%2Fendo.143.3.8692&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CCrosslink%7CDOI&quot;&gt;CrossRef&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=Endocrinology.&amp;amp;title=de+C,+V,+frank+SJ,+Edery+M,+Thissen+JP.+Impairment+of+liver+GH+receptor+signaling+by+fasting&amp;amp;author=V+Beauloye&amp;amp;author=B+Willems&amp;amp;volume=143&amp;amp;issue=3&amp;amp;publication_year=2002&amp;amp;pages=792-800&amp;amp;pmid=11861499&amp;amp;doi=10.1210/endo.143.3.8692&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR58&quot;&gt;58. &lt;span class=&quot;element-citation&quot;&gt;Leung KC, Doyle N, Ballesteros M, Waters MJ, Ho KK. Insulin regulation of human hepatic growth hormone receptors: divergent effects on biosynthesis and surface translocation. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;J Clin Endocrinol Metab.&lt;/span&gt; 2000;&lt;span class=&quot;ref-vol&quot;&gt;85&lt;/span&gt;(12):4712‚Äì4720.&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/11134133&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=J+Clin+Endocrinol+Metab&amp;amp;title=Insulin+regulation+of+human+hepatic+growth+hormone+receptors:+divergent+effects+on+biosynthesis+and+surface+translocation&amp;amp;author=KC+Leung&amp;amp;author=N+Doyle&amp;amp;author=M+Ballesteros&amp;amp;author=MJ+Waters&amp;amp;author=KK+Ho&amp;amp;volume=85&amp;amp;issue=12&amp;amp;publication_year=2000&amp;amp;pages=4712-4720&amp;amp;pmid=11134133&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR59&quot;&gt;59. &lt;span class=&quot;element-citation&quot;&gt;Yakar S, Liu JL, Stannard B, Butler A, Accili D, Sauer B, et al. Normal growth and development in the absence of hepatic insulin-like growth factor I. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;Proc Natl Acad Sci U S A.&lt;/span&gt; 1999;&lt;span class=&quot;ref-vol&quot;&gt;96&lt;/span&gt;(13):7324‚Äì7329. doi: 10.1073/pnas.96.13.7324.&lt;/span&gt; &lt;span class=&quot;nowrap&quot;&gt;[&lt;a class=&quot;int-reflink&quot; href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC22084/&quot;&gt;PMC free article&lt;/a&gt;]&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/10377413&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] [&lt;a href=&quot;https://dx.doi.org/10.1073%2Fpnas.96.13.7324&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CCrosslink%7CDOI&quot;&gt;CrossRef&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+U+S+A&amp;amp;title=Normal+growth+and+development+in+the+absence+of+hepatic+insulin-like+growth+factor+I&amp;amp;author=S+Yakar&amp;amp;author=JL+Liu&amp;amp;author=B+Stannard&amp;amp;author=A+Butler&amp;amp;author=D+Accili&amp;amp;volume=96&amp;amp;issue=13&amp;amp;publication_year=1999&amp;amp;pages=7324-7329&amp;amp;pmid=10377413&amp;amp;doi=10.1073/pnas.96.13.7324&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR60&quot;&gt;60. &lt;span class=&quot;element-citation&quot;&gt;Anzo M, Cobb LJ, Hwang DL, Mehta H, Said JW, Yakar S, et al. Targeted deletion of hepatic Igf1 in TRAMP mice leads to dramatic alterations in the circulating insulin-like growth factor axis but does not reduce tumor progression. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;Cancer Res.&lt;/span&gt; 2008;&lt;span class=&quot;ref-vol&quot;&gt;68&lt;/span&gt;(9):3342‚Äì3349. doi: 10.1158/0008-5472.CAN-07-3165.&lt;/span&gt; &lt;span class=&quot;nowrap&quot;&gt;[&lt;a class=&quot;int-reflink&quot; href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2928555/&quot;&gt;PMC free article&lt;/a&gt;]&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/18451161&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] [&lt;a href=&quot;https://dx.doi.org/10.1158%2F0008-5472.CAN-07-3165&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CCrosslink%7CDOI&quot;&gt;CrossRef&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=Cancer+Res&amp;amp;title=Targeted+deletion+of+hepatic+Igf1+in+TRAMP+mice+leads+to+dramatic+alterations+in+the+circulating+insulin-like+growth+factor+axis+but+does+not+reduce+tumor+progression&amp;amp;author=M+Anzo&amp;amp;author=LJ+Cobb&amp;amp;author=DL+Hwang&amp;amp;author=H+Mehta&amp;amp;author=JW+Said&amp;amp;volume=68&amp;amp;issue=9&amp;amp;publication_year=2008&amp;amp;pages=3342-3349&amp;amp;pmid=18451161&amp;amp;doi=10.1158/0008-5472.CAN-07-3165&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR61&quot;&gt;61. &lt;span class=&quot;element-citation&quot;&gt;Wu Y, Yakar S, Zhao L, Hennighausen L, LeRoith D. Circulating insulin-like growth factor-I levels regulate colon cancer growth and metastasis. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;Cancer Res.&lt;/span&gt; 2002;&lt;span class=&quot;ref-vol&quot;&gt;62&lt;/span&gt;(4):1030‚Äì1035.&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/11861378&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=Cancer+Res&amp;amp;title=Circulating+insulin-like+growth+factor-I+levels+regulate+colon+cancer+growth+and+metastasis&amp;amp;author=Y+Wu&amp;amp;author=S+Yakar&amp;amp;author=L+Zhao&amp;amp;author=L+Hennighausen&amp;amp;author=D+LeRoith&amp;amp;volume=62&amp;amp;issue=4&amp;amp;publication_year=2002&amp;amp;pages=1030-1035&amp;amp;pmid=11861378&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR62&quot;&gt;62. &lt;span class=&quot;element-citation&quot;&gt;Kawaguchi T, Takemura G, Kanamori H, Takeyama T, Watanabe T, Morishita K, et al. Prior starvation mitigates acute doxorubicin cardiotoxicity through restoration of autophagy in affected cardiomyocytes. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;Cardiovasc Res.&lt;/span&gt; 2012;&lt;span class=&quot;ref-vol&quot;&gt;96&lt;/span&gt;(3):456‚Äì465. doi: 10.1093/cvr/cvs282.&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/22952253&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] [&lt;a href=&quot;https://dx.doi.org/10.1093%2Fcvr%2Fcvs282&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CCrosslink%7CDOI&quot;&gt;CrossRef&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=Cardiovasc+Res&amp;amp;title=Prior+starvation+mitigates+acute+doxorubicin+cardiotoxicity+through+restoration+of+autophagy+in+affected+cardiomyocytes&amp;amp;author=T+Kawaguchi&amp;amp;author=G+Takemura&amp;amp;author=H+Kanamori&amp;amp;author=T+Takeyama&amp;amp;author=T+Watanabe&amp;amp;volume=96&amp;amp;issue=3&amp;amp;publication_year=2012&amp;amp;pages=456-465&amp;amp;pmid=22952253&amp;amp;doi=10.1093/cvr/cvs282&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR63&quot;&gt;63. &lt;span class=&quot;mixed-citation&quot;&gt;Withers SS, Kass PH, Rodriguez CO, Jr., Skorupski KA, O'Brien D, Guerrero TA, et al. , Fasting Reduces the Incidence of Delayed-Type Vomiting Associated with Doxorubicin Treatment in Dogs with Lymphoma. Transl. Oncol. 2014. &lt;span class=&quot;nowrap&quot;&gt;[&lt;a class=&quot;int-reflink&quot; href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4145391/&quot;&gt;PMC free article&lt;/a&gt;]&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/24831580&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;]&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR64&quot;&gt;64. &lt;span class=&quot;element-citation&quot;&gt;Djiogue S, Nwabo Kamdje AH, Vecchio L, Kipanyula MJ, Farahna M, Aldebasi Y, et al. Insulin resistance and cancer: the role of insulin and IGFs. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;Endocr Relat Cancer.&lt;/span&gt; 2013;&lt;span class=&quot;ref-vol&quot;&gt;20&lt;/span&gt;(1):R1‚ÄìR17. doi: 10.1530/ERC-12-0324.&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/23207292&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] [&lt;a href=&quot;https://dx.doi.org/10.1530%2FERC-12-0324&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CCrosslink%7CDOI&quot;&gt;CrossRef&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=Endocr+Relat+Cancer&amp;amp;title=Insulin+resistance+and+cancer:+the+role+of+insulin+and+IGFs&amp;amp;author=S+Djiogue&amp;amp;author=AH+Nwabo+Kamdje&amp;amp;author=L+Vecchio&amp;amp;author=MJ+Kipanyula&amp;amp;author=M+Farahna&amp;amp;volume=20&amp;amp;issue=1&amp;amp;publication_year=2013&amp;amp;pages=R1-R17&amp;amp;pmid=23207292&amp;amp;doi=10.1530/ERC-12-0324&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR66&quot;&gt;66. &lt;span class=&quot;mixed-citation&quot;&gt;Zhang Y, Moerkens M, Ramaiahgari S, de BH, Price L, Meerman J, et al. Elevated insulin-like growth factor 1 receptor signaling induces antiestrogen resistance through the MAPK/ERK and PI3K/Akt signaling routes. Breast Cancer Res. 2011;13(3):R52. &lt;span class=&quot;nowrap&quot;&gt;[&lt;a class=&quot;int-reflink&quot; href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3218939/&quot;&gt;PMC free article&lt;/a&gt;]&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/21595894&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;]&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR67&quot;&gt;67. &lt;span class=&quot;mixed-citation&quot;&gt;de Groot S, Charehbili A, van Laarhoven HW, Mooyaart AL, Dekker-Ensink NG, van de Ven S,¬†et al. Insulin-like growth factor 1 receptor expression and IGF1R 3129G &amp;gt; T polymorphism are associated with response to neoadjuvant chemotherapy in breast cancer patients: results from the NEOZOTAC trial (BOOG 2010‚Äì01). Breast Cancer Res. 2016;18(1):3. &lt;span class=&quot;nowrap&quot;&gt;[&lt;a class=&quot;int-reflink&quot; href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4702399/&quot;&gt;PMC free article&lt;/a&gt;]&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/26738606&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;]&lt;/span&gt;&lt;/div&gt;
&lt;p&gt;68. &lt;span class=&quot;mixed-citation&quot;&gt;S de Groot RL, MJ Welters, I Ehsan, MP Vreeswijk, VT Smit, H de Graaf, JB Heijns, JE Portielje, AJ van de Wouw, AL Imholz, LW Kessels, S Vrijaldenhoven, A Baars, E Meershoek-Klein Kranenbarg, M Duijm-de Carpentier, E van Leeuwen-Stok, H Putter, VD Longo, JJ van der Hoeven, JW Nortier, H Pijl and JR Kroep&lt;strong&gt;.&lt;/strong&gt; Abstract P1‚Äì15-20: DIetary REstriction as an adjunct to neoadjuvant ChemoTherapy for HER2-negative breast cancer: Final results from the DIRECT trial (BOOG 2013‚Äì04). American Association for Cancer Research. 2019.&lt;/span&gt;&lt;/p&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR69&quot;&gt;69. &lt;span class=&quot;element-citation&quot;&gt;Jiang W, Zhu Z, Thompson HJ. Dietary energy restriction modulates the activity of AMP-activated protein kinase, Akt, and mammalian target of rapamycin in mammary carcinomas, mammary gland, and liver. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;Cancer Res.&lt;/span&gt; 2008;&lt;span class=&quot;ref-vol&quot;&gt;68&lt;/span&gt;(13):5492‚Äì5499. doi: 10.1158/0008-5472.CAN-07-6721.&lt;/span&gt; &lt;span class=&quot;nowrap&quot;&gt;[&lt;a class=&quot;int-reflink&quot; href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2587286/&quot;&gt;PMC free article&lt;/a&gt;]&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/18593953&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] [&lt;a href=&quot;https://dx.doi.org/10.1158%2F0008-5472.CAN-07-6721&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CCrosslink%7CDOI&quot;&gt;CrossRef&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=Cancer+Res&amp;amp;title=Dietary+energy+restriction+modulates+the+activity+of+AMP-activated+protein+kinase,+Akt,+and+mammalian+target+of+rapamycin+in+mammary+carcinomas,+mammary+gland,+and+liver&amp;amp;author=W+Jiang&amp;amp;author=Z+Zhu&amp;amp;author=HJ+Thompson&amp;amp;volume=68&amp;amp;issue=13&amp;amp;publication_year=2008&amp;amp;pages=5492-5499&amp;amp;pmid=18593953&amp;amp;doi=10.1158/0008-5472.CAN-07-6721&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR70&quot;&gt;70. &lt;span class=&quot;element-citation&quot;&gt;Hardie DG. AMP-activated protein kinase: a cellular energy sensor with a key role in metabolic disorders and in cancer. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;Biochem Soc Trans.&lt;/span&gt; 2011;&lt;span class=&quot;ref-vol&quot;&gt;39&lt;/span&gt;(1):1‚Äì13. doi: 10.1042/BST0390001.&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/21265739&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] [&lt;a href=&quot;https://dx.doi.org/10.1042%2FBST0390001&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CCrosslink%7CDOI&quot;&gt;CrossRef&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=Biochem+Soc+Trans&amp;amp;title=AMP-activated+protein+kinase:+a+cellular+energy+sensor+with+a+key+role+in+metabolic+disorders+and+in+cancer&amp;amp;author=DG+Hardie&amp;amp;volume=39&amp;amp;issue=1&amp;amp;publication_year=2011&amp;amp;pages=1-13&amp;amp;pmid=21265739&amp;amp;doi=10.1042/BST0390001&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR71&quot;&gt;71. &lt;span class=&quot;element-citation&quot;&gt;Mihaylova MM, Shaw RJ. The AMPK signalling pathway coordinates cell growth, autophagy and metabolism. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;Nat Cell Biol.&lt;/span&gt; 2011;&lt;span class=&quot;ref-vol&quot;&gt;13&lt;/span&gt;(9):1016‚Äì1023. doi: 10.1038/ncb2329.&lt;/span&gt; &lt;span class=&quot;nowrap&quot;&gt;[&lt;a class=&quot;int-reflink&quot; href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3249400/&quot;&gt;PMC free article&lt;/a&gt;]&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/21892142&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] [&lt;a href=&quot;https://dx.doi.org/10.1038%2Fncb2329&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CCrosslink%7CDOI&quot;&gt;CrossRef&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=Nat+Cell+Biol&amp;amp;title=The+AMPK+signalling+pathway+coordinates+cell+growth,+autophagy+and+metabolism&amp;amp;author=MM+Mihaylova&amp;amp;author=RJ+Shaw&amp;amp;volume=13&amp;amp;issue=9&amp;amp;publication_year=2011&amp;amp;pages=1016-1023&amp;amp;pmid=21892142&amp;amp;doi=10.1038/ncb2329&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR72&quot;&gt;72. &lt;span class=&quot;element-citation&quot;&gt;Mizushima N. Autophagy: process and function. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;Genes Dev.&lt;/span&gt; 2007;&lt;span class=&quot;ref-vol&quot;&gt;21&lt;/span&gt;(22):2861‚Äì2873. doi: 10.1101/gad.1599207.&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/18006683&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] [&lt;a href=&quot;https://dx.doi.org/10.1101%2Fgad.1599207&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CCrosslink%7CDOI&quot;&gt;CrossRef&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=Genes+Dev&amp;amp;title=Autophagy:+process+and+function&amp;amp;author=N+Mizushima&amp;amp;volume=21&amp;amp;issue=22&amp;amp;publication_year=2007&amp;amp;pages=2861-2873&amp;amp;pmid=18006683&amp;amp;doi=10.1101/gad.1599207&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR74&quot;&gt;74. &lt;span class=&quot;element-citation&quot;&gt;Vidal AP, Andrade BM, Vaisman F, Cazarin J, Pinto LF, Breitenbach MM, et al. AMP-activated protein kinase signaling is upregulated in papillary thyroid cancer. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;Eur J Endocrinol.&lt;/span&gt; 2013;&lt;span class=&quot;ref-vol&quot;&gt;169&lt;/span&gt;(4):521‚Äì528. doi: 10.1530/EJE-13-0284.&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/23904275&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] [&lt;a href=&quot;https://dx.doi.org/10.1530%2FEJE-13-0284&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CCrosslink%7CDOI&quot;&gt;CrossRef&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=Eur+J+Endocrinol&amp;amp;title=AMP-activated+protein+kinase+signaling+is+upregulated+in+papillary+thyroid+cancer&amp;amp;author=AP+Vidal&amp;amp;author=BM+Andrade&amp;amp;author=F+Vaisman&amp;amp;author=J+Cazarin&amp;amp;author=LF+Pinto&amp;amp;volume=169&amp;amp;issue=4&amp;amp;publication_year=2013&amp;amp;pages=521-528&amp;amp;pmid=23904275&amp;amp;doi=10.1530/EJE-13-0284&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR75&quot;&gt;75. &lt;span class=&quot;element-citation&quot;&gt;Zadra G, Batista JL, Loda M. Dissecting the dual role of AMPK in Cancer: from experimental to human studies. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;Mol Cancer Res.&lt;/span&gt; 2015;&lt;span class=&quot;ref-vol&quot;&gt;13&lt;/span&gt;(7):1059‚Äì1072. doi: 10.1158/1541-7786.MCR-15-0068.&lt;/span&gt; &lt;span class=&quot;nowrap&quot;&gt;[&lt;a class=&quot;int-reflink&quot; href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4504770/&quot;&gt;PMC free article&lt;/a&gt;]&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/25956158&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] [&lt;a href=&quot;https://dx.doi.org/10.1158%2F1541-7786.MCR-15-0068&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CCrosslink%7CDOI&quot;&gt;CrossRef&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=Mol+Cancer+Res&amp;amp;title=Dissecting+the+dual+role+of+AMPK+in+Cancer:+from+experimental+to+human+studies&amp;amp;author=G+Zadra&amp;amp;author=JL+Batista&amp;amp;author=M+Loda&amp;amp;volume=13&amp;amp;issue=7&amp;amp;publication_year=2015&amp;amp;pages=1059-1072&amp;amp;pmid=25956158&amp;amp;doi=10.1158/1541-7786.MCR-15-0068&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR76&quot;&gt;76. &lt;span class=&quot;element-citation&quot;&gt;Hadad SM, Baker L, Quinlan PR, Robertson KE, Bray SE, Thomson G, et al. Histological evaluation of AMPK signalling in primary breast cancer. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;BMC Cancer.&lt;/span&gt; 2009;&lt;span class=&quot;ref-vol&quot;&gt;9&lt;/span&gt;:307. doi: 10.1186/1471-2407-9-307.&lt;/span&gt; &lt;span class=&quot;nowrap&quot;&gt;[&lt;a class=&quot;int-reflink&quot; href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2744705/&quot;&gt;PMC free article&lt;/a&gt;]&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/19723334&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] [&lt;a href=&quot;https://dx.doi.org/10.1186%2F1471-2407-9-307&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CCrosslink%7CDOI&quot;&gt;CrossRef&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=BMC+Cancer&amp;amp;title=Histological+evaluation+of+AMPK+signalling+in+primary+breast+cancer&amp;amp;author=SM+Hadad&amp;amp;author=L+Baker&amp;amp;author=PR+Quinlan&amp;amp;author=KE+Robertson&amp;amp;author=SE+Bray&amp;amp;volume=9&amp;amp;publication_year=2009&amp;amp;pages=307&amp;amp;pmid=19723334&amp;amp;doi=10.1186/1471-2407-9-307&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR77&quot;&gt;77. &lt;span class=&quot;element-citation&quot;&gt;Leprivier G, Remke M, Rotblat B, Dubuc A, Mateo AR, Kool M, et al. The eEF2 kinase confers resistance to nutrient deprivation by blocking translation elongation. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;Cell.&lt;/span&gt; 2013;&lt;span class=&quot;ref-vol&quot;&gt;153&lt;/span&gt;(5):1064‚Äì1079. doi: 10.1016/j.cell.2013.04.055.&lt;/span&gt; &lt;span class=&quot;nowrap&quot;&gt;[&lt;a class=&quot;int-reflink&quot; href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4395874/&quot;&gt;PMC free article&lt;/a&gt;]&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/23706743&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] [&lt;a href=&quot;https://dx.doi.org/10.1016%2Fj.cell.2013.04.055&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CCrosslink%7CDOI&quot;&gt;CrossRef&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=Cell.&amp;amp;title=The+eEF2+kinase+confers+resistance+to+nutrient+deprivation+by+blocking+translation+elongation&amp;amp;author=G+Leprivier&amp;amp;author=M+Remke&amp;amp;author=B+Rotblat&amp;amp;author=A+Dubuc&amp;amp;author=AR+Mateo&amp;amp;volume=153&amp;amp;issue=5&amp;amp;publication_year=2013&amp;amp;pages=1064-1079&amp;amp;pmid=23706743&amp;amp;doi=10.1016/j.cell.2013.04.055&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR78&quot;&gt;78. &lt;span class=&quot;element-citation&quot;&gt;Zheng L, Yang W, Wu F, Wang C, Yu L, Tang L, et al. Prognostic significance of AMPK activation and therapeutic effects of metformin in hepatocellular carcinoma. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;Clin Cancer Res.&lt;/span&gt; 2013;&lt;span class=&quot;ref-vol&quot;&gt;19&lt;/span&gt;(19):5372‚Äì5380. doi: 10.1158/1078-0432.CCR-13-0203.&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/23942093&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] [&lt;a href=&quot;https://dx.doi.org/10.1158%2F1078-0432.CCR-13-0203&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CCrosslink%7CDOI&quot;&gt;CrossRef&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=Clin+Cancer+Res&amp;amp;title=Prognostic+significance+of+AMPK+activation+and+therapeutic+effects+of+metformin+in+hepatocellular+carcinoma&amp;amp;author=L+Zheng&amp;amp;author=W+Yang&amp;amp;author=F+Wu&amp;amp;author=C+Wang&amp;amp;author=L+Yu&amp;amp;volume=19&amp;amp;issue=19&amp;amp;publication_year=2013&amp;amp;pages=5372-5380&amp;amp;pmid=23942093&amp;amp;doi=10.1158/1078-0432.CCR-13-0203&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR79&quot;&gt;79. &lt;span class=&quot;element-citation&quot;&gt;Wang L, Shang Z, Zhou Y, Hu X, Chen Y, Fan Y, et al. Autophagy mediates glucose starvation-induced glioblastoma cell quiescence and chemoresistance through coordinating cell metabolism, cell cycle, and survival. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;Cell Death Dis.&lt;/span&gt; 2018;&lt;span class=&quot;ref-vol&quot;&gt;9&lt;/span&gt;(2):213. doi: 10.1038/s41419-017-0242-x.&lt;/span&gt; &lt;span class=&quot;nowrap&quot;&gt;[&lt;a class=&quot;int-reflink&quot; href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5833690/&quot;&gt;PMC free article&lt;/a&gt;]&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/29434213&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] [&lt;a href=&quot;https://dx.doi.org/10.1038%2Fs41419-017-0242-x&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CCrosslink%7CDOI&quot;&gt;CrossRef&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=Cell+Death+Dis&amp;amp;title=Autophagy+mediates+glucose+starvation-induced+glioblastoma+cell+quiescence+and+chemoresistance+through+coordinating+cell+metabolism,+cell+cycle,+and+survival&amp;amp;author=L+Wang&amp;amp;author=Z+Shang&amp;amp;author=Y+Zhou&amp;amp;author=X+Hu&amp;amp;author=Y+Chen&amp;amp;volume=9&amp;amp;issue=2&amp;amp;publication_year=2018&amp;amp;pages=213&amp;amp;pmid=29434213&amp;amp;doi=10.1038/s41419-017-0242-x&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR80&quot;&gt;80. &lt;span class=&quot;element-citation&quot;&gt;Sato K, Tsuchihara K, Fujii S, Sugiyama M, Goya T, Atomi Y, et al. Autophagy is activated in colorectal cancer cells and contributes to the tolerance to nutrient deprivation. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;Cancer Res.&lt;/span&gt; 2007;&lt;span class=&quot;ref-vol&quot;&gt;67&lt;/span&gt;(20):9677‚Äì9684. doi: 10.1158/0008-5472.CAN-07-1462.&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/17942897&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] [&lt;a href=&quot;https://dx.doi.org/10.1158%2F0008-5472.CAN-07-1462&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CCrosslink%7CDOI&quot;&gt;CrossRef&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=Cancer+Res&amp;amp;title=Autophagy+is+activated+in+colorectal+cancer+cells+and+contributes+to+the+tolerance+to+nutrient+deprivation&amp;amp;author=K+Sato&amp;amp;author=K+Tsuchihara&amp;amp;author=S+Fujii&amp;amp;author=M+Sugiyama&amp;amp;author=T+Goya&amp;amp;volume=67&amp;amp;issue=20&amp;amp;publication_year=2007&amp;amp;pages=9677-9684&amp;amp;pmid=17942897&amp;amp;doi=10.1158/0008-5472.CAN-07-1462&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR81&quot;&gt;81. &lt;span class=&quot;element-citation&quot;&gt;Petibone DM, Majeed W, Casciano DA. Autophagy function and its relationship to pathology, clinical applications, drug metabolism and toxicity. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;J Appl Toxicol.&lt;/span&gt; 2017;&lt;span class=&quot;ref-vol&quot;&gt;37&lt;/span&gt;(1):23‚Äì37. doi: 10.1002/jat.3393.&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/27682190&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] [&lt;a href=&quot;https://dx.doi.org/10.1002%2Fjat.3393&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CCrosslink%7CDOI&quot;&gt;CrossRef&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=J+Appl+Toxicol&amp;amp;title=Autophagy+function+and+its+relationship+to+pathology,+clinical+applications,+drug+metabolism+and+toxicity&amp;amp;author=DM+Petibone&amp;amp;author=W+Majeed&amp;amp;author=DA+Casciano&amp;amp;volume=37&amp;amp;issue=1&amp;amp;publication_year=2017&amp;amp;pages=23-37&amp;amp;pmid=27682190&amp;amp;doi=10.1002/jat.3393&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR82&quot;&gt;82. &lt;span class=&quot;element-citation&quot;&gt;van Niekerk G, Hattingh SM, Engelbrecht AM. Enhanced therapeutic efficacy in Cancer patients by short-term fasting: the autophagy connection. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;Front Oncol.&lt;/span&gt; 2016;&lt;span class=&quot;ref-vol&quot;&gt;6&lt;/span&gt;:242.&lt;/span&gt; &lt;span class=&quot;nowrap&quot;&gt;[&lt;a class=&quot;int-reflink&quot; href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5107564/&quot;&gt;PMC free article&lt;/a&gt;]&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/27896219&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=Front+Oncol&amp;amp;title=Enhanced+therapeutic+efficacy+in+Cancer+patients+by+short-term+fasting:+the+autophagy+connection&amp;amp;author=G+van+Niekerk&amp;amp;author=SM+Hattingh&amp;amp;author=AM+Engelbrecht&amp;amp;volume=6&amp;amp;publication_year=2016&amp;amp;pages=242&amp;amp;pmid=27896219&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR83&quot;&gt;83. &lt;span class=&quot;element-citation&quot;&gt;DeBerardinis RJ, Lum JJ, Hatzivassiliou G, Thompson CB. The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;Cell Metab.&lt;/span&gt; 2008;&lt;span class=&quot;ref-vol&quot;&gt;7&lt;/span&gt;(1):11‚Äì20. doi: 10.1016/j.cmet.2007.10.002.&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/18177721&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] [&lt;a href=&quot;https://dx.doi.org/10.1016%2Fj.cmet.2007.10.002&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CCrosslink%7CDOI&quot;&gt;CrossRef&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=Cell+Metab&amp;amp;title=The+biology+of+cancer:+metabolic+reprogramming+fuels+cell+growth+and+proliferation&amp;amp;author=RJ+DeBerardinis&amp;amp;author=JJ+Lum&amp;amp;author=G+Hatzivassiliou&amp;amp;author=CB+Thompson&amp;amp;volume=7&amp;amp;issue=1&amp;amp;publication_year=2008&amp;amp;pages=11-20&amp;amp;pmid=18177721&amp;amp;doi=10.1016/j.cmet.2007.10.002&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR84&quot;&gt;84. &lt;span class=&quot;element-citation&quot;&gt;Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;Science.&lt;/span&gt; 2009;&lt;span class=&quot;ref-vol&quot;&gt;324&lt;/span&gt;(5930):1029‚Äì1033. doi: 10.1126/science.1160809.&lt;/span&gt; &lt;span class=&quot;nowrap&quot;&gt;[&lt;a class=&quot;int-reflink&quot; href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2849637/&quot;&gt;PMC free article&lt;/a&gt;]&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/19460998&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] [&lt;a href=&quot;https://dx.doi.org/10.1126%2Fscience.1160809&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CCrosslink%7CDOI&quot;&gt;CrossRef&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=Science.&amp;amp;title=Understanding+the+Warburg+effect:+the+metabolic+requirements+of+cell+proliferation&amp;amp;author=MG+Vander+Heiden&amp;amp;author=LC+Cantley&amp;amp;author=CB+Thompson&amp;amp;volume=324&amp;amp;issue=5930&amp;amp;publication_year=2009&amp;amp;pages=1029-1033&amp;amp;pmid=19460998&amp;amp;doi=10.1126/science.1160809&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR85&quot;&gt;85. &lt;span class=&quot;element-citation&quot;&gt;Lankelma J, Kooi B, Krab K, Dorsman JC, Joenje H, Westerhoff HV. A reason for intermittent fasting to suppress the awakening of dormant breast tumors. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;Biosystems.&lt;/span&gt; 2015;&lt;span class=&quot;ref-vol&quot;&gt;127&lt;/span&gt;:1‚Äì6. doi: 10.1016/j.biosystems.2014.11.001.&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/25448890&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] [&lt;a href=&quot;https://dx.doi.org/10.1016%2Fj.biosystems.2014.11.001&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CCrosslink%7CDOI&quot;&gt;CrossRef&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=Biosystems.&amp;amp;title=A+reason+for+intermittent+fasting+to+suppress+the+awakening+of+dormant+breast+tumors&amp;amp;author=J+Lankelma&amp;amp;author=B+Kooi&amp;amp;author=K+Krab&amp;amp;author=JC+Dorsman&amp;amp;author=H+Joenje&amp;amp;volume=127&amp;amp;publication_year=2015&amp;amp;pages=1-6&amp;amp;pmid=25448890&amp;amp;doi=10.1016/j.biosystems.2014.11.001&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR86&quot;&gt;86. &lt;span class=&quot;element-citation&quot;&gt;Kusuoka O, Fujiwara-Tani R, Nakashima C, Fujii K, Ohmori H, Mori T, et al. Intermittent calorie restriction enhances epithelial-mesenchymal transition through the alteration of energy metabolism in a mouse tumor model. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;Int J Oncol.&lt;/span&gt; 2018;&lt;span class=&quot;ref-vol&quot;&gt;52&lt;/span&gt;(2):413‚Äì423.&lt;/span&gt; &lt;span class=&quot;nowrap&quot;&gt;[&lt;a class=&quot;int-reflink&quot; href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5741368/&quot;&gt;PMC free article&lt;/a&gt;]&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/29345287&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=Int+J+Oncol&amp;amp;title=Intermittent+calorie+restriction+enhances+epithelial-mesenchymal+transition+through+the+alteration+of+energy+metabolism+in+a+mouse+tumor+model&amp;amp;author=O+Kusuoka&amp;amp;author=R+Fujiwara-Tani&amp;amp;author=C+Nakashima&amp;amp;author=K+Fujii&amp;amp;author=H+Ohmori&amp;amp;volume=52&amp;amp;issue=2&amp;amp;publication_year=2018&amp;amp;pages=413-423&amp;amp;pmid=29345287&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR87&quot;&gt;87. &lt;span class=&quot;element-citation&quot;&gt;Chen Y, Jungsuwadee P, Vore M, Butterfield DA, St Clair DK. Collateral damage in cancer chemotherapy: oxidative stress in nontargeted tissues. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;Mol Interv.&lt;/span&gt; 2007;&lt;span class=&quot;ref-vol&quot;&gt;7&lt;/span&gt;(3):147‚Äì156. doi: 10.1124/mi.7.3.6.&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/17609521&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] [&lt;a href=&quot;https://dx.doi.org/10.1124%2Fmi.7.3.6&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CCrosslink%7CDOI&quot;&gt;CrossRef&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=Mol+Interv&amp;amp;title=Collateral+damage+in+cancer+chemotherapy:+oxidative+stress+in+nontargeted+tissues&amp;amp;author=Y+Chen&amp;amp;author=P+Jungsuwadee&amp;amp;author=M+Vore&amp;amp;author=DA+Butterfield&amp;amp;author=DK+St+Clair&amp;amp;volume=7&amp;amp;issue=3&amp;amp;publication_year=2007&amp;amp;pages=147-156&amp;amp;pmid=17609521&amp;amp;doi=10.1124/mi.7.3.6&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR89&quot;&gt;89. &lt;span class=&quot;element-citation&quot;&gt;Aapro MS, Bohlius J, Cameron DA, Dal LL, Donnelly JP, Kearney N, et al. 2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;Eur J Cancer.&lt;/span&gt; 2011;&lt;span class=&quot;ref-vol&quot;&gt;47&lt;/span&gt;(1):8‚Äì32. doi: 10.1016/j.ejca.2010.10.013.&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/21095116&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] [&lt;a href=&quot;https://dx.doi.org/10.1016%2Fj.ejca.2010.10.013&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CCrosslink%7CDOI&quot;&gt;CrossRef&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=Eur+J+Cancer&amp;amp;title=2010+update+of+EORTC+guidelines+for+the+use+of+granulocyte-colony+stimulating+factor+to+reduce+the+incidence+of+chemotherapy-induced+febrile+neutropenia+in+adult+patients+with+lymphoproliferative+disorders+and+solid+tumours&amp;amp;author=MS+Aapro&amp;amp;author=J+Bohlius&amp;amp;author=DA+Cameron&amp;amp;author=LL+Dal&amp;amp;author=JP+Donnelly&amp;amp;volume=47&amp;amp;issue=1&amp;amp;publication_year=2011&amp;amp;pages=8-32&amp;amp;pmid=21095116&amp;amp;doi=10.1016/j.ejca.2010.10.013&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR90&quot;&gt;90. &lt;span class=&quot;mixed-citation&quot;&gt;Marij J. Welters, Tetje C. van der Sluis, H√©l√®ne van Meir, Nikki M. Loof, Vanessa J. van Ham, Suzanne van Duikeren et al. Vaccination during myeloid cell depletion by cancer chemotherapy fosters robust T-cell responses. Sci Transl Med. 2016. [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/27075626&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;]&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR91&quot;&gt;91. &lt;span class=&quot;element-citation&quot;&gt;Brandhorst S, Choi IY, Wei M, Cheng CW, Sedrakyan S, Navarrete G, et al. A periodic diet that mimics fasting promotes multi-system regeneration, enhanced cognitive performance, and Healthspan. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;Cell Metab.&lt;/span&gt; 2015;&lt;span class=&quot;ref-vol&quot;&gt;22&lt;/span&gt;(1):86‚Äì99. doi: 10.1016/j.cmet.2015.05.012.&lt;/span&gt; &lt;span class=&quot;nowrap&quot;&gt;[&lt;a class=&quot;int-reflink&quot; href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4509734/&quot;&gt;PMC free article&lt;/a&gt;]&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/26094889&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] [&lt;a href=&quot;https://dx.doi.org/10.1016%2Fj.cmet.2015.05.012&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CCrosslink%7CDOI&quot;&gt;CrossRef&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=Cell+Metab&amp;amp;title=A+periodic+diet+that+mimics+fasting+promotes+multi-system+regeneration,+enhanced+cognitive+performance,+and+Healthspan&amp;amp;author=S+Brandhorst&amp;amp;author=IY+Choi&amp;amp;author=M+Wei&amp;amp;author=CW+Cheng&amp;amp;author=S+Sedrakyan&amp;amp;volume=22&amp;amp;issue=1&amp;amp;publication_year=2015&amp;amp;pages=86-99&amp;amp;pmid=26094889&amp;amp;doi=10.1016/j.cmet.2015.05.012&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR92&quot;&gt;92. &lt;span class=&quot;element-citation&quot;&gt;Wing EJ, Stanko RT, Winkelstein A, Adibi SA. Fasting-enhanced immune effector mechanisms in obese subjects. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;Am J Med.&lt;/span&gt; 1983;&lt;span class=&quot;ref-vol&quot;&gt;75&lt;/span&gt;(1):91‚Äì96. doi: 10.1016/0002-9343(83)91172-5.&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/6859089&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] [&lt;a href=&quot;https://dx.doi.org/10.1016%2F0002-9343(83)91172-5&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CCrosslink%7CDOI&quot;&gt;CrossRef&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=Am+J+Med&amp;amp;title=Fasting-enhanced+immune+effector+mechanisms+in+obese+subjects&amp;amp;author=EJ+Wing&amp;amp;author=RT+Stanko&amp;amp;author=A+Winkelstein&amp;amp;author=SA+Adibi&amp;amp;volume=75&amp;amp;issue=1&amp;amp;publication_year=1983&amp;amp;pages=91-96&amp;amp;pmid=6859089&amp;amp;doi=10.1016/0002-9343(83)91172-5&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR93&quot;&gt;93. &lt;span class=&quot;element-citation&quot;&gt;Englert JM, Powell JD. Hunger pains: stimulating the appetite of the immune system for Cancer. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;Cancer Cell.&lt;/span&gt; 2016;&lt;span class=&quot;ref-vol&quot;&gt;30&lt;/span&gt;(1):13‚Äì15. doi: 10.1016/j.ccell.2016.06.019.&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/27411584&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] [&lt;a href=&quot;https://dx.doi.org/10.1016%2Fj.ccell.2016.06.019&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CCrosslink%7CDOI&quot;&gt;CrossRef&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=Cancer+Cell&amp;amp;title=Hunger+pains:+stimulating+the+appetite+of+the+immune+system+for+Cancer&amp;amp;author=JM+Englert&amp;amp;author=JD+Powell&amp;amp;volume=30&amp;amp;issue=1&amp;amp;publication_year=2016&amp;amp;pages=13-15&amp;amp;pmid=27411584&amp;amp;doi=10.1016/j.ccell.2016.06.019&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR94&quot;&gt;94. &lt;span class=&quot;element-citation&quot;&gt;Di Biase S, Lee C, Brandhorst S, Manes B, Buono R, Cheng CW, et al. Fasting-mimicking diet reduces HO-1 to promote T cell-mediated tumor cytotoxicity. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;Cancer Cell.&lt;/span&gt; 2016;&lt;span class=&quot;ref-vol&quot;&gt;30&lt;/span&gt;(1):136‚Äì146. doi: 10.1016/j.ccell.2016.06.005.&lt;/span&gt; &lt;span class=&quot;nowrap&quot;&gt;[&lt;a class=&quot;int-reflink&quot; href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5388544/&quot;&gt;PMC free article&lt;/a&gt;]&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/27411588&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] [&lt;a href=&quot;https://dx.doi.org/10.1016%2Fj.ccell.2016.06.005&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CCrosslink%7CDOI&quot;&gt;CrossRef&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=Cancer+Cell&amp;amp;title=Fasting-mimicking+diet+reduces+HO-1+to+promote+T+cell-mediated+tumor+cytotoxicity&amp;amp;author=S+Di+Biase&amp;amp;author=C+Lee&amp;amp;author=S+Brandhorst&amp;amp;author=B+Manes&amp;amp;author=R+Buono&amp;amp;volume=30&amp;amp;issue=1&amp;amp;publication_year=2016&amp;amp;pages=136-146&amp;amp;pmid=27411588&amp;amp;doi=10.1016/j.ccell.2016.06.005&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR95&quot;&gt;95. &lt;span class=&quot;element-citation&quot;&gt;Jensen TL, Kiersgaard MK, Sorensen DB, Mikkelsen LF. Fasting of mice: a review. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;Lab Anim.&lt;/span&gt; 2013;&lt;span class=&quot;ref-vol&quot;&gt;47&lt;/span&gt;(4):225‚Äì240. doi: 10.1177/0023677213501659.&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/24025567&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] [&lt;a href=&quot;https://dx.doi.org/10.1177%2F0023677213501659&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CCrosslink%7CDOI&quot;&gt;CrossRef&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=Lab+Anim&amp;amp;title=Fasting+of+mice:+a+review&amp;amp;author=TL+Jensen&amp;amp;author=MK+Kiersgaard&amp;amp;author=DB+Sorensen&amp;amp;author=LF+Mikkelsen&amp;amp;volume=47&amp;amp;issue=4&amp;amp;publication_year=2013&amp;amp;pages=225-240&amp;amp;pmid=24025567&amp;amp;doi=10.1177/0023677213501659&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR96&quot;&gt;96. &lt;span class=&quot;element-citation&quot;&gt;Bhaskaran K, Douglas I, Forbes H. dos-Santos-Silva I, Leon DA, Smeeth L&lt;strong&gt;.&lt;/strong&gt; body-mass index and risk of 22 specific cancers: a population-based cohort study of 5.24 million UK adults. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;Lancet.&lt;/span&gt; 2014;&lt;span class=&quot;ref-vol&quot;&gt;384&lt;/span&gt;(9945):755‚Äì765. doi: 10.1016/S0140-6736(14)60892-8.&lt;/span&gt; &lt;span class=&quot;nowrap&quot;&gt;[&lt;a class=&quot;int-reflink&quot; href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4151483/&quot;&gt;PMC free article&lt;/a&gt;]&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/25129328&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] [&lt;a href=&quot;https://dx.doi.org/10.1016%2FS0140-6736(14)60892-8&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CCrosslink%7CDOI&quot;&gt;CrossRef&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=Lancet.&amp;amp;title=dos-Santos-Silva+I,+Leon+DA,+Smeeth+L.+body-mass+index+and+risk+of+22+specific+cancers:+a+population-based+cohort+study+of+5.24+million+UK+adults&amp;amp;author=K+Bhaskaran&amp;amp;author=I+Douglas&amp;amp;author=H+Forbes&amp;amp;volume=384&amp;amp;issue=9945&amp;amp;publication_year=2014&amp;amp;pages=755-765&amp;amp;pmid=25129328&amp;amp;doi=10.1016/S0140-6736(14)60892-8&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR97&quot;&gt;97. &lt;span class=&quot;element-citation&quot;&gt;Chan DS, Vieira AR, Aune D, Bandera EV, Greenwood DC, McTiernan A, et al. Body mass index and survival in women with breast cancer-systematic literature review and meta-analysis of 82 follow-up studies. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;Ann Oncol.&lt;/span&gt; 2014;&lt;span class=&quot;ref-vol&quot;&gt;25&lt;/span&gt;(10):1901‚Äì14. doi: 10.1093/annonc/mdu042.&lt;/span&gt; &lt;span class=&quot;nowrap&quot;&gt;[&lt;a class=&quot;int-reflink&quot; href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4176449/&quot;&gt;PMC free article&lt;/a&gt;]&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/24769692&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] [&lt;a href=&quot;https://dx.doi.org/10.1093%2Fannonc%2Fmdu042&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CCrosslink%7CDOI&quot;&gt;CrossRef&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=Ann+Oncol&amp;amp;title=Body+mass+index+and+survival+in+women+with+breast+cancer-systematic+literature+review+and+meta-analysis+of+82+follow-up+studies&amp;amp;author=DS+Chan&amp;amp;author=AR+Vieira&amp;amp;author=D+Aune&amp;amp;author=EV+Bandera&amp;amp;author=DC+Greenwood&amp;amp;volume=25&amp;amp;issue=10&amp;amp;publication_year=2014&amp;amp;pages=1901-14&amp;amp;pmid=24769692&amp;amp;doi=10.1093/annonc/mdu042&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR98&quot;&gt;98. &lt;span class=&quot;element-citation&quot;&gt;Rowlands MA, Gunnell D, Harris R, Vatten LJ, Holly JM, Martin RM. Circulating insulin-like growth factor peptides and prostate cancer risk: a systematic review and meta-analysis. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;Int J Cancer.&lt;/span&gt; 2009;&lt;span class=&quot;ref-vol&quot;&gt;124&lt;/span&gt;(10):2416‚Äì2429. doi: 10.1002/ijc.24202.&lt;/span&gt; &lt;span class=&quot;nowrap&quot;&gt;[&lt;a class=&quot;int-reflink&quot; href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2743036/&quot;&gt;PMC free article&lt;/a&gt;]&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/19142965&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] [&lt;a href=&quot;https://dx.doi.org/10.1002%2Fijc.24202&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CCrosslink%7CDOI&quot;&gt;CrossRef&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=Int+J+Cancer&amp;amp;title=Circulating+insulin-like+growth+factor+peptides+and+prostate+cancer+risk:+a+systematic+review+and+meta-analysis&amp;amp;author=MA+Rowlands&amp;amp;author=D+Gunnell&amp;amp;author=R+Harris&amp;amp;author=LJ+Vatten&amp;amp;author=JM+Holly&amp;amp;volume=124&amp;amp;issue=10&amp;amp;publication_year=2009&amp;amp;pages=2416-2429&amp;amp;pmid=19142965&amp;amp;doi=10.1002/ijc.24202&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR99&quot;&gt;99. &lt;span class=&quot;element-citation&quot;&gt;Endogenous H. Breast Cancer collaborative G, key TJ, Appleby PN, reeves GK, Roddam AW&lt;strong&gt;.&lt;/strong&gt; Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;Lancet Oncol.&lt;/span&gt; 2010;&lt;span class=&quot;ref-vol&quot;&gt;11&lt;/span&gt;(6):530‚Äì542. doi: 10.1016/S1470-2045(10)70095-4.&lt;/span&gt; &lt;span class=&quot;nowrap&quot;&gt;[&lt;a class=&quot;int-reflink&quot; href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3113287/&quot;&gt;PMC free article&lt;/a&gt;]&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/20472501&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] [&lt;a href=&quot;https://dx.doi.org/10.1016%2FS1470-2045(10)70095-4&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CCrosslink%7CDOI&quot;&gt;CrossRef&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=Lancet+Oncol&amp;amp;title=Breast+Cancer+collaborative+G,+key+TJ,+Appleby+PN,+reeves+GK,+Roddam+AW.+Insulin-like+growth+factor+1+(IGF1),+IGF+binding+protein+3+(IGFBP3),+and+breast+cancer+risk:+pooled+individual+data+analysis+of+17+prospective+studies&amp;amp;author=H+Endogenous&amp;amp;volume=11&amp;amp;issue=6&amp;amp;publication_year=2010&amp;amp;pages=530-542&amp;amp;pmid=20472501&amp;amp;doi=10.1016/S1470-2045(10)70095-4&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR100&quot;&gt;100. &lt;span class=&quot;element-citation&quot;&gt;Ferroni P, Riondino S, Laudisi A, Portarena I, Formica V, Alessandroni J, et al. Pretreatment insulin levels as a prognostic factor for breast Cancer progression. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;Oncologist.&lt;/span&gt; 2016;&lt;span class=&quot;ref-vol&quot;&gt;21&lt;/span&gt;(9):1041‚Äì1049. doi: 10.1634/theoncologist.2015-0462.&lt;/span&gt; &lt;span class=&quot;nowrap&quot;&gt;[&lt;a class=&quot;int-reflink&quot; href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5016062/&quot;&gt;PMC free article&lt;/a&gt;]&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/27388232&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] [&lt;a href=&quot;https://dx.doi.org/10.1634%2Ftheoncologist.2015-0462&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CCrosslink%7CDOI&quot;&gt;CrossRef&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=Oncologist.&amp;amp;title=Pretreatment+insulin+levels+as+a+prognostic+factor+for+breast+Cancer+progression&amp;amp;author=P+Ferroni&amp;amp;author=S+Riondino&amp;amp;author=A+Laudisi&amp;amp;author=I+Portarena&amp;amp;author=V+Formica&amp;amp;volume=21&amp;amp;issue=9&amp;amp;publication_year=2016&amp;amp;pages=1041-1049&amp;amp;pmid=27388232&amp;amp;doi=10.1634/theoncologist.2015-0462&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR101&quot;&gt;101. &lt;span class=&quot;element-citation&quot;&gt;Duggan C, Wang CY, Neuhouser ML, Xiao L, Smith AW, Reding KW, et al. Associations of insulin-like growth factor and insulin-like growth factor binding protein-3 with mortality in women with breast cancer. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;Int J Cancer.&lt;/span&gt; 2013;&lt;span class=&quot;ref-vol&quot;&gt;132&lt;/span&gt;(5):1191‚Äì1200. doi: 10.1002/ijc.27753.&lt;/span&gt; &lt;span class=&quot;nowrap&quot;&gt;[&lt;a class=&quot;int-reflink&quot; href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3764990/&quot;&gt;PMC free article&lt;/a&gt;]&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/22847383&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] [&lt;a href=&quot;https://dx.doi.org/10.1002%2Fijc.27753&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CCrosslink%7CDOI&quot;&gt;CrossRef&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=Int+J+Cancer&amp;amp;title=Associations+of+insulin-like+growth+factor+and+insulin-like+growth+factor+binding+protein-3+with+mortality+in+women+with+breast+cancer&amp;amp;author=C+Duggan&amp;amp;author=CY+Wang&amp;amp;author=ML+Neuhouser&amp;amp;author=L+Xiao&amp;amp;author=AW+Smith&amp;amp;volume=132&amp;amp;issue=5&amp;amp;publication_year=2013&amp;amp;pages=1191-1200&amp;amp;pmid=22847383&amp;amp;doi=10.1002/ijc.27753&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR102&quot;&gt;102. &lt;span class=&quot;element-citation&quot;&gt;Meyerhardt JA, Catalano PJ, Haller DG, Mayer RJ, Macdonald JS, Benson AB, 3rd, et al. Impact of diabetes mellitus on outcomes in patients with colon cancer. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;J Clin Oncol.&lt;/span&gt; 2003;&lt;span class=&quot;ref-vol&quot;&gt;21&lt;/span&gt;(3):433‚Äì440. doi: 10.1200/JCO.2003.07.125.&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/12560431&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] [&lt;a href=&quot;https://dx.doi.org/10.1200%2FJCO.2003.07.125&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CCrosslink%7CDOI&quot;&gt;CrossRef&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=J+Clin+Oncol&amp;amp;title=Impact+of+diabetes+mellitus+on+outcomes+in+patients+with+colon+cancer&amp;amp;author=JA+Meyerhardt&amp;amp;author=PJ+Catalano&amp;amp;author=DG+Haller&amp;amp;author=RJ+Mayer&amp;amp;author=JS+Macdonald&amp;amp;volume=21&amp;amp;issue=3&amp;amp;publication_year=2003&amp;amp;pages=433-440&amp;amp;pmid=12560431&amp;amp;doi=10.1200/JCO.2003.07.125&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR103&quot;&gt;103. &lt;span class=&quot;element-citation&quot;&gt;Derr RL, Ye X, Islas MU, Desideri S, Saudek CD, Grossman SA. Association between hyperglycemia and survival in patients with newly diagnosed glioblastoma. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;J Clin Oncol.&lt;/span&gt; 2009;&lt;span class=&quot;ref-vol&quot;&gt;27&lt;/span&gt;(7):1082‚Äì1086. doi: 10.1200/JCO.2008.19.1098.&lt;/span&gt; &lt;span class=&quot;nowrap&quot;&gt;[&lt;a class=&quot;int-reflink&quot; href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2667812/&quot;&gt;PMC free article&lt;/a&gt;]&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/19139429&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] [&lt;a href=&quot;https://dx.doi.org/10.1200%2FJCO.2008.19.1098&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CCrosslink%7CDOI&quot;&gt;CrossRef&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=J+Clin+Oncol&amp;amp;title=Association+between+hyperglycemia+and+survival+in+patients+with+newly+diagnosed+glioblastoma&amp;amp;author=RL+Derr&amp;amp;author=X+Ye&amp;amp;author=MU+Islas&amp;amp;author=S+Desideri&amp;amp;author=CD+Saudek&amp;amp;volume=27&amp;amp;issue=7&amp;amp;publication_year=2009&amp;amp;pages=1082-1086&amp;amp;pmid=19139429&amp;amp;doi=10.1200/JCO.2008.19.1098&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR104&quot;&gt;104. &lt;span class=&quot;element-citation&quot;&gt;van Kruijsdijk RC, van der Wall E, Visseren FL. Obesity and cancer: the role of dysfunctional adipose tissue. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;Cancer Epidemiol Biomark Prev.&lt;/span&gt; 2009;&lt;span class=&quot;ref-vol&quot;&gt;18&lt;/span&gt;(10):2569‚Äì2578. doi: 10.1158/1055-9965.EPI-09-0372.&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/19755644&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] [&lt;a href=&quot;https://dx.doi.org/10.1158%2F1055-9965.EPI-09-0372&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CCrosslink%7CDOI&quot;&gt;CrossRef&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=Cancer+Epidemiol+Biomark+Prev&amp;amp;title=Obesity+and+cancer:+the+role+of+dysfunctional+adipose+tissue&amp;amp;author=RC+van+Kruijsdijk&amp;amp;author=E+van+der+Wall&amp;amp;author=FL+Visseren&amp;amp;volume=18&amp;amp;issue=10&amp;amp;publication_year=2009&amp;amp;pages=2569-2578&amp;amp;doi=10.1158/1055-9965.EPI-09-0372&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR105&quot;&gt;105. &lt;span class=&quot;element-citation&quot;&gt;Vella Veronica, Milluzzo Agostino, Scalisi Nunzio, Vigneri Paolo, Sciacca Laura. Insulin Receptor Isoforms in Cancer. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;International Journal of Molecular Sciences.&lt;/span&gt; 2018;&lt;span class=&quot;ref-vol&quot;&gt;19&lt;/span&gt;(11):3615. doi: 10.3390/ijms19113615.&lt;/span&gt; &lt;span class=&quot;nowrap&quot;&gt;[&lt;a class=&quot;int-reflink&quot; href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6274710/&quot;&gt;PMC free article&lt;/a&gt;]&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/30453495&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] [&lt;a href=&quot;https://dx.doi.org/10.3390%2Fijms19113615&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CCrosslink%7CDOI&quot;&gt;CrossRef&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=International+Journal+of+Molecular+Sciences&amp;amp;title=Insulin+Receptor+Isoforms+in+Cancer&amp;amp;author=Veronica+Vella&amp;amp;author=Agostino+Milluzzo&amp;amp;author=Nunzio+Scalisi&amp;amp;author=Paolo+Vigneri&amp;amp;author=Laura+Sciacca&amp;amp;volume=19&amp;amp;issue=11&amp;amp;publication_year=2018&amp;amp;pages=3615&amp;amp;pmid=6274710&amp;amp;doi=10.3390/ijms19113615&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR106&quot;&gt;106. &lt;span class=&quot;element-citation&quot;&gt;Pollak M. Insulin, insulin-like growth factors and neoplasia. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;Best Pract Res Clin Endocrinol Metab.&lt;/span&gt; 2008;&lt;span class=&quot;ref-vol&quot;&gt;22&lt;/span&gt;(4):625‚Äì638. doi: 10.1016/j.beem.2008.08.004.&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/18971123&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] [&lt;a href=&quot;https://dx.doi.org/10.1016%2Fj.beem.2008.08.004&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CCrosslink%7CDOI&quot;&gt;CrossRef&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=Best+Pract+Res+Clin+Endocrinol+Metab&amp;amp;title=Insulin,+insulin-like+growth+factors+and+neoplasia&amp;amp;author=M+Pollak&amp;amp;volume=22&amp;amp;issue=4&amp;amp;publication_year=2008&amp;amp;pages=625-638&amp;amp;pmid=18971123&amp;amp;doi=10.1016/j.beem.2008.08.004&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR107&quot;&gt;107. &lt;span class=&quot;element-citation&quot;&gt;Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW., Jr Obesity is associated with macrophage accumulation in adipose tissue. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;J Clin Invest.&lt;/span&gt; 2003;&lt;span class=&quot;ref-vol&quot;&gt;112&lt;/span&gt;(12):1796‚Äì1808. doi: 10.1172/JCI200319246.&lt;/span&gt; &lt;span class=&quot;nowrap&quot;&gt;[&lt;a class=&quot;int-reflink&quot; href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC296995/&quot;&gt;PMC free article&lt;/a&gt;]&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/14679176&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] [&lt;a href=&quot;https://dx.doi.org/10.1172%2FJCI200319246&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CCrosslink%7CDOI&quot;&gt;CrossRef&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=J+Clin+Invest&amp;amp;title=Obesity+is+associated+with+macrophage+accumulation+in+adipose+tissue&amp;amp;author=SP+Weisberg&amp;amp;author=D+McCann&amp;amp;author=M+Desai&amp;amp;author=M+Rosenbaum&amp;amp;author=RL+Leibel&amp;amp;volume=112&amp;amp;issue=12&amp;amp;publication_year=2003&amp;amp;pages=1796-1808&amp;amp;pmid=14679176&amp;amp;doi=10.1172/JCI200319246&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR108&quot;&gt;108. &lt;span class=&quot;element-citation&quot;&gt;Johnstone AM. Fasting - the ultimate diet? &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;Obes Rev.&lt;/span&gt; 2007;&lt;span class=&quot;ref-vol&quot;&gt;8&lt;/span&gt;(3):211‚Äì222. doi: 10.1111/j.1467-789X.2006.00266.x.&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/17444963&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] [&lt;a href=&quot;https://dx.doi.org/10.1111%2Fj.1467-789X.2006.00266.x&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CCrosslink%7CDOI&quot;&gt;CrossRef&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=Obes+Rev&amp;amp;title=Fasting+-+the+ultimate+diet?&amp;amp;author=AM+Johnstone&amp;amp;volume=8&amp;amp;issue=3&amp;amp;publication_year=2007&amp;amp;pages=211-222&amp;amp;pmid=17444963&amp;amp;doi=10.1111/j.1467-789X.2006.00266.x&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR109&quot;&gt;109. &lt;span class=&quot;element-citation&quot;&gt;Folin O, Denis W. On starvation and obesity, with special reference to acidosis. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;J Biol Chem.&lt;/span&gt; 1915;&lt;span class=&quot;ref-vol&quot;&gt;21&lt;/span&gt;:183‚Äì192.&lt;/span&gt; &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;amp;title=On+starvation+and+obesity,+with+special+reference+to+acidosis&amp;amp;author=O+Folin&amp;amp;author=W+Denis&amp;amp;volume=21&amp;amp;publication_year=1915&amp;amp;pages=183-192&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR111&quot;&gt;111. &lt;span class=&quot;element-citation&quot;&gt;Thomson TJ, Runcie J, Miller V. Treatment of obesity by total fasting for up to 249 days. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;Lancet.&lt;/span&gt; 1966;&lt;span class=&quot;ref-vol&quot;&gt;2&lt;/span&gt;(7471):992‚Äì996. doi: 10.1016/S0140-6736(66)92925-4.&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/4162668&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] [&lt;a href=&quot;https://dx.doi.org/10.1016%2FS0140-6736(66)92925-4&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CCrosslink%7CDOI&quot;&gt;CrossRef&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=Lancet.&amp;amp;title=Treatment+of+obesity+by+total+fasting+for+up+to+249+days&amp;amp;author=TJ+Thomson&amp;amp;author=J+Runcie&amp;amp;author=V+Miller&amp;amp;volume=2&amp;amp;issue=7471&amp;amp;publication_year=1966&amp;amp;pages=992-996&amp;amp;pmid=4162668&amp;amp;doi=10.1016/S0140-6736(66)92925-4&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR112&quot;&gt;112. &lt;span class=&quot;element-citation&quot;&gt;BLOOM WL. Fasting as an introduction to the treatment of obesity. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;Metabolism.&lt;/span&gt; 1959;&lt;span class=&quot;ref-vol&quot;&gt;8&lt;/span&gt;(3):214‚Äì220.&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/13656492&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=Metabolism.&amp;amp;title=Fasting+as+an+introduction+to+the+treatment+of+obesity&amp;amp;author=WL+BLOOM&amp;amp;volume=8&amp;amp;issue=3&amp;amp;publication_year=1959&amp;amp;pages=214-220&amp;amp;pmid=13656492&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR113&quot;&gt;113. &lt;span class=&quot;element-citation&quot;&gt;Drenick Ernst J., Smith Roger. Weight Reduction by Prolonged Starvation. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;Postgraduate Medicine.&lt;/span&gt; 1964;&lt;span class=&quot;ref-vol&quot;&gt;36&lt;/span&gt;(6):A-95-A-100. doi: 10.1080/00325481.1964.11695378.&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/14234330&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] [&lt;a href=&quot;https://dx.doi.org/10.1080%2F00325481.1964.11695378&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CCrosslink%7CDOI&quot;&gt;CrossRef&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=Postgraduate+Medicine&amp;amp;title=Weight+Reduction+by+Prolonged+Starvation&amp;amp;author=Ernst+J.+Drenick&amp;amp;author=Roger+Smith&amp;amp;volume=36&amp;amp;issue=6&amp;amp;publication_year=1964&amp;amp;pages=A-95-A-100&amp;amp;doi=10.1080/00325481.1964.11695378&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR114&quot;&gt;114. &lt;span class=&quot;mixed-citation&quot;&gt;Franc¬∏oise Wilhelmi de Toledo FG, Audrey Bergouignan, , Stefan Drinda AM&lt;strong&gt;.&lt;/strong&gt; Safety, health improvement and well-being during a 4 to 21-day fasting period in an observational study including 1422 subjects. PLoS One. 2019. &lt;span class=&quot;nowrap&quot;&gt;[&lt;a class=&quot;int-reflink&quot; href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6314618/&quot;&gt;PMC free article&lt;/a&gt;]&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/30601864&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;]&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR115&quot;&gt;115. &lt;span class=&quot;element-citation&quot;&gt;Spencer IO. Death during therapeutic starvation for obesity. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;Lancet.&lt;/span&gt; 1968;&lt;span class=&quot;ref-vol&quot;&gt;1&lt;/span&gt;(7555):1288‚Äì1290. doi: 10.1016/S0140-6736(68)92299-X.&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/4172144&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] [&lt;a href=&quot;https://dx.doi.org/10.1016%2FS0140-6736(68)92299-X&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CCrosslink%7CDOI&quot;&gt;CrossRef&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=Lancet.&amp;amp;title=Death+during+therapeutic+starvation+for+obesity&amp;amp;author=IO+Spencer&amp;amp;volume=1&amp;amp;issue=7555&amp;amp;publication_year=1968&amp;amp;pages=1288-1290&amp;amp;pmid=4172144&amp;amp;doi=10.1016/S0140-6736(68)92299-X&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR116&quot;&gt;116. &lt;span class=&quot;element-citation&quot;&gt;Cubberley Peter T., Polster Sheldon A., Schulman Charles L. Lactic Acidosis and Death after the Treatment of Obesity by Fasting. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;New England Journal of Medicine.&lt;/span&gt; 1965;&lt;span class=&quot;ref-vol&quot;&gt;272&lt;/span&gt;(12):628‚Äì630. doi: 10.1056/NEJM196503252721208.&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/14255340&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] [&lt;a href=&quot;https://dx.doi.org/10.1056%2FNEJM196503252721208&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CCrosslink%7CDOI&quot;&gt;CrossRef&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=New+England+Journal+of+Medicine&amp;amp;title=Lactic+Acidosis+and+Death+after+the+Treatment+of+Obesity+by+Fasting&amp;amp;author=Peter+T.+Cubberley&amp;amp;author=Sheldon+A.+Polster&amp;amp;author=Charles+L.+Schulman&amp;amp;volume=272&amp;amp;issue=12&amp;amp;publication_year=1965&amp;amp;pages=628-630&amp;amp;pmid=14255340&amp;amp;doi=10.1056/NEJM196503252721208&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR118&quot;&gt;118. &lt;span class=&quot;element-citation&quot;&gt;Brazg J, Ruest A, Law S, Bosoy D. A therapeutic fast for lymphoma resulting in Wernicke encephalopathy. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;J Emerg Med.&lt;/span&gt; 2015;&lt;span class=&quot;ref-vol&quot;&gt;49&lt;/span&gt;(4):471‚Äì474. doi: 10.1016/j.jemermed.2015.03.022.&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/26104844&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] [&lt;a href=&quot;https://dx.doi.org/10.1016%2Fj.jemermed.2015.03.022&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CCrosslink%7CDOI&quot;&gt;CrossRef&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=J+Emerg+Med&amp;amp;title=A+therapeutic+fast+for+lymphoma+resulting+in+Wernicke+encephalopathy&amp;amp;author=J+Brazg&amp;amp;author=A+Ruest&amp;amp;author=S+Law&amp;amp;author=D+Bosoy&amp;amp;volume=49&amp;amp;issue=4&amp;amp;publication_year=2015&amp;amp;pages=471-474&amp;amp;pmid=26104844&amp;amp;doi=10.1016/j.jemermed.2015.03.022&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR119&quot;&gt;119. &lt;span class=&quot;element-citation&quot;&gt;Douillard C, Mention K, Dobbelaere D, Wemeau JL, Saudubray JM, Vantyghem MC. Hypoglycaemia related to inherited metabolic diseases in adults. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;Orphanet J Rare Dis.&lt;/span&gt; 2012;&lt;span class=&quot;ref-vol&quot;&gt;7&lt;/span&gt;:26. doi: 10.1186/1750-1172-7-26.&lt;/span&gt; &lt;span class=&quot;nowrap&quot;&gt;[&lt;a class=&quot;int-reflink&quot; href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3458880/&quot;&gt;PMC free article&lt;/a&gt;]&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/22587661&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] [&lt;a href=&quot;https://dx.doi.org/10.1186%2F1750-1172-7-26&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CCrosslink%7CDOI&quot;&gt;CrossRef&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=Orphanet+J+Rare+Dis&amp;amp;title=Hypoglycaemia+related+to+inherited+metabolic+diseases+in+adults&amp;amp;author=C+Douillard&amp;amp;author=K+Mention&amp;amp;author=D+Dobbelaere&amp;amp;author=JL+Wemeau&amp;amp;author=JM+Saudubray&amp;amp;volume=7&amp;amp;publication_year=2012&amp;amp;pages=26&amp;amp;pmid=22587661&amp;amp;doi=10.1186/1750-1172-7-26&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR120&quot;&gt;120. &lt;span class=&quot;element-citation&quot;&gt;Goldhamer AC, Lisle DJ, Sultana P, Anderson SV, Parpia B, Hughes B, et al. Medically supervised water-only fasting in the treatment of borderline hypertension. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;J Altern Complement Med.&lt;/span&gt; 2002;&lt;span class=&quot;ref-vol&quot;&gt;8&lt;/span&gt;(5):643‚Äì650. doi: 10.1089/107555302320825165.&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/12470446&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] [&lt;a href=&quot;https://dx.doi.org/10.1089%2F107555302320825165&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CCrosslink%7CDOI&quot;&gt;CrossRef&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=J+Altern+Complement+Med&amp;amp;title=Medically+supervised+water-only+fasting+in+the+treatment+of+borderline+hypertension&amp;amp;author=AC+Goldhamer&amp;amp;author=DJ+Lisle&amp;amp;author=P+Sultana&amp;amp;author=SV+Anderson&amp;amp;author=B+Parpia&amp;amp;volume=8&amp;amp;issue=5&amp;amp;publication_year=2002&amp;amp;pages=643-650&amp;amp;pmid=12470446&amp;amp;doi=10.1089/107555302320825165&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;

&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR122&quot;&gt;122. &lt;span class=&quot;element-citation&quot;&gt;Michalsen A, Hoffmann B, Moebus S, Backer M, Langhorst J, Dobos GJ. Incorporation of fasting therapy in an integrative medicine ward: evaluation of outcome, safety, and effects on lifestyle adherence in a large prospective cohort study. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;J Altern Complement Med.&lt;/span&gt; 2005;&lt;span class=&quot;ref-vol&quot;&gt;11&lt;/span&gt;(4):601‚Äì607. doi: 10.1089/acm.2005.11.601.&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/16131283&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] [&lt;a href=&quot;https://dx.doi.org/10.1089%2Facm.2005.11.601&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CCrosslink%7CDOI&quot;&gt;CrossRef&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=J+Altern+Complement+Med&amp;amp;title=Incorporation+of+fasting+therapy+in+an+integrative+medicine+ward:+evaluation+of+outcome,+safety,+and+effects+on+lifestyle+adherence+in+a+large+prospective+cohort+study&amp;amp;author=A+Michalsen&amp;amp;author=B+Hoffmann&amp;amp;author=S+Moebus&amp;amp;author=M+Backer&amp;amp;author=J+Langhorst&amp;amp;volume=11&amp;amp;issue=4&amp;amp;publication_year=2005&amp;amp;pages=601-607&amp;amp;pmid=16131283&amp;amp;doi=10.1089/acm.2005.11.601&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR123&quot;&gt;123. &lt;span class=&quot;element-citation&quot;&gt;Han K, Nguyen A, Traba J, Yao X, Kaler M, Huffstutler RD, et al. A pilot study to investigate the immune-modulatory effects of fasting in steroid-naive mild asthmatics. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;J Immunol.&lt;/span&gt; 2018;&lt;span class=&quot;ref-vol&quot;&gt;201&lt;/span&gt;(5):1382‚Äì1388. doi: 10.4049/jimmunol.1800585.&lt;/span&gt; &lt;span class=&quot;nowrap&quot;&gt;[&lt;a class=&quot;int-reflink&quot; href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6103907/&quot;&gt;PMC free article&lt;/a&gt;]&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/30021766&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] [&lt;a href=&quot;https://dx.doi.org/10.4049%2Fjimmunol.1800585&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CCrosslink%7CDOI&quot;&gt;CrossRef&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=J+Immunol&amp;amp;title=A+pilot+study+to+investigate+the+immune-modulatory+effects+of+fasting+in+steroid-naive+mild+asthmatics&amp;amp;author=K+Han&amp;amp;author=A+Nguyen&amp;amp;author=J+Traba&amp;amp;author=X+Yao&amp;amp;author=M+Kaler&amp;amp;volume=201&amp;amp;issue=5&amp;amp;publication_year=2018&amp;amp;pages=1382-1388&amp;amp;pmid=30021766&amp;amp;doi=10.4049/jimmunol.1800585&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR124&quot;&gt;124. &lt;span class=&quot;element-citation&quot;&gt;Wei Min, Brandhorst Sebastian, Shelehchi Mahshid, Mirzaei Hamed, Cheng Chia Wei, Budniak Julia, Groshen Susan, Mack Wendy J., Guen Esra, Di Biase Stefano, Cohen Pinchas, Morgan Todd E., Dorff Tanya, Hong Kurt, Michalsen Andreas, Laviano Alessandro, Longo Valter D. Fasting-mimicking diet and markers/risk factors for aging, diabetes, cancer, and cardiovascular disease. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;Science Translational Medicine.&lt;/span&gt; 2017;&lt;span class=&quot;ref-vol&quot;&gt;9&lt;/span&gt;(377):eaai8700. doi: 10.1126/scitranslmed.aai8700.&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/28202779&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] [&lt;a href=&quot;https://dx.doi.org/10.1126%2Fscitranslmed.aai8700&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CCrosslink%7CDOI&quot;&gt;CrossRef&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=Science+Translational+Medicine&amp;amp;title=Fasting-mimicking+diet+and+markers/risk+factors+for+aging,+diabetes,+cancer,+and+cardiovascular+disease&amp;amp;author=Min+Wei&amp;amp;author=Sebastian+Brandhorst&amp;amp;author=Mahshid+Shelehchi&amp;amp;author=Hamed+Mirzaei&amp;amp;author=Chia+Wei+Cheng&amp;amp;volume=9&amp;amp;issue=377&amp;amp;publication_year=2017&amp;amp;pages=eaai8700&amp;amp;pmid=28202779&amp;amp;doi=10.1126/scitranslmed.aai8700&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR125&quot;&gt;125. &lt;span class=&quot;element-citation&quot;&gt;Zhan C, Dai X, Shen G, Lu X, Wang X, Lu L, et al. Preoperative short-term fasting protects liver injury in patients undergoing hepatectomy. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;Ann Transl Med.&lt;/span&gt; 2018;&lt;span class=&quot;ref-vol&quot;&gt;6&lt;/span&gt;(23):449. doi: 10.21037/atm.2018.10.64.&lt;/span&gt; &lt;span class=&quot;nowrap&quot;&gt;[&lt;a class=&quot;int-reflink&quot; href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6312820/&quot;&gt;PMC free article&lt;/a&gt;]&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/30603637&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] [&lt;a href=&quot;https://dx.doi.org/10.21037%2Fatm.2018.10.64&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CCrosslink%7CDOI&quot;&gt;CrossRef&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=Ann+Transl+Med&amp;amp;title=Preoperative+short-term+fasting+protects+liver+injury+in+patients+undergoing+hepatectomy&amp;amp;author=C+Zhan&amp;amp;author=X+Dai&amp;amp;author=G+Shen&amp;amp;author=X+Lu&amp;amp;author=X+Wang&amp;amp;volume=6&amp;amp;issue=23&amp;amp;publication_year=2018&amp;amp;pages=449&amp;amp;pmid=30603637&amp;amp;doi=10.21037/atm.2018.10.64&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR126&quot;&gt;126. &lt;span class=&quot;mixed-citation&quot;&gt;Grundmann F, Muller RU, Reppenhorst A, Hulswitt L, Spath MR, Kubacki T, et al. Preoperative Short-Term Calorie Restriction for Prevention of Acute Kidney Injury After Cardiac Surgery: A Randomized, Controlled, Open-Label, Pilot Trial. J Am Heart Assoc. 2018;7(6). &lt;span class=&quot;nowrap&quot;&gt;[&lt;a class=&quot;int-reflink&quot; href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5907569/&quot;&gt;PMC free article&lt;/a&gt;]&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/29535139&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;]&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR127&quot;&gt;127. &lt;span class=&quot;element-citation&quot;&gt;Cahill G, Jr, Felig P, Owen O, Wahren J. Metabolic adaptation to prolonged starvation in man. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;Nord Med.&lt;/span&gt; 1970;&lt;span class=&quot;ref-vol&quot;&gt;83&lt;/span&gt;(3):89.&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/5426055&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=Nord+Med&amp;amp;title=Metabolic+adaptation+to+prolonged+starvation+in+man&amp;amp;author=G+Cahill&amp;amp;author=P+Felig&amp;amp;author=O+Owen&amp;amp;author=J+Wahren&amp;amp;volume=83&amp;amp;issue=3&amp;amp;publication_year=1970&amp;amp;pages=89&amp;amp;pmid=5426055&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR128&quot;&gt;128. &lt;span class=&quot;element-citation&quot;&gt;Ho KY, Veldhuis JD, Johnson ML, Furlanetto R, Evans WS, Alberti KG, et al. Fasting enhances growth hormone secretion and amplifies the complex rhythms of growth hormone secretion in man. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;J Clin Invest.&lt;/span&gt; 1988;&lt;span class=&quot;ref-vol&quot;&gt;81&lt;/span&gt;(4):968‚Äì975. doi: 10.1172/JCI113450.&lt;/span&gt; &lt;span class=&quot;nowrap&quot;&gt;[&lt;a class=&quot;int-reflink&quot; href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC329619/&quot;&gt;PMC free article&lt;/a&gt;]&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/3127426&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] [&lt;a href=&quot;https://dx.doi.org/10.1172%2FJCI113450&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CCrosslink%7CDOI&quot;&gt;CrossRef&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=J+Clin+Invest&amp;amp;title=Fasting+enhances+growth+hormone+secretion+and+amplifies+the+complex+rhythms+of+growth+hormone+secretion+in+man&amp;amp;author=KY+Ho&amp;amp;author=JD+Veldhuis&amp;amp;author=ML+Johnson&amp;amp;author=R+Furlanetto&amp;amp;author=WS+Evans&amp;amp;volume=81&amp;amp;issue=4&amp;amp;publication_year=1988&amp;amp;pages=968-975&amp;amp;pmid=3127426&amp;amp;doi=10.1172/JCI113450&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR129&quot;&gt;129. &lt;span class=&quot;element-citation&quot;&gt;Norrelund H. The metabolic role of growth hormone in humans with particular reference to fasting. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;Growth Hormon IGF Res.&lt;/span&gt; 2005;&lt;span class=&quot;ref-vol&quot;&gt;15&lt;/span&gt;(2):95‚Äì122. doi: 10.1016/j.ghir.2005.02.005.&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/15809014&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] [&lt;a href=&quot;https://dx.doi.org/10.1016%2Fj.ghir.2005.02.005&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CCrosslink%7CDOI&quot;&gt;CrossRef&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=Growth+Hormon+IGF+Res&amp;amp;title=The+metabolic+role+of+growth+hormone+in+humans+with+particular+reference+to+fasting&amp;amp;author=H+Norrelund&amp;amp;volume=15&amp;amp;issue=2&amp;amp;publication_year=2005&amp;amp;pages=95-122&amp;amp;doi=10.1016/j.ghir.2005.02.005&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR130&quot;&gt;130. &lt;span class=&quot;element-citation&quot;&gt;Moller L, Dalman L, Norrelund H, Billestrup N, Frystyk J, Moller N, et al. Impact of fasting on growth hormone signaling and action in muscle and fat. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;J Clin Endocrinol Metab.&lt;/span&gt; 2009;&lt;span class=&quot;ref-vol&quot;&gt;94&lt;/span&gt;(3):965‚Äì972. doi: 10.1210/jc.2008-1385.&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/19066303&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] [&lt;a href=&quot;https://dx.doi.org/10.1210%2Fjc.2008-1385&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CCrosslink%7CDOI&quot;&gt;CrossRef&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=J+Clin+Endocrinol+Metab&amp;amp;title=Impact+of+fasting+on+growth+hormone+signaling+and+action+in+muscle+and+fat&amp;amp;author=L+Moller&amp;amp;author=L+Dalman&amp;amp;author=H+Norrelund&amp;amp;author=N+Billestrup&amp;amp;author=J+Frystyk&amp;amp;volume=94&amp;amp;issue=3&amp;amp;publication_year=2009&amp;amp;pages=965-972&amp;amp;pmid=19066303&amp;amp;doi=10.1210/jc.2008-1385&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR131&quot;&gt;131. &lt;span class=&quot;mixed-citation&quot;&gt;de Groot S, Vreeswijk MP, Welters MJ, Gravesteijn G, Boei JJ, Jochems A, et al. The effects of short-term fasting on tolerance to (neo) adjuvant chemotherapy in HER2-negative breast cancer patients: a randomized pilot study. BMC. Cancer. 2015;15:652. &lt;span class=&quot;nowrap&quot;&gt;[&lt;a class=&quot;int-reflink&quot; href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4595051/&quot;&gt;PMC free article&lt;/a&gt;]&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/26438237&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;]&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR132&quot;&gt;132. &lt;span class=&quot;element-citation&quot;&gt;Maccario M, Aimaretti G, Grottoli S, Gauna C, Tassone F, Corneli G, et al. Effects of 36 hour fasting on GH/IGF-I axis and metabolic parameters in patients with simple obesity. Comparison with normal subjects and hypopituitary patients with severe GH deficiency. Int. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;J Obes Relat Metab Disord.&lt;/span&gt; 2001;&lt;span class=&quot;ref-vol&quot;&gt;25&lt;/span&gt;(8):1233‚Äì1239. doi: 10.1038/sj.ijo.0801671.&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/11477509&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] [&lt;a href=&quot;https://dx.doi.org/10.1038%2Fsj.ijo.0801671&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CCrosslink%7CDOI&quot;&gt;CrossRef&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=J+Obes+Relat+Metab+Disord&amp;amp;title=Effects+of+36+hour+fasting+on+GH/IGF-I+axis+and+metabolic+parameters+in+patients+with+simple+obesity.+Comparison+with+normal+subjects+and+hypopituitary+patients+with+severe+GH+deficiency.+Int&amp;amp;author=M+Maccario&amp;amp;author=G+Aimaretti&amp;amp;author=S+Grottoli&amp;amp;author=C+Gauna&amp;amp;author=F+Tassone&amp;amp;volume=25&amp;amp;issue=8&amp;amp;publication_year=2001&amp;amp;pages=1233-1239&amp;amp;doi=10.1038/sj.ijo.0801671&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR133&quot;&gt;133. &lt;span class=&quot;element-citation&quot;&gt;Cotterill Andrew M., Holly Jeffrey M. P., Wass John A. H. The regulation of insulin-like growth factor binding protein (IGFBP)-1 during prolonged fasting. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;Clinical Endocrinology.&lt;/span&gt; 1993;&lt;span class=&quot;ref-vol&quot;&gt;39&lt;/span&gt;(3):357‚Äì362. doi: 10.1111/j.1365-2265.1993.tb02377.x.&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/7693379&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] [&lt;a href=&quot;https://dx.doi.org/10.1111%2Fj.1365-2265.1993.tb02377.x&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CCrosslink%7CDOI&quot;&gt;CrossRef&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=Clinical+Endocrinology&amp;amp;title=The+regulation+of+insulin-like+growth+factor+binding+protein+(IGFBP)-1+during+prolonged+fasting&amp;amp;author=Andrew+M.+Cotterill&amp;amp;author=Jeffrey+M.+P.+Holly&amp;amp;author=John+A.+H.+Wass&amp;amp;volume=39&amp;amp;issue=3&amp;amp;publication_year=1993&amp;amp;pages=357-362&amp;amp;pmid=7693379&amp;amp;doi=10.1111/j.1365-2265.1993.tb02377.x&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR134&quot;&gt;134. &lt;span class=&quot;element-citation&quot;&gt;Boelen A, Wiersinga WM, Fliers E. Fasting-induced changes in the hypothalamus-pituitary-thyroid axis. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;Thyroid.&lt;/span&gt; 2008;&lt;span class=&quot;ref-vol&quot;&gt;18&lt;/span&gt;(2):123‚Äì129. doi: 10.1089/thy.2007.0253.&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/18225975&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] [&lt;a href=&quot;https://dx.doi.org/10.1089%2Fthy.2007.0253&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CCrosslink%7CDOI&quot;&gt;CrossRef&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=Thyroid.&amp;amp;title=Fasting-induced+changes+in+the+hypothalamus-pituitary-thyroid+axis&amp;amp;author=A+Boelen&amp;amp;author=WM+Wiersinga&amp;amp;author=E+Fliers&amp;amp;volume=18&amp;amp;issue=2&amp;amp;publication_year=2008&amp;amp;pages=123-129&amp;amp;pmid=18225975&amp;amp;doi=10.1089/thy.2007.0253&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;p&gt;135. &lt;span class=&quot;mixed-citation&quot;&gt;Badar T, Ismail A,¬†AlShanqeeti A. Safety and Feasability of Muslim Fasting While Receiving Chemotherapy. IOSR Journal of Pharmacy. 2014.&lt;/span&gt;&lt;/p&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR136&quot;&gt;136. &lt;span class=&quot;element-citation&quot;&gt;Safdie Fernando M., Dorff Tanya, Quinn David, Fontana Luigi, Wei Min, Lee Changhan, Cohen Pinchas, Longo Valter D. Fasting and cancer treatment in humans: A case series report. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;Aging.&lt;/span&gt; 2009;&lt;span class=&quot;ref-vol&quot;&gt;1&lt;/span&gt;(12):988‚Äì1007. doi: 10.18632/aging.100114.&lt;/span&gt; &lt;span class=&quot;nowrap&quot;&gt;[&lt;a class=&quot;int-reflink&quot; href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2815756/&quot;&gt;PMC free article&lt;/a&gt;]&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/20157582&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] [&lt;a href=&quot;https://dx.doi.org/10.18632%2Faging.100114&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CCrosslink%7CDOI&quot;&gt;CrossRef&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=Aging&amp;amp;title=Fasting+and+cancer+treatment+in+humans:+A+case+series+report&amp;amp;author=Fernando+M.+Safdie&amp;amp;author=Tanya+Dorff&amp;amp;author=David+Quinn&amp;amp;author=Luigi+Fontana&amp;amp;author=Min+Wei&amp;amp;volume=1&amp;amp;issue=12&amp;amp;publication_year=2009&amp;amp;pages=988-1007&amp;amp;pmid=20157582&amp;amp;doi=10.18632/aging.100114&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR137&quot;&gt;137. &lt;span class=&quot;element-citation&quot;&gt;Dorff TB, Groshen S, Garcia A, Shah M, Tsao-Wei D, Pham H, et al. Safety and feasibility of fasting in combination with platinum-based chemotherapy. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;BMC Cancer.&lt;/span&gt; 2016;&lt;span class=&quot;ref-vol&quot;&gt;16&lt;/span&gt;:360. doi: 10.1186/s12885-016-2370-6.&lt;/span&gt; &lt;span class=&quot;nowrap&quot;&gt;[&lt;a class=&quot;int-reflink&quot; href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4901417/&quot;&gt;PMC free article&lt;/a&gt;]&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/27282289&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] [&lt;a href=&quot;https://dx.doi.org/10.1186%2Fs12885-016-2370-6&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CCrosslink%7CDOI&quot;&gt;CrossRef&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=BMC+Cancer&amp;amp;title=Safety+and+feasibility+of+fasting+in+combination+with+platinum-based+chemotherapy&amp;amp;author=TB+Dorff&amp;amp;author=S+Groshen&amp;amp;author=A+Garcia&amp;amp;author=M+Shah&amp;amp;author=D+Tsao-Wei&amp;amp;volume=16&amp;amp;publication_year=2016&amp;amp;pages=360&amp;amp;pmid=27282289&amp;amp;doi=10.1186/s12885-016-2370-6&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR138&quot;&gt;138. &lt;span class=&quot;element-citation&quot;&gt;Bauersfeld SP, Kessler CS, Wischnewsky M, Jaensch A, Steckhan N, Stange R, et al. The effects of short-term fasting on quality of life and tolerance to chemotherapy in patients with breast and ovarian cancer: a randomized cross-over pilot study. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;BMC Cancer.&lt;/span&gt; 2018;&lt;span class=&quot;ref-vol&quot;&gt;18&lt;/span&gt;(1):476. doi: 10.1186/s12885-018-4353-2.&lt;/span&gt; &lt;span class=&quot;nowrap&quot;&gt;[&lt;a class=&quot;int-reflink&quot; href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5921787/&quot;&gt;PMC free article&lt;/a&gt;]&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/29699509&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] [&lt;a href=&quot;https://dx.doi.org/10.1186%2Fs12885-018-4353-2&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CCrosslink%7CDOI&quot;&gt;CrossRef&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=BMC+Cancer&amp;amp;title=The+effects+of+short-term+fasting+on+quality+of+life+and+tolerance+to+chemotherapy+in+patients+with+breast+and+ovarian+cancer:+a+randomized+cross-over+pilot+study&amp;amp;author=SP+Bauersfeld&amp;amp;author=CS+Kessler&amp;amp;author=M+Wischnewsky&amp;amp;author=A+Jaensch&amp;amp;author=N+Steckhan&amp;amp;volume=18&amp;amp;issue=1&amp;amp;publication_year=2018&amp;amp;pages=476&amp;amp;pmid=29699509&amp;amp;doi=10.1186/s12885-018-4353-2&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR139&quot;&gt;139. &lt;span class=&quot;element-citation&quot;&gt;Raffaghello L, Safdie F, Bianchi G, Dorff T, Fontana L, Longo VD. Fasting and differential chemotherapy protection in patients. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;Cell Cycle.&lt;/span&gt; 2010;&lt;span class=&quot;ref-vol&quot;&gt;9&lt;/span&gt;(22):4474‚Äì4476. doi: 10.4161/cc.9.22.13954.&lt;/span&gt; &lt;span class=&quot;nowrap&quot;&gt;[&lt;a class=&quot;int-reflink&quot; href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3048045/&quot;&gt;PMC free article&lt;/a&gt;]&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/21088487&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] [&lt;a href=&quot;https://dx.doi.org/10.4161%2Fcc.9.22.13954&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CCrosslink%7CDOI&quot;&gt;CrossRef&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=Cell+Cycle&amp;amp;title=Fasting+and+differential+chemotherapy+protection+in+patients&amp;amp;author=L+Raffaghello&amp;amp;author=F+Safdie&amp;amp;author=G+Bianchi&amp;amp;author=T+Dorff&amp;amp;author=L+Fontana&amp;amp;volume=9&amp;amp;issue=22&amp;amp;publication_year=2010&amp;amp;pages=4474-4476&amp;amp;pmid=21088487&amp;amp;doi=10.4161/cc.9.22.13954&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR140&quot;&gt;140. &lt;span class=&quot;element-citation&quot;&gt;Bouhlel E, Zaouali M, Miled A, Tabka Z, Bigard X, Shephard R. Ramadan fasting and the GH/IGF-1 axis of trained men during submaximal exercise. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;Ann Nutr Metab.&lt;/span&gt; 2008;&lt;span class=&quot;ref-vol&quot;&gt;52&lt;/span&gt;(4):261‚Äì266. doi: 10.1159/000140517.&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/18617733&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] [&lt;a href=&quot;https://dx.doi.org/10.1159%2F000140517&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CCrosslink%7CDOI&quot;&gt;CrossRef&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=Ann+Nutr+Metab&amp;amp;title=Ramadan+fasting+and+the+GH/IGF-1+axis+of+trained+men+during+submaximal+exercise&amp;amp;author=E+Bouhlel&amp;amp;author=M+Zaouali&amp;amp;author=A+Miled&amp;amp;author=Z+Tabka&amp;amp;author=X+Bigard&amp;amp;volume=52&amp;amp;issue=4&amp;amp;publication_year=2008&amp;amp;pages=261-266&amp;amp;pmid=18617733&amp;amp;doi=10.1159/000140517&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR141&quot;&gt;141. &lt;span class=&quot;mixed-citation&quot;&gt;Inder WJ, Jang C, Obeyesekere VR, Alford FP&lt;strong&gt;.&lt;/strong&gt; Dexamethasone administration inhibits skeletal muscle expression of the androgen receptor and IGF-1--implications for steroid-induced myopathy. Clin. Endocrinol. (Oxf). 2010;73(1):126‚Äì32. [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/19681914&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;]&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR142&quot;&gt;142. &lt;span class=&quot;element-citation&quot;&gt;Veldhuis JD, Lizarralde G, Iranmanesh A. Divergent effects of short term glucocorticoid excess on the gonadotropic and somatotropic axes in normal men. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;J Clin Endocrinol Metab.&lt;/span&gt; 1992;&lt;span class=&quot;ref-vol&quot;&gt;74&lt;/span&gt;(1):96‚Äì102.&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/1727834&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=J+Clin+Endocrinol+Metab&amp;amp;title=Divergent+effects+of+short+term+glucocorticoid+excess+on+the+gonadotropic+and+somatotropic+axes+in+normal+men&amp;amp;author=JD+Veldhuis&amp;amp;author=G+Lizarralde&amp;amp;author=A+Iranmanesh&amp;amp;volume=74&amp;amp;issue=1&amp;amp;publication_year=1992&amp;amp;pages=96-102&amp;amp;pmid=1727834&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;ref-cit-blk half_rhythm&quot; id=&quot;CR143&quot;&gt;143. &lt;span class=&quot;element-citation&quot;&gt;Levolger S, van den Engel S, Ambagtsheer G, JNM IJ, de Bruin RWF. Caloric restriction is associated with preservation of muscle strength in experimental cancer cachexia. &lt;span&gt;&lt;span class=&quot;ref-journal&quot;&gt;Aging (Albany NY)&lt;/span&gt; 2018;&lt;span class=&quot;ref-vol&quot;&gt;10&lt;/span&gt;(12):4213‚Äì4223. doi: 10.18632/aging.101724.&lt;/span&gt; &lt;span class=&quot;nowrap&quot;&gt;[&lt;a class=&quot;int-reflink&quot; href=&quot;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6326673/&quot;&gt;PMC free article&lt;/a&gt;]&lt;/span&gt; [&lt;a href=&quot;https://www.ncbi.nlm.nih.gov/pubmed/30591621&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=pubmed&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Entrez%7CPubMed%7CRecord&quot;&gt;PubMed&lt;/a&gt;] [&lt;a href=&quot;https://dx.doi.org/10.18632%2Faging.101724&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CCrosslink%7CDOI&quot;&gt;CrossRef&lt;/a&gt;] &lt;span class=&quot;nowrap&quot;&gt;[&lt;a href=&quot;https://scholar.google.com/scholar_lookup?journal=Aging+(Albany+NY)&amp;amp;title=Caloric+restriction+is+associated+with+preservation+of+muscle+strength+in+experimental+cancer+cachexia&amp;amp;author=S+Levolger&amp;amp;author=S+van+den+Engel&amp;amp;author=G+Ambagtsheer&amp;amp;author=IJ+JNM&amp;amp;author=RWF+de+Bruin&amp;amp;volume=10&amp;amp;issue=12&amp;amp;publication_year=2018&amp;amp;pages=4213-4223&amp;amp;pmid=30591621&amp;amp;doi=10.18632/aging.101724&amp;amp;&quot; target=&quot;pmc_ext&quot; ref=&quot;reftype=other&amp;amp;article-id=6530042&amp;amp;issue-id=326841&amp;amp;journal-id=618&amp;amp;FROM=Article%7CCitationRef&amp;amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar&quot;&gt;Google Scholar&lt;/a&gt;]&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/div&gt;&lt;hr /&gt;
Articles from &lt;span class=&quot;acknowledgment-journal-title&quot;&gt;Journal of Experimental &amp;amp; Clinical Cancer Research : CR&lt;/span&gt; are provided here courtesy of &lt;strong&gt;BioMed Central&lt;/strong&gt;</description>
<pubDate>Mon, 02 Sep 2019 14:36:29 +0000</pubDate>
<dc:creator>JPLeRouzic</dc:creator>
<og:title>Effects of short-term fasting on cancer treatment</og:title>
<og:type>article</og:type>
<og:description>Growing preclinical evidence shows that short-term fasting (STF) protects from toxicity while enhancing the efficacy of a variety of chemotherapeutic agents in the treatment of various tumour types. STF reinforces stress resistance of healthy cells, while ...</og:description>
<og:url>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/</og:url>
<og:image>https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png</og:image>
<dc:language>en</dc:language>
<dc:format>text/html</dc:format>
<dc:identifier>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530042/</dc:identifier>
</item>
<item>
<title>Just Delete Me ‚Äì A directory of direct links to delete your account</title>
<link>https://backgroundchecks.org/justdeleteme/</link>
<guid isPermaLink="true" >https://backgroundchecks.org/justdeleteme/</guid>
<description>&lt;p class=&quot;no-results&quot;&gt;Can't find what you're looking for? &lt;a href=&quot;%20https://github.com/justdeleteme/justdelete.me&quot;&gt;Help make justdelete.me better&lt;/a&gt;.&lt;/p&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;4.6629213483146&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;Login to your account, go to parameters, click Delete my account. Confirm by clicking I want to delete my account. And again by clicking Delete my 9GAG account.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block hard&quot; readability=&quot;2.6869565217391&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;hard&lt;/p&gt;
&lt;p&gt;You have to call them in order to delete your account. Alternatively, you can send them an email.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;3.8167938931298&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;Log in to your account and click the top-left link to 'Member Preferences'. Scroll to the bottom of the page and ensure both of the password fields are empty. Check the 'De-activate my account' box and and click the 'Update Preferences' button.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block hard&quot; readability=&quot;3.8339100346021&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;hard&lt;/p&gt;
&lt;p&gt;Despite what it says in their FAQ there is actually no automatic way to delete your account. But they do see to be happy to do it if you ask them - you can contact them via http://www.alibaba.com/help/contact-us.html - I cancelled my account via their online chat system.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;1.7333333333333&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;Follow the link to edit your profile and click cancel account at bottom.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;2.7142857142857&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;Just head to the account page and click the red button 'Delete your account' at the bottom left of the page.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block hard&quot; readability=&quot;3.6279069767442&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;hard&lt;/p&gt;
&lt;p&gt;To close your account, contact Amazon by email (via this contact form) and request that your account be closed.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;1.5862068965517&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;You must login before visiting the link.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block impossible&quot; readability=&quot;3.756345177665&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;impossible&lt;/p&gt;
&lt;p&gt;We do not 'delete' or 'terminate' accounts on ACC. If you no longer wish to use the site, you may delete all personal information from your profile and then stop logging in.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block hard&quot; readability=&quot;1.6402877697842&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;hard&lt;/p&gt;
&lt;div class=&quot;tooltip-content&quot; readability=&quot;8.0330578512397&quot;&gt;Remove all applications and services from your account, then request deletion by emailing customer services.&lt;br/&gt;&lt;a href=&quot;mailto:support@appfog.com?Subject=Account%20Deletion%20Request&amp;amp;body=Please%20delete%20my%20account,%20my%20username%20is%20%20XXXXXX&quot;&gt;Send email ¬ª&lt;/a&gt;&lt;/div&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block impossible&quot; readability=&quot;6.7851662404092&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;impossible&lt;/p&gt;
&lt;p&gt;Response from support@argylesocial.com: We really don't have a way to delete accounts entirely. The account won't be usable by anyone else, so there won't be any security issues. One smart thing to do to make doubly sure that everything is secure is to go to any social media pages that Argyle was authorized to use, and remove Argyle's authorization. Hope that helps&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block hard&quot; readability=&quot;1.5862068965517&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;hard&lt;/p&gt;
&lt;p&gt;Request deletion from customer services.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;3.5294117647059&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;Login, go to &quot;Profile Details&quot; tab, and simply click on the &quot;Delete Account&quot; button.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block hard&quot; readability=&quot;1.1848739495798&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;hard&lt;/p&gt;
&lt;div class=&quot;tooltip-content&quot; readability=&quot;6.970297029703&quot;&gt;Remove all songs from your account, then request deletion by emailing customer services.&lt;br/&gt;&lt;a href=&quot;mailto:support@awdio.com?Subject=Account%20Deletion%20Request&amp;amp;body=Please%20delete%20my%20account,%20my%20username%20is%20%20XXXXXX&quot;&gt;Send email ¬ª&lt;/a&gt;&lt;/div&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block impossible&quot; readability=&quot;3.6962025316456&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;impossible&lt;/p&gt;
&lt;p&gt;Accounts cannot be deleted, even when contacting customer service. User account credentials will be permanently retained by Backblaze.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;9.6352583586626&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;On the top right corner click 'Settings', then on the left hand side click 'Delete'. Type your information, to delete Badoo, enter your password and in the other box, explain why you want to leave. Click on the 'Confirm' button, you will receive a message page confirming your rquest was successfully completed.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;3.6903225806452&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;Go to your Settings page and scroll down to find 'Deactivate' account. Click on 'Close Account' button, and confirm the account deletion.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;5.5609756097561&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;To terminate an artist account, you must click on the 'Artists' pane, click on the desired artist's profile, and click the termination link there.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block impossible&quot; readability=&quot;2.7966101694915&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;impossible&lt;/p&gt;
&lt;p&gt;It is not possible to delete your Barnes and Noble account. The best you can do is delete any personal information that you have stored on their website.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;1.6307692307692&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;Data will be permanantly deleted after 30 days.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block hard&quot; readability=&quot;5.6962025316456&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;hard&lt;/p&gt;
&lt;p&gt;Customer Support will require you to send a signed written letter confirming your wishes, your account details and a copy of legal identification (passport, drivers license) to your account region's office headquarters.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block hard&quot; readability=&quot;1.6268656716418&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;hard&lt;/p&gt;
&lt;div class=&quot;tooltip-content&quot; readability=&quot;7.9913793103448&quot;&gt;Remove all personal information from your account, then request deletion by emailing customer services.&lt;br/&gt;&lt;a href=&quot;mailto:support@beam.pro?Subject=Account%20Deletion%20Request&amp;amp;body=Please%20delete%20my%20account,%20my%20username%20is%20%20XXXXXX&quot;&gt;Send email ¬ª&lt;/a&gt;&lt;/div&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;3.7525773195876&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;To delete your account, login and then next to your name select the drop down and go to 'Settings' once there scroll to the bottom of the page and select 'delete your account'.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;5.55&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;To delete your account, please go into your 'Me' tab, visit account settings and hit the privacy tab. There, you'll have the option to delete.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;4.6449704142012&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;On the side menu, click on 'Delete Account' and on the confirmation page click 'Delete Account', all repositories and the account is immediately wiped.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;2.712&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;Select why you are deleting your account. Your account will be deleted but all your shortlinks will remain.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block impossible&quot; readability=&quot;2.75&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;impossible&lt;/p&gt;
&lt;p&gt;You can't delete your Blogger Account without deleting your entire Google Account. But you can delete your blog.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt; &lt;span class=&quot;meta&quot;&gt;popular&lt;/span&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;1.6962025316456&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;Log-in and use the link provided to request account deletion.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;1.5789473684211&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;Click the ‚ÄúDelete My Account‚Äù link.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block impossible&quot; readability=&quot;4.7489539748954&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;impossible&lt;/p&gt;
&lt;p&gt;You can only deactivate your account by contacting support as they state on the help page. There is no way to permanently delete your account or data, and an inactive public profile will always be visible to public.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block impossible&quot; readability=&quot;1.6190476190476&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;impossible&lt;/p&gt;
&lt;p&gt;Accounts cannot be removed at this time&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block hard&quot; readability=&quot;1.7551020408163&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;hard&lt;/p&gt;
&lt;p&gt;You need to request deletion of your data via the contact form after logging in.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;span class=&quot;meta&quot;&gt;popular&lt;/span&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block impossible&quot; readability=&quot;1.7857142857143&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;impossible&lt;/p&gt;
&lt;p&gt;TL;DR you can't do it. Discussion at http://www.bungie.net/en-US/Forum/Post/66636671/0/0&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block impossible&quot; readability=&quot;1.741935483871&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;impossible&lt;/p&gt;
&lt;p&gt;Support staff refuses to delete accounts due to 'accounting purposes'&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;Just click 'Abschicken'&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block impossible&quot; readability=&quot;1.68&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;impossible&lt;/p&gt;
&lt;p&gt;'There is no way to close or shut down an account.'&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;1.52&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;Must remove uploaded files first&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block hard&quot; readability=&quot;0.80769230769231&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;hard&lt;/p&gt;
&lt;div class=&quot;tooltip-content&quot; readability=&quot;6.1875&quot;&gt;You can't delete your account without contacting them. You must set the subject to 'Delete Account'&lt;br/&gt;&lt;a href=&quot;mailto:support@cex.io?Subject=Account%20Deletion%20Request&amp;amp;body=Please%20delete%20my%20account,%20my%20username%20is%20%20XXXXXX&quot;&gt;Send email ¬ª&lt;/a&gt;&lt;/div&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block impossible&quot; readability=&quot;2.7482517482517&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;impossible&lt;/p&gt;
&lt;p&gt;According to the app you can email feedback@cinemagr.am for questions. Unfortunatly removal requests aren't replied to.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block impossible&quot; readability=&quot;1.5471698113208&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;impossible&lt;/p&gt;
&lt;p&gt;We don't delete old accounts.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block hard&quot; readability=&quot;0.66216216216216&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;hard&lt;/p&gt;

&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;2.5555555555556&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;Login to your account, then click 'delete account' on the page.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block hard&quot; readability=&quot;2.0860927152318&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;hard&lt;/p&gt;
&lt;div class=&quot;tooltip-content&quot; readability=&quot;9.0225563909774&quot;&gt;The site claims that you must call their support line (888-988-5036, ext 1), but they deactivated my account over email.&lt;br/&gt;&lt;a href=&quot;mailto:support@getcloudapp.com?Subject=Account%20Deletion%20Request&amp;amp;body=Please%20delete%20my%20account,%20my%20username%20is%20%20XXXXXX&quot;&gt;Send email ¬ª&lt;/a&gt;&lt;/div&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block hard&quot; readability=&quot;1.7857142857143&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;hard&lt;/p&gt;
&lt;p&gt;You have to ask the support to get your account deleted. Choose the category CNET Registration&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block impossible&quot; readability=&quot;1.7692307692308&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;impossible&lt;/p&gt;
&lt;p&gt;You can't delete yourself. You can only change your phone nr. to a bogus number.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;2.6086956521739&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;Go to your Profile, at the bottom you will find a 'Delete Account' button.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;2.5324675324675&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;Simply click the &quot;I understand, delete my account.&quot; button.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;1.6712328767123&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;Sign in then visit https://coderwall.com/delete_account&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;1.6883116883117&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;Sign in then visit https://www.coinbase.com/settings/cancel&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block medium&quot; readability=&quot;1.6&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;medium&lt;/p&gt;
&lt;p&gt;Your messages will remain on the forums.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block impossible&quot; readability=&quot;3.6883116883117&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;impossible&lt;/p&gt;
&lt;p&gt;Cannot be deleted fully, reactivation is always available. Fill out the form and select 'I understand. Please delete my profile.'.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block hard&quot; readability=&quot;1.6619718309859&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;hard&lt;/p&gt;
&lt;p&gt;Contact support and request they delete your account.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block hard&quot; readability=&quot;0.72222222222222&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;hard&lt;/p&gt;
&lt;div class=&quot;tooltip-content&quot; readability=&quot;5.7361111111111&quot;&gt;Send an email to abuse@craigslist.org and request deletion.&lt;br/&gt;&lt;a href=&quot;mailto:abuse@craigslist.org?Subject=Account%20Deletion%20Request&amp;amp;body=Please%20delete%20my%20account,%20my%20username%20is%20%20XXXXXX&quot;&gt;Send email ¬ª&lt;/a&gt;&lt;/div&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block hard&quot; readability=&quot;1.7333333333333&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;hard&lt;/p&gt;
&lt;p&gt;Start a live chat session and a representative will delete your account.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block hard&quot; readability=&quot;4.8070739549839&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;hard&lt;/p&gt;
&lt;p&gt;You can cancel by email but only if your membership includes insurance. Otherwise, an email cancellation will be ignored. You have to call 0800 561 0083 to cancel your account. This is the only way. More info here: http://experian.metafaq.com/help/CreditExpertBRS/Cancel_and_duration/CancelBRS&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block impossible&quot; readability=&quot;2.7721518987342&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;impossible&lt;/p&gt;
&lt;p&gt;They mock the very idea of wanting to delete your account in their faq: &quot;Can I delete my account cause I totally h8 you guise??!!!111&quot;&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;1.6923076923077&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;Log into your User Profile and visit the Delete Account tab.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;1.6417910447761&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;Edit your account and select 'Remove my account'.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;3.7857142857143&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;You have to enter your mailadress and have to choose a 'why are you leaving' answer'. To verify this step you'll become a mail with a security code to fill into the form. After that your account is deleted.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;2.7&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;Click the &quot;Delete your account&quot; at the bottom of the settings page and type &quot;DELETE&quot; in the popup box.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block impossible&quot; readability=&quot;4.7196261682243&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;impossible&lt;/p&gt;
&lt;p&gt;You may discontinue your use of the Service at any time without informing us. We may, however, retain and continue to use any Content that you have submitted or uploaded through the Service.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block medium&quot; readability=&quot;2.8032786885246&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;medium&lt;/p&gt;
&lt;p&gt;You can not delete your account on the site. You must use the linked form. Then select SkyMiles ‚Üí Update SkyMiles Account and request them to close your account.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block medium&quot; readability=&quot;4.6648044692737&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;medium&lt;/p&gt;
&lt;p&gt;All your data is ereased immediately, except comments which will remain. Accounts can be reactivated within 30 days. After that, Accounts can't be reactivated.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block impossible&quot; readability=&quot;2.7482517482517&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;impossible&lt;/p&gt;
&lt;p&gt;There's no information about account-deletion in their FAQ. The hotline also says that account-deletion isn't possible.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;1.6666666666667&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;Click close my account and confirm with your password.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block hard&quot; readability=&quot;1.7446808510638&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;hard&lt;/p&gt;
&lt;p&gt;Contact Digg‚Äôs customer support and request for your account to be closed.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;1.6521739130435&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;Check the &quot;Deactivate Account&quot; box in the settings.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block hard&quot; readability=&quot;0.77272727272727&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;hard&lt;/p&gt;
&lt;div class=&quot;tooltip-content&quot; readability=&quot;6.0108695652174&quot;&gt;Contact Discord‚Äôs customer support and request for your account to be closed.&lt;br/&gt;&lt;a href=&quot;mailto:support@discordapp.com?Subject=Account%20Deletion%20Request&amp;amp;body=Please%20delete%20my%20account,%20my%20username%20is%20%20XXXXXX&quot;&gt;Send email ¬ª&lt;/a&gt;&lt;/div&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block medium&quot; readability=&quot;1.2242647058824&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;medium&lt;/p&gt;
&lt;div class=&quot;tooltip-content&quot; readability=&quot;7.1034482758621&quot;&gt;You need to remove the App in your Facebook settings and mail feedback@downapp.com to delete your data.&lt;br/&gt;&lt;a href=&quot;mailto:feedback@downapp.com?Subject=Account%20Deletion%20Request&amp;amp;body=Please%20delete%20my%20account,%20my%20username%20is%20%20XXXXXX&quot;&gt;Send email ¬ª&lt;/a&gt;&lt;/div&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block hard&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;hard&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block impossible&quot; readability=&quot;3.6643356643357&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;impossible&lt;/p&gt;
&lt;p&gt;It‚Äôs not possible to delete an account, you can either remove or replace your contact information with bogus details.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block hard&quot; readability=&quot;2.7073170731707&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;hard&lt;/p&gt;
&lt;p&gt;All accounts stay in their system for at least 3 years. Remove any banking information before you delete.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block hard&quot; readability=&quot;1.7857142857143&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;hard&lt;/p&gt;
&lt;p&gt;Contact customer services to request deletion. If you're outside the US this must be by phone.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;1.7303370786517&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;A few survey questions will be asked prior to account deletion.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt; &lt;span class=&quot;meta&quot;&gt;popular&lt;/span&gt;&lt;/section&gt;&lt;section class=&quot;site-block medium&quot; readability=&quot;3.710843373494&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;medium&lt;/p&gt;
&lt;p&gt;click on the contrat popup on the bottom of the screen and fill out the form, an admin will email asking for your username and will then delete it&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block impossible&quot; readability=&quot;3.6190476190476&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;impossible&lt;/p&gt;
&lt;p&gt;FAQ states that account can be deleted upon request, but e-mails requesting it are completely ignored.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block impossible&quot; readability=&quot;3.6842105263158&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;impossible&lt;/p&gt;
&lt;p&gt;There's no need to delete your account. An old, unused edX account with no course completions associated with it will disappear.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block hard&quot; readability=&quot;3.8248175182482&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;hard&lt;/p&gt;
&lt;p&gt;You must send an e-mail to hello@elevateapp.com requesting deletion. You will then receive a response from support asking for feedback and to confirm the deletion. The next e-mail you receive from support will notify you that your account has been deleted.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;2.7446808510638&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;Quoted from Ello: By deleting your account you remove your personal information from Ello. Your account cannot be restored.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;3.7587939698492&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;Select 'Close Profile' at the bottom of the page, select any reason for closing your profile. After that you have to complete the process by clicking a link in an email sent to you.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block hard&quot; readability=&quot;1.7473684210526&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;hard&lt;/p&gt;
&lt;p&gt;You have to send them a request to delete the account using the contact form.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block hard&quot; readability=&quot;1.6842105263158&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;hard&lt;/p&gt;
&lt;p&gt;Create new Game Support ticket to request account removal.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block hard&quot; readability=&quot;2.7165354330709&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;hard&lt;/p&gt;
&lt;p&gt;You can't have any unpaid Etsy bills or an open non-delivery reports. Your email address will remain on file.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block hard&quot; readability=&quot;1.6417910447761&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;hard&lt;/p&gt;
&lt;p&gt;Contact support and they will delete your account&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block impossible&quot; readability=&quot;5.7096774193548&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;impossible&lt;/p&gt;
&lt;p&gt;You cannot delete your Evernote account, just deactivate it temporarily. Deactivation does not remove your data so you will have to manually delete all notes and personal info, perform a sync and then deactivate the account.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block hard&quot; readability=&quot;1.6124031007752&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;hard&lt;/p&gt;
&lt;div class=&quot;tooltip-content&quot; readability=&quot;7.9459459459459&quot;&gt;You have to call or email them. They respond to email quickly, however, so it is not that painful.&lt;br/&gt;&lt;a href=&quot;mailto:support@experiandirect.com?Subject=Account%20Deletion%20Request&amp;amp;body=Please%20delete%20my%20account,%20my%20username%20is%20%20XXXXXX&quot;&gt;Send email ¬ª&lt;/a&gt;&lt;/div&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block medium&quot; readability=&quot;5.6022099447514&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;medium&lt;/p&gt;
&lt;p&gt;While you can delete your account easily, some of the data including messages, are there to stay forever, just as stated in the website's privacy policy.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt; &lt;span class=&quot;meta&quot;&gt;popular&lt;/span&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;1.6065573770492&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;Email customer support to request deletion.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block medium&quot; readability=&quot;2.75&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;medium&lt;/p&gt;
&lt;p&gt;Click on your username (top left) &amp;amp;rarr; click on 'Profileinstellungen' &amp;amp;rarr; 'Account l√∂schen'. All data is fully erased.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block hard&quot; readability=&quot;2.6435643564356&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;hard&lt;/p&gt;
&lt;p&gt;To delete or deactivate your account, contact Fitbit by email via the contact form.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;1.5789473684211&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;Go to account management within the app&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block hard&quot; readability=&quot;1.7209302325581&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;hard&lt;/p&gt;
&lt;p&gt;Email privacy@flixster-inc.com and ask to have your account deleted.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block medium&quot; readability=&quot;2.4193548387097&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;medium&lt;/p&gt;
&lt;p&gt;Account can only be disabled, not deleted.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block medium&quot; readability=&quot;2.6210526315789&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;medium&lt;/p&gt;
&lt;p&gt;To delete your account, you must not post anything for at least three days.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;span class=&quot;meta&quot;&gt;popular&lt;/span&gt;&lt;/section&gt;&lt;section class=&quot;site-block hard&quot; readability=&quot;3.609756097561&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;hard&lt;/p&gt;
&lt;p&gt;Make sure your account balance is positive, then issue a support ticket requesting to close your account.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;1.52&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;/msg NickServ DROP nick password&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block medium&quot; readability=&quot;8.7773195876289&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;medium&lt;/p&gt;
&lt;p&gt;You cannot delete your account yourself if you have sounds uploaded to your account. In their own words: &quot;Because you have sounds on freesound, deleting your user is not a trivial task. As such, we ask you to please contact the administrators via the Contact Form [http://www.freesound.org/contact/]. They will help you with the deletion of your account....&quot;. Alternatively - you can go through all your sounds, delete them one-by-one, and then delete your account.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;3.7377049180328&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;You will find option to remove your account under Profile - My Account tab, after log in. Removed GG account number is going back to available numbers for new users.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block hard&quot; readability=&quot;1.6666666666667&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;hard&lt;/p&gt;
&lt;p&gt;Account deletion requires contacting Customer Support.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block hard&quot; readability=&quot;1.6619718309859&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;hard&lt;/p&gt;
&lt;p&gt;Contact support and request they delete your account.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block impossible&quot; readability=&quot;4.7196261682243&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;impossible&lt;/p&gt;
&lt;p&gt;You may discontinue your use of the Service at any time without informing us. We may, however, retain and continue to use any Content that you have submitted or uploaded through the Service.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block medium&quot; readability=&quot;2.7391304347826&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;medium&lt;/p&gt;
&lt;p&gt;Delete any of the information you would like removed from the site. Then select 'Account Settings' and 'Close Account'&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block medium&quot; readability=&quot;2.758389261745&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;medium&lt;/p&gt;
&lt;p&gt;You must email support from the registered email to remove this account. Any outstanding Premium Memberships will not be refunded&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block hard&quot; readability=&quot;2.7372262773723&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;hard&lt;/p&gt;
&lt;p&gt;You can't delete your account without contacting them. You must submit a ticket and set the subject to 'Delete Account'&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block hard&quot; readability=&quot;0.80769230769231&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;hard&lt;/p&gt;
&lt;div class=&quot;tooltip-content&quot; readability=&quot;6.1875&quot;&gt;You can't delete your account without contacting them. You must set the subject to 'Delete Account'&lt;br/&gt;&lt;a href=&quot;mailto:support@cex.io?Subject=Account%20Deletion%20Request&amp;amp;body=Please%20delete%20my%20account,%20my%20username%20is%20%20XXXXXX&quot;&gt;Send email ¬ª&lt;/a&gt;&lt;/div&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block hard&quot; readability=&quot;0.69512195121951&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;hard&lt;/p&gt;

&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block impossible&quot; readability=&quot;0.73404255319149&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;impossible&lt;/p&gt;
&lt;div class=&quot;tooltip-content&quot; readability=&quot;5.7&quot;&gt;You can't delete your account without contacting support.&lt;br/&gt;&lt;a href=&quot;mailto:support@giantbomb.com?Subject=Account%20Deletion%20Request&amp;amp;body=Please%20delete%20my%20account,%20my%20username%20is%20%20XXXXXX&quot;&gt;Send email ¬ª&lt;/a&gt;&lt;/div&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block impossible&quot; readability=&quot;4.7196261682243&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;impossible&lt;/p&gt;
&lt;p&gt;You may discontinue your use of the Service at any time without informing us. We may, however, retain and continue to use any Content that you have submitted or uploaded through the Service.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block hard&quot; readability=&quot;0.73684210526316&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;hard&lt;/p&gt;
&lt;div class=&quot;tooltip-content&quot; readability=&quot;5.8181818181818&quot;&gt;Use the support email address to ask them to close your account.&lt;br/&gt;&lt;a href=&quot;mailto:support@sepialabs.com?Subject=Account%20Deletion%20Request&amp;amp;body=Please%20delete%20my%20account,%20my%20username%20is%20%20XXXXXX&quot;&gt;Send email ¬ª&lt;/a&gt;&lt;/div&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block hard&quot; readability=&quot;1.6307692307692&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;hard&lt;/p&gt;
&lt;p&gt;Contact customer services and request deletion.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;1.7714285714286&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;Login into your account ‚Üí Data Tools ‚Üí Delete Products ‚Üí Remove Gmail permanently&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block impossible&quot; readability=&quot;3.6279069767442&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;impossible&lt;/p&gt;
&lt;p&gt;You can't delete your account, but you can deactivate it. (Start ‚Üí Mein Account ‚Üí Account stilllegen)&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block impossible&quot; readability=&quot;2.8217821782178&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;impossible&lt;/p&gt;
&lt;p&gt;GoDaddy Accounts are apparently retained ‚Äúto comply with [their] legal obligations‚Äù though you are able to clear out most of your information by editing your profile.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt; &lt;span class=&quot;meta&quot;&gt;popular&lt;/span&gt;&lt;/section&gt;&lt;section class=&quot;site-block hard&quot; readability=&quot;1.7209302325581&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;hard&lt;/p&gt;
&lt;p&gt;Email customercare@gogoair.com and ask to have your account deleted.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;4.5238095238095&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;On the top bar, click on 'Your name', then click on the 'Delete Account' button at the bottom of the dialog.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block medium&quot; readability=&quot;5.4330708661417&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;medium&lt;/p&gt;
&lt;p&gt;On the top bar, click on your photo, go to 'Settings', go to 'Miscellaneous' and then hit 'Cancel Account'.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;span class=&quot;meta&quot;&gt;popular&lt;/span&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;1.6571428571429&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;Select a reason for closing and it'll take 2 clicks.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;1.6571428571429&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;Select a reason for closing and it'll take 2 clicks.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block hard&quot; readability=&quot;0.7093023255814&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;hard&lt;/p&gt;
&lt;div class=&quot;tooltip-content&quot; readability=&quot;5.6617647058824&quot;&gt;Send an email to arun@grailed.com and request deletion.&lt;br/&gt;&lt;a href=&quot;mailto:arun@grailed.com?Subject=Account%20Deletion%20Request&amp;amp;body=Please%20delete%20my%20account,%20my%20username%20is%20%20XXXXXX&quot;&gt;Send email ¬ª&lt;/a&gt;&lt;/div&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block impossible&quot; readability=&quot;1.7818181818182&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;impossible&lt;/p&gt;
&lt;p&gt;You can't delete your Gravatar Account without deleting your entire WordPress Account.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block medium&quot; readability=&quot;2.712&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;medium&lt;/p&gt;
&lt;p&gt;You can remove your profile and chat history from within the app or you can email support with your UDID.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block hard&quot; readability=&quot;3.6595744680851&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;hard&lt;/p&gt;
&lt;p&gt;According to Groupon's privacy statement, you have to contact support directly and ask them to delete your account.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt; &lt;span class=&quot;meta&quot;&gt;popular&lt;/span&gt;&lt;/section&gt;&lt;section class=&quot;site-block hard&quot; readability=&quot;1.7572815533981&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;hard&lt;/p&gt;
&lt;div class=&quot;tooltip-content&quot; readability=&quot;8.3776595744681&quot;&gt;Privacy Policy Letter D: Account e-mail addresses cannot be deleted. However, an Account may be closed and GrubHub will cause the corresponding e-mail address to be scrambled.&lt;br/&gt;&lt;a href=&quot;mailto:accounts@grubhub.com?Subject=Account%20Deletion%20Request&amp;amp;body=Please%20delete%20my%20account,%20my%20username%20is%20%20XXXXXX&quot;&gt;Send email ¬ª&lt;/a&gt;&lt;/div&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;1.7391304347826&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;There is a link at the bottom of the Settings page to delete your account.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block impossible&quot; readability=&quot;2.7942857142857&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;impossible&lt;/p&gt;
&lt;p&gt;It is not possible to delete your Hack This Site account. The best you can do is delete any personal information that you have stored on their website.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block impossible&quot; readability=&quot;3.6390977443609&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;impossible&lt;/p&gt;
&lt;p&gt;Your contributions are there to stay, but you can at least clear out your profile -- even your email address.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block hard&quot; readability=&quot;0.66666666666667&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;hard&lt;/p&gt;

&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;1.7142857142857&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;Click &quot;Delete my account&quot; and follow the instructions that appear.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;1.6842105263158&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;Click 'Cancel My Membership' on the above URL and confirm.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;1.6883116883117&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;‚ÄúClose your account...‚Äù link at the bottom of the page.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block impossible&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;impossible&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;1.7362637362637&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;The website automatically deletes your account after a predetermined time&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block hard&quot; readability=&quot;4.7345132743363&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;hard&lt;/p&gt;
&lt;p&gt;You have to send an email to the support team asking for deletion of your account. Your account will be added to a list of accounts for deletion, and it may take some time before it has actually been deleted.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block impossible&quot; readability=&quot;2.6571428571429&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;impossible&lt;/p&gt;
&lt;p&gt;You can remove information and manually quit HOL, but your account stays forever.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block impossible&quot; readability=&quot;2.7272727272727&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;impossible&lt;/p&gt;
&lt;p&gt;You can remove every information from your account or if you signed up using a social network disconnect it.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;3.7525773195876&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;Sign in to your account, go to the 'Account' options in your settings and delete your profile. See also 'Can I deactivate or delete my Profile?' on http://hotornot.com/privacy/&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;span class=&quot;meta&quot;&gt;popular&lt;/span&gt;&lt;/section&gt;&lt;section class=&quot;site-block hard&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;hard&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;3.625&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;Deleting this account will also delete your Mac and Windows accounts on 'i use this', if you have them set up.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;3.6335877862595&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;Deleting this account will also delete your iPhone and Windows accounts on 'i use this', if you have them set up.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;3.6220472440945&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;Deleting this account will also delete your iPhone and Mac accounts on 'i use this', if you have them set up.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;2.6603773584906&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;On top bar: 'Your name', 'My Account' and just click on 'Delete Account' link at bottom.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;3.6496350364964&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;You must login, go to your account settings and then click on the &amp;amp;lsquo;Delete Account&amp;amp;rsquo; link on the bottom left.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;3.5384615384615&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;Go to ‚ÄúMy Settings‚Äù, scroll down to the bottom, and click the ‚ÄúDelete‚Äù button.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block hard&quot; readability=&quot;0.72826086956522&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;hard&lt;/p&gt;
&lt;div class=&quot;tooltip-content&quot; readability=&quot;5.7702702702703&quot;&gt;Email customer support. Requests are handled within 48 hours.&lt;br/&gt;&lt;a href=&quot;mailto:customersupport@infibot.com?Subject=Account%20Deletion%20Request&amp;amp;body=Please%20delete%20my%20account,%20my%20username%20is%20%20XXXXXX&quot;&gt;Send email ¬ª&lt;/a&gt;&lt;/div&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block hard&quot; readability=&quot;4.6703296703297&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;hard&lt;/p&gt;
&lt;p&gt;You need to fill in the form linked in the support article by clicking &quot;contact us&quot;. Fill in your email address, agent name, device you play on and submit the form.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;span class=&quot;meta&quot;&gt;popular&lt;/span&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block hard&quot; readability=&quot;0.77064220183486&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;hard&lt;/p&gt;
&lt;div class=&quot;tooltip-content&quot; readability=&quot;6&quot;&gt;You have to email them (service@instructables.com) to get your account deleted&lt;br/&gt;&lt;a href=&quot;mailto:service@instructables.com?Subject=Account%20Deletion%20Request&amp;amp;body=Please%20delete%20my%20account,%20my%20username%20is%20%20XXXXXX&quot;&gt;Send email ¬ª&lt;/a&gt;&lt;/div&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block impossible&quot; readability=&quot;2.780487804878&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;impossible&lt;/p&gt;
&lt;p&gt;Site provides no user account management interface or account deletion options. Email sent to internets@technoized.com was never replied to.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block impossible&quot; readability=&quot;4.7196261682243&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;impossible&lt;/p&gt;
&lt;p&gt;You may discontinue your use of the Service at any time without informing us. We may, however, retain and continue to use any Content that you have submitted or uploaded through the Service.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;7.2727272727273&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;Go to IRCCloud, sign in, click 'Settings', scroll down, enter your password in 'Delete your account', and confirm.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;3.68&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;Closing your account will delete your profile and all of your publications. There is no going back, so don't say we didn't warn you.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block hard&quot; readability=&quot;2.702479338843&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;hard&lt;/p&gt;
&lt;p&gt;Contact customer services. You will lose access to any media you haven‚Äôt downloaded to your computer.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block impossible&quot; readability=&quot;4.7196261682243&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;impossible&lt;/p&gt;
&lt;p&gt;You may discontinue your use of the Service at any time without informing us. We may, however, retain and continue to use any Content that you have submitted or uploaded through the Service.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;2.7209302325581&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;Under 'Membership Management' click 'Remove my Profile'. Fill out the survey and submit to delete your profile.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block impossible&quot; readability=&quot;4.7196261682243&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;impossible&lt;/p&gt;
&lt;p&gt;You may discontinue your use of the Service at any time without informing us. We may, however, retain and continue to use any Content that you have submitted or uploaded through the Service.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;1.7142857142857&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;Click 'Delete Account' at the botom of the account preference page&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;1.5932203389831&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;Log in. Type in password. Press 'delete'.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block hard&quot; readability=&quot;0.74226804123711&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;hard&lt;/p&gt;
&lt;div class=&quot;tooltip-content&quot; readability=&quot;5.8481012658228&quot;&gt;Please email a request if you‚Äôd like your account to be deleted.&lt;br/&gt;&lt;a href=&quot;mailto:support@jsfiddle.net?Subject=Account%20Deletion%20Request&amp;amp;body=Please%20delete%20my%20account,%20my%20username%20is%20%20XXXXXX&quot;&gt;Send email ¬ª&lt;/a&gt;&lt;/div&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block impossible&quot; readability=&quot;2.7272727272727&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;impossible&lt;/p&gt;
&lt;p&gt;You can only deactivate your account. There appears to be no way to permanently delete your account or data.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block impossible&quot; readability=&quot;4.7196261682243&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;impossible&lt;/p&gt;
&lt;p&gt;You may discontinue your use of the Service at any time without informing us. We may, however, retain and continue to use any Content that you have submitted or uploaded through the Service.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;1.7362637362637&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;Click 'Account deletion page' at the bottom of the account settings page.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block medium&quot; readability=&quot;1.7473684210526&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;medium&lt;/p&gt;
&lt;p&gt;It can take up to 180 days for all your data to be removed from the system.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block hard&quot; readability=&quot;1.7714285714286&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;hard&lt;/p&gt;
&lt;p&gt;You can close your account if you contact customer service either by phone or live chat&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block hard&quot; readability=&quot;3.6268656716418&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;hard&lt;/p&gt;
&lt;div class=&quot;tooltip-content&quot; readability=&quot;12.324&quot;&gt;You are unable to remove an account, but they can permanently ban your account upon request. They will remove stored information upon request as well, such as e-mail address, developer payment information, and stored payment information.&lt;br/&gt;&lt;a href=&quot;mailto:support@kongregate.com?Subject=Account%20Deletion%20Request&amp;amp;body=Please%20delete%20my%20account,%20my%20username%20is%20%20XXXXXX&quot;&gt;Send email ¬ª&lt;/a&gt;&lt;/div&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block impossible&quot; readability=&quot;4.7196261682243&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;impossible&lt;/p&gt;
&lt;p&gt;You may discontinue your use of the Service at any time without informing us. We may, however, retain and continue to use any Content that you have submitted or uploaded through the Service.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block hard&quot; readability=&quot;4.5121951219512&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;hard&lt;/p&gt;
&lt;p&gt;To close your account, you need to submit a request to support, which may take up to 24 hours to process.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;1.6&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;May take up to 7 days to delete your data.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block impossible&quot; readability=&quot;3.1771217712177&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;impossible&lt;/p&gt;
&lt;div class=&quot;tooltip-content&quot; readability=&quot;11.368421052632&quot;&gt;Accounts may be disabled, but some data will be retained. E-mail support@riotgames.com with the subject &quot;Account Deactivation&quot; and include your username, summoner name, server and email used when registering the account in your ticket&lt;br/&gt;&lt;a href=&quot;mailto:support@riotgames.com?Subject=Account%20Deletion%20Request&amp;amp;body=Please%20delete%20my%20account,%20my%20username%20is%20%20XXXXXX&quot;&gt;Send email ¬ª&lt;/a&gt;&lt;/div&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;5.4461538461538&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;Click 'Profile', then 'Edit', then 'Show advanced settings', and finally check the 'Delete my account' checkbox.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block impossible&quot; readability=&quot;4.7196261682243&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;impossible&lt;/p&gt;
&lt;p&gt;You may discontinue your use of the Service at any time without informing us. We may, however, retain and continue to use any Content that you have submitted or uploaded through the Service.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block medium&quot; readability=&quot;2.8163265306122&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;medium&lt;/p&gt;
&lt;p&gt;There are reports that LinkedIn continues to email people with a closed account. You may need to contact customer services to delete account instead of just closing it.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt; &lt;span class=&quot;meta&quot;&gt;popular&lt;/span&gt;&lt;/section&gt;&lt;section class=&quot;site-block impossible&quot; readability=&quot;1.5932203389831&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;impossible&lt;/p&gt;
&lt;p&gt;One cannot even change the password&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;1.5932203389831&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;Login -&amp;gt; Profile -&amp;gt; Delete account -&amp;gt; Yes&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block medium&quot; readability=&quot;4.7087378640777&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;medium&lt;/p&gt;
&lt;p&gt;Once you delete your journal you have 30 days to undelete it, in case you change your mind. After 30 days, the journal will be permanently deleted and there will be no way to recover it.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;1.4545454545455&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;Click ‚ÄúClose account‚Äù.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;2.4098360655738&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;log into your account, in the middle right.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block medium&quot; readability=&quot;2.7073170731707&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;medium&lt;/p&gt;
&lt;p&gt;Requires any physical discs to be returned‚Äîaccount will be ‚Äúcancellation pending‚Äù until received.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block medium&quot; readability=&quot;2.7372262773723&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;medium&lt;/p&gt;
&lt;p&gt;Account Settings ‚Üí Account Settings Drop-down ‚Üí Close my account ‚Üí Type DELETE and press Delete Account button.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;1.6923076923077&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;Enter Password -&amp;gt; Scroll to bottom -&amp;gt; Click 'Delete Account'&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block medium&quot; readability=&quot;1.7692307692308&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;medium&lt;/p&gt;
&lt;p&gt;Login -&amp;gt; Suspend Account -&amp;gt; Enter email &amp;amp; password -&amp;gt; Save -&amp;gt; Delete Account&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt; &lt;span class=&quot;meta&quot;&gt;popular&lt;/span&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;1.7391304347826&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;A 'Delete my account' button is available from your account settings page.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;4.6791443850267&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;Click 'Accounts' in the upper right, then select the 'Settings' tab. Scroll to the bottom and click 'Delete Your Mint Account' and finally 'YES, delete my Mint account'.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block hard&quot; readability=&quot;0.79674796747967&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;hard&lt;/p&gt;
&lt;div class=&quot;tooltip-content&quot; readability=&quot;6.1333333333333&quot;&gt;You need to send an email to support and it may take up to 48 hours to process your request.&lt;br/&gt;&lt;a href=&quot;mailto:support@mister-wong.de?Subject=Account%20Deletion%20Request&amp;amp;body=Please%20delete%20my%20account,%20my%20username%20is%20%20XXXXXX&quot;&gt;Send email ¬ª&lt;/a&gt;&lt;/div&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;3.609756097561&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;Login to your account, go to account section of the settings page and choose the &quot;delete account&quot; option.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block hard&quot; readability=&quot;1.6883116883117&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;hard&lt;/p&gt;
&lt;p&gt;You have to send a message in order to remove your account.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;6.7162162162162&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;If you have registered a Mojang account and would like to delete your account, please visit your account settings page. Please be aware that if your account is deleted, you will no longer be able to log into Mojang services, and will not be able to purchase future Mojang games.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block hard&quot; readability=&quot;6.8112359550562&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;hard&lt;/p&gt;
&lt;p&gt;Contact customer services and they'll respond in 24-48 hours. Not to mention the ways they try to hide you removing your card details. If you want to remove your card details, do the following: The easiest way to do this would be to go to the My Account page then click on the ‚ÄòAdd Moonpig Prepay Credit‚Äô link, click on the Buy link and your saved card details will be shown onscreen. Click on the ‚ÄòRemove Card‚Äô option.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block hard&quot; readability=&quot;1.7692307692308&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;hard&lt;/p&gt;
&lt;p&gt;You need send email to support and it may take up to 24 hours to process your request.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block hard&quot; readability=&quot;3.7575757575758&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;hard&lt;/p&gt;
&lt;p&gt;Fill out the feedback form, asking them to delete your account. Be sure to specify that you‚Äôre not just unsubscribing from e-mail but that you want your account deleted entirely.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;1.68&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;‚ÄúCancel your account‚Äù link at the bottom of the page.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block hard&quot; readability=&quot;1.6712328767123&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;hard&lt;/p&gt;
&lt;p&gt;You have to contact Multiplay by their contact us page.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;1.6571428571429&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;Click on delete my account at the bottom of the page&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;1.7241379310345&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;Replace &amp;lt;code&amp;gt;USERNAME&amp;lt;/code&amp;gt; with your My Opera username in the URL.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;2.6842105263158&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;Go to your account settings (top right, click on your E-Mail-Adress) and select 'Delete Account'&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;6.7316293929712&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;At the bottom of the Account Settings page is a &quot;Delete My Account&quot; button. Your account will be &quot;disabled and scheduled for permanent deletion.&quot; After 30 days, &quot;your past novels, author profile, and unique account info will be permanently deleted.&quot; It is unclear if forum posts will be deleted.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block hard&quot; readability=&quot;2.7073170731707&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;hard&lt;/p&gt;
&lt;p&gt;Requires to fill out contact form. Will still get Promotional emails until you also unsubscribe from them&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block hard&quot; readability=&quot;0.78448275862069&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;hard&lt;/p&gt;
&lt;div class=&quot;tooltip-content&quot; readability=&quot;6.0714285714286&quot;&gt;Send an email to the unsubscribe@neopets.com stating you wish to delete your account.&lt;br/&gt;&lt;a href=&quot;mailto:unsubscribe@neopets.com?Subject=Account%20Deletion%20Request&amp;amp;body=Please%20delete%20my%20account,%20my%20username%20is%20%20XXXXXX&quot;&gt;Send email ¬ª&lt;/a&gt;&lt;/div&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block impossible&quot; readability=&quot;2.8125&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;impossible&lt;/p&gt;
&lt;p&gt;Contact customer services. Even then they may not delete your account under the premise that you might want to rejoin and keep your history and recommendations.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt; &lt;span class=&quot;meta&quot;&gt;popular&lt;/span&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;3.2835820895522&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;Select 'settings', then 'account', then 'delete'.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;3.6470588235294&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;From the New Relic menu bar, select (account) &amp;gt; Upgrade subscription &amp;gt; Cancel account. Select the confirmation prompt.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block hard&quot; readability=&quot;1.75&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;hard&lt;/p&gt;
&lt;p&gt;Use the form to write to customer services and ask them to close your account.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;5.6923076923077&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;At the bottom of the account form, there is a 'Deactivate Account' button. Upon clicking, there will be a set of information that explains the process of account deactivation. All account information will be deleted.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;1.7623762376238&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;You will see an option to delete your account just below the password reset option.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;1.6417910447761&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;Check the box to confirm and then click 'Change'.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;6.4716981132075&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;Login to your account, scroll License Agreement down, click Delete profile, check any boxes you want, enter password and press Remove button.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;2.4929577464789&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;Visit your settings page, and select 'Delete Account'&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block impossible&quot; readability=&quot;2.7735849056604&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;impossible&lt;/p&gt;
&lt;p&gt;You can deactivate your account with the link. But the data isn't deleted. Even if you contact the support they don't delete your data.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block impossible&quot; readability=&quot;2.6842105263158&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;impossible&lt;/p&gt;
&lt;p&gt;It's possible to close your account if you request it, but it's not possible to delete it.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block impossible&quot; readability=&quot;3.6903225806452&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;impossible&lt;/p&gt;
&lt;p&gt;You can't delete your account including all data, only a ‚Äòsoft delete‚Äô is possible where you can always re-enable your account.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block hard&quot; readability=&quot;0.73118279569892&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;hard&lt;/p&gt;
&lt;div class=&quot;tooltip-content&quot; readability=&quot;5.7866666666667&quot;&gt;You must open a ticket to completely get your account deleted.&lt;br/&gt;&lt;a href=&quot;mailto:contact@opendns.com?Subject=Account%20Deletion%20Request&amp;amp;body=Please%20delete%20my%20account,%20my%20username%20is%20%20XXXXXX&quot;&gt;Send email ¬ª&lt;/a&gt;&lt;/div&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block hard&quot; readability=&quot;3.7037037037037&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;hard&lt;/p&gt;
&lt;p&gt;You must contact support directly and ask them to invalidate your account. However, your transaction data may not be deleted from their records.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block hard&quot; readability=&quot;5.6453201970443&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;hard&lt;/p&gt;
&lt;p&gt;You have to email support from the email associated with your account. If you do not have access to that, you need to provide the email address, birth year, and zip code on the account.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;4.4915254237288&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;In order to delete an account, you first have to delete all active Sites, or transfer the ownership.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block hard&quot; readability=&quot;4.6508379888268&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;hard&lt;/p&gt;
&lt;div class=&quot;tooltip-content&quot; readability=&quot;14.426470588235&quot;&gt;To cancel your account, send an e-mail message request to the Parkmobile Help Desk at helpdesk@parkmobileglobal.com and include your name, mobile number, license plate number, and/or the last 4 digits of the card we have on file for you. After the Help Desk cancels your account, you will receive a confirmation e-mail message.&lt;br/&gt;&lt;a href=&quot;mailto:helpdesk@parkmobileglobal.com?Subject=Account%20Deletion%20Request&amp;amp;body=Please%20delete%20my%20account,%20my%20username%20is%20%20XXXXXX&quot;&gt;Send email ¬ª&lt;/a&gt;&lt;/div&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block impossible&quot; readability=&quot;2.6210526315789&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;impossible&lt;/p&gt;
&lt;p&gt;You can remove your pastes, but there's no link to delete your account.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block medium&quot; readability=&quot;3.6981132075472&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;medium&lt;/p&gt;
&lt;p&gt;You cannot delete your account from the website. Open the iOS/Android app, go to settings ‚Üí about ‚Üí disable account ‚Üí delete account.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;4.6319018404908&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;Login to your account, go to settings (small gear next to your username), click Delete my account. You'll receive a confirmation link via e-mail.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block hard&quot; readability=&quot;2.7869822485207&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;hard&lt;/p&gt;
&lt;p&gt;Log in. Click 'Profile' near the top of the page. Click 'My settings'. Click 'Close Account' in the 'Account type' section and follow the steps listed.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block hard&quot; readability=&quot;2.6&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;hard&lt;/p&gt;
&lt;p&gt;I had to contact via email, but they then immediately deleted my account&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block hard&quot; readability=&quot;3.8222222222222&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;hard&lt;/p&gt;
&lt;p&gt;You must send an e-mail to support@peak.net requesting deletion. You will then receive a response from support asking for feedback and to confirm the deletion. The next e-mail you receive from support will notify you that your account has been deleted.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;1.7073170731707&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;You only need to click on 'Delete Account' on your account site.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block hard&quot; readability=&quot;2.6785714285714&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;hard&lt;/p&gt;
&lt;p&gt;It is necessary to contact the support, for example through 'Mein Konto' -&amp;gt; 'Meinung abgeben'.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block impossible&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;impossible&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block impossible&quot; readability=&quot;1.6521739130435&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;impossible&lt;/p&gt;
&lt;p&gt;They refuse to delete accounts from the site.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block impossible&quot; readability=&quot;2.7165354330709&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;impossible&lt;/p&gt;
&lt;p&gt;You can't delete your Google Account for Picasa Web Albums without deleting your entire Google Account.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block hard&quot; readability=&quot;0.77678571428571&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;hard&lt;/p&gt;
&lt;div class=&quot;tooltip-content&quot; readability=&quot;6.031914893617&quot;&gt;Send us an e-mail from the address that you have registered - we take care of it.&lt;br/&gt;&lt;a href=&quot;mailto:support@pinboard.in?Subject=Account%20Deletion%20Request&amp;amp;body=Please%20delete%20my%20account,%20my%20username%20is%20%20XXXXXX&quot;&gt;Send email ¬ª&lt;/a&gt;&lt;/div&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block impossible&quot; readability=&quot;2.7165354330709&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;impossible&lt;/p&gt;
&lt;p&gt;Accounts can be deactivated, which means that your pins and profile are hidden but not deleted.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt; &lt;span class=&quot;meta&quot;&gt;popular&lt;/span&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block impossible&quot; readability=&quot;2.8&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;impossible&lt;/p&gt;
&lt;p&gt;It is not possible to delete your PlayStation Network account. The best you can do is delete any personal information that you have stored on their website.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;1.4545454545455&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;Fill out the deletion form&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;2.4626865671642&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;Under 'Danger Zone', click 'Delete your account'.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;2.6086956521739&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;Log in to your account, press the delete button and type the phrase asked.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block hard&quot; readability=&quot;1.6842105263158&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;hard&lt;/p&gt;
&lt;p&gt;Must contact support through Contanct form or online chat.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;2.6666666666667&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;Log into your account -&amp;gt; Click the link (data fully deleted, not possible to revert this).&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;2.7142857142857&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;Log into your account -&amp;gt; Click 'Need to close your account?' near the bottom of the page -&amp;gt; Confirm deletion&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;1.7798165137615&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;Log into your account -&amp;gt; Click the link -&amp;gt; Enter your password and click on Delete Account.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;1.7362637362637&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;Log into your account -&amp;gt; Click the link -&amp;gt; Click on Close My Account Now.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;2.5714285714286&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;Click Destroy my account completely, then click Delete everything.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block hard&quot; readability=&quot;5.6417910447761&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;hard&lt;/p&gt;
&lt;p&gt;First deactivate your account. Log in, go to 'Settings', 'Privacy', and then 'Deactivate Account'. You can then e-mail privacy@quora.com if you want to completely delete your account.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;3.5051546391753&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;Login, go to profile page, it's in tab 'my data' and click 'delete my account'.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;2.5955056179775&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;Login, go to the settings page and click 'I want to delete my account'.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block impossible&quot; readability=&quot;5.6651162790698&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;impossible&lt;/p&gt;
&lt;p&gt;After deleteing the account, it will be deactivated for 30 days before being deleted permanently. Messages, forum posts, and contributions stay on the site even after your account is deleted.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block impossible&quot; readability=&quot;2.5955056179775&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;impossible&lt;/p&gt;
&lt;p&gt;You can't delete your account, but you can deactivate it.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt; &lt;span class=&quot;meta&quot;&gt;popular&lt;/span&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;2.5714285714286&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;Go to your profile page, and use the 'Delete Your Account' button.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;1.8048780487805&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;Increase your productivity by over 5 times with this one trick they don't want you to know about!&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt; &lt;span class=&quot;meta&quot;&gt;popular&lt;/span&gt;&lt;/section&gt;&lt;section class=&quot;site-block hard&quot; readability=&quot;1.7844827586207&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;hard&lt;/p&gt;
&lt;div class=&quot;tooltip-content&quot; readability=&quot;8.4532710280374&quot;&gt;If you decide you would like to delete your account you must email us at support@redditgifts.com. You must email us from the email address associated with your account and provide your reddit username.&lt;br/&gt;&lt;a href=&quot;mailto:support@redditgifts.com?Subject=Account%20Deletion%20Request&amp;amp;body=Please%20delete%20my%20account,%20my%20username%20is%20%20XXXXXX&quot;&gt;Send email ¬ª&lt;/a&gt;&lt;/div&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;2.7&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;Please enter a reason for deactivating your account and then click 'Deactivate' after you're finished.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;1.7142857142857&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;Use the 'Delete your account' link in the lower right-hand corner.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;1.6363636363636&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;Use the Delete button at the bottom of the page.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block impossible&quot; readability=&quot;3.8064516129032&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;impossible&lt;/p&gt;
&lt;p&gt;You can only cancel the auto-renewal feature. I called them and asked to cancel my account and be removed from their mailing list and they told me my account was already not renewing and there was nothing else they could do.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;2.6288659793814&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;On your profile page, click 'Edit Profile' and use the 'Cancel account' button.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block impossible&quot; readability=&quot;3.778801843318&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;impossible&lt;/p&gt;
&lt;p&gt;Not possible. 'We currently do not have a feature for players to delete their accounts. If you no longer wish to play on your account, it will remain inactive until you're ready to play again.'&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;4.6629213483146&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;On the account page, scroll down to the &quot;Danger Zone&quot; and click on the &quot;Delete My Account&quot; button. After that, you will have to type &quot;DELETE&quot; in the pop-up box.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block hard&quot; readability=&quot;3.6712328767123&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;hard&lt;/p&gt;
&lt;p&gt;You need to contact flixster to cancel a native RT profile, while Facebook linked or Flixster.com accounts are easier to cancel.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;1.4782608695652&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;Bottom link 'Delete Account'&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block hard&quot; readability=&quot;2.8153846153846&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;hard&lt;/p&gt;
&lt;p&gt;Under 5. Account Settings &amp;gt; A. Account Management &amp;gt; V. Account Deletion. You must mail or fax an affidavit to the Runescape office along with a copy of your legal identification&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block medium&quot; readability=&quot;6.4683544303797&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;medium&lt;/p&gt;
&lt;p&gt;After clicking the button, you will have to enter your password, complete a capcha, click another button, AND a confirmation modal dialog.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;7.5914893617021&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;To delete your account go to Runtastic.com &amp;amp; log in, click on the arrow on the right side of your user name, click on &quot;Settings&quot;, click on &quot;Login Data&quot; on the left hand side, click on &quot;Delete my account&quot; at the bottom&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;1.7176470588235&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;Login to your account and follow 'Account Suspension' instructions.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;4.7058823529412&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;Click the link 'Delete your account' at the bottom. Note: On your dropbox, the content of this site will not be removed. If needed, you can delete the folder 'Apps/scriptogram' manually.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;2.7&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;Click the &quot;Delete your account&quot; at the bottom of the settings page and type &quot;DELETE&quot; in the popup box.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;1.7735849056604&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;Select 'Please cancel my account'. Choose a reason then select 'close my shopify store'.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block impossible&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;impossible&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block hard&quot; readability=&quot;1.7272727272727&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;hard&lt;/p&gt;
&lt;p&gt;Contact customers services by email or live chat and request deletion.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block hard&quot; readability=&quot;2.7831325301205&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;hard&lt;/p&gt;
&lt;p&gt;If you wish to delete your account or request that we no longer use your information to provide you services contact us at Support@Shutterstock.com.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block hard&quot; readability=&quot;0.7093023255814&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;hard&lt;/p&gt;
&lt;div class=&quot;tooltip-content&quot; readability=&quot;5.6617647058824&quot;&gt;Contact customer service by email and request deletion.&lt;br/&gt;&lt;a href=&quot;mailto:support@sigfig.com?Subject=Account%20Deletion%20Request&amp;amp;body=Please%20delete%20my%20account,%20my%20username%20is%20%20XXXXXX&quot;&gt;Send email ¬ª&lt;/a&gt;&lt;/div&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block hard&quot; readability=&quot;2.82&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;hard&lt;/p&gt;
&lt;p&gt;Enter your password to have your account marked for deletion by an administrator or moderator. You can do this for any other Simple Machines forums if the forum administrator allows.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block hard&quot; readability=&quot;3.7225433526012&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;hard&lt;/p&gt;
&lt;p&gt;Contact customer services on chat. You‚Äôll need to know whether you bought services from Skype, you‚Äôll need to verify your signup email address.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt; &lt;span class=&quot;meta&quot;&gt;popular&lt;/span&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;2.7662337662338&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;If you are the Slack team's primary owner you will need to either delete the team or transfer its ownership before deleting your account&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block impossible&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;impossible&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;1.7037037037037&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;A direct link is not available as it is based on your username.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block hard&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;hard&lt;/p&gt;
&lt;p&gt;Email request required.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block hard&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;hard&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;1.6307692307692&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;Enter username and password and click 'Delete'.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block hard&quot; readability=&quot;1.7391304347826&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;hard&lt;/p&gt;
&lt;p&gt;You need to create a support ticket and set the subject to Delete Account.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block hard&quot; readability=&quot;0.71264367816092&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;hard&lt;/p&gt;
&lt;div class=&quot;tooltip-content&quot; readability=&quot;5.6811594202899&quot;&gt;Send a request to legal@sonico.com and request deletion.&lt;br/&gt;&lt;a href=&quot;mailto:legal@sonico.com?Subject=Account%20Deletion%20Request&amp;amp;body=Please%20delete%20my%20account,%20my%20username%20is%20%20XXXXXX&quot;&gt;Send email ¬ª&lt;/a&gt;&lt;/div&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block hard&quot; readability=&quot;1.248322147651&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;hard&lt;/p&gt;
&lt;div class=&quot;tooltip-content&quot; readability=&quot;7.206106870229&quot;&gt;Put 'delete me' in the description box on your profile and mail team@soup.io with your soup URL and request a deletion&lt;br/&gt;&lt;a href=&quot;mailto:team@soup.io?Subject=Account%20Deletion%20Request&amp;amp;body=Please%20delete%20my%20account,%20my%20username%20is%20%20XXXXXX&quot;&gt;Send email ¬ª&lt;/a&gt;&lt;/div&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block medium&quot; readability=&quot;3.7225433526012&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;medium&lt;/p&gt;
&lt;p&gt;Data created by the user such as posts and tickets will remain and be attributed to the account, even if deleted. The username will not become available.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block impossible&quot; readability=&quot;2.7049180327869&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;impossible&lt;/p&gt;
&lt;p&gt;If you wish to terminate your Speaker Deck account, you may simply discontinue using Speaker Deck.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block medium&quot; readability=&quot;3.6521739130435&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;medium&lt;/p&gt;
&lt;p&gt;Your account can't be deleted. It can be disabled using the link, but your data will stay inactive on servers.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt; &lt;span class=&quot;meta&quot;&gt;popular&lt;/span&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block hard&quot; readability=&quot;6.7133105802048&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;hard&lt;/p&gt;
&lt;p&gt;If you haven‚Äôt posted on the site, it‚Äôs just one click. If you have voted or posted, please contact the Stack Exchange Team: Visit the contact form and select ‚ÄòI need to delete my user profile‚Äô. After you contact us, the team will reach out with further instructions.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block impossible&quot; readability=&quot;3.7913043478261&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;impossible&lt;/p&gt;
&lt;p&gt;They will not delete your account but upon request they can ‚Äúscramble all of your information so that you don‚Äôt receive emails and none of your information is available to [them] for potential fraud‚Äù.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block hard&quot; readability=&quot;0.76851851851852&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;hard&lt;/p&gt;
&lt;div class=&quot;tooltip-content&quot; readability=&quot;5.9888888888889&quot;&gt;You have to write an Email to the Support. Your activites will be anonymized.&lt;br/&gt;&lt;a href=&quot;mailto:support@startnext.de?Subject=Account%20Deletion%20Request&amp;amp;body=Please%20delete%20my%20account,%20my%20username%20is%20%20XXXXXX&quot;&gt;Send email ¬ª&lt;/a&gt;&lt;/div&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;1.7241379310345&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;Under 'Account' scroll down and click the red button 'Remove Account'&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;4.7209302325581&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;The deletion of your entry can not be undone. All your profile data, contacts, messages and pictures will be permanently removed. Your classmates and contacts can no longer StayFriends contact you.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block impossible&quot; readability=&quot;4.6739130434783&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;impossible&lt;/p&gt;
&lt;p&gt;If you contact Steam support, they will most likely tell you just to not use the account. If your account has no games on it, it will be disabled after a while.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block hard&quot; readability=&quot;1.780701754386&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;hard&lt;/p&gt;
&lt;div class=&quot;tooltip-content&quot; readability=&quot;8.4428571428571&quot;&gt;To delete your StepMap account, let us know by sending an e-mail with info@stepmap.de and enter your username. The sender address must be your e-mail address that you have subscribed to at StepMap.&lt;br/&gt;&lt;a href=&quot;mailto:info@stepmap.de?Subject=Account%20Deletion%20Request&amp;amp;body=Please%20delete%20my%20account,%20my%20username%20is%20%20XXXXXX&quot;&gt;Send email ¬ª&lt;/a&gt;&lt;/div&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;1.6190476190476&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;Just click the 'Delete account' button in red&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block medium&quot; readability=&quot;5.7142857142857&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;medium&lt;/p&gt;
&lt;p&gt;Upon deactivation, all of your activities will be deleted and you will be removed from all leaderboards. Strava will keep an archive of your raw GPS data as uploaded to Strava, but the archive cannot be used to restore your account.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;1.7241379310345&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;You can reactivate within 14 days. After that the account is deleted.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block impossible&quot; readability=&quot;1.7512437810945&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;impossible&lt;/p&gt;
&lt;div class=&quot;tooltip-content&quot; readability=&quot;8.3389830508475&quot;&gt;If you have an account, you can delete any document by right clicking the file and selecting 'Delete'. If you do not have an account please email support@stypi.com.&lt;br/&gt;&lt;a href=&quot;mailto:support@stypi.com?Subject=Account%20Deletion%20Request&amp;amp;body=Please%20delete%20my%20account,%20my%20username%20is%20%20XXXXXX&quot;&gt;Send email ¬ª&lt;/a&gt;&lt;/div&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block medium&quot; readability=&quot;2.7230769230769&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;medium&lt;/p&gt;
&lt;p&gt;You have to contact them selecting the issue Login &amp;amp; account details and the issue details Deleting my account&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;1.7818181818182&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;Use the 'Cancel My Account' link on your Account Settings page. Requires email confirmation.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;1.6962025316456&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;You can reactivate at any time by logging in to your account.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block medium&quot; readability=&quot;2.566265060241&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;medium&lt;/p&gt;
&lt;p&gt;In order to delete your account, you have to fill out the form.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;1.7525773195876&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;Edit profile (menu item at the top right corner of the page) ‚Üí Delete account&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block impossible&quot; readability=&quot;2.625&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;impossible&lt;/p&gt;
&lt;p&gt;It's not possible to remove your account, but you can remove your blogs.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block hard&quot; readability=&quot;1.7073170731707&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;hard&lt;/p&gt;
&lt;p&gt;TED has to be contacted via e-mail for account deletion requests&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;2.75&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;Open deactivation page. Enter your phone number and one time password sent to your Telegram account. Delete your account then.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;1.7575757575758&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;Click on 'Konto l√∂schen' and then on 'Mein Konto jetzt unwiederruflich l√∂schen'&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block hard&quot; readability=&quot;1.6962025316456&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;hard&lt;/p&gt;
&lt;p&gt;You must submit a request to close your account via the form.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block impossible&quot; readability=&quot;2.7230769230769&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;impossible&lt;/p&gt;
&lt;p&gt;You will most likely be told that it's impossible to delete your account when contacting customer service.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;4.5522388059701&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;At the bottom of the page is a delete account buttom, after clicking on it, you will need to re-enter your password.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block hard&quot; readability=&quot;2.6435643564356&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;hard&lt;/p&gt;
&lt;p&gt;You can't delete your account, but you can contact them via email to deactivate it.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block hard&quot; readability=&quot;1.6363636363636&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;hard&lt;/p&gt;
&lt;p&gt;you have to ask the staff to delete your account&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block impossible&quot; readability=&quot;2.6635514018692&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;impossible&lt;/p&gt;
&lt;p&gt;You can't delete your account, but you can contact them via email to deactivate it.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;1.6883116883117&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;Select 'Delete your account?' option to delete your account&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block hard&quot; readability=&quot;1.6962025316456&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;hard&lt;/p&gt;
&lt;p&gt;You must log in and contact the staff to delete your account.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;2.7410071942446&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;Your account is deactivated before being deleted. After 30 days of remaining deactivated it will then be deleted.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt; &lt;span class=&quot;meta&quot;&gt;popular&lt;/span&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block hard&quot; readability=&quot;12.758513931889&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;hard&lt;/p&gt;
&lt;p&gt;Yes and no, it depends on which type(s) of accounts, and you will need to delete the accounts in the correct order. All accounts are tied to Ubuntu One's Single Sign-On (login.ubuntu.com), so that is the account you should close last. Everything else, such as Launchpad.net, cloud file storage, AskUbuntu, and other accounts should be closed first if possible. This is especially important if you have any paid services attached, to make sure you won't be billed for anything after closing the accounts. The last step is to delete your Single Sign-On (SSO) account. SSO accounts must be deleted manually by the Ubuntu One staff.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block impossible&quot; readability=&quot;3.6756756756757&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;impossible&lt;/p&gt;
&lt;p&gt;A Udacity employee recommends that you stop using the account, which means there's currently no way of deleting the account.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block medium&quot; readability=&quot;2.6666666666667&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;medium&lt;/p&gt;
&lt;p&gt;In order to delete your account, you need to first unsubscribe from all of your courses.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;1.7142857142857&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;Click 'Delete my account' at the bottom of the user settings page.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block hard&quot; readability=&quot;0.70588235294118&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;hard&lt;/p&gt;
&lt;div class=&quot;tooltip-content&quot; readability=&quot;5.6417910447761&quot;&gt;Send an email with the subject ‚ÄòDelete my account‚Äô&lt;br/&gt;&lt;a href=&quot;mailto:help@usersnap.com?Subject=Account%20Deletion%20Request&amp;amp;body=Please%20delete%20my%20account,%20my%20username%20is%20%20XXXXXX&quot;&gt;Send email ¬ª&lt;/a&gt;&lt;/div&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;1.7623762376238&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;Scroll down to the bottom of the 'Account Settings' page and click 'Delete Account'&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block impossible&quot; readability=&quot;4.7196261682243&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;impossible&lt;/p&gt;
&lt;p&gt;You may discontinue your use of the Service at any time without informing us. We may, however, retain and continue to use any Content that you have submitted or uploaded through the Service.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block impossible&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;impossible&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;2.4782608695652&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;There's a button on the right, just under the menu.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block hard&quot; readability=&quot;2.7534246575342&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;hard&lt;/p&gt;
&lt;p&gt;The only way to delete your Vine account without deleting your Twitter account is to contact Twitter through their contact form.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block impossible&quot; readability=&quot;1.7669902912621&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;impossible&lt;/p&gt;
&lt;p&gt;Site provides no user account management interface or account deletion options.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;1.7446808510638&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;Site uses the term &quot;unsubscribe&quot; to describe completely deleting an account.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block hard&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;hard&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;4.7101449275362&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;When logged into the website, select &quot;My WhatPulse&quot; from the navigation bar, then click &quot;Unregister from WhatPulse&quot; towards the bottom of the page. This will permanently delete the account.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block medium&quot; readability=&quot;1.6962025316456&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;medium&lt;/p&gt;
&lt;p&gt;From the app: Settings ‚Üí Account ‚Üí Delete your account.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;1.7623762376238&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;Menu ‚Üí Edit vCard ‚Üí Account management ‚Üí Delete everything (cannot be undone)&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;Just click 'Deactivate'.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block impossible&quot; readability=&quot;2.6504854368932&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;impossible&lt;/p&gt;
&lt;p&gt;'A username cannot be deleted.' However, they do have some suggestions.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt; &lt;span class=&quot;meta&quot;&gt;popular&lt;/span&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;2.7894736842105&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;'Delete any built sites and subscribtions then follow the link to a deletion request form. Email is sent straght away with a link to confirm the deletion&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block hard&quot; readability=&quot;2.0335820895522&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;hard&lt;/p&gt;
&lt;div class=&quot;tooltip-content&quot; readability=&quot;8.8793103448276&quot;&gt;For the immediate future, send a message to WolframAlpha, and your Wolfram ID will be deleted manually.&lt;br/&gt;&lt;a href=&quot;mailto:info@wolframalpha.com?Subject=Account%20Deletion%20Request&amp;amp;body=Please%20delete%20my%20account,%20my%20username%20is%20%20XXXXXX&quot;&gt;Send email ¬ª&lt;/a&gt;&lt;/div&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block impossible&quot; readability=&quot;2.758389261745&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;impossible&lt;/p&gt;
&lt;p&gt;‚ÄúWordPress.com accounts cannot be deleted.‚Äù The best you can do is remove any identifying data from your account.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt; &lt;span class=&quot;meta&quot;&gt;popular&lt;/span&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;1.7272727272727&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;Click 'Delete Account' at the bottom of the account preferences panel.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block impossible&quot; readability=&quot;3.6129032258065&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;impossible&lt;/p&gt;
&lt;p&gt;There is no way to delete your account, you can only make some information private and/or delete it.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;1.6619718309859&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;Select 'delete my profile' at the bottom of the page.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;1.6571428571429&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;‚ÄúDelete account‚Äù link at the bottom of the page.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;span class=&quot;meta&quot;&gt;popular&lt;/span&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot; readability=&quot;2.6666666666667&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p&gt;On the above URL, click the 'Delete your Yammer account' link in the topright and confirm.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block medium&quot; readability=&quot;1.7798165137615&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;medium&lt;/p&gt;
&lt;p&gt;You must request deletion of your Yatado data before deleting the related social account.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;span class=&quot;meta&quot;&gt;popular&lt;/span&gt;&lt;/section&gt;&lt;section class=&quot;site-block impossible&quot; readability=&quot;2.7857142857143&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;impossible&lt;/p&gt;
&lt;p&gt;You can‚Äôt delete your YouTube account without deleting your entire Google or Google+ account. But you can delete your YouTube channel.&lt;/p&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt; &lt;span class=&quot;meta&quot;&gt;popular&lt;/span&gt;&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block easy&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;easy&lt;/p&gt;
&lt;p class=&quot;tooltip-toggle&quot;&gt;No Info Available&lt;/p&gt;
&lt;/section&gt;&lt;section class=&quot;site-block hard&quot; readability=&quot;2.6808510638298&quot;&gt;
&lt;p class=&quot;site-difficulty&quot;&gt;hard&lt;/p&gt;
&lt;div class=&quot;tooltip-content&quot; readability=&quot;10.341013824885&quot;&gt;Place Delete My Account in the subject line and include your first name, last name, e-mail address and user ID number for the SNS from which you access our games (if applicable) in the body of the e-mail.&lt;br/&gt;&lt;a href=&quot;mailto:privacy@zynga.com?subject=Delete%20My%20Account?Subject=Account%20Deletion%20Request&amp;amp;body=Please%20delete%20my%20account,%20my%20username%20is%20%20XXXXXX&quot;&gt;Send email ¬ª&lt;/a&gt;&lt;/div&gt;
&lt;a href=&quot;https://backgroundchecks.org/justdeleteme/#&quot; class=&quot;tooltip-toggle contains-info&quot;&gt;show info...&lt;/a&gt;&lt;/section&gt;</description>
<pubDate>Mon, 02 Sep 2019 14:14:55 +0000</pubDate>
<dc:creator>octosphere</dc:creator>
<dc:format>text/html</dc:format>
<dc:identifier>https://backgroundchecks.org/justdeleteme/</dc:identifier>
</item>
<item>
<title>The Secret History of Dune</title>
<link>https://lareviewofbooks.org/article/the-secret-history-of-dune/</link>
<guid isPermaLink="true" >https://lareviewofbooks.org/article/the-secret-history-of-dune/</guid>
<description>&lt;p class=&quot;post-date&quot;&gt;SEPTEMBER 16, 2017&lt;/p&gt;&lt;div class=&quot;featuredImage&quot;&gt;&lt;img src=&quot;https://lareviewofbooks-org-cgwbfgl6lklqqj3f4t3.netdna-ssl.com/media/image.php?w=640&amp;amp;h=640&amp;amp;zc=1&amp;amp;q=80&amp;amp;src=%2Fwp-content%2Fuploads%2F2017%2F09%2Fthesabresofparadise.jpeg&amp;amp;hash=d08dd0d3814642226de4b9bcf8864b2a&quot; width=&quot;100%&quot; height=&quot;auto&quot;/&gt;&lt;/div&gt;
&lt;p&gt;FRANK HERBERT‚ÄôS &lt;em&gt;Dune&lt;/em&gt; (1965) is a science-fiction classic in part because it‚Äôs such brilliant pastiche. Drawing inspiration from the midcentury United States‚Äôs nascent environmental movement, European feudalism, Middle Eastern oil politics, and Zen Buddhism, Herbert created a universe that is at once exotic and familiar. Not all of the book‚Äôs success is a result of inspired borrowing, but much of the richness and depth in Herbert‚Äôs imagined future of religious fanaticism and aristocratic intrigue can be traced to its creator‚Äôs talent for appropriation.&lt;/p&gt;
&lt;p&gt;Melange, the hallucinogenic drug at the heart of Herbert‚Äôs book, acts as a prerequisite for interstellar travel and can only be obtained on one harsh, desert planet populated by tribes of warlike nomads. Even a casual political observer will recognize the parallels between the universe of &lt;em&gt;Dune&lt;/em&gt; and the Middle East of the late 20th century. Islamic theology, mysticism, and the history of the Arab world clearly influenced &lt;em&gt;Dune&lt;/em&gt;, but part of Herbert‚Äôs genius lay in his willingness to reach for more idiosyncratic sources of inspiration. &lt;em&gt;The Sabres of Paradise&lt;/em&gt; (1960) served as one of those sources, a half-forgotten masterpiece of narrative history recounting a mid-19th century Islamic holy war against Russian imperialism in the Caucasus.&lt;/p&gt;
&lt;p&gt;Lesley Blanch, the book‚Äôs author, has a memorable biography. A British travel writer of some renown, she is perhaps best known for &lt;em&gt;On the Wilder Shores of Love&lt;/em&gt; (1954), an account of the romantic adventures of four British women in the Middle East. She was also a seasoned traveler, a keen observer of Middle Eastern politics and culture, and a passionate Russophile. She called &lt;em&gt;The Sabres of Paradise&lt;/em&gt; ‚Äúthe book I was meant to do in my life,‚Äù and the novel offers the magnificent, overstuffed account of Imam Shamyl, ‚ÄúThe Lion of Dagestan,‚Äù and his decades-long struggle against Russian encroachment.&lt;/p&gt;
&lt;p&gt;Anyone who has obsessed over the mythology of &lt;em&gt;Dune&lt;/em&gt; will immediately recognize the language Herbert borrowed from Blanch‚Äôs work. &lt;em&gt;Chakobsa&lt;/em&gt;, a Caucasian hunting language, becomes the language of a galactic diaspora in Herbert‚Äôs universe. &lt;em&gt;Kanly&lt;/em&gt;, from a word for blood feud among the Islamic tribes of the Caucasus, signifies a vendetta between Dune‚Äôs great spacefaring dynasties. &lt;em&gt;Kindjal&lt;/em&gt;, the personal weapon of the region‚Äôs Islamic warriors, becomes a knife favored by Herbert‚Äôs techno-aristocrats. As Blanch writes, ‚ÄúNo Caucasian man was properly dressed without his &lt;em&gt;kindjal&lt;/em&gt;.‚Äù&lt;/p&gt;
&lt;p&gt;Herbert is ecumenical with his borrowing, lifting terminology and rituals from both sides of this obscure Central Asian conflict. When Paul Atreides, &lt;em&gt;Dune&lt;/em&gt;‚Äôs youthful protagonist, is adopted by a desert tribe whose rituals and feuds bear a marked resemblance to the warrior culture of the Islamic Caucasus, he lives at the exotically named Sietch Tabr. &lt;em&gt;Sietch&lt;/em&gt; and &lt;em&gt;tabr&lt;/em&gt; are both words for camp borrowed from the Cossacks, the Czarist warrior caste who would become the great Christian antagonists of Shamyl‚Äôs Islamic holy warriors.&lt;/p&gt;
&lt;p&gt;Herbert also lifted two of &lt;em&gt;Dune‚Äôs&lt;/em&gt; most memorable lines directly from Blanch. While describing the Caucasians‚Äô fondness for swordplay, Blanch writes, ‚ÄúTo kill with the point lacked artistry.‚Äù In &lt;em&gt;Dune&lt;/em&gt;, this becomes ‚Äú[k]illing with the tip lacks artistry,‚Äù advice given to a young Paul Atreides by a loquacious weapons instructor. A Caucasian proverb recorded by Blanch transforms into a common desert aphorism. ‚ÄúPolish comes from the city, wisdom from the hills,‚Äù an apt saying for a mountain people, becomes ‚ÄúPolish comes from the cities, wisdom from the desert‚Äù in &lt;em&gt;Dune&lt;/em&gt;.&lt;/p&gt;
&lt;p&gt;&lt;em&gt;Dune&lt;/em&gt;‚Äôs narrative, however, owes more to &lt;em&gt;The Sabres of Paradise&lt;/em&gt; than just terminology and customs. The story of a fiercely independent, religiously inspired people resisting an outside power is certainly not unique to the Caucasus, but Blanch‚Äôs influence can be found here, too. The name of Herbert‚Äôs major villain, Baron Vladimir Harkonnen, is redolent of Russian imperialism. Meanwhile, Imam Shamyl, the charismatic leader of Islamic resistance in the Caucasus, describes the Russian Czar as ‚ÄúPadishah‚Äù and his provincial governor as ‚ÄúSiridar,‚Äù titles that Herbert would later borrow for &lt;em&gt;Dune&lt;/em&gt;‚Äôs galactic emperor and his military underlings.&lt;/p&gt;
&lt;p&gt;There are even some interesting echoes of Blanch‚Äôs writing style and tendencies in Herbert‚Äôs book. Both authors traffic in evocative descriptions of stark, unforgiving landscapes and equally unforgiving peoples. And their shared tendency to describe their protagonists in raptor-like terms may not be a coincidence. (For Blanch, the Caucasus was a land of ‚Äúeagle-faced warriors‚Äù and Imam Shamyl was possessed of ‚Äúhandsome eagle features.‚Äù Naturally, the Atreides are also notable for their ‚Äúhawk features.‚Äù) Even &lt;em&gt;Dune&lt;/em&gt;‚Äôs colors owe something to Blanch‚Äôs history. The banners of House Atreides are green and black. The first is, of course, the color of Islam and the second was adopted by Imam Shamyl‚Äôs Murids, holy Islamic warriors pledged to fight Russian imperialism to the death.&lt;/p&gt;
&lt;p&gt;Why is Blanch‚Äôs influence on &lt;em&gt;Dune&lt;/em&gt; worth recognizing? Celebrating Blanch is not a means to discredit Herbert, whose imaginative novel transcends the sum of its influences. But &lt;em&gt;Dune&lt;/em&gt; remains massively popular while &lt;em&gt;The Sabres of Paradise&lt;/em&gt; languishes in relative obscurity, and renewed public interest in Blanch‚Äôs forgotten history would be a welcome development.&lt;/p&gt;
&lt;p&gt;Great travel writing makes no pretense of objectivity, and &lt;em&gt;The Sabres of Paradise&lt;/em&gt; owes more to Blanch‚Äôs background as a travel writer than any traditional history. Blanch traveled and wrote extensively about the Middle East and Russia, and she doesn‚Äôt bother hiding her affection for her subject matter. She was clearly captivated by the culture and peoples of the Caucasus, and it‚Äôs difficult not to be swept away by her enthusiasm.&lt;/p&gt;
&lt;p&gt;The history she produced is a minor masterpiece, an unabashedly romantic account of a conflict that continues to inform religious and political tensions in the Caucasus to this day. (It‚Äôs no accident that Chechnya was the geographic core of Imam Shamyl‚Äôs movement, or that the Murids‚Äô austerely militant Islamic faith recalls the theology of modern fundamentalists.) Blanch was not a professional historian, and one suspects that an academic would have produced an altogether less satisfying account of this period. The climax of &lt;em&gt;The Sabres of Paradise&lt;/em&gt;, a tension-fraught exchange of hostages between the Russian army and the insurgents, would probably be relegated to a few dry paragraphs in an academic tome. For Blanch, it occupies an entire chapter ‚Äî a magnificent account of the trade of three Georgian princesses, kidnapped in a daring Muslim raid, for Shamyl‚Äôs firstborn son, captured as a boy and raised to manhood in the court of the The Great White Czar.&lt;/p&gt;
&lt;p&gt;In strategic terms, this entire episode held little importance: the audacity of Shamyl‚Äôs raiders and the drama and pageantry of the exchange would not change the fact that the Russians had more men and more guns. Indeed, the comparative insignificance of the Caucasus campaign is thrown into stark relief by the fact that the implacable Russian advance was barely slowed by the disastrous Crimean War. But Blanch‚Äôs account, aside from being brilliantly written, captures the essential tragedy of Imam Shamyl‚Äôs struggle. Just as his son was overawed and then seduced by the Czarist court, only to wither away in one of his father‚Äôs mountain citadels after reluctantly returning to the land of his birth, Shamyl‚Äôs support among the Caucasian tribes was gradually being eroded by a combination of overwhelming force and strategic conciliation. It was only a matter of time until the Russians prevailed.&lt;/p&gt;
&lt;p&gt;Occasionally, &lt;em&gt;The Sabres of Paradise&lt;/em&gt; creaks under the weight of its author‚Äôs ambitions. While the story remains unfailingly interesting, Blanch‚Äôs detours into the habits of the Russian aristocracy and European power politics, and the memorable personalities that populate the period occasionally detract from the book‚Äôs narrative momentum. Of course, a ruthless editor may have also excised Blanch‚Äôs wonderful asides about Pushkin and Tolstoy‚Äôs connections to the Caucasus. These narrative detours give testament to the staggering research required for such a comprehensive history. Blanch was no academic, but her command of military facts and her impressive array of primary sources, including her interviews with Shamyl‚Äôs exiled great-granddaughter, should disabuse skeptics of the notion that she didn‚Äôt do her homework.&lt;/p&gt;
&lt;p&gt;Science fiction and fantasy have always been syncretic genres. The extravagant world-building that fires the imagination of so many readers would be nearly impossible if authors refused to seek inspiration in our own histories, religious traditions, and myths. Isaac Asimov‚Äôs Foundation trilogy was famously inspired by Edward Gibbon‚Äôs &lt;em&gt;Decline and Fall of the Roman Empire&lt;/em&gt;. J. R. R. Tolkien‚Äôs background in medieval languages helped shape the mythology of Middle Earth. Frank Herbert‚Äôs &lt;em&gt;Dune&lt;/em&gt; is no different, and rediscovering one of the book‚Äôs most significant influences is a rewarding experience. At a time when our most popular science fiction sagas have been reduced to &lt;a href=&quot;http://www.imdb.com/title/tt2488496/&quot;&gt;cannibalizing&lt;/a&gt; &lt;a href=&quot;http://www.imdb.com/title/tt1408101/&quot;&gt;themselves&lt;/a&gt;, we would do well to celebrate genre pioneers who were more ambitious in their borrowing.&lt;/p&gt;
&lt;p&gt;¬§&lt;/p&gt;
&lt;p&gt;&lt;a href=&quot;https://lareviewofbooks.org/contributor/will-collins/&quot;&gt;&lt;em&gt;Will Collins is a high school English teacher in Eger, Hungary.&lt;/em&gt;&lt;/a&gt;&lt;/p&gt;
&lt;br/&gt;&lt;center&gt;

&lt;/center&gt;
</description>
<pubDate>Mon, 02 Sep 2019 13:07:45 +0000</pubDate>
<dc:creator>currymj</dc:creator>
<og:type>article</og:type>
<og:title>The Secret History of Dune - Los Angeles Review of Books</og:title>
<og:description>Frank Herbert‚Äôs ‚ÄúDune,‚Äù an enduring science fiction classic, owes much of its mythology to ‚ÄúThe Sabres of Paradise,‚Äù an undeservedly forgotten history.</og:description>
<og:url>https://lareviewofbooks.org/article/the-secret-history-of-dune/</og:url>
<og:image>https://lareviewofbooks-org-cgwbfgl6lklqqj3f4t3.netdna-ssl.com/wp-content/uploads/2017/09/thesabresofparadise.jpeg</og:image>
<dc:format>text/html</dc:format>
<dc:identifier>https://lareviewofbooks.org/article/the-secret-history-of-dune/</dc:identifier>
</item>
<item>
<title>Dual AMD EPYC 7742 Crushes Quad Intel Xeon 8180M&amp;#039;s in Geekbench 4</title>
<link>https://www.tomshardware.com/news/dual-amd-epyc-7742-vs-quad-intel-xeon-platinum-8180m,40288.html</link>
<guid isPermaLink="true" >https://www.tomshardware.com/news/dual-amd-epyc-7742-vs-quad-intel-xeon-platinum-8180m,40288.html</guid>
<description>&lt;p&gt;Patrick Kennedy, Editor-in-Chief at &lt;a href=&quot;https://www.servethehome.com/geekbench-4-2p-amd-epyc-7742-sets-world-record/&quot; target=&quot;_blank&quot;&gt;ServeTheHome&lt;/a&gt;, recently set a new world record on Geekbench 4 with pair of &lt;a href=&quot;https://www.tomshardware.com/news/amd-epyc-rome-7000-series-data-center-processor-zen-2-7nm,40108.html&quot; target=&quot;_blank&quot;&gt;AMD EPYC 7742&lt;/a&gt; processors. The publication also compared the pair of EPYC 7742 chips against four Intel Xeon Platinum 8180M processors, with the AMD system being the clear winner.&lt;/p&gt;
&lt;p&gt;&lt;span class=&quot;imgContent imgCenter&quot;&gt;&lt;span class=&quot;imgWrapperOutter&quot;&gt;&lt;span class=&quot;imgWrapperInner&quot;&gt;&lt;span class=&quot;iZoom&quot;&gt;&lt;img class=&quot;lazy&quot; data-src=&quot;https://img.purch.com/amd-epyc-7742-jpg/w/755/aHR0cDovL21lZGlhLmJlc3RvZm1pY3JvLmNvbS9FL0wvODQ5NDA1L29yaWdpbmFsL0FNRC1FUFlDLTc3NDIuanBn&quot; big-src=&quot;https://img.purch.com/amd-epyc-7742-jpg/o/aHR0cDovL21lZGlhLmJlc3RvZm1pY3JvLmNvbS9FL0wvODQ5NDA1L29yaWdpbmFsL0FNRC1FUFlDLTc3NDIuanBn&quot; alt=&quot;Credit: AMD&quot; title=&quot;Credit: AMD&quot;/&gt;&lt;span class=&quot;imgCaption&quot;&gt;Credit: AMD&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;In one corner, we have the AMD EPYC 7742, which comes out punching with 64 cores and 128 threads, and the Intel Xeon Platinum 8180M with its 28 cores and 56 threads in the opposing corner. The AMD system consists of two EPYC 7742 and tallies up to 128 cores and 256 threads while the Intel system has four Xeon Platinum 8180M for a total of 112 cores and 224 threads.&lt;/p&gt;
&lt;div&gt;
&lt;table class=&quot;editorTblTablecenter editorTblSize100 editorTblStyledefault&quot;&gt;&lt;tbody&gt;&lt;tr class=&quot;tblEven&quot;&gt;&lt;td&gt;&lt;strong&gt;Model&lt;/strong&gt;&lt;/td&gt;
&lt;td&gt;&lt;strong&gt;Price (USD)&lt;br/&gt;&lt;/strong&gt;&lt;/td&gt;
&lt;td&gt;&lt;strong&gt;Cores / Threads&lt;br/&gt;&lt;/strong&gt;&lt;/td&gt;
&lt;td&gt;&lt;strong&gt;TDP&lt;br/&gt;&lt;/strong&gt;&lt;/td&gt;
&lt;td&gt;&lt;strong&gt;Base Clock&lt;br/&gt;&lt;/strong&gt;&lt;/td&gt;
&lt;td&gt;&lt;strong&gt;Boost Clock&lt;br/&gt;&lt;/strong&gt;&lt;/td&gt;
&lt;td&gt;&lt;strong&gt;L3 Cache&lt;br/&gt;&lt;/strong&gt;&lt;/td&gt;
&lt;td&gt;&lt;strong&gt;PCIe Lanes&lt;br/&gt;&lt;/strong&gt;&lt;/td&gt;
&lt;td&gt;&lt;strong&gt;Memory Support&lt;br/&gt;&lt;/strong&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;tr class=&quot;tblRow&quot;&gt;&lt;td&gt;&lt;strong&gt;AMD EPYC 7742&lt;/strong&gt;&lt;/td&gt;
&lt;td&gt;$6,950&lt;/td&gt;
&lt;td&gt;54 / 128&lt;br/&gt;&lt;/td&gt;
&lt;td&gt;225W&lt;/td&gt;
&lt;td&gt;2.25 GHz&lt;/td&gt;
&lt;td&gt;3.40 GHz&lt;/td&gt;
&lt;td&gt;256MB&lt;/td&gt;
&lt;td&gt;PCIe 4.0 x 128&lt;/td&gt;
&lt;td&gt;Octa DDR4-3200&lt;/td&gt;
&lt;/tr&gt;&lt;tr class=&quot;tblEven&quot;&gt;&lt;td&gt;&lt;strong&gt;Intel Xeon Platinum 8180M&lt;/strong&gt;&lt;/td&gt;
&lt;td&gt;$13,011&lt;br/&gt;&lt;/td&gt;
&lt;td&gt;28 / 56&lt;br/&gt;&lt;/td&gt;
&lt;td&gt;205W&lt;/td&gt;
&lt;td&gt;2.50 GHz&lt;/td&gt;
&lt;td&gt;3.80 GHz&lt;/td&gt;
&lt;td&gt;38.5MB&lt;/td&gt;
&lt;td&gt;PCIe 3.0 x 48&lt;/td&gt;
&lt;td&gt;Hexa DDR4-2666&lt;/td&gt;
&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p&gt;ServeTheHome ran Geekbench 4 on the AMD system several times and obtained multi-core scores that vary between 184,000 to 193,000 points. The best run racked in 193,554 points. The highest-ranking Intel system on Geekbench 4 belongs to a Dell PowerEdge R840 equipped with four Intel Xeon Platinum 8180M processors. Therefore, ServeTheHome used the aforementioned system as a point of reference for the comparison.&lt;/p&gt;
&lt;p&gt;&lt;span class=&quot;imgContent imgCenter&quot;&gt;&lt;span class=&quot;imgWrapperOutter&quot;&gt;&lt;span class=&quot;imgWrapperInner&quot;&gt;&lt;span class=&quot;iZoom&quot;&gt;&lt;img class=&quot;lazy&quot; data-src=&quot;https://img.purch.com/epyc-7742-vs-8180m-png/w/755/aHR0cDovL21lZGlhLmJlc3RvZm1pY3JvLmNvbS9FL00vODQ5NDA2L29yaWdpbmFsL0VQWUMtNzc0Mi12cy04MTgwTS5QTkc=&quot; big-src=&quot;https://img.purch.com/epyc-7742-vs-8180m-png/o/aHR0cDovL21lZGlhLmJlc3RvZm1pY3JvLmNvbS9FL00vODQ5NDA2L29yaWdpbmFsL0VQWUMtNzc0Mi12cy04MTgwTS5QTkc=&quot; alt=&quot;Credit: Geekbench&quot; title=&quot;Credit: Geekbench&quot;/&gt;&lt;span class=&quot;imgCaption&quot;&gt;Credit: Geekbench&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;The dual EPYC 7742 system puts in single-and multi-core score of 4,876 and 193,554 points, respectively. The quad Xeon Platinum 8180M system scores 4,700 and 155,050 points in the single-core and multi-core tests, respectively. The AMD system basically outperforms the Intel system by up to 3.74% in single-core workloads and 24.83% in multi-core workloads.&lt;/p&gt;
&lt;p&gt;ServeTheHome notes that it used a reference AMD platform and believes its record will surely be broken when big-name vendors start releasing their dual-socket EPYC 7742 servers. Additionally, ServeTheHome didn't really fool with any tweaks or whatsoever. Therefore, a pair of EPYC 7742 should be able to crack the 200,000 points mark with the right optimizations.&lt;/p&gt;
&lt;p&gt;The Geekbench 4 benchmark holds little to no relevance in the enterprise world. Nevertheless, it gives us a small taste of how AMD's EPYC 7002-series can provide enterprises with more bang for their buck.&lt;/p&gt;
&lt;p&gt;If we do the math, each EPYC 7742 costs $6,950 each Xeon Platinum 8180M goes for $13,011. So two EPYC 7742 cost you $13,900 and four Xeon Platinum 8180M sets you back $52,044. You're getting 24.83% more performance while costing 73.29% less. Besides the very attractive price tag and more cores, the EPYC 7002-series brings other goodies to the table that enterprise users will surely appreciate, such as higher memory capacity and a more generous serving of PCIe bandwidth.&lt;br/&gt;&lt;/p&gt;

&lt;br/&gt;
&lt;/div&gt;
</description>
<pubDate>Mon, 02 Sep 2019 11:36:58 +0000</pubDate>
<dc:creator>rbanffy</dc:creator>
<og:url>https://www.tomshardware.com/news/dual-amd-epyc-7742-vs-quad-intel-xeon-platinum-8180m,40288.html</og:url>
<og:title>Dual AMD EPYC 7742 Crushes Quad Intel Xeon 8180M's In Geekbench 4</og:title>
<og:description>ServeTheHome benchmarks two AMD EPYC 7742 and compares them to four Intel Xeon Platinum 8180M.</og:description>
<og:image>https://img.purch.com/o/aHR0cDovL21lZGlhLmJlc3RvZm1pY3JvLmNvbS9FL0wvODQ5NDA1L29yaWdpbmFsL0FNRC1FUFlDLTc3NDIuanBn</og:image>
<og:type>article</og:type>
<dc:language>en</dc:language>
<dc:format>text/html</dc:format>
<dc:identifier>https://www.tomshardware.com/news/dual-amd-epyc-7742-vs-quad-intel-xeon-platinum-8180m,40288.html</dc:identifier>
</item>
<item>
<title>Bugatti has broken the 300mph barrier</title>
<link>https://www.topgear.com/car-news/bugatti-has-broken-300mph-barrier</link>
<guid isPermaLink="true" >https://www.topgear.com/car-news/bugatti-has-broken-300mph-barrier</guid>
<description>&lt;p&gt;Top Gear can exclusively reveal that Bugatti has smashed through the 300mph barrier. On 2 August 2019, Andy Wallace hit a vmax of 304.77mph in a go-faster Chiron at Ehra-Lessien, becoming the first hypercar to break¬†300mph.&lt;/p&gt;
&lt;p&gt;The velocity is verified by the T√úV ‚Äì Germany‚Äôs Technical Inspection Association ‚Äì meaning Andy and the prototype Chiron supersede previous really, really fast runs from SSC (256.18mph two-way average, 2007), Hennessey (270.49mph two-way average, 2013) and Koenigsegg (284.55 vmax, 277.87 two-way average, 2017) as well as punching through the mythical 300mph¬†target.&lt;/p&gt;
&lt;p&gt;Over the past six months, a team of engineers from Bugatti, Michelin and chassis wizards Dallara set about creating a car that can break the 300mph barrier. And what a car. This is no ordinary Chiron. First, there‚Äôs the way it looks. At 25cm longer, this Chiron has an elegant but menacing presence. Its purposeful intent is amplified by laser-controlled ride height, set significantly lower to reduce drag, giving the impression that the car is melting into the¬†tarmac.&lt;/p&gt;

&lt;p&gt;At the rear, the long tail with its reduced cross section (to aid aero and minimise drag) is punctuated by a pair of over-and-under shotgun tail-pipes (first seen on the &lt;a href=&quot;https://www.topgear.com/car-news/supercars/ps9m-bugatti-centodieci&quot;&gt;Centodieci limited special&lt;/a&gt;). Objectively, these project the exhaust emissions as far from the rear as possible to reduce their effect on drag and aero. Subjectively, they add even more drama and a whole new menace and sense of purpose to the Chiron¬†aesthetic.&lt;/p&gt;
&lt;p&gt;To reduce drag, the rear wing and airbrake have been removed and replaced with a static unit recessed into the tail. Somehow the design team has managed to incorporate the demands for low drag and high-speed stability, while improving aesthetics to the extent that when you look at the regular car, it looks stumpy in¬†comparison.&lt;/p&gt;
&lt;p&gt;‚ÄúThe biggest challenge is to get the overall package right, not only design, not only aerodynamics, not only engine, not only tyres. It‚Äôs to get everything together and working in one car,‚Äù says Frank Heyl, the man with the most outrageous title at Bugatti ‚Äì master of arts, head of exterior¬†design.&lt;/p&gt;

&lt;p&gt;Inside, the high-speed Chiron has been stripped of a passenger seat, replaced with myriad computer systems. There‚Äôs a full roll cage and a safety seat for the driver, and any number of visible and invisible weight-saving measures have been¬†deployed.&lt;/p&gt;
&lt;p&gt;Given speed is driven by two factors ‚Äì aerodynamic efficiency and power ‚Äì the engine powering the Chiron is rather special too. The 8.0-litre, quad-turbo W16 unit, nicknamed Thor, delivers 1,578bhp. In a testament to Bugatti‚Äôs engineering, the gearbox remains standard ‚Äì as does the all-wheel-drive¬†system.&lt;/p&gt;
&lt;p&gt;‚ÄúBugatti has once again shown what it‚Äôs capable of. With this new record of the Chiron we enter again uncharted territory. Never before has a series manufacturer reached this high speed,‚Äù says Stephan Winkelmann, President of Bugatti. ‚ÄúOur goal was to be the first manufacturer ever to reach the magic 300mph mark. We have now achieved this ‚Äì making ourselves, the entire team and myself, incredibly proud.‚Äù With this record, Bugatti will also withdraw from the competition to produce the fastest serial production cars. ‚ÄúWe have shown several times that we build the fastest cars in the world. In future we will focus on other areas,‚Äù says¬†Winkelmann.&lt;/p&gt;
&lt;p&gt;The 300mph project will inevitably result in a production Super Sport version of the Chiron (even if Bugatti refuses to confirm it as yet) and future generations of the Chiron, each improved by the lessons learned breaking the 300mph barrier. But what will this incredible achievement do for the likes of Koenigsegg and Hennessey? Well, we‚Äôll have to wait and see. But there‚Äôs a new watermark for going fast, everybody. And it‚Äôs really bloody¬†fast.&lt;/p&gt;
</description>
<pubDate>Mon, 02 Sep 2019 07:55:54 +0000</pubDate>
<dc:creator>tiernano</dc:creator>
<og:type>article</og:type>
<og:title>Bugatti has broken the 300mph barrier</og:title>
<og:url>https://www.topgear.com/car-news/bugatti-has-broken-300mph-barrier</og:url>
<og:description>Top Gear can exclusively reveal that Bugatti has smashed through the 300mph barrier. On 2 August 2019, Andy Wallace hit a vmax of 304.77mph in a go-faster Chiron at Ehra-Lessien, becoming the first hypercar to break 300mph.</og:description>
<og:image>https://www.topgear.com/sites/default/files/styles/16x9_1280w/public/images/news-article/2019/09/99e383c680dc58b1af30fdb143dd5992/thumb2.jpg?itok=90tBYywF</og:image>
<dc:language>en</dc:language>
<dc:format>text/html</dc:format>
<dc:identifier>https://www.topgear.com/car-news/bugatti-has-broken-300mph-barrier</dc:identifier>
</item>
<item>
<title>Building Interactive SSH Applications</title>
<link>https://drewdevault.com/2019/09/02/Interactive-SSH-programs.html</link>
<guid isPermaLink="true" >https://drewdevault.com/2019/09/02/Interactive-SSH-programs.html</guid>
<description>&lt;p&gt;After the announcement of &lt;a href=&quot;https://drewdevault.com/2019/08/19/Introducing-shell-access-for-builds.html&quot;&gt;shell access for builds.sr.ht jobs&lt;/a&gt;, a few people sent me some questions, wondering how this sort of thing is done. Writing interactive SSH applications is actually pretty easy, but it does require some knowledge of the pieces involved and a little bit of general Unix literacy.&lt;/p&gt;&lt;p&gt;On the server, there are three steps which you can meddle with using OpenSSH: authentication, the shell session, and the command. The shell is pretty easily manipulated. For example, if you set the user‚Äôs login shell to &lt;code class=&quot;highlighter-rouge&quot;&gt;/usr/bin/nethack&lt;/code&gt;, then &lt;a href=&quot;https://www.nethack.org/&quot;&gt;nethack&lt;/a&gt; will run when they log in. Editing this is pretty straightforward, just pop open &lt;code class=&quot;highlighter-rouge&quot;&gt;/etc/passwd&lt;/code&gt; as root and set their shell to your desired binary. If the user SSHes into your server with a TTY allocated (which is done by default), then you‚Äôll be able to run a curses application or something interactive.&lt;/p&gt;
&lt;noscript readability=&quot;4&quot;&gt;
&lt;p&gt;&lt;em&gt;This article includes third-party JavaScript content from asciinema.org, a free- and open-source platform that I trust.&lt;/em&gt;&lt;/p&gt;
&lt;/noscript&gt;
&lt;p&gt;However, a downside to this is that, if you choose a ‚Äúshell‚Äù which does not behave like a shell, it will break when the user passes additional command line arguments, such as &lt;code class=&quot;highlighter-rouge&quot;&gt;ssh user@host ls -a&lt;/code&gt;. To address this, instead of overriding the shell, we can override the &lt;em&gt;command&lt;/em&gt; which is run. The best place to do this is in the user‚Äôs &lt;code class=&quot;highlighter-rouge&quot;&gt;authorized_keys&lt;/code&gt; file. Before each line, you can add options which apply to users who log in with that key. One of these options is the ‚Äúcommand‚Äù option. If you add this to &lt;code class=&quot;highlighter-rouge&quot;&gt;/home/user/.ssh/authorized_keys&lt;/code&gt; instead:&lt;/p&gt;
&lt;div class=&quot;highlighter-rouge&quot; readability=&quot;6&quot;&gt;
&lt;div class=&quot;highlight&quot; readability=&quot;7&quot;&gt;
&lt;pre class=&quot;highlight&quot;&gt;
&lt;code&gt;command=&quot;/usr/bin/nethack&quot; ssh-rsa ... user
&lt;/code&gt;
&lt;/pre&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;p&gt;Then it‚Äôll use the user‚Äôs shell (which should probably be &lt;code class=&quot;highlighter-rouge&quot;&gt;/bin/sh&lt;/code&gt;) to run &lt;code class=&quot;highlighter-rouge&quot;&gt;nethack&lt;/code&gt;, which will work regardless of the command supplied by the user (which is stored into &lt;code class=&quot;highlighter-rouge&quot;&gt;SSH_ORIGINAL_COMMAND&lt;/code&gt; in the environment, should you need it). There are probably some other options you want to set here, as well, for security reasons:&lt;/p&gt;
&lt;div class=&quot;highlighter-rouge&quot; readability=&quot;7&quot;&gt;
&lt;div class=&quot;highlight&quot; readability=&quot;9&quot;&gt;
&lt;pre class=&quot;highlight&quot;&gt;
&lt;code&gt;restrict,pty,command=&quot;...&quot; ssh-rsa ... user
&lt;/code&gt;
&lt;/pre&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;p&gt;The full list of options you can set here is available in the &lt;code class=&quot;highlighter-rouge&quot;&gt;sshd(8)&lt;/code&gt; man page. &lt;code class=&quot;highlighter-rouge&quot;&gt;restrict&lt;/code&gt; just turns off most stuff by default, and &lt;code class=&quot;highlighter-rouge&quot;&gt;pty&lt;/code&gt; explicitly re-enables TTY allocation, so that we can do things like curses. This will work if you want to explicitly authorize specific people, one at a time, in your &lt;code class=&quot;highlighter-rouge&quot;&gt;authorized_keys&lt;/code&gt; file, to use your SSH-driven application. However, there‚Äôs one more place where we can meddle: the &lt;code class=&quot;highlighter-rouge&quot;&gt;AuthorizedKeysCommand&lt;/code&gt; in &lt;code class=&quot;highlighter-rouge&quot;&gt;/etc/ssh/sshd_config&lt;/code&gt;. Instead of having OpenSSH read from the &lt;code class=&quot;highlighter-rouge&quot;&gt;authorized_keys&lt;/code&gt; file in the user‚Äôs home directory, it can execute an arbitrary program and read the &lt;code class=&quot;highlighter-rouge&quot;&gt;authorized_keys&lt;/code&gt; file from its stdout. For example, on Sourcehut we use something like this:&lt;/p&gt;
&lt;div class=&quot;highlighter-rouge&quot; readability=&quot;6&quot;&gt;
&lt;div class=&quot;highlight&quot; readability=&quot;7&quot;&gt;
&lt;pre class=&quot;highlight&quot;&gt;
&lt;code&gt;AuthorizedKeysCommand /usr/bin/gitsrht-dispatch &quot;%u&quot; &quot;%h&quot; &quot;%t&quot; &quot;%k&quot;
AuthorizedKeysUser root
&lt;/code&gt;
&lt;/pre&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;p&gt;Respectively, these format strings will supply the command with the username attempting login, the user‚Äôs home directory, the type of key in use (e.g. &lt;code class=&quot;highlighter-rouge&quot;&gt;ssh-rsa&lt;/code&gt;), and the base64-encoded key itself. More options are available - see &lt;code class=&quot;highlighter-rouge&quot;&gt;TOKENS&lt;/code&gt;, in the &lt;code class=&quot;highlighter-rouge&quot;&gt;sshd_config(8)&lt;/code&gt; man page. The key supplied here can be used to identify the user - on Sourcehut we look up their SSH key in the database. Then you can choose whether or not to admit the user based on any logic of your choosing, and print an appropriate &lt;code class=&quot;highlighter-rouge&quot;&gt;authorized_keys&lt;/code&gt; to stdout. You can also take this opportunity to forward this information along to the command that gets executed, by appending them to the command option or by using the environment options.&lt;/p&gt;
&lt;h2 id=&quot;how-this-works-on-buildssrht&quot;&gt;How this works on builds.sr.ht&lt;/h2&gt;
&lt;p&gt;We use a somewhat complex system for incoming SSH connections, which I won‚Äôt go into here - it‚Äôs only necessary to support multiple SSH applications on the same server, like git.sr.ht and builds.sr.ht. For builds.sr.ht, we accept all connections and authenticate later on. This means our AuthorizedKeysCommand is quite simple:&lt;/p&gt;
&lt;div class=&quot;language-python highlighter-rouge&quot; readability=&quot;8.5&quot;&gt;
&lt;div class=&quot;highlight&quot; readability=&quot;12&quot;&gt;
&lt;pre class=&quot;highlight&quot;&gt;
&lt;code&gt;&lt;span class=&quot;c&quot;&gt;#!/usr/bin/env python3&lt;/span&gt;
&lt;span class=&quot;c&quot;&gt;# We just let everyone in at this stage, authentication is done later on.&lt;/span&gt;
&lt;span class=&quot;kn&quot;&gt;import&lt;/span&gt; &lt;span class=&quot;nn&quot;&gt;sys&lt;/span&gt;
&lt;span class=&quot;n&quot;&gt;key_type&lt;/span&gt; &lt;span class=&quot;o&quot;&gt;=&lt;/span&gt; &lt;span class=&quot;n&quot;&gt;sys&lt;/span&gt;&lt;span class=&quot;o&quot;&gt;.&lt;/span&gt;&lt;span class=&quot;n&quot;&gt;argv&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;[&lt;/span&gt;&lt;span class=&quot;mi&quot;&gt;3&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;]&lt;/span&gt;
&lt;span class=&quot;n&quot;&gt;b64key&lt;/span&gt; &lt;span class=&quot;o&quot;&gt;=&lt;/span&gt; &lt;span class=&quot;n&quot;&gt;sys&lt;/span&gt;&lt;span class=&quot;o&quot;&gt;.&lt;/span&gt;&lt;span class=&quot;n&quot;&gt;argv&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;[&lt;/span&gt;&lt;span class=&quot;mi&quot;&gt;4&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;]&lt;/span&gt;

&lt;span class=&quot;n&quot;&gt;keys&lt;/span&gt; &lt;span class=&quot;o&quot;&gt;=&lt;/span&gt; &lt;span class=&quot;p&quot;&gt;(&lt;/span&gt;&lt;span class=&quot;n&quot;&gt;f&lt;/span&gt;&lt;span class=&quot;s&quot;&gt;&quot;command=&lt;/span&gt;&lt;span class=&quot;se&quot;&gt;\&quot;&lt;/span&gt;&lt;span class=&quot;s&quot;&gt;buildsrht-shell '{b64key}'&lt;/span&gt;&lt;span class=&quot;se&quot;&gt;\&quot;&lt;/span&gt;&lt;span class=&quot;s&quot;&gt;,restrict,pty &quot;&lt;/span&gt; &lt;span class=&quot;o&quot;&gt;+&lt;/span&gt;
    &lt;span class=&quot;n&quot;&gt;f&lt;/span&gt;&lt;span class=&quot;s&quot;&gt;&quot;{key_type} {b64key} somebody&lt;/span&gt;&lt;span class=&quot;se&quot;&gt;\n&lt;/span&gt;&lt;span class=&quot;s&quot;&gt;&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;)&lt;/span&gt;
&lt;span class=&quot;k&quot;&gt;print&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;(&lt;/span&gt;&lt;span class=&quot;n&quot;&gt;keys&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;)&lt;/span&gt;
&lt;span class=&quot;n&quot;&gt;sys&lt;/span&gt;&lt;span class=&quot;o&quot;&gt;.&lt;/span&gt;&lt;span class=&quot;nb&quot;&gt;exit&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;(&lt;/span&gt;&lt;span class=&quot;mi&quot;&gt;0&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;)&lt;/span&gt;
&lt;/code&gt;
&lt;/pre&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;p&gt;The command, &lt;code class=&quot;highlighter-rouge&quot;&gt;buildsrht-shell&lt;/code&gt;, does some more interesting stuff. First, the user is told to connect with a command like &lt;code class=&quot;highlighter-rouge&quot;&gt;ssh builds@buildhost connect &amp;lt;job ID&amp;gt;&lt;/code&gt;, so we use the &lt;code class=&quot;highlighter-rouge&quot;&gt;SSH_ORIGINAL_COMMAND&lt;/code&gt; variable to grab the command line they included:&lt;/p&gt;
&lt;div class=&quot;language-python highlighter-rouge&quot; readability=&quot;7.5&quot;&gt;
&lt;div class=&quot;highlight&quot; readability=&quot;10&quot;&gt;
&lt;pre class=&quot;highlight&quot;&gt;
&lt;code&gt;&lt;span class=&quot;n&quot;&gt;cmd&lt;/span&gt; &lt;span class=&quot;o&quot;&gt;=&lt;/span&gt; &lt;span class=&quot;n&quot;&gt;os&lt;/span&gt;&lt;span class=&quot;o&quot;&gt;.&lt;/span&gt;&lt;span class=&quot;n&quot;&gt;environ&lt;/span&gt;&lt;span class=&quot;o&quot;&gt;.&lt;/span&gt;&lt;span class=&quot;n&quot;&gt;get&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;(&lt;/span&gt;&lt;span class=&quot;s&quot;&gt;&quot;SSH_ORIGINAL_COMMAND&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;)&lt;/span&gt; &lt;span class=&quot;ow&quot;&gt;or&lt;/span&gt; &lt;span class=&quot;s&quot;&gt;&quot;&quot;&lt;/span&gt;
&lt;span class=&quot;n&quot;&gt;cmd&lt;/span&gt; &lt;span class=&quot;o&quot;&gt;=&lt;/span&gt; &lt;span class=&quot;n&quot;&gt;shlex&lt;/span&gt;&lt;span class=&quot;o&quot;&gt;.&lt;/span&gt;&lt;span class=&quot;n&quot;&gt;split&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;(&lt;/span&gt;&lt;span class=&quot;n&quot;&gt;cmd&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;)&lt;/span&gt;
&lt;span class=&quot;k&quot;&gt;if&lt;/span&gt; &lt;span class=&quot;nb&quot;&gt;len&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;(&lt;/span&gt;&lt;span class=&quot;n&quot;&gt;cmd&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;)&lt;/span&gt; &lt;span class=&quot;o&quot;&gt;!=&lt;/span&gt; &lt;span class=&quot;mi&quot;&gt;2&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;:&lt;/span&gt;
    &lt;span class=&quot;n&quot;&gt;fail&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;(&lt;/span&gt;&lt;span class=&quot;s&quot;&gt;&quot;Usage: ssh ... connect &amp;lt;job ID&amp;gt;&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;)&lt;/span&gt;
&lt;span class=&quot;n&quot;&gt;op&lt;/span&gt; &lt;span class=&quot;o&quot;&gt;=&lt;/span&gt; &lt;span class=&quot;n&quot;&gt;cmd&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;[&lt;/span&gt;&lt;span class=&quot;mi&quot;&gt;0&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;]&lt;/span&gt;
&lt;span class=&quot;k&quot;&gt;if&lt;/span&gt; &lt;span class=&quot;n&quot;&gt;op&lt;/span&gt; &lt;span class=&quot;ow&quot;&gt;not&lt;/span&gt; &lt;span class=&quot;ow&quot;&gt;in&lt;/span&gt; &lt;span class=&quot;p&quot;&gt;[&lt;/span&gt;&lt;span class=&quot;s&quot;&gt;&quot;connect&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt; &lt;span class=&quot;s&quot;&gt;&quot;tail&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;]:&lt;/span&gt;
    &lt;span class=&quot;n&quot;&gt;fail&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;(&lt;/span&gt;&lt;span class=&quot;s&quot;&gt;&quot;Usage: ssh ... connect &amp;lt;job ID&amp;gt;&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;)&lt;/span&gt;
&lt;span class=&quot;n&quot;&gt;job_id&lt;/span&gt; &lt;span class=&quot;o&quot;&gt;=&lt;/span&gt; &lt;span class=&quot;nb&quot;&gt;int&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;(&lt;/span&gt;&lt;span class=&quot;n&quot;&gt;cmd&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;[&lt;/span&gt;&lt;span class=&quot;mi&quot;&gt;1&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;])&lt;/span&gt;
&lt;/code&gt;
&lt;/pre&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;p&gt;Then we do some authentication, fetching the job info from the local job runner and checking their key against meta.sr.ht (the authentication service).&lt;/p&gt;
&lt;div class=&quot;language-python highlighter-rouge&quot; readability=&quot;8&quot;&gt;
&lt;div class=&quot;highlight&quot; readability=&quot;11&quot;&gt;
&lt;pre class=&quot;highlight&quot;&gt;
&lt;code&gt;&lt;span class=&quot;n&quot;&gt;b64key&lt;/span&gt; &lt;span class=&quot;o&quot;&gt;=&lt;/span&gt; &lt;span class=&quot;n&quot;&gt;sys&lt;/span&gt;&lt;span class=&quot;o&quot;&gt;.&lt;/span&gt;&lt;span class=&quot;n&quot;&gt;argv&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;[&lt;/span&gt;&lt;span class=&quot;mi&quot;&gt;1&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;]&lt;/span&gt;

&lt;span class=&quot;k&quot;&gt;def&lt;/span&gt; &lt;span class=&quot;nf&quot;&gt;get_info&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;(&lt;/span&gt;&lt;span class=&quot;n&quot;&gt;job_id&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;):&lt;/span&gt;
    &lt;span class=&quot;n&quot;&gt;r&lt;/span&gt; &lt;span class=&quot;o&quot;&gt;=&lt;/span&gt; &lt;span class=&quot;n&quot;&gt;requests&lt;/span&gt;&lt;span class=&quot;o&quot;&gt;.&lt;/span&gt;&lt;span class=&quot;n&quot;&gt;get&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;(&lt;/span&gt;&lt;span class=&quot;n&quot;&gt;f&lt;/span&gt;&lt;span class=&quot;s&quot;&gt;&quot;http://localhost:8080/job/{job_id}/info&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;)&lt;/span&gt;
    &lt;span class=&quot;k&quot;&gt;if&lt;/span&gt; &lt;span class=&quot;n&quot;&gt;r&lt;/span&gt;&lt;span class=&quot;o&quot;&gt;.&lt;/span&gt;&lt;span class=&quot;n&quot;&gt;status_code&lt;/span&gt; &lt;span class=&quot;o&quot;&gt;!=&lt;/span&gt; &lt;span class=&quot;mi&quot;&gt;200&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;:&lt;/span&gt;
        &lt;span class=&quot;k&quot;&gt;return&lt;/span&gt; &lt;span class=&quot;bp&quot;&gt;None&lt;/span&gt;
    &lt;span class=&quot;k&quot;&gt;return&lt;/span&gt; &lt;span class=&quot;n&quot;&gt;r&lt;/span&gt;&lt;span class=&quot;o&quot;&gt;.&lt;/span&gt;&lt;span class=&quot;n&quot;&gt;json&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;()&lt;/span&gt;

&lt;span class=&quot;n&quot;&gt;info&lt;/span&gt; &lt;span class=&quot;o&quot;&gt;=&lt;/span&gt; &lt;span class=&quot;n&quot;&gt;get_info&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;(&lt;/span&gt;&lt;span class=&quot;n&quot;&gt;job_id&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;)&lt;/span&gt;
&lt;span class=&quot;k&quot;&gt;if&lt;/span&gt; &lt;span class=&quot;ow&quot;&gt;not&lt;/span&gt; &lt;span class=&quot;n&quot;&gt;info&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;:&lt;/span&gt;
    &lt;span class=&quot;n&quot;&gt;fail&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;(&lt;/span&gt;&lt;span class=&quot;s&quot;&gt;&quot;No such job found.&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;)&lt;/span&gt;

&lt;span class=&quot;n&quot;&gt;meta_origin&lt;/span&gt; &lt;span class=&quot;o&quot;&gt;=&lt;/span&gt; &lt;span class=&quot;n&quot;&gt;get_origin&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;(&lt;/span&gt;&lt;span class=&quot;s&quot;&gt;&quot;meta.sr.ht&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;)&lt;/span&gt;
&lt;span class=&quot;n&quot;&gt;r&lt;/span&gt; &lt;span class=&quot;o&quot;&gt;=&lt;/span&gt; &lt;span class=&quot;n&quot;&gt;requests&lt;/span&gt;&lt;span class=&quot;o&quot;&gt;.&lt;/span&gt;&lt;span class=&quot;n&quot;&gt;get&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;(&lt;/span&gt;&lt;span class=&quot;n&quot;&gt;f&lt;/span&gt;&lt;span class=&quot;s&quot;&gt;&quot;{meta_origin}/api/ssh-key/{b64key}&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;)&lt;/span&gt;
&lt;span class=&quot;k&quot;&gt;if&lt;/span&gt; &lt;span class=&quot;n&quot;&gt;r&lt;/span&gt;&lt;span class=&quot;o&quot;&gt;.&lt;/span&gt;&lt;span class=&quot;n&quot;&gt;status_code&lt;/span&gt; &lt;span class=&quot;o&quot;&gt;==&lt;/span&gt; &lt;span class=&quot;mi&quot;&gt;200&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;:&lt;/span&gt;
    &lt;span class=&quot;n&quot;&gt;username&lt;/span&gt; &lt;span class=&quot;o&quot;&gt;=&lt;/span&gt; &lt;span class=&quot;n&quot;&gt;r&lt;/span&gt;&lt;span class=&quot;o&quot;&gt;.&lt;/span&gt;&lt;span class=&quot;n&quot;&gt;json&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;()[&lt;/span&gt;&lt;span class=&quot;s&quot;&gt;&quot;owner&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;][&lt;/span&gt;&lt;span class=&quot;s&quot;&gt;&quot;name&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;]&lt;/span&gt;
&lt;span class=&quot;k&quot;&gt;elif&lt;/span&gt; &lt;span class=&quot;n&quot;&gt;r&lt;/span&gt;&lt;span class=&quot;o&quot;&gt;.&lt;/span&gt;&lt;span class=&quot;n&quot;&gt;status_code&lt;/span&gt; &lt;span class=&quot;o&quot;&gt;==&lt;/span&gt; &lt;span class=&quot;mi&quot;&gt;404&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;:&lt;/span&gt;
    &lt;span class=&quot;n&quot;&gt;fail&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;(&lt;/span&gt;&lt;span class=&quot;s&quot;&gt;&quot;We don't recognize your SSH key. Make sure you've added it to &quot;&lt;/span&gt; &lt;span class=&quot;o&quot;&gt;+&lt;/span&gt;
        &lt;span class=&quot;n&quot;&gt;f&lt;/span&gt;&lt;span class=&quot;s&quot;&gt;&quot;your account.&lt;/span&gt;&lt;span class=&quot;se&quot;&gt;\n&lt;/span&gt;&lt;span class=&quot;s&quot;&gt;{get_origin('meta.sr.ht', external=True)}/keys&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;)&lt;/span&gt;
&lt;span class=&quot;k&quot;&gt;else&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;:&lt;/span&gt;
    &lt;span class=&quot;n&quot;&gt;fail&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;(&lt;/span&gt;&lt;span class=&quot;s&quot;&gt;&quot;Temporary authentication failure. Try again later.&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;)&lt;/span&gt;

&lt;span class=&quot;k&quot;&gt;if&lt;/span&gt; &lt;span class=&quot;n&quot;&gt;username&lt;/span&gt; &lt;span class=&quot;o&quot;&gt;!=&lt;/span&gt; &lt;span class=&quot;n&quot;&gt;info&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;[&lt;/span&gt;&lt;span class=&quot;s&quot;&gt;&quot;username&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;]:&lt;/span&gt;
    &lt;span class=&quot;n&quot;&gt;fail&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;(&lt;/span&gt;&lt;span class=&quot;s&quot;&gt;&quot;You are not permitted to connect to this job.&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;)&lt;/span&gt;
&lt;/code&gt;
&lt;/pre&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;p&gt;There are two modes from here on out: connecting and tailing. The former logs into the local build VM, and the latter prints the logs to the terminal. Connecting looks like this:&lt;/p&gt;
&lt;div class=&quot;language-python highlighter-rouge&quot; readability=&quot;15&quot;&gt;
&lt;div class=&quot;highlight&quot; readability=&quot;25&quot;&gt;
&lt;pre class=&quot;highlight&quot;&gt;
&lt;code&gt;&lt;span class=&quot;k&quot;&gt;def&lt;/span&gt; &lt;span class=&quot;nf&quot;&gt;connect&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;(&lt;/span&gt;&lt;span class=&quot;n&quot;&gt;job_id&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt; &lt;span class=&quot;n&quot;&gt;info&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;):&lt;/span&gt;
    &lt;span class=&quot;s&quot;&gt;&quot;&quot;&quot;Opens a shell on the build VM&quot;&quot;&quot;&lt;/span&gt;
    &lt;span class=&quot;n&quot;&gt;limit&lt;/span&gt; &lt;span class=&quot;o&quot;&gt;=&lt;/span&gt; &lt;span class=&quot;n&quot;&gt;naturaltime&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;(&lt;/span&gt;&lt;span class=&quot;n&quot;&gt;datetime&lt;/span&gt;&lt;span class=&quot;o&quot;&gt;.&lt;/span&gt;&lt;span class=&quot;n&quot;&gt;utcnow&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;()&lt;/span&gt; &lt;span class=&quot;o&quot;&gt;-&lt;/span&gt; &lt;span class=&quot;n&quot;&gt;deadline&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;)&lt;/span&gt;
    &lt;span class=&quot;k&quot;&gt;print&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;(&lt;/span&gt;&lt;span class=&quot;n&quot;&gt;f&lt;/span&gt;&lt;span class=&quot;s&quot;&gt;&quot;Your VM will be terminated {limit}, or when you log out.&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;)&lt;/span&gt;
    &lt;span class=&quot;k&quot;&gt;print&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;()&lt;/span&gt;
    &lt;span class=&quot;n&quot;&gt;requests&lt;/span&gt;&lt;span class=&quot;o&quot;&gt;.&lt;/span&gt;&lt;span class=&quot;n&quot;&gt;post&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;(&lt;/span&gt;&lt;span class=&quot;n&quot;&gt;f&lt;/span&gt;&lt;span class=&quot;s&quot;&gt;&quot;http://localhost:8080/job/{job_id}/claim&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;)&lt;/span&gt;
    &lt;span class=&quot;n&quot;&gt;sys&lt;/span&gt;&lt;span class=&quot;o&quot;&gt;.&lt;/span&gt;&lt;span class=&quot;n&quot;&gt;stdout&lt;/span&gt;&lt;span class=&quot;o&quot;&gt;.&lt;/span&gt;&lt;span class=&quot;n&quot;&gt;flush&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;()&lt;/span&gt;
    &lt;span class=&quot;n&quot;&gt;sys&lt;/span&gt;&lt;span class=&quot;o&quot;&gt;.&lt;/span&gt;&lt;span class=&quot;n&quot;&gt;stderr&lt;/span&gt;&lt;span class=&quot;o&quot;&gt;.&lt;/span&gt;&lt;span class=&quot;n&quot;&gt;flush&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;()&lt;/span&gt;
    &lt;span class=&quot;n&quot;&gt;tty&lt;/span&gt; &lt;span class=&quot;o&quot;&gt;=&lt;/span&gt; &lt;span class=&quot;n&quot;&gt;os&lt;/span&gt;&lt;span class=&quot;o&quot;&gt;.&lt;/span&gt;&lt;span class=&quot;nb&quot;&gt;open&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;(&lt;/span&gt;&lt;span class=&quot;s&quot;&gt;&quot;/dev/tty&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt; &lt;span class=&quot;n&quot;&gt;os&lt;/span&gt;&lt;span class=&quot;o&quot;&gt;.&lt;/span&gt;&lt;span class=&quot;n&quot;&gt;O_RDWR&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;)&lt;/span&gt;
    &lt;span class=&quot;n&quot;&gt;os&lt;/span&gt;&lt;span class=&quot;o&quot;&gt;.&lt;/span&gt;&lt;span class=&quot;n&quot;&gt;dup2&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;(&lt;/span&gt;&lt;span class=&quot;mi&quot;&gt;0&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt; &lt;span class=&quot;n&quot;&gt;tty&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;)&lt;/span&gt;
    &lt;span class=&quot;n&quot;&gt;subprocess&lt;/span&gt;&lt;span class=&quot;o&quot;&gt;.&lt;/span&gt;&lt;span class=&quot;n&quot;&gt;call&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;([&lt;/span&gt;
        &lt;span class=&quot;s&quot;&gt;&quot;ssh&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt; &lt;span class=&quot;s&quot;&gt;&quot;-qt&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;
        &lt;span class=&quot;s&quot;&gt;&quot;-p&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt; &lt;span class=&quot;nb&quot;&gt;str&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;(&lt;/span&gt;&lt;span class=&quot;n&quot;&gt;info&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;[&lt;/span&gt;&lt;span class=&quot;s&quot;&gt;&quot;port&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;]),&lt;/span&gt;
        &lt;span class=&quot;s&quot;&gt;&quot;-o&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt; &lt;span class=&quot;s&quot;&gt;&quot;UserKnownHostsFile=/dev/null&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;
        &lt;span class=&quot;s&quot;&gt;&quot;-o&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt; &lt;span class=&quot;s&quot;&gt;&quot;StrictHostKeyChecking=no&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;
        &lt;span class=&quot;s&quot;&gt;&quot;-o&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt; &lt;span class=&quot;s&quot;&gt;&quot;LogLevel=quiet&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;
        &lt;span class=&quot;s&quot;&gt;&quot;build@localhost&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt; &lt;span class=&quot;s&quot;&gt;&quot;bash&quot;&lt;/span&gt;
    &lt;span class=&quot;p&quot;&gt;])&lt;/span&gt;
    &lt;span class=&quot;n&quot;&gt;requests&lt;/span&gt;&lt;span class=&quot;o&quot;&gt;.&lt;/span&gt;&lt;span class=&quot;n&quot;&gt;post&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;(&lt;/span&gt;&lt;span class=&quot;n&quot;&gt;f&lt;/span&gt;&lt;span class=&quot;s&quot;&gt;&quot;http://localhost:8080/job/{job_id}/terminate&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;)&lt;/span&gt;
&lt;/code&gt;
&lt;/pre&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;p&gt;This is pretty self explanatory, except perhaps for the dup2 - we just open &lt;code class=&quot;highlighter-rouge&quot;&gt;/dev/tty&lt;/code&gt; and make &lt;code class=&quot;highlighter-rouge&quot;&gt;stdin&lt;/code&gt; a copy of it. Some interactive applications misbehave if stdin is not a tty, and this mimics the normal behavior of SSH. Then we log into the build VM over SSH, which with stdin/stdout/stderr rigged up like so will allow the user to interact with the build VM. After that completes, we terminate the VM.&lt;/p&gt;
&lt;p&gt;This is mostly plumbing work that just serves to get the user from point A to point B. The tail functionality is more application-like:&lt;/p&gt;
&lt;div class=&quot;language-python highlighter-rouge&quot; readability=&quot;13.5&quot;&gt;
&lt;div class=&quot;highlight&quot; readability=&quot;22&quot;&gt;
&lt;pre class=&quot;highlight&quot;&gt;
&lt;code&gt;&lt;span class=&quot;k&quot;&gt;def&lt;/span&gt; &lt;span class=&quot;nf&quot;&gt;tail&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;(&lt;/span&gt;&lt;span class=&quot;n&quot;&gt;job_id&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt; &lt;span class=&quot;n&quot;&gt;info&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;):&lt;/span&gt;
    &lt;span class=&quot;s&quot;&gt;&quot;&quot;&quot;Tails the build logs to stdout&quot;&quot;&quot;&lt;/span&gt;
    &lt;span class=&quot;n&quot;&gt;logs&lt;/span&gt; &lt;span class=&quot;o&quot;&gt;=&lt;/span&gt; &lt;span class=&quot;n&quot;&gt;os&lt;/span&gt;&lt;span class=&quot;o&quot;&gt;.&lt;/span&gt;&lt;span class=&quot;n&quot;&gt;path&lt;/span&gt;&lt;span class=&quot;o&quot;&gt;.&lt;/span&gt;&lt;span class=&quot;n&quot;&gt;join&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;(&lt;/span&gt;&lt;span class=&quot;n&quot;&gt;cfg&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;(&lt;/span&gt;&lt;span class=&quot;s&quot;&gt;&quot;builds.sr.ht::worker&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt; &lt;span class=&quot;s&quot;&gt;&quot;buildlogs&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;),&lt;/span&gt; &lt;span class=&quot;nb&quot;&gt;str&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;(&lt;/span&gt;&lt;span class=&quot;n&quot;&gt;job_id&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;))&lt;/span&gt;
    &lt;span class=&quot;n&quot;&gt;p&lt;/span&gt; &lt;span class=&quot;o&quot;&gt;=&lt;/span&gt; &lt;span class=&quot;n&quot;&gt;subprocess&lt;/span&gt;&lt;span class=&quot;o&quot;&gt;.&lt;/span&gt;&lt;span class=&quot;n&quot;&gt;Popen&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;([&lt;/span&gt;&lt;span class=&quot;s&quot;&gt;&quot;tail&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt; &lt;span class=&quot;s&quot;&gt;&quot;-f&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt; &lt;span class=&quot;n&quot;&gt;os&lt;/span&gt;&lt;span class=&quot;o&quot;&gt;.&lt;/span&gt;&lt;span class=&quot;n&quot;&gt;path&lt;/span&gt;&lt;span class=&quot;o&quot;&gt;.&lt;/span&gt;&lt;span class=&quot;n&quot;&gt;join&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;(&lt;/span&gt;&lt;span class=&quot;n&quot;&gt;logs&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt; &lt;span class=&quot;s&quot;&gt;&quot;log&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;)])&lt;/span&gt;
    &lt;span class=&quot;n&quot;&gt;tasks&lt;/span&gt; &lt;span class=&quot;o&quot;&gt;=&lt;/span&gt; &lt;span class=&quot;nb&quot;&gt;set&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;()&lt;/span&gt;
    &lt;span class=&quot;n&quot;&gt;procs&lt;/span&gt; &lt;span class=&quot;o&quot;&gt;=&lt;/span&gt; &lt;span class=&quot;p&quot;&gt;[&lt;/span&gt;&lt;span class=&quot;n&quot;&gt;p&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;]&lt;/span&gt;
    &lt;span class=&quot;c&quot;&gt;# holy bejeezus this is hacky&lt;/span&gt;
    &lt;span class=&quot;k&quot;&gt;while&lt;/span&gt; &lt;span class=&quot;bp&quot;&gt;True&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;:&lt;/span&gt;
        &lt;span class=&quot;k&quot;&gt;for&lt;/span&gt; &lt;span class=&quot;n&quot;&gt;task&lt;/span&gt; &lt;span class=&quot;ow&quot;&gt;in&lt;/span&gt; &lt;span class=&quot;n&quot;&gt;manifest&lt;/span&gt;&lt;span class=&quot;o&quot;&gt;.&lt;/span&gt;&lt;span class=&quot;n&quot;&gt;tasks&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;:&lt;/span&gt;
            &lt;span class=&quot;k&quot;&gt;if&lt;/span&gt; &lt;span class=&quot;n&quot;&gt;task&lt;/span&gt;&lt;span class=&quot;o&quot;&gt;.&lt;/span&gt;&lt;span class=&quot;n&quot;&gt;name&lt;/span&gt; &lt;span class=&quot;ow&quot;&gt;in&lt;/span&gt; &lt;span class=&quot;n&quot;&gt;tasks&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;:&lt;/span&gt;
                &lt;span class=&quot;k&quot;&gt;continue&lt;/span&gt;
            &lt;span class=&quot;n&quot;&gt;path&lt;/span&gt; &lt;span class=&quot;o&quot;&gt;=&lt;/span&gt; &lt;span class=&quot;n&quot;&gt;os&lt;/span&gt;&lt;span class=&quot;o&quot;&gt;.&lt;/span&gt;&lt;span class=&quot;n&quot;&gt;path&lt;/span&gt;&lt;span class=&quot;o&quot;&gt;.&lt;/span&gt;&lt;span class=&quot;n&quot;&gt;join&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;(&lt;/span&gt;&lt;span class=&quot;n&quot;&gt;logs&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt; &lt;span class=&quot;n&quot;&gt;task&lt;/span&gt;&lt;span class=&quot;o&quot;&gt;.&lt;/span&gt;&lt;span class=&quot;n&quot;&gt;name&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt; &lt;span class=&quot;s&quot;&gt;&quot;log&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;)&lt;/span&gt;
            &lt;span class=&quot;k&quot;&gt;if&lt;/span&gt; &lt;span class=&quot;n&quot;&gt;os&lt;/span&gt;&lt;span class=&quot;o&quot;&gt;.&lt;/span&gt;&lt;span class=&quot;n&quot;&gt;path&lt;/span&gt;&lt;span class=&quot;o&quot;&gt;.&lt;/span&gt;&lt;span class=&quot;n&quot;&gt;exists&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;(&lt;/span&gt;&lt;span class=&quot;n&quot;&gt;path&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;):&lt;/span&gt;
                &lt;span class=&quot;n&quot;&gt;procs&lt;/span&gt;&lt;span class=&quot;o&quot;&gt;.&lt;/span&gt;&lt;span class=&quot;n&quot;&gt;append&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;(&lt;/span&gt;&lt;span class=&quot;n&quot;&gt;subprocess&lt;/span&gt;&lt;span class=&quot;o&quot;&gt;.&lt;/span&gt;&lt;span class=&quot;n&quot;&gt;Popen&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;(&lt;/span&gt;
                    &lt;span class=&quot;n&quot;&gt;f&lt;/span&gt;&lt;span class=&quot;s&quot;&gt;&quot;tail -f {shlex.quote(path)} | &quot;&lt;/span&gt; &lt;span class=&quot;o&quot;&gt;+&lt;/span&gt;
                    &lt;span class=&quot;s&quot;&gt;&quot;awk '{ print &lt;/span&gt;&lt;span class=&quot;se&quot;&gt;\&quot;&lt;/span&gt;&lt;span class=&quot;s&quot;&gt;[&quot;&lt;/span&gt; &lt;span class=&quot;o&quot;&gt;+&lt;/span&gt; &lt;span class=&quot;n&quot;&gt;shlex&lt;/span&gt;&lt;span class=&quot;o&quot;&gt;.&lt;/span&gt;&lt;span class=&quot;n&quot;&gt;quote&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;(&lt;/span&gt;&lt;span class=&quot;n&quot;&gt;task&lt;/span&gt;&lt;span class=&quot;o&quot;&gt;.&lt;/span&gt;&lt;span class=&quot;n&quot;&gt;name&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;)&lt;/span&gt; &lt;span class=&quot;o&quot;&gt;+&lt;/span&gt; &lt;span class=&quot;s&quot;&gt;&quot;] &lt;/span&gt;&lt;span class=&quot;se&quot;&gt;\&quot;&lt;/span&gt;&lt;span class=&quot;s&quot;&gt; $0 }'&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt;
                    &lt;span class=&quot;n&quot;&gt;shell&lt;/span&gt;&lt;span class=&quot;o&quot;&gt;=&lt;/span&gt;&lt;span class=&quot;bp&quot;&gt;True&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;))&lt;/span&gt;
                &lt;span class=&quot;n&quot;&gt;tasks&lt;/span&gt;&lt;span class=&quot;o&quot;&gt;.&lt;/span&gt;&lt;span class=&quot;n&quot;&gt;update&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;({&lt;/span&gt; &lt;span class=&quot;n&quot;&gt;task&lt;/span&gt;&lt;span class=&quot;o&quot;&gt;.&lt;/span&gt;&lt;span class=&quot;n&quot;&gt;name&lt;/span&gt; &lt;span class=&quot;p&quot;&gt;})&lt;/span&gt;
        &lt;span class=&quot;n&quot;&gt;info&lt;/span&gt; &lt;span class=&quot;o&quot;&gt;=&lt;/span&gt; &lt;span class=&quot;n&quot;&gt;get_info&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;(&lt;/span&gt;&lt;span class=&quot;n&quot;&gt;job_id&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;)&lt;/span&gt;
        &lt;span class=&quot;k&quot;&gt;if&lt;/span&gt; &lt;span class=&quot;ow&quot;&gt;not&lt;/span&gt; &lt;span class=&quot;n&quot;&gt;info&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;:&lt;/span&gt;
            &lt;span class=&quot;k&quot;&gt;break&lt;/span&gt;
        &lt;span class=&quot;k&quot;&gt;if&lt;/span&gt; &lt;span class=&quot;n&quot;&gt;info&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;[&lt;/span&gt;&lt;span class=&quot;s&quot;&gt;&quot;task&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;]&lt;/span&gt; &lt;span class=&quot;o&quot;&gt;==&lt;/span&gt; &lt;span class=&quot;n&quot;&gt;info&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;[&lt;/span&gt;&lt;span class=&quot;s&quot;&gt;&quot;tasks&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;]:&lt;/span&gt;
            &lt;span class=&quot;k&quot;&gt;for&lt;/span&gt; &lt;span class=&quot;n&quot;&gt;p&lt;/span&gt; &lt;span class=&quot;ow&quot;&gt;in&lt;/span&gt; &lt;span class=&quot;n&quot;&gt;procs&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;:&lt;/span&gt;
                &lt;span class=&quot;n&quot;&gt;p&lt;/span&gt;&lt;span class=&quot;o&quot;&gt;.&lt;/span&gt;&lt;span class=&quot;n&quot;&gt;kill&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;()&lt;/span&gt;
            &lt;span class=&quot;k&quot;&gt;break&lt;/span&gt;
        &lt;span class=&quot;n&quot;&gt;time&lt;/span&gt;&lt;span class=&quot;o&quot;&gt;.&lt;/span&gt;&lt;span class=&quot;n&quot;&gt;sleep&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;(&lt;/span&gt;&lt;span class=&quot;mi&quot;&gt;3&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;)&lt;/span&gt;

&lt;span class=&quot;k&quot;&gt;if&lt;/span&gt; &lt;span class=&quot;n&quot;&gt;op&lt;/span&gt; &lt;span class=&quot;o&quot;&gt;==&lt;/span&gt; &lt;span class=&quot;s&quot;&gt;&quot;connect&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;:&lt;/span&gt;
    &lt;span class=&quot;k&quot;&gt;if&lt;/span&gt; &lt;span class=&quot;n&quot;&gt;info&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;[&lt;/span&gt;&lt;span class=&quot;s&quot;&gt;&quot;task&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;]&lt;/span&gt; &lt;span class=&quot;o&quot;&gt;!=&lt;/span&gt; &lt;span class=&quot;n&quot;&gt;info&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;[&lt;/span&gt;&lt;span class=&quot;s&quot;&gt;&quot;tasks&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;]&lt;/span&gt; &lt;span class=&quot;ow&quot;&gt;and&lt;/span&gt; &lt;span class=&quot;n&quot;&gt;info&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;[&lt;/span&gt;&lt;span class=&quot;s&quot;&gt;&quot;status&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;]&lt;/span&gt; &lt;span class=&quot;o&quot;&gt;==&lt;/span&gt; &lt;span class=&quot;s&quot;&gt;&quot;running&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;:&lt;/span&gt;
        &lt;span class=&quot;n&quot;&gt;tail&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;(&lt;/span&gt;&lt;span class=&quot;n&quot;&gt;job_id&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt; &lt;span class=&quot;n&quot;&gt;info&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;)&lt;/span&gt;
    &lt;span class=&quot;n&quot;&gt;connect&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;(&lt;/span&gt;&lt;span class=&quot;n&quot;&gt;job_id&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt; &lt;span class=&quot;n&quot;&gt;info&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;)&lt;/span&gt;
&lt;span class=&quot;k&quot;&gt;elif&lt;/span&gt; &lt;span class=&quot;n&quot;&gt;op&lt;/span&gt; &lt;span class=&quot;o&quot;&gt;==&lt;/span&gt; &lt;span class=&quot;s&quot;&gt;&quot;tail&quot;&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;:&lt;/span&gt;
    &lt;span class=&quot;n&quot;&gt;tail&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;(&lt;/span&gt;&lt;span class=&quot;n&quot;&gt;job_id&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;,&lt;/span&gt; &lt;span class=&quot;n&quot;&gt;info&lt;/span&gt;&lt;span class=&quot;p&quot;&gt;)&lt;/span&gt;
&lt;/code&gt;
&lt;/pre&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;p&gt;This‚Ä¶ I‚Ä¶ let‚Äôs just pretend you never saw this. And that‚Äôs how SSH access to builds.sr.ht works!&lt;/p&gt;
&lt;p class=&quot;text-muted&quot;&gt;Have a comment on one of my posts? Start a discussion in my &lt;a href=&quot;https://lists.sr.ht/~sircmpwn/public-inbox&quot;&gt;public inbox&lt;/a&gt; by sending an email to &lt;a href=&quot;mailto:~sircmpwn/public-inbox@lists.sr.ht?Subject=Re%3A%20Building%20interactive%20SSH%20applications&quot;&gt;~sircmpwn/public-inbox@lists.sr.ht&lt;/a&gt; &lt;small&gt;[&lt;a href=&quot;https://man.sr.ht/lists.sr.ht/etiquette.md&quot;&gt;mailing list etiquette&lt;/a&gt;]&lt;/small&gt;&lt;/p&gt;
&lt;hr/&gt;&lt;section class=&quot;webring&quot;&gt;&lt;h3&gt;Articles from blogs I follow around the net&lt;/h3&gt;
&lt;section class=&quot;articles&quot; readability=&quot;28.768556701031&quot;&gt;&lt;div class=&quot;article&quot; readability=&quot;28.421052631579&quot;&gt;
&lt;h4 class=&quot;title&quot;&gt;&lt;a href=&quot;https://blog.golang.org/module-mirror-launch&quot; target=&quot;_blank&quot; rel=&quot;noopener&quot;&gt;Module Mirror and Checksum Database Launched&lt;/a&gt;&lt;/h4&gt;
&lt;p class=&quot;summary&quot;&gt;We are excited to share that our module mirror, index, and checksum database are now production ready! The go command will use the module mirror and checksum database by default for Go 1.13 module users. See proxy.golang.org/privacy for privacy information abo‚Ä¶&lt;/p&gt;
&lt;small class=&quot;source&quot;&gt;via &lt;a href=&quot;https://blog.golang.org/feed.atom&quot;&gt;The Go Programming Language Blog&lt;/a&gt;&lt;/small&gt; &lt;small class=&quot;date&quot;&gt;August 29, 2019&lt;/small&gt;&lt;/div&gt;
&lt;div class=&quot;article&quot; readability=&quot;30.415335463259&quot;&gt;
&lt;h4 class=&quot;title&quot;&gt;&lt;a href=&quot;https://os.phil-opp.com/status-update/2019-08-02/&quot; target=&quot;_blank&quot; rel=&quot;noopener&quot;&gt;Updates in July 2019&lt;/a&gt;&lt;/h4&gt;
&lt;p class=&quot;summary&quot;&gt;This post gives an overview of the recent updates to the Writing an OS in Rust blog and the used libraries and tools. Since I'm still very busy with my master thesis, I haven't had the time to work on a new post. But there were quite a few maintena‚Ä¶&lt;/p&gt;
&lt;small class=&quot;source&quot;&gt;via &lt;a href=&quot;https://os.phil-opp.com&quot;&gt;Writing an OS in Rust&lt;/a&gt;&lt;/small&gt; &lt;small class=&quot;date&quot;&gt;August 2, 2019&lt;/small&gt;&lt;/div&gt;
&lt;div class=&quot;article&quot; readability=&quot;33.551020408163&quot;&gt;
&lt;h4 class=&quot;title&quot;&gt;&lt;a href=&quot;https://danluu.com/risc-definition/&quot; target=&quot;_blank&quot; rel=&quot;noopener&quot;&gt;What is RISC?&lt;/a&gt;&lt;/h4&gt;
&lt;p class=&quot;summary&quot;&gt;This is an archive of a series of comp.arch USENET posts by John Mashey in the early to mid 90s, on the defnition of reduced instruction set computer (RISC). Contrary to popular belief, RISC isn't about the number of instructions! This is archived her‚Ä¶&lt;/p&gt;
&lt;small class=&quot;source&quot;&gt;via &lt;a href=&quot;https://danluu.com/atom/index.xml&quot;&gt;Dan Luu&lt;/a&gt;&lt;/small&gt; &lt;small class=&quot;date&quot;&gt;July 29, 2019&lt;/small&gt;&lt;/div&gt;
&lt;/section&gt;&lt;p class=&quot;attribution&quot;&gt;Generated by &lt;a href=&quot;https://git.sr.ht/~sircmpwn/openring&quot;&gt;openring&lt;/a&gt;&lt;/p&gt;
&lt;/section&gt;</description>
<pubDate>Mon, 02 Sep 2019 07:28:52 +0000</pubDate>
<dc:creator>stargrave</dc:creator>
<og:title>Building interactive SSH applications</og:title>
<og:description>After the announcement of shell access for builds.sr.ht jobs, a few people sent me some questions, wondering how this sort of thing is done. Writing interactive SSH applications is actually pretty easy, but it does require some knowledge of the pieces involved and a little bit of general Unix literacy.</og:description>
<og:type>article</og:type>
<dc:format>text/html</dc:format>
<dc:identifier>https://drewdevault.com/2019/09/02/Interactive-SSH-programs.html</dc:identifier>
</item>
<item>
<title>A guide to Oauth2</title>
<link>https://milapneupane.com.np/2019/09/02/a-complete-guide-to-oauth2-protocol/</link>
<guid isPermaLink="true" >https://milapneupane.com.np/2019/09/02/a-complete-guide-to-oauth2-protocol/</guid>
<description>&lt;ins class=&quot;adsbygoogle&quot; data-ad-client=&quot;ca-pub-4292778843837836&quot; data-ad-slot=&quot;3217464829&quot; data-ad-format=&quot;auto&quot; data-full-width-responsive=&quot;true&quot;/&gt; &lt;p&gt;When we visit most of the site these days, we have seen a screen that says log in with Facebook, Twitter, GitHub, Google, and many more. It is a fairly common thing on the internet. What this does is take your current account information from one of these providers and use it to signup. This makes it a lot easier to signup as a user because we do not need to add our profile information such as our picture, name, or email. We all have used these as a user to sign up and also as a developer to integrate these services into our application.&lt;/p&gt;
&lt;p&gt;The one thing that is common among all these service providers like facebook and google is that they use the same protocol, OAuth2 protocol and OpenID connect. Oauth2 protocol was designed to solve the delegation problem. OpenID is a protocol on top of Oauth2 for authentication.&lt;/p&gt;
&lt;h3&gt;The delegation problem&lt;/h3&gt;
&lt;p&gt;Let us take a scenario where you want to create a new account in skype. You join skype, but you do not have any contacts there yet. You used a Gmail account to signup your account. You want to add all your contacts in Gmail who are in skype. In this scenario, skype will need to get access to your Gmail contacts and recommend you the contacts who are in skype.¬†&lt;/p&gt;
&lt;p&gt;The simple solution to this would be to provide Skype, your Gmail account password. Skype can access your account and recommend you the contacts.¬†&lt;/p&gt;
&lt;p&gt;There are a few problems with this approach:&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;You have no mechanism to revoke the access&lt;/li&gt;
&lt;li&gt;Even though it needs access for a couple of minutes you cannot limit the duration of access.&lt;/li&gt;
&lt;li&gt;You cannot provide only read access to the contacts. You are giving all read/write access. With this skype can write/read your email and do everything that you can do.&lt;/li&gt;
&lt;li&gt;There is no mechanism to know who accessed your account.&lt;/li&gt;
&lt;/ol&gt;&lt;h3&gt;How Oauth2 solves the delegation problem&lt;/h3&gt;
&lt;p&gt;Oauth2 protocol was designed as an industry pattern to solve the delegation problem. Oauth2 protocol provides a secure resource delegation between services.¬†&lt;/p&gt;
&lt;p&gt;Let us use the same Skype-Gmail example to explain the solution. There are four different roles:&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;Resource owner&lt;/li&gt;
&lt;li&gt;Client&lt;/li&gt;
&lt;li&gt;Resource-Server&lt;/li&gt;
&lt;li&gt;Authorization-Server&lt;/li&gt;
&lt;/ol&gt;&lt;p&gt;The&lt;strong&gt;¬†resource owner&lt;/strong&gt;¬†is the actual owner of the resource. In our example, the end-users login into the skype is the owner.&lt;/p&gt;
&lt;p&gt;The server which wants to access data is called a¬†&lt;strong&gt;client-server&lt;/strong&gt;. In our case, Skype is a client-server.&lt;/p&gt;
&lt;p&gt;The¬†&lt;strong&gt;resource-server&lt;/strong&gt;¬†provides the resource client wants to access. Here, the resource server is Gmail. The resource-server has details about the&lt;em&gt;¬†‚Äòcontacts‚Äô&lt;/em&gt;¬†resource.&lt;/p&gt;
&lt;p&gt;The¬†&lt;strong&gt;authorization-server&lt;/strong&gt;¬†provides the client-server access to the resource on the resource server.&lt;/p&gt;
&lt;p&gt;Let us look into how there 4 roles interact while granting resource access. Here, the¬†&lt;strong&gt;Resource owner&lt;/strong&gt;(we) wants to provide the¬†&lt;strong&gt;Client&lt;/strong&gt;(Skpye), access to the¬†&lt;strong&gt;resource-server&lt;/strong&gt;(Gmail contacts).&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;The client (Skype) requests authorization from the resource owner.¬†&lt;/li&gt;
&lt;li&gt;The client requests the authorization server for a token, based on the grant flow.&lt;/li&gt;
&lt;li&gt;The authorization server validates the grant and the client and provides the access token&lt;/li&gt;
&lt;li&gt;The client uses this access token to access the resource(Gmail contacts)&lt;/li&gt;
&lt;/ol&gt;&lt;img src=&quot;https://milapneupane.com.np/wp-content/uploads/2019/08/Untitled-Diagram.jpg&quot; alt=&quot;Oauth2 Flow diagram&quot; class=&quot;wp-image-145&quot; srcset=&quot;https://milapneupane.com.np/wp-content/uploads/2019/08/Untitled-Diagram.jpg 590w, https://milapneupane.com.np/wp-content/uploads/2019/08/Untitled-Diagram-300x125.jpg 300w&quot; sizes=&quot;(max-width: 590px) 100vw, 590px&quot;/&gt;&lt;em&gt;Diagram: Oauth2 Grant Flow&lt;/em&gt;
&lt;h3&gt;Different Oauth2 grants:&lt;/h3&gt;
&lt;p&gt;Oauth2 provides different grant flows for different use cases. Let us take a look into the details of each auth flow.&lt;/p&gt;
&lt;h3&gt;Code grant&lt;/h3&gt;
&lt;p&gt;Code grant flow is the most used auth flow for public clients to exchange the authorization code with a token. The resource owner wants to grant access to a resource to a client. In this case, the client redirects the user to the login server. Here the user is authenticated and redirected back to the client with an authorization code. This code can be used by the client to exchange it with a token.&lt;/p&gt;
&lt;p&gt;Let us look at the Skype-Gmail example here as well:&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;The client(Skype) requests authorization from the resource owner&lt;/li&gt;
&lt;li&gt;The resource owner is redirected to the authorization server with a Client ID, redirect URL and scope of access.&lt;/li&gt;
&lt;li&gt;The authorization server authenticates the resource owner and redirects to the provided redirect URL from step 2. It also validates if the Client ID provided in step 2 is valid.&lt;/li&gt;
&lt;li&gt;In the client, the authorization code provided by the authorization server is used to exchange it with the authorization code. In this phase, the client provides a client secret. The authorization server validates the client‚Äôs secret.&lt;/li&gt;
&lt;/ol&gt;&lt;p&gt;The code should be invalidated to protect from repetitive token fetch.&lt;/p&gt;
&lt;p&gt;The code should not be valid for a long duration and should expire after a few minutes.&lt;/p&gt;
&lt;p&gt;While a client requests code a state parameter is generated in the client and send to the auth server. The auth server redirects the user to the redirect URL with the same state. This state is validated by the client to protect against XSRF.&lt;/p&gt;
&lt;p&gt;There are two API calls needed for the steps above.&lt;/p&gt;
&lt;h4&gt;Get Authorization Code¬†&lt;/h4&gt;
&lt;pre class=&quot;wp-block-preformatted&quot;&gt;
&lt;strong&gt;URL:&lt;/strong&gt; https://auth-server.com/auth&lt;br/&gt;&lt;strong&gt;request params:&lt;/strong&gt;&lt;br/&gt;response_type=code&lt;br/&gt;client_id=29352915982374239857&lt;br/&gt;redirect_uri=https://client.com/redirect&lt;br/&gt;scope=create+delete&lt;br/&gt;state=xcoiv98y2kd22vusuye3kch
&lt;/pre&gt;
&lt;p&gt;With the above request, code is returned in response to the provided redirect URL.&lt;/p&gt;
&lt;h4&gt;Exchange Code for a Token&lt;/h4&gt;
&lt;pre class=&quot;wp-block-preformatted&quot;&gt;
&lt;strong&gt;URL&lt;/strong&gt;: https://auth-server.com/token&lt;br/&gt;&lt;strong&gt;request params:&lt;/strong&gt;&lt;br/&gt;code: nao1n3f&lt;br/&gt;grant_type: authorization_code&lt;br/&gt;client_id: 29352915982374239857&lt;br/&gt;client_secret: uf1ie98f2kda2vu25uye3k1h
&lt;/pre&gt;
&lt;p&gt;The response of the API will provide a token:&lt;/p&gt;
&lt;pre class=&quot;wp-block-preformatted&quot;&gt;
{&lt;br/&gt;&quot;access_token&quot;:&quot;K1Z04lLdZ1S0pIMF09DI1FTZjJ1jmOO06&quot;,&lt;br/&gt;&quot;token_type&quot;:&quot;bearer&quot;,&lt;br/&gt;&quot;expires_in&quot;:3600,&lt;br/&gt;&quot;refresh_token&quot;:&quot;IzH6bFh6laf6gQ6TgA3sj19mfgA5egZx9a&quot;,&lt;br/&gt;&quot;scope&quot;:&quot;create delete&quot;&lt;br/&gt;}
&lt;/pre&gt;
&lt;p&gt;The client can use the ‚Äú&lt;em&gt;access_token‚Äù&lt;/em&gt;¬†to access the resource.&lt;/p&gt;
&lt;h3&gt;Refresh token&lt;/h3&gt;
&lt;p&gt;The access token provided by any other grant flow has an expiration time. The client can use the refresh token as a grant to fetch the access token after the access token is expired.&lt;/p&gt;
&lt;p&gt;A refresh token generally has a longer expiry duration. With the refresh token, the client can get the access token without reauthorization from the resource owner.&lt;/p&gt;
&lt;p&gt;The client needs to provide refresh_token, client_id and client_secret while using this flow.¬†&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;The client tries to access the resource and get a response that the token is expired.&lt;/li&gt;
&lt;li&gt;The client uses the existing refresh token and requests the auth server for a new token.&lt;/li&gt;
&lt;li&gt;Auth server validates the refresh token and response with a new access token.&lt;/li&gt;
&lt;li&gt;The client uses this new token to access the resource&lt;/li&gt;
&lt;/ol&gt;&lt;pre class=&quot;wp-block-preformatted&quot;&gt;
&lt;strong&gt;URL&lt;/strong&gt;: https://auth-server.com/token&lt;br/&gt;&lt;strong&gt;request params:&lt;/strong&gt;&lt;br/&gt;grant_type: refresh_token&lt;br/&gt;client_id: 29352915982374239857&lt;br/&gt;client_secret: uf1ie98f2kda2vu25uye3k1h
&lt;/pre&gt;
&lt;p&gt;The response of API is the same as the access token.&lt;/p&gt;
&lt;h3&gt;Client Credential grant&lt;/h3&gt;
&lt;p&gt;This auth flow is used to grant the token outside the context of a user. The trusted client can use this to access resources that are not related to a user.¬†&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;Client provides client id and client secret to auth server for an access token&lt;/li&gt;
&lt;li&gt;Auth server validates the client&lt;/li&gt;
&lt;li&gt;Auth server returns an access token&lt;/li&gt;
&lt;li&gt;The client uses the access token to access the resource&lt;/li&gt;
&lt;/ol&gt;&lt;pre class=&quot;wp-block-preformatted&quot;&gt;
&lt;strong&gt;URL&lt;/strong&gt;: https://auth-server.com/token&lt;br/&gt;&lt;strong&gt;request params:&lt;/strong&gt;&lt;br/&gt;grant_type: client_credential&lt;br/&gt;client_id: 29352915982374239857&lt;br/&gt;client_secret: uf1ie98f2kda2vu25uye3k1h
&lt;/pre&gt;
&lt;p&gt;The response of API is the same as the access token.¬†&lt;/p&gt;
&lt;p&gt;Besides, the above grants there are other auth grants available too:&lt;/p&gt;
&lt;ul&gt;&lt;li&gt;&lt;strong&gt;Implicit&lt;/strong&gt;¬†‚Äì Implicit grant flow provides the token directly without the code step. This grant flow is not recommended for security reasons.&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;Password&lt;/strong&gt;¬†‚Äì This flow is used by the trusted first-party client only. In this flow, the username and password are directly provided to the client. The client can directly use it to access the token.&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;Device Code&lt;/strong&gt;&lt;/li&gt;
&lt;/ul&gt;&lt;p&gt;Oauth2 is a protocol that solves the deligation problem in a secure way. It is an industry-standard protocol. On top of the oauth2 is OpenID connect which helps in the authentication of a user. I will be writing about OpenID in my next blog.&lt;/p&gt;
&lt;ins class=&quot;adsbygoogle&quot; data-ad-client=&quot;ca-pub-4292778843837836&quot; data-ad-slot=&quot;3217464829&quot; data-ad-format=&quot;auto&quot; data-full-width-responsive=&quot;true&quot;/&gt; 
</description>
<pubDate>Mon, 02 Sep 2019 02:51:17 +0000</pubDate>
<dc:creator>milap</dc:creator>
<og:type>article</og:type>
<og:title>A complete guide to Oauth2 protocol | Milap Neupane Blog</og:title>
<og:description>Oauth2 protocol was designed as an industry pattern to solve the delegation problem. Oauth2 protocol provides a secure resource delegation between services</og:description>
<og:url>https://milapneupane.com.np/2019/09/02/a-complete-guide-to-oauth2-protocol/</og:url>
<og:image>https://milapneupane.com.np/wp-content/uploads/2019/08/cyber-security-1915628_1280-300x300.png</og:image>
<dc:language>en-US</dc:language>
<dc:format>text/html</dc:format>
<dc:identifier>https://milapneupane.com.np/2019/09/02/a-complete-guide-to-oauth2-protocol/</dc:identifier>
</item>
<item>
<title>The more you learn, the faster you can learn</title>
<link>http://pranay.gp/how-to-learn-things-at-1000x-the-speed</link>
<guid isPermaLink="true" >http://pranay.gp/how-to-learn-things-at-1000x-the-speed</guid>
<description>&lt;time datetime=&quot;2019-09-01&quot; class=&quot;article_time&quot;&gt;September 1, 2019&lt;/time&gt;&lt;p&gt;Throughout my schooling and career, I‚Äôve impressed people over and over again with how quickly I pick up things, especially &lt;strong&gt;hard&lt;/strong&gt; things. For instance, exactly 4y ago I did my first ever interview, got a &lt;a href=&quot;https://leetcode.com/problems/number-of-islands/&quot;&gt;simple question&lt;/a&gt; and failed miserably after spending 4h on it and finally asking the interviewer what ‚Äúrecursion‚Äù was. Since then I‚Äôve created core UI components at Facebook used by billions, worked on the language spec for GraphQL and Relay, ported an optimization made popular by Haskell to JS by writing an &lt;a href=&quot;https://www.youtube.com/watch?v=XvTsxa9i13o&quot;&gt;optimizing compiler&lt;/a&gt;, built &lt;a href=&quot;https://marketplace.visualstudio.com/items?itemName=pranaygp.vscode-css-peek&quot;&gt;an extension for VSCode&lt;/a&gt; that has half a million installs and has been listed on multiple &lt;a href=&quot;https://blog.bitsrc.io/top-10-vs-code-extensions-for-frontend-developers-in-2018-7992282db2ca&quot;&gt;top 10 articles&lt;/a&gt;, scaled a botnet of over 2,000 bots that made money from a popular trivia game, shipped to production an &lt;a href=&quot;https://youtu.be/yqACl3tRHNI?t=2370&quot;&gt;IPFS inspired decentralized file server&lt;/a&gt; and &lt;a href=&quot;https://zeit.co/blog/serverless-docker&quot;&gt;the fastest Serverless Docker runtime&lt;/a&gt;, &lt;em&gt;almost&lt;/em&gt; completed a design minor while successfully creating a brand that‚Äôs still recognized by every CS student at my alma mater, and finally &lt;a href=&quot;https://windsor.io&quot;&gt;started a company&lt;/a&gt; funded by &lt;a href=&quot;https://www.ycombinator.com/&quot;&gt;Y Combinator&lt;/a&gt; and &lt;a href=&quot;https://pioneer.app/blog/meet-the-pioneers/&quot;&gt;Pioneer&lt;/a&gt;.&lt;/p&gt;
&lt;p&gt;I built the right skillset for a generalist, which is highly regarded in Silicon Valley. However, I &lt;u&gt;think&lt;/u&gt; I‚Äôm actually really good at only one thing - learning. It‚Äôs the only skill with which I‚Äôve achieved the 10,000 hour rule. In this post I want to share what I‚Äôve learnt.&lt;/p&gt;
&lt;h2 id=&quot;the-system_2&quot;&gt;The System &lt;a class=&quot;head_anchor&quot; href=&quot;http://pranay.gp/how-to-learn-things-at-1000x-the-speed#the-system_2&quot;&gt;#&lt;/a&gt;&lt;/h2&gt;
&lt;p&gt;&lt;strong&gt;The more you learn, the faster you can learn.&lt;/strong&gt; Keep this in the back of your mind as you read the rest üëá&lt;/p&gt;
&lt;p&gt;In design, there‚Äôs a well known concept of affordances (see Don Norman‚Äôs ‚ÄúDesign of Everyday Things‚Äù). When &lt;strong&gt;someone&lt;/strong&gt; interacts with &lt;strong&gt;something&lt;/strong&gt;, the &lt;strong&gt;user&lt;/strong&gt; draws on all their past experiences to quickly learn how to use the &lt;strong&gt;thing&lt;/strong&gt;. Well designed things optimize for affordances that would be evident to a user. The canonical example of this from Don Norman‚Äôs book is the door - a vertical bar indicates pull, and a horizontal bar (or no bar) is push. You can learn to use a new door quickly.&lt;/p&gt;
&lt;p&gt;Let‚Äôs break down this system. A well designed object &lt;strong&gt;teaches&lt;/strong&gt; a user how to interact with it by drawing on their past experience. This means simply using something well designed actually teaches you how to learn other things. Conversely, a poorly design object doesn‚Äôt make proper use of the user‚Äôs past experience, and may actually hinder your rate of learning by teaching you the wrong thing (see &lt;a href=&quot;https://youtu.be/MFzDaBzBlL0&quot;&gt;The Backwards Brain Bicycle&lt;/a&gt;). Replace ‚Äúobject‚Äù above with ‚Äúlearning resource‚Äù (ex: blogs, videos, screencasts, podcasts, docs, etc. - any learning resource) and you‚Äôll see where I‚Äôm going with this.&lt;/p&gt;
&lt;p&gt;If you pick the best resource to learn something, you‚Äôll not only learn fast, you‚Äôll be able to cut through the crap on other resources and be able to learn even faster.&lt;/p&gt;
&lt;h3 id=&quot;the-process_3&quot;&gt;The Process &lt;a class=&quot;head_anchor&quot; href=&quot;http://pranay.gp/how-to-learn-things-at-1000x-the-speed#the-process_3&quot;&gt;#&lt;/a&gt;&lt;/h3&gt;
&lt;p&gt;&lt;a href=&quot;https://svbtleusercontent.com/vUpafhkp6Soii79Z5gQ1610xspap.jpg&quot;&gt;&lt;img src=&quot;https://svbtleusercontent.com/vUpafhkp6Soii79Z5gQ1610xspap_small.jpg&quot; alt=&quot;Find good resources. Ignore the rest&quot;/&gt;&lt;/a&gt;&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;Find the &lt;strong&gt;best&lt;/strong&gt; resource on something, usually you won‚Äôt be looking for it when you find it.&lt;/li&gt;
&lt;li&gt;Extract everything you can from it. This usually means you should try to implement its lessons immediately because you need to know what the complementary skills you‚Äôre missing are.&lt;/li&gt;
&lt;li&gt;Because you now know enough ‚Äúlingo‚Äù about the skill, you can easily find the &lt;strong&gt;best&lt;/strong&gt; resource for each complimentary skill. Here‚Äôs where you unlock real power, because you‚Äôve prematurely graduated past the ‚Äúbeginner‚Äù guides - and that‚Äôs a great thing.&lt;/li&gt;
&lt;li&gt;Stop. This is counter-intuitive, but unless you want to become a master at &lt;strong&gt;something&lt;/strong&gt; (besides learning), you really just want to know &lt;strong&gt;everything&lt;/strong&gt; at an intermediate level.&lt;/li&gt;
&lt;/ol&gt;&lt;p&gt;The steps above will get you to a good level of proficiency in one &lt;strong&gt;domain&lt;/strong&gt;. Usually when you start learning about a new domain, it‚Äôs because you know nearly nothing about it and your view is limited to what ‚Äúthe public‚Äù knows (which leads you to believe there isn‚Äôt much to this domain and it could be ‚Äúeasy‚Äù). The aim is always to learn just enough that you can have an interesting discussion with a domain expert and gain their respect while realizing you know nearly nothing compared to them (see the &lt;a href=&quot;https://pdfs.semanticscholar.org/e320/9ca64cbed9a441e55568797cbd3683cf7f8c.pdf&quot;&gt;original paper on the Dunning-Kruger effect&lt;/a&gt; but know that what I described has been liberally extrapolated from this paper).&lt;/p&gt;
&lt;p&gt;I discovered a hidden benefit here. If you know a lot about a domain, you‚Äôll be able to relate to that knowledge when diving into another domain. I‚Äôm not talking about a vague subconscious effect, but something you should consciously try to do - come up with analogies to the domains you already know about when learning something new. You can then explain this new domain to people proficient in other domains you‚Äôve learnt about (see &lt;a href=&quot;https://strategyumwelt.com/frameworks/feynman-technique&quot;&gt;The Feynman Technique&lt;/a&gt;).&lt;/p&gt;
&lt;p&gt;Schools often teach you a lot of things that aren‚Äôt obviously useful, especially in domains you couldn‚Äôt care less for - but this is the benefit in knowing everything.&lt;/p&gt;
&lt;p&gt;This is also why learning a bit about a lot of things helps you learn a new domain better &lt;u&gt;faster&lt;/u&gt; than just focussing on mastering a single domain.&lt;/p&gt;
&lt;p&gt;I left an important part out of the process above - how do you actually find the &lt;strong&gt;best&lt;/strong&gt; resource. I don‚Äôt know.&lt;/p&gt;
&lt;p&gt;That said, I‚Äôve gotten ‚Äúlucky‚Äù enough times that I think I know how to optimize for finding it.&lt;/p&gt;
&lt;h3 id=&quot;finding-the-best-resource_3&quot;&gt;Finding the best resource &lt;a class=&quot;head_anchor&quot; href=&quot;http://pranay.gp/how-to-learn-things-at-1000x-the-speed#finding-the-best-resource_3&quot;&gt;#&lt;/a&gt;&lt;/h3&gt;
&lt;ol&gt;&lt;li&gt;Figure out what resource &lt;strong&gt;type&lt;/strong&gt; works best for you - Video? Screencast? Books? Docs?. For me, videos get me interested in a topic, but jumping into a hard project in a new domain and clawing my way through documentation is the fastest way to get good. I can‚Äôt read long-form text, but audio books work.&lt;/li&gt;
&lt;li&gt;Keep exposing yourself to that type of content and ignore all else, unless there‚Äôs a widely considered ‚Äúgreat‚Äù resource for your domain in a form you dislike. An example for me was reading &lt;a href=&quot;http://learnyouahaskell.com/&quot;&gt;Learn You a Haskell&lt;/a&gt;.&lt;/li&gt;
&lt;li&gt;As you process the content, see if you can come up with analogies that help you understand it - if you can, and if what you come up with blows your mind, that‚Äôs a good sign.&lt;/li&gt;
&lt;li&gt;Follow the previous process, figure out what the complementary skills are, and repeat step 1.&lt;/li&gt;
&lt;/ol&gt;&lt;p&gt;The &lt;strong&gt;best&lt;/strong&gt; resource is a bit of a lie - it‚Äôs really just the one that‚Äôs &lt;em&gt;best for you&lt;/em&gt;, given your prior experiences and the medium you enjoy. You‚Äôll usually only know you found it in hindsight. For example&lt;/p&gt;
&lt;ol&gt;&lt;li&gt;&lt;a href=&quot;https://code.tutsplus.com/courses/30-days-to-learn-jquery&quot;&gt;This course&lt;/a&gt; by &lt;a href=&quot;https://twitter.com/jeffrey_way&quot;&gt;Jeffrey Way&lt;/a&gt; alone had the biggest impact on my career - it was my gateway into JavaScript (I‚Äôm one of those people who learnt jQuery first), then&lt;/li&gt;
&lt;li&gt;&lt;a href=&quot;https://egghead.io/courses/getting-started-with-redux&quot;&gt;This course&lt;/a&gt; by &lt;a href=&quot;https://twitter.com/dan_abramov&quot;&gt;Dan Abramov&lt;/a&gt; OR &lt;a href=&quot;https://www.youtube.com/watch?v=BMUiFMZr7vk&quot;&gt;this video&lt;/a&gt; by &lt;a href=&quot;https://twitter.com/mpjme&quot;&gt;mpj&lt;/a&gt; (I can‚Äôt decide) was my gateway into functional programming, and eventually&lt;/li&gt;
&lt;li&gt;Hacking on &lt;a href=&quot;https://github.com/relayjs/eslint-plugin-relay/commits?author=pranaygp&quot;&gt;eslint-plugin-relay&lt;/a&gt; as a side project while at Facebook was my gateway into compilers and language theory&lt;/li&gt;
&lt;/ol&gt;&lt;p&gt;Together, this chain of events got me to giving &lt;a href=&quot;https://www.youtube.com/watch?v=XvTsxa9i13o&quot;&gt;this talk&lt;/a&gt; less than a year later.&lt;/p&gt;
&lt;h3 id=&quot;more-thoughts_3&quot;&gt;More thoughts &lt;a class=&quot;head_anchor&quot; href=&quot;http://pranay.gp/how-to-learn-things-at-1000x-the-speed#more-thoughts_3&quot;&gt;#&lt;/a&gt;&lt;/h3&gt;
&lt;p&gt;There are a lot of things I haven‚Äôt learnt yet. I keep trying while following a &lt;a href=&quot;https://en.wikipedia.org/wiki/Breadth-first_search&quot;&gt;breadth-first-search&lt;/a&gt; approach to domains and resources as described above. Consequently, I‚Äôve failed at learning things. Sometimes I can‚Äôt find the best resource, but more often, I haven‚Äôt given a good resource an adequate amount of time.&lt;/p&gt;
&lt;p&gt;&lt;u&gt;Writing&lt;/u&gt; is a great example of something I‚Äôve constantly failed at (multiple attempts at the SAT and ACT proved this to me, and this piece might be evident of that fact). I may have found a good resource to help me with that, so I dove right in.&lt;/p&gt;


&lt;p&gt;744&lt;/p&gt;
&lt;p&gt;Kudos&lt;/p&gt;


&lt;p&gt;744&lt;/p&gt;
&lt;p&gt;Kudos&lt;/p&gt;
</description>
<pubDate>Mon, 02 Sep 2019 00:32:15 +0000</pubDate>
<dc:creator>pranaygp</dc:creator>
<og:url>http://pranay.gp/how-to-learn-things-at-1000x-the-speed</og:url>
<og:title>How to learn things at 1000x the speed ‚Ä¢ Pranay Prakash</og:title>
<og:type>article</og:type>
<og:description>Throughout my schooling and career, I‚Äôve impressed people over and over again with how quickly I pick up things, especially hard things. For instance, exactly 4y ago I did my first ever interview, got a simple question and failed miserably after... | Pranay Prakash | I care about tech and work on reference implementations for idealistic projects</og:description>
<og:image>https://svbtleusercontent.com/vUpafhkp6Soii79Z5gQ1610xspap.jpg</og:image>
<dc:language>en</dc:language>
<dc:format>text/html</dc:format>
<dc:identifier>http://pranay.gp/how-to-learn-things-at-1000x-the-speed</dc:identifier>
</item>
<item>
<title>Ways to Tweak Slow SQL Queries</title>
<link>http://www.helenanderson.co.nz/sql-query-tweaks/</link>
<guid isPermaLink="true" >http://www.helenanderson.co.nz/sql-query-tweaks/</guid>
<description>&lt;hr/&gt;&lt;p&gt;You‚Äôve gathered the requirements, checked out the tables, and you‚Äôre ready to push execute on the queries.&lt;/p&gt;
&lt;p&gt;The query runs.&lt;/p&gt;
&lt;p&gt;and runs.&lt;/p&gt;
&lt;p&gt;and runs‚Ä¶&lt;/p&gt;
&lt;p&gt;Before you rage quit or call in your DBA, check these things aren‚Äôt slowing things down. A few tweaks could be all you need to get things moving again.&lt;/p&gt;

&lt;hr/&gt;&lt;blockquote&gt;
&lt;p&gt;&lt;a href=&quot;http://www.helenanderson.co.nz/sql-query-tweaks/#chapter-1&quot;&gt;Timing is everything&lt;/a&gt;&lt;br/&gt;&lt;a href=&quot;http://www.helenanderson.co.nz/sql-query-tweaks/#chapter-2&quot;&gt;Locked out&lt;/a&gt;&lt;br/&gt;&lt;a href=&quot;http://www.helenanderson.co.nz/sql-query-tweaks/#chapter-3&quot;&gt;You don‚Äôt need ALL the things&lt;/a&gt;&lt;br/&gt;&lt;a href=&quot;http://www.helenanderson.co.nz/sql-query-tweaks/#chapter-4&quot;&gt;Uppers and Lowers&lt;/a&gt;&lt;br/&gt;&lt;a href=&quot;http://www.helenanderson.co.nz/sql-query-tweaks/#chapter-5&quot;&gt;Not, NOT IN&lt;/a&gt;&lt;br/&gt;&lt;a href=&quot;http://www.helenanderson.co.nz/sql-query-tweaks/#chapter-6&quot;&gt;To CTE or not to CTE?&lt;/a&gt;&lt;br/&gt;&lt;a href=&quot;http://www.helenanderson.co.nz/sql-query-tweaks/#chapter-7&quot;&gt;Wild, wild, wildcards&lt;/a&gt;&lt;br/&gt;&lt;a href=&quot;http://www.helenanderson.co.nz/sql-query-tweaks/#chapter-8&quot;&gt;Try a table&lt;/a&gt;&lt;br/&gt;&lt;a href=&quot;http://www.helenanderson.co.nz/sql-query-tweaks/#chapter-9&quot;&gt;Views on views on views&lt;/a&gt;&lt;br/&gt;&lt;a href=&quot;http://www.helenanderson.co.nz/sql-query-tweaks/#chapter-10&quot;&gt;Indexes&lt;/a&gt;&lt;/p&gt;
&lt;/blockquote&gt;
&lt;hr/&gt;&lt;p&gt;&lt;em&gt;This is written with PostgreSQL in mind but if you‚Äôre using something else, these may still help, give them a try.&lt;/em&gt;&lt;/p&gt;
&lt;hr/&gt;
&lt;h2&gt;Timing is everything&lt;/h2&gt;
&lt;p&gt;Before we go any further. How busy is the database? Are you running a complex query at a peak time when there are multiple users competing for memory?&lt;/p&gt;
&lt;h3&gt;Strategy:&lt;/h3&gt;
&lt;p&gt;You can do this by asking the database ‚Ä¶ not by shoulder tapping everyone in the company.&lt;/p&gt;
&lt;p&gt;&lt;em&gt;This may have been locked down by your friendly DBA so results may vary&lt;/em&gt;&lt;/p&gt;

&lt;div id=&quot;crayon-5d6dbb6c43ae7436252669&quot; class=&quot;crayon-syntax crayon-theme-eclipse crayon-font-monaco crayon-os-pc print-yes notranslate&quot; data-settings=&quot; minimize scroll-mouseover&quot;&gt;


&lt;div class=&quot;crayon-plain-wrap&quot;&gt;
&lt;textarea wrap=&quot;soft&quot; class=&quot;crayon-plain print-no&quot; data-settings=&quot;dblclick&quot; readonly=&quot;readonly&quot;&gt;
select *
from pg_stat_activity

/* This lists all queries currently running and idle. */

select
pid,
usename,
pg_blocking_pids(pid) as blocked_by,
query as blocked_query
from pg_stat_activity
where
cardinality(pg_blocking_pids(pid)) &amp;amp;gt; 0;

/* This lists queries causing locks. */
&lt;/textarea&gt;&lt;/div&gt;
&lt;div class=&quot;crayon-main&quot;&gt;
&lt;table class=&quot;crayon-table&quot;&gt;&lt;tr class=&quot;crayon-row&quot;&gt;&lt;td class=&quot;crayon-nums&quot; data-settings=&quot;show&quot;&gt;

&lt;/td&gt;
&lt;td class=&quot;crayon-code&quot;&gt;
&lt;div class=&quot;crayon-pre&quot;&gt;


&lt;div class=&quot;crayon-line&quot; id=&quot;crayon-5d6dbb6c43ae7436252669-3&quot;&gt;&lt;span class=&quot;crayon-k&quot;&gt;from&lt;/span&gt; &lt;span class=&quot;crayon-i&quot;&gt;pg_stat_activity&lt;/span&gt;&lt;/div&gt;

&lt;div class=&quot;crayon-line&quot; id=&quot;crayon-5d6dbb6c43ae7436252669-5&quot;&gt;&lt;span class=&quot;crayon-c&quot;&gt;/* This lists all queries currently running and idle. */&lt;/span&gt;&lt;/div&gt;




&lt;div class=&quot;crayon-line crayon-striped-line&quot; id=&quot;crayon-5d6dbb6c43ae7436252669-10&quot;&gt;&lt;span class=&quot;crayon-e&quot;&gt;pg_blocking_pids&lt;/span&gt;&lt;span class=&quot;crayon-sy&quot;&gt;(&lt;/span&gt;&lt;span class=&quot;crayon-i&quot;&gt;pid&lt;/span&gt;&lt;span class=&quot;crayon-sy&quot;&gt;)&lt;/span&gt; &lt;span class=&quot;crayon-k&quot;&gt;as&lt;/span&gt; &lt;span class=&quot;crayon-i&quot;&gt;blocked_by&lt;/span&gt;&lt;span class=&quot;crayon-sy&quot;&gt;,&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;crayon-line&quot; id=&quot;crayon-5d6dbb6c43ae7436252669-11&quot;&gt;&lt;span class=&quot;crayon-i&quot;&gt;query&lt;/span&gt; &lt;span class=&quot;crayon-k&quot;&gt;as&lt;/span&gt; &lt;span class=&quot;crayon-i&quot;&gt;blocked_query&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;crayon-line crayon-striped-line&quot; id=&quot;crayon-5d6dbb6c43ae7436252669-12&quot;&gt;&lt;span class=&quot;crayon-k&quot;&gt;from&lt;/span&gt; &lt;span class=&quot;crayon-i&quot;&gt;pg_stat_activity&lt;/span&gt;&lt;/div&gt;

&lt;div class=&quot;crayon-line crayon-striped-line&quot; id=&quot;crayon-5d6dbb6c43ae7436252669-14&quot;&gt;&lt;span class=&quot;crayon-e&quot;&gt;cardinality&lt;/span&gt;&lt;span class=&quot;crayon-sy&quot;&gt;(&lt;/span&gt;&lt;span class=&quot;crayon-e&quot;&gt;pg_blocking_pids&lt;/span&gt;&lt;span class=&quot;crayon-sy&quot;&gt;(&lt;/span&gt;&lt;span class=&quot;crayon-i&quot;&gt;pid&lt;/span&gt;&lt;span class=&quot;crayon-sy&quot;&gt;)&lt;/span&gt;&lt;span class=&quot;crayon-sy&quot;&gt;)&lt;/span&gt; &lt;span class=&quot;crayon-o&quot;&gt;&amp;amp;&lt;/span&gt;&lt;span class=&quot;crayon-i&quot;&gt;gt&lt;/span&gt;&lt;span class=&quot;crayon-sy&quot;&gt;;&lt;/span&gt; &lt;span class=&quot;crayon-cn&quot;&gt;0&lt;/span&gt;&lt;span class=&quot;crayon-sy&quot;&gt;;&lt;/span&gt;&lt;/div&gt;

&lt;div class=&quot;crayon-line crayon-striped-line&quot; id=&quot;crayon-5d6dbb6c43ae7436252669-16&quot;&gt;&lt;span class=&quot;crayon-c&quot;&gt;/* This lists queries causing locks. */&lt;/span&gt;&lt;/div&gt;

&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;/div&gt;

&lt;hr/&gt;
&lt;h2&gt;Locked out&lt;/h2&gt;
&lt;p&gt;Is the table being updated? If you‚Äôve crashed into a table that is being updated by an ETL process you may be blocking the update and won‚Äôt get far in running your query.&lt;/p&gt;
&lt;h3&gt;Strategy:&lt;/h3&gt;
&lt;p&gt;Have a chat with the team doing ETL and make sure you know when the update window is.&lt;/p&gt;
&lt;hr/&gt;
&lt;h2&gt;You don‚Äôt need ALL the things&lt;/h2&gt;
&lt;p&gt;If you‚Äôve got the all clear, then we can start pulling your query apart to see if there are any tweaks that could be made before using the query planner or the DBA.&lt;/p&gt;
&lt;p&gt;Starting at the top ‚Ä¶ Do you really need to SELECT * ?&lt;/p&gt;
&lt;h3&gt;Strategy:&lt;/h3&gt;
&lt;ul&gt;&lt;li&gt;If you are looking for an idea of what is in the table, try expanding the column list in the schema tree.&lt;/li&gt;
&lt;li&gt;Pull out the names of only the columns you need instead of using SELECT * to speed things up further.&lt;/li&gt;
&lt;li&gt;If you have an especially large table or wide table, the query engine is going to struggle to pull back absolutely everything into the client side. Unless you are going to ‚Äòeyeball‚Äô every row make sure you are using ‚ÄòLIMIT‚Äô to restrict the results.&lt;/li&gt;
&lt;li&gt;If you are looking for a COUNT, rather than running the query to spot the count of rows at the bottom of the screen, use a subquery that counts the rows for you.&lt;/li&gt;
&lt;/ul&gt;&lt;div id=&quot;crayon-5d6dbb6c43af0201204401&quot; class=&quot;crayon-syntax crayon-theme-eclipse crayon-font-monaco crayon-os-pc print-yes notranslate&quot; data-settings=&quot; minimize scroll-mouseover&quot;&gt;


&lt;div class=&quot;crayon-plain-wrap&quot;&gt;
&lt;textarea wrap=&quot;soft&quot; class=&quot;crayon-plain print-no&quot; data-settings=&quot;dblclick&quot; readonly=&quot;readonly&quot;&gt;
select count(*) from
(
    select
    userid
    from userschema.usertable
    where market = 'UK'
    and payingcustomer = 1 
) as derivedtable;
&lt;/textarea&gt;&lt;/div&gt;
&lt;div class=&quot;crayon-main&quot;&gt;
&lt;table class=&quot;crayon-table&quot;&gt;&lt;tr class=&quot;crayon-row&quot;&gt;&lt;td class=&quot;crayon-nums&quot; data-settings=&quot;show&quot;&gt;

&lt;/td&gt;
&lt;td class=&quot;crayon-code&quot;&gt;
&lt;div class=&quot;crayon-pre&quot;&gt;

&lt;div class=&quot;crayon-line crayon-striped-line&quot; id=&quot;crayon-5d6dbb6c43af0201204401-2&quot;&gt;&lt;span class=&quot;crayon-k&quot;&gt;select&lt;/span&gt; &lt;span class=&quot;crayon-e&quot;&gt;count&lt;/span&gt;&lt;span class=&quot;crayon-sy&quot;&gt;(&lt;/span&gt;&lt;span class=&quot;crayon-o&quot;&gt;*&lt;/span&gt;&lt;span class=&quot;crayon-sy&quot;&gt;)&lt;/span&gt; &lt;span class=&quot;crayon-k&quot;&gt;from&lt;/span&gt;&lt;/div&gt;

&lt;div class=&quot;crayon-line crayon-striped-line&quot; id=&quot;crayon-5d6dbb6c43af0201204401-4&quot;&gt;&lt;span class=&quot;crayon-h&quot;&gt;¬†¬†¬†¬†&lt;/span&gt;&lt;span class=&quot;crayon-k&quot;&gt;select&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;crayon-line&quot; id=&quot;crayon-5d6dbb6c43af0201204401-5&quot;&gt;&lt;span class=&quot;crayon-h&quot;&gt;¬†¬†¬†¬†&lt;/span&gt;&lt;span class=&quot;crayon-i&quot;&gt;userid&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;crayon-line crayon-striped-line&quot; id=&quot;crayon-5d6dbb6c43af0201204401-6&quot;&gt;&lt;span class=&quot;crayon-h&quot;&gt;¬†¬†¬†¬†&lt;/span&gt;&lt;span class=&quot;crayon-k&quot;&gt;from&lt;/span&gt; &lt;span class=&quot;crayon-i&quot;&gt;userschema&lt;/span&gt;&lt;span class=&quot;crayon-sy&quot;&gt;.&lt;/span&gt;&lt;span class=&quot;crayon-i&quot;&gt;usertable&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;crayon-line&quot; id=&quot;crayon-5d6dbb6c43af0201204401-7&quot;&gt;&lt;span class=&quot;crayon-h&quot;&gt;¬†¬†¬†¬†&lt;/span&gt;&lt;span class=&quot;crayon-k&quot;&gt;where&lt;/span&gt; &lt;span class=&quot;crayon-i&quot;&gt;market&lt;/span&gt; &lt;span class=&quot;crayon-o&quot;&gt;=&lt;/span&gt; &lt;span class=&quot;crayon-s&quot;&gt;'UK'&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;crayon-line crayon-striped-line&quot; id=&quot;crayon-5d6dbb6c43af0201204401-8&quot;&gt;&lt;span class=&quot;crayon-h&quot;&gt;¬†¬†¬†¬†&lt;/span&gt;&lt;span class=&quot;crayon-k&quot;&gt;and&lt;/span&gt; &lt;span class=&quot;crayon-i&quot;&gt;payingcustomer&lt;/span&gt; &lt;span class=&quot;crayon-o&quot;&gt;=&lt;/span&gt; &lt;span class=&quot;crayon-cn&quot;&gt;1&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;crayon-line&quot; id=&quot;crayon-5d6dbb6c43af0201204401-9&quot;&gt;&lt;span class=&quot;crayon-sy&quot;&gt;)&lt;/span&gt; &lt;span class=&quot;crayon-k&quot;&gt;as&lt;/span&gt; &lt;span class=&quot;crayon-i&quot;&gt;derivedtable&lt;/span&gt;&lt;span class=&quot;crayon-sy&quot;&gt;;&lt;/span&gt;&lt;/div&gt;

&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;hr/&gt;
&lt;h2&gt;Uppers and Lowers&lt;/h2&gt;
&lt;p&gt;PostgreSQL is case sensitive which can take some getting used to if you‚Äôve come from &lt;a href=&quot;http://www.helenanderson.co.nz/10-ways-to-make-the-most-of-ssms/&quot;&gt;SQL Server.&lt;/a&gt;&lt;/p&gt;
&lt;h3&gt;Strategy:&lt;/h3&gt;
&lt;ul&gt;&lt;li&gt;If you are ‚Äòlowering‚Äô or ‚Äòuppering‚Äô your data this is labour intensive. Only do it if it is absolutely required. Check out what your data looks like first before arbitrarily adding it to your query.&lt;/li&gt;
&lt;li&gt;If it is necessary on a join, use it on one side only or try using ILIKE for a case insensitive match.&lt;/li&gt;
&lt;/ul&gt;&lt;hr/&gt;
&lt;h2&gt;Not NOT IN&lt;/h2&gt;
&lt;p&gt;Try to avoid the use of ‚ÄòIN‚Äô or ‚ÄòNOT IN‚Äô. By doing this you are performing a full table scan as the query engine looks through every row to check if the condition is met.&lt;/p&gt;
&lt;h3&gt;Strategy:&lt;/h3&gt;
&lt;ul&gt;&lt;li&gt;Try to use ‚ÄòEXCEPT‚Äô or ‚ÄòNOT EXISTS‚Äô these have a significantly smaller impact on the query plan than ‚ÄòNOT IN‚Äô.&lt;/li&gt;
&lt;/ul&gt;&lt;hr/&gt;
&lt;h2&gt;To CTE or not to CTE&lt;/h2&gt;
&lt;p&gt;While CTEs are arguably &lt;a href=&quot;http://www.helenanderson.co.nz/sql-ctes/&quot;&gt;easier to read&lt;/a&gt; than subqueries, in PostgreSQL they are an ‚Äòoptimisation fence‚Äô, preventing the query optimiser from rewriting queries by moving constraints into or out of the CTE.&lt;/p&gt;
&lt;h3&gt;Strategy:&lt;/h3&gt;
&lt;ul&gt;&lt;li&gt;Both CTEs and subqueries are useful, and one or the other may perform better in a specific case. Consider the table size, the number of rows likely to be returned and the actions being performed in the CTE when writing it.&lt;/li&gt;
&lt;/ul&gt;&lt;hr/&gt;
&lt;h2&gt;Wild, wild, wildcards&lt;/h2&gt;
&lt;p&gt;Using wildcards at the start and end of a LIKE will slow queries down. And potentially give you more results than you intended.&lt;/p&gt;
&lt;h3&gt;Strategy:&lt;/h3&gt;
&lt;ul&gt;&lt;li&gt;Use the wildcard only where you need them, generally, this will only be required on one side so be conscious of what you are asking the query engine to do.&lt;/li&gt;
&lt;/ul&gt;&lt;div id=&quot;crayon-5d6dbb6c43af5159180485&quot; class=&quot;crayon-syntax crayon-theme-eclipse crayon-font-monaco crayon-os-pc print-yes notranslate&quot; data-settings=&quot; minimize scroll-mouseover&quot;&gt;


&lt;div class=&quot;crayon-plain-wrap&quot;&gt;
&lt;textarea wrap=&quot;soft&quot; class=&quot;crayon-plain print-no&quot; data-settings=&quot;dblclick&quot; readonly=&quot;readonly&quot;&gt;
select
    firstname, lastname, userid
    from userschema.usertable
    where lastname like 'anders%' 
       -- only on the end of the string

&lt;/textarea&gt;&lt;/div&gt;
&lt;div class=&quot;crayon-main&quot;&gt;
&lt;table class=&quot;crayon-table&quot;&gt;&lt;tr class=&quot;crayon-row&quot;&gt;&lt;td class=&quot;crayon-nums&quot; data-settings=&quot;show&quot;&gt;

&lt;/td&gt;
&lt;td class=&quot;crayon-code&quot;&gt;
&lt;div class=&quot;crayon-pre&quot;&gt;


&lt;div class=&quot;crayon-line&quot; id=&quot;crayon-5d6dbb6c43af5159180485-3&quot;&gt;&lt;span class=&quot;crayon-h&quot;&gt;¬†¬†&lt;/span&gt;&lt;span class=&quot;crayon-k&quot;&gt;select&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;crayon-line crayon-striped-line&quot; id=&quot;crayon-5d6dbb6c43af5159180485-4&quot;&gt;&lt;span class=&quot;crayon-h&quot;&gt;¬†¬†¬†¬†&lt;/span&gt;&lt;span class=&quot;crayon-i&quot;&gt;firstname&lt;/span&gt;&lt;span class=&quot;crayon-sy&quot;&gt;,&lt;/span&gt; &lt;span class=&quot;crayon-i&quot;&gt;lastname&lt;/span&gt;&lt;span class=&quot;crayon-sy&quot;&gt;,&lt;/span&gt; &lt;span class=&quot;crayon-i&quot;&gt;userid&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;crayon-line&quot; id=&quot;crayon-5d6dbb6c43af5159180485-5&quot;&gt;&lt;span class=&quot;crayon-h&quot;&gt;¬†¬†¬†¬†&lt;/span&gt;&lt;span class=&quot;crayon-k&quot;&gt;from&lt;/span&gt; &lt;span class=&quot;crayon-i&quot;&gt;userschema&lt;/span&gt;&lt;span class=&quot;crayon-sy&quot;&gt;.&lt;/span&gt;&lt;span class=&quot;crayon-i&quot;&gt;usertable&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;crayon-line crayon-striped-line&quot; id=&quot;crayon-5d6dbb6c43af5159180485-6&quot;&gt;&lt;span class=&quot;crayon-h&quot;&gt;¬†¬†¬†¬†&lt;/span&gt;&lt;span class=&quot;crayon-k&quot;&gt;where&lt;/span&gt; &lt;span class=&quot;crayon-i&quot;&gt;lastname&lt;/span&gt; &lt;span class=&quot;crayon-k&quot;&gt;like&lt;/span&gt; &lt;span class=&quot;crayon-s&quot;&gt;'anders%'&lt;/span&gt;&lt;/div&gt;
&lt;div class=&quot;crayon-line&quot; id=&quot;crayon-5d6dbb6c43af5159180485-7&quot;&gt;&lt;span class=&quot;crayon-h&quot;&gt;¬†¬†¬†¬†¬†¬†&lt;/span&gt; &lt;span class=&quot;crayon-c&quot;&gt;-- only on the end of the string&lt;/span&gt;&lt;/div&gt;


&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;hr/&gt;
&lt;h2&gt;Try a table&lt;/h2&gt;
&lt;p&gt;Running several nested queries as a Function is costly and could be quicker if you were to write into a table.&lt;/p&gt;
&lt;h3&gt;Strategy:&lt;/h3&gt;
&lt;ul&gt;&lt;li&gt;Consider creating &lt;a href=&quot;http://www.helenanderson.co.nz/relational-database-fundamentals/&quot;&gt;staging tables&lt;/a&gt; if there are a lot of steps to your process so you are joining to a smaller subset of data.&lt;/li&gt;
&lt;/ul&gt;&lt;hr/&gt;
&lt;h2&gt;Views on views on views&lt;/h2&gt;
&lt;p&gt;Views are queries that run when you access the view. If you are calling multiple views, or worse, views on views on views you are asking the query engine to run multiple queries to return your columns.&lt;/p&gt;
&lt;h3&gt;Strategy:&lt;/h3&gt;
&lt;ul&gt;&lt;li&gt;Write to a table if you need to take a snapshot each day/week/month rather than using views to filter.&lt;/li&gt;
&lt;li&gt;If you are using nested views consider if there is a more direct way to get to the columns you need by writing a query, instead of causing multiple queries to run to get to the required columns from the final nested view.&lt;/li&gt;
&lt;/ul&gt;&lt;hr/&gt;
&lt;h2&gt;Indexes&lt;/h2&gt;
&lt;p&gt;Indexes speed up your query by ordering the data so the database engine knows where to look, or giving it a lookup table so it can use that to know where to look. The type of index you use determines &lt;a href=&quot;http://www.helenanderson.co.nz/sql-indexes/&quot;&gt;which way the index works.&lt;/a&gt;&lt;/p&gt;
&lt;h3&gt;Strategy:&lt;/h3&gt;
&lt;ul&gt;&lt;li&gt;Apply indexes to columns you use often in your queries with high cardinality or rates of change.&lt;/li&gt;
&lt;li&gt;Take stock of your indexes to make sure you don‚Äôt have too many on a table.&lt;/li&gt;
&lt;/ul&gt;&lt;hr/&gt;&lt;p&gt;Hope these tips help with your query tweaking. Every database is different so as always when it comes to the best strategy for your query, it depends.&lt;/p&gt;
&lt;p&gt;What strategies do you use to tweak your slow SQL queries before you shoulder tap your DBA and use and interpret the Query Plan?&lt;/p&gt;

&lt;hr/&gt;&lt;p&gt;Photo by &lt;a href=&quot;https://www.pexels.com/photo/stainless-steel-wrench-220638/&quot;&gt;icon0.com&lt;/a&gt;¬†on Pexels&lt;/p&gt;

</description>
<pubDate>Sun, 01 Sep 2019 22:30:27 +0000</pubDate>
<dc:creator>helenanders26</dc:creator>
<og:type>article</og:type>
<og:title>10 Ways to Tweak Slow SQL Queries | Helen Anderson</og:title>
<og:description>Before you rage quit or call in your DBA, check these things aren't causing slow SQL queries. A few tweaks could be all you need.</og:description>
<og:url>http://www.helenanderson.co.nz/sql-query-tweaks/</og:url>
<og:image>http://www.helenanderson.co.nz/wp-content/uploads/2019/04/pexels-photo-220638.jpeg</og:image>
<dc:language>en-NZ</dc:language>
<dc:format>text/html</dc:format>
<dc:identifier>http://www.helenanderson.co.nz/sql-query-tweaks/</dc:identifier>
</item>
</channel>
</rss>